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ABSTRACT

DEVELOPMENT OF A MODEL FOR THE KINETICS
AND MECHANISM OF NITROGENASE

Phillip E. Wilson
Department of Chemistry and Biochemistry
Doctor of Philosophy

Nitrogenase has a central role in the global nitrogen cycle as the enzyme that
catalyzes the reduction of atmospheric N2 to NH3. Fixed nitrogen is generally limiting in
the environment and in agriculture, so nitrogenase has received much attention as an
alternative to nitrogen fertilizers. Characterizing the mechanism of nitrogenase is the
goal of this work. The molybdenum nitrogenase enzyme system is comprised of the
MoFe protein and the Fe protein. Interactions between these proteins and nucleotides are
crucial to catalysis. An important approach to characterize these interactions is to
correlate the kinetics of nitrogenase catalysis to a mechanism based on the properties of
the nitrogenase components. Ironically, the most successful kinetic model of nitrogenase
was devised by R. N. F. Thorneley and D. J. Lowe (T&L) before any crystal structures of
nitrogenase were solved. This work critiques the ability of the T&L model to predict

nitrogenase catalysis accurately. Several defects in the model are described, but it is
qualitatively correct. A literature review and critique leads to the rational design of a new
kinetic model of nitrogenase catalysis. Because of its comprehensive scope and superior
detail, this model has the potential to describe nitrogenase catalysis quantitatively.
However, the development of this model is an ambitious project only begun in this work,
step by step. Some of the areas of study include: an analysis of Fe protein reduction by
dithionite; the characterization of a form of Fe protein reduced to the all-ferrous
[4Fe-4S]0 state with a novel spin S = 0 state by the in vivo reductant flavodoxin; and a
novel account of salt effects that weaken the nitrogenase complex to increase the rate of
complex dissociation, the rate-limiting step in nitrogenase catalysis.
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• MVn– methyl viologen, with n indicating the level of reduction.
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Methods & Instrumentation
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• EPR– electron paramagnetic resonance
• NMR– nuclear magnetic resonance
• UV-vis– ultraviolet-visible
Other
• PDB– protein data bank
2. NITROGENASE
Organisms– abbreviations generally refer to a protein from a particular organism, with
the organism abbreviation first followed by the abbreviation for the protein itself. See
example in first entry.
• Av– Azotobacter vinelandii, e.g. “AvFld” is Fld protein from A. vinelandii.
• Cp– Clostridium pasteurianum.
• Kp– Klebsiella pneumoniae.
Models
• T&L– Thorneley & Lowe kinetic model for nitrogenase.
• W&W– Wilson & Watt kinetic model for nitrogenase.
Biological Nitrogen Fixation
• Gene Clusters
o nif– nitrogen fixation genes and/or gene products required for the
synthesis, structure, functionality, and regulation of molybdenum
nitrogenase, or nitrogenase 1; nif gene products are Nif proteins.
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•

•

•

o vnf– alternate but analogous to nif; encodes the set of proteins for
nitrogenase 2, or vanadium nitrogenase.
o anf– alternate but analogous to anf; encodes the set of gene products for
nitrogenase 3, or Fe-only nitrogenase.
Nitrogenase. Unless otherwise specified, Mo nitrogenase is discussed.
o Component 1– α2β2 structure (nifD, nifK) with each αβ dimer possessing
both a P-cluster and a FeMoco. Generally, component 1 of nitrogenase is
referred to as the MoFe protein. Some researchers call it dinitrogenase.
 Av1, Cp1, Kp1, etc.– MoFe protein from A. vinelandii, C.
pasteurianum, K. pneumoniae, etc.
 En– one half (αβ) of two independently functioning halves of
MoFe protein, reduced by n electrons beyond the DT-reduced
state. If the species origin is of interest, then this abbreviation
becomes AvE, CpE, KpE, etc.
 P-cluster– [8Fe-7S] cluster bridging the α and β subunits of each
αβ half of MoFe protein; an electron relay station between the
surface of MoFe protein and the more centrally located FeMoco.
 FeMoco– Fe-Mo cofactor [7Fe-9S-Mo-X-homocitrate] located in
the α subunit and the site of substrate reduction of nitrogenase.
Each αβ of MoFe protein has a single FeMoco.
o Component 2– γ2 structure (nifH) bridged by a [4Fe-4S] cluster and the
site of nucleotide binding. Generally, component 2 of nitrogenase is
referred to as the Fe protein. Some researchers call it dinitrogenase
reductase.
 Av2n– Fe protein Azotobacter vinelandii with n corresponding to
the level of reduction of the protein’s [4Fe-4S] cluster—an
analogous notation of En for MoFe protein. So Av20 is in an
oxidized [Fe4S4]2+ state; Av21 is in a reduced [Fe4S4]1+; and Av22 is
in an all-ferrous [Fe4S4]0 state.
 MgAXP– generic adenine nucleotide, where either MgADP or
MgATP would apply. Two MgAXP bind to Fe protein.
 Rn– analogous to Av2n and used when greater brevity is sought is
complex kinetic schemes.
• D– MgADP, e.g. R0D2 is oxidized Fe protein bound to two
MgADP.
• T– MgATP, e.g. R1T2 is reduced Fe protein bound to two
MgATP.
Flavodoxin– nifF gene product, FMN-containing flavoprotein and electron carrier
to Fe protein in many species.
o Fld– flavodoxin in an arbitrary oxidation state.
o FldOX– oxidized flavodoxin quinone
o FldSQ– radical singly reduced flavodoxin semiquinone.
o FldHQ– fully reduced flavodoxin hydroquinone.
Mechanistic Models
o T&L model– Thorneley-Lowe model of nitrogenase catalysis.
o W&W model– Wilson-Watt model of nitrogenase catalysis.
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Chapter 1
Introduction to Nitrogenase

1.1. Purpose
Diazotrophs are a diverse group of bacteria responsible for the biological
reduction of nitrogen to ammonia, accounting for the majority of ammonia available to
plants in the environment (1). All diazotrophs use the enzyme system nitrogenase to fix
nitrogen. The most dominant kinetic model for nitrogenase is the Thorneley-Lowe
(T&L) model, which was developed over the course of several publications (2-7).
Additions and changes were later made to the model by Thorneley and Lowe and
members of their research group (8, 9). I was initiated to the study of nitrogenase when I
analyzed the original T&L model and its later changes. This analysis was later published
(10). I determined that the T&L model was not quantitative, and I realized that there was
a need to develop a new model of nitrogenase catalysis that would be both
comprehensive in scope and quantitative in nature. The purpose of my work on
nitrogenase is to develop such a model.

1.2. Organization of this Work
There is a brief introduction to nitrogenase in the remainder of this chapter. In
Chapter 2, I introduce you to my analysis of the T&L model in its original form. In
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Chapter 3, this analysis extends to changes and additions that have been proposed for the
T&L model over the years. In Chapter 4, there is an extensive literature review on
nitrogenase in context of the first three chapters, exploring which details of nitrogenase
catalysis have been well accounted for by the T&L model, and which need to be
accounted for. My own Wilson & Watt (W&W) model will be proposed in the context of
this critical review. In the remaining chapters on nitrogenase (Chapters 5-7), I discuss
my efforts to characterize the details of my model. The appendices at the end of this
dissertation are a resource describing some of the numerical and programming
approaches I have used, and advances to the nitrogenase prep that I have developed.

1.3. Significance of Nitrogenase
Since uncovering problems with the T&L model, I have wondered why it does not
work very well. I have come across some startling answers to this question. First, the
T&L model has some incorrect assumptions, and second, it is too simplistic. Thorneley
and Lowe claimed theirs was a quantitative model. This claim was accepted for years by
many people in the nitrogenase community. However, after my analysis of the model
(10), it is clear that the T&L model is only qualitative. Now the model’s assumptions are
being challenged, leading to more scientific progress rather than stagnation.
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1.3.1. Characterizing Nitrogenase Behavior
The value of developing a replacement to the T&L model is to answer questions
about nitrogenase that have real kinetic relevance. Kinetics in turn assists us in
understanding the mechanism of nitrogenase action. A model that can predict accurately
nitrogenase behavior over a variety of experimental conditions serves as a springboard
for biochemists to understand how the structure of nitrogenase relates to its behavior.
When such a model fails, we analyze when and why it fails, conceding that we must not
have all the details figured out yet. Allowing for the possibility that a model can fail, we
continue the effort to uncover the secrets of nitrogenase activity.
So even in the worst-case scenario that my model is not completely satisfactory, it
will nevertheless be an advance over the T&L model and may help propel scientific
investigation towards a more complete understanding of nitrogenase.

1.3.2. Role of Nitrogenase in the Nitrogen Cycle
But why be concerned with nitrogenase research at all? Nitrogenase is one of the
most important enzymes in nature because of its role in processing atmospheric nitrogen
(11). Nitrogen is vital to life as a requisite component of DNA, protein, and a multitude
of other bio-molecules. Much nitrogen is relatively inert as N2(g), which makes up 78%
of the atmosphere. However, plants and animals cannot process this atmospheric
nitrogen. They are limited to processing nitrogen “fixed” into ammonia, nitrates, or
complex bio-molecules. Fixed nitrogen in the global nitrogen cycle (see Figure 1-1) is a
major limiting resource in global ecosystems and in agricultural production and human
population growth. Ironically, nitrogen’s abundance belies its practical availability.
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Figure 1-1. The global nitrogen cycle. This is an original composition incorporating
information from several textbook sources and ref (11).
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The global nitrogen cycle maintains the world’s pool of biologically active
nitrogen. Ultimately, all fixed nitrogen comes from atmospheric N2, which is either
oxidized to several nitrogen oxides in the atmosphere (e.g. N2O, NO, NO2, etc.) by
lightning and industrial combustion processes, or reduced to NH3/NH4+ by biological
nitrogen fixation and by industrial ammonia synthesis. Nitrogen oxides play an
important role in atmospheric chemistry. Some cause smog, exacerbate the greenhouse
effect, and/or deplete the ozone layer. Nitrogen oxides ultimately form into nitric acid
that falls to the ground in acid rain and ends up as nitrate in the soil.
However, the input of oxidized nitrogen from lightning and combustion are minor
compared to biological nitrogen fixation, which is the forte of a diverse group of
nitrogen-fixing bacteria, or diazotrophs, that express nitrogenase. The product of ATPdependent nitrogenase action is NH4+. Most organisms can use NH4+ directly to
synthesize biomolecules. In addition, bacterial consortia use NH4+ as an energy source in
the oxidative production of NO2– and NO3–. In particular, Nitrosomonas nitrifies NH4+ to
NO2–, and depends on Nitrobacter to process the NO2– further to NO3–.

Each organism

benefits from the other in this process. NO3– is then used by some anaerobic bacteria and
most plants as a nitrogen source.
Fixed nitrogen does not accumulate beyond a certain point in the environment
because denitrifying bacteria reduce NO3– to as far as N2 to produce ATP in a complex
electron transport process similar to oxidative phosphorylation. Hence, there is ongoing
turnover of nitrogen in the global nitrogen cycle, and fixed nitrogen is a major limiting
resource in the environment and in agriculture.
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1.3.3. The Haber-Bosch Synthesis
1.3.3.1. The Good of Nitrogen Fertilizers. Today the global population depends
extensively on nitrogen fertilizers derived from ammonia (e.g. NH4NO3, (NH4)2SO4, and
(NH2)2CO). Without fertilizers, there simply is not enough fixed nitrogen to maintain a
food supply for six billion people (12), even with the most advanced traditional farming
techniques. Rather, the intense agricultural practices of the modern era, without nitrogen
fertilizers, could provide for only about 3.2 billion people (13).
This nitrogen limitation was relieved in the early to mid 20th century by industrial
preparation of ammonia in the Haber-Bosch synthesis, involving the reaction:

N2(g) + 3 H2(g) ⎯
⎯→ 2 NH3(g).

(1-1)

Extreme conditions of temperature (400 oC) and pressure (200 atm), and the use of metal
catalysts are required to overcome the high activation energy of N2 and obtain a
commercially viable yield of ammonia. While the overall reaction under standard
o

conditions is thermodynamically favorable (the ΔGf for NH3(g) is –17 kJ/mol), it is not
kinetically practical.
Considering the global population today, the Haber-Bosch synthesis was among
the most significant advances in the 20th century. Not only could 20th-century farms
produce enough food for the growing population, but they could do it with less land.
Farmland was extensively reclaimed for reforestation and wilderness reclamation.

1.3.3.2. The Bad of Nitrogen Fertilizers. However, the Haber-Bosch synthesis
depends on another resource that is becoming more limited and costly: fossil fuels,
especially natural gas. Not only do fuels provide the appropriate conditions of high
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temperature and pressure for the Haber-Bosch synthesis, but they are also a source of
pure H2(g) for use in Equation 1-1. It is worrisome that at some point in the future, the
scarcity and cost of fossil fuels may limit how much ammonia can be synthesized
feasibly, and without an artificial input source of fixed nitrogen, it will take less than two
centuries for natural processes of denitrification to diminish the world’s nitrogen stores
until a level of fixed nitrogen equivalent with that of the early 20th century is reached
(13). Wherever possible, land will have to be converted to fields, reversing longstanding
conservation and habitat recovery projects (13), in an attempt to compensate for declining
agricultural productivity.
The ramifications of these problems are difficult to envision in detail, though
clearly there will be significant stress on the world’s populations competing for food
resources, even given current trends of declining global fertility rates. The world’s
human population is expected to stabilize at about 8.9 billion by 2050 (13), and most of
the population growth will come from poorer nations that are already the highest
consumers of nitrogen fertilizers. Their dependence on the Haber-Bosch synthesis will
only increase. If synthesized ammonia becomes scarce from lack of fuel stock, these
countries will suffer the most.
Concerns over a global nitrogen crisis could be mitigated by fossil fuel
conservation, but there does not seem to be a universal sense of urgency for preserving
this commodity. For instance, rates of natural gas consumption in homes are now
outstripping rates of discovering new natural gas resources. We may exhaust our natural
gas supply in 50 years (14, 15). Furthermore, other potential feedstocks—oil & gas—are
considered more rare than previously thought (16).

7

1.3.3.3. The Ugly of Nitrogen Fertilizers. It is possible that societies will practice
some restraint, postponing the inevitable exhaustion of fossil fuels. Alternative sources
of H2 for the Haber-Bosch process are rapidly becoming available. But while a global
nitrogen crisis may not be imminent, other problems with using nitrogen fertilizers need
to be addressed. Fertilizer application is not efficient—only about half of applied fixed
nitrogen is used by crops (13). The excess is lost to the environment, where fixed
nitrogen is generally the limiting nutrient. Newfound access to fixed nitrogen favors
species that can use nitrogen quickly and efficiently, at the expense of nitrogen-fixing
species and species that are adapted to low-nitrogen environments (17). This is not just a
matter of diminishing plant diversity in an insidious way, but can also have more
immediate and disastrous consequences, such as eutrophication. In this process, NH4+ is
processed by ubiquitous nitrifying bacteria to NO3–. Whereas NH4+ sticks to clay
colloids and organic soil matter, NO3– washes away in a process called “leaching” (see
Figure 1-1), collecting in ponds, lakes, and streams. With this newfound nitrogen source
algae proliferate rapidly, consuming all the dissolved oxygen in the process. With anoxic
waters, aerobic life is killed off. Episodes of eutrophication in the 1960s and 1970s
brought the issue of nitrogen excess to the forefront of public thought. Eutrophication
continues into the present, becoming more and more frequent, though news coverage has
waned (18).
Additionally, NO3– collects in groundwater, and eventually in drinking water.
This can pose a serious health risk if not monitored closely. An excess of NO3– is
converted to NO2– in the gut. NO2– in turn can be absorbed into the blood stream where
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it binds to hemoglobin to reduce oxygen binding capacity, leading to respiratory distress
in infants (e.g. “blue baby syndrome”). Alternatively, NO2– reacts with amino
compounds in the gut to produce carcinogenic nitrosamines.
The use of nitrogen fertilizers is to blame for these environmental problems.
Biological nitrogen fixation is much more controlled physiologically so that a large
excess of NH4+ does not built up. Unfortunately, we are dependent on nitrogen fertilizers
at present. If we stopped their use, more serious consequences would result. There is the
potential for widespread famine, loss of human life, and destruction of wildlife habitats to
grow more food. The dilemma of artificially fixed nitrogen is that we are dependent
upon it, but we must try to mitigate the negative consequences of its use.

1.3.4. Alternatives to Nitrogen Fertilizers
Hopefully, science and society will develop widespread alternative sources of
fixed nitrogen to prevent a global nitrogen crisis in the future, and to alleviate current
detrimental environmental impacts of fertilizer use.

1.3.4.1. Synthetic Ammonia Production. There have been improvements in the
synthetic production of ammonia towards more ambient temperature and pressure (1922). Of note, a nonmetal system for nitrogen fixation was recently devised from a
buckminsterfullerene caged in two cyclodextrin molecules (19). This system is run at 60
o

C under an atmosphere of nitrogen and under visible light to give a yield of ammonia

approaching that of nitrogenase. The reaction time is still very long, so industrial
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implementation of this system is not yet practical. Other systems are also beginning to
approach the efficiency of nitrogenase but are also not yet practical for various reasons.

1.3.4.2. Biological Nitrogen Fixation. A concerted effort has been underway for
some decades now to understand biological nitrogen fixation and apply it to the cereal
crops. This effort was fruitless for many years, and so interest in this approach waned. A
recent discovery may reverse all the pessimism—nitrogen fixation has now been
established in wheat (23).

1.3.4.3. Glutamine Synthetase. Another option is to increase the efficiency of
food crops to uptake ammonia so it is not lost to contaminate the environment. Success
is seen in over-expressing glutamine synthetase (13). This is the most important and
ubiquitous enzyme for NH4+ assimilation by converting glutamate and NH4+ into
glutamine:

+
NH3
–

OOC—CH2—CH2—CH—COO–
L-Glutamate

ATP
glutamine
synthetase

ADP
NH4+
Pi

O

+
NH3
C—CH2—CH2—CH—COO–
L-Glutamine

H2N
10

1.4. Biological Nitrogen Fixation
Biological nitrogen fixation accounts for about 69% of all fixed nitrogen annually
(from agricultural and non-agricultural land, and oceans) (24). Non-biological nitrogen
fixation includes lightning strikes (4%), combustion of fossil fuels (8%), and industrial
Haber-Bosch synthesis (20%). As the dominant input of fixed nitrogen, biological
nitrogen fixation is the topic of intense research.

1.4.1. Diazotrophs
Only a relatively small number of prokaryotes and archaea are capable of fixing
nitrogen. These organisms, known collectively as diazotrophs, are widespread in nature.
They can be free-living in terrestrial environments (25), in our oceans (26-29), and in
environmental extremes from the arctic (30-32) to deserts (33), salt marshes (34), and
deep-sea hydrothermal vents (35-37).
More importantly, some diazotrophs form symbiotic relationships with other
organisms. The cyanobacteria in lichens fix nitrogen, and so lichens are good pioneer
species in nitrogen-poor environments. Surprisingly, some diazotrophs live in the guts of
insects (38-40) and simple marine animals (41, 42), supplying these organisms with fixed
nitrogen to satisfy the higher protein requirements of animals compared to the vegetation
in their diets. It is more well-known that certain diazotrophs live within or around plant
tissues. This association can be very loose in certain cases, such as diazotrophs living in
or around grass tissues (43-45), the leaflets of certain ferns, and in the roots, stems, and
leaves of sugar cane (13).
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a

b

Figure 1-2. Symbiotic root nodules. (a)
Macroscopic view of nodules. (b)
Microscopic view of diazotrophic bacteria
(green) invading a specialized plant cell in
a nodule (yellow). Other plant cells
produce leghemoglobin (red) to scavenge
oxygen. Leghemoglobin gives nodules
their pinkish color macroscopically (a).
Pictures were taken from an expired
website for a biochemistry class taught by
Dr. Don P. Bourque.

The diazotroph-plant association is much more complex within the roots of
leguminous plants (e.g. beans, peas, etc. housing Rhizobium bacterial species) and select
woody plants (e.g. alder and sea buckthorn housing Frankia bacterial species). These
plants have evolved nodules on their roots (see Figure 1-2a) that are the ideal habitat for
the appropriate symbiotic bacteria. Bacterial nitrogenase is a very oxygen-sensitive
enzyme, so plant nodules express the oxygen-binding protein leghemoglobin (see Figure
1-2b). The plant also satisfies the bacteria’s energy and nutrient needs. The diazotrophlegume symbiosis is highly productive in adding fixed nitrogen to the soil for other plants
and organisms.
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1.4.2. Solving the Nitrogen Crisis
Unfortunately, legumes are not suitable for large-scale consumption as are the
cereal crops, none of which normally enjoys symbiosis with diazotrophs. Rather, there is
only a loose association of diazotrophs with the roots and tissues of certain crops such as
rice (46). A diverse crop field with different plant species that interact better with
diazotrophs can help to alleviate nitrogen limitation in rice fields (47), but fixed nitrogen
is still limiting.
All diazotrophs have one thing in common—they all express the metalloenzyme
system nitrogenase which is responsible for biological nitrogen fixation. An ideal
solution to the nitrogen crisis would be to capacitate cereal crops with biological nitrogen
fixation (12). This solution could be achieved by direct introduction of nitrogenase and
associated genes into plants, or introduction of genes required for symbiosis with
diazotrophs. Not only would this solve the problems of nitrogen shortage in agriculture,
but it would keep excess fixed nitrogen from contributing to the global extinction of
species adapted to nitrogen-limited environments.
Much of the optimism regarding this approach has waned with lack of progress
towards a practical solution (48). Still, in an age of proteomics and bioinformatics,
scientists are coming to terms with the level of complexity of biological systems. Indeed,
even the interactions between host plant and guest diazotrophs are very complex (49-52),
as are the genetic and physiological control of nitrogenase expressed within diazotrophs
(53-61). Our level of understanding may be very limited compared with what we need to
know before successful genetic engineering of cereal crops for biological nitrogen
fixation proves successful.
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1.4.2.1. A Recent Breakthrough. Iniguez et al have successfully inoculated a
particular strain of wheat with a strain of the diazotroph Klebsiella pneumoniae (23).
Now the major food crop in the world is about to be taken off dependence on nitrogen
fertilizers. There is much optimism that ongoing efforts to expand the repertoire of
symbiotic food crops and crop strains will be successful in the future.

1.4.2.2. Nitrogenase Research. The success of inoculating wheat with a
diazotroph reinvigorates efforts to understand nitrogenase function. Now the vision of
the research goes beyond simply having major food crops independent of nitrogen
fertilizers. It is relevant to consider how protein and genetic engineering may produce
more efficient diazotroph-food crop symbiosis and nitrogenase action. To this end,
understanding the nitrogenase mechanism gains a very high level of immediacy.
Much progress has been made towards characterizing nitrogenase and its metal
cofactors, and understanding the nitrogenase mechanism from the action of model
synthetic compounds and from theoretical studies. However, many of the details of
substrate reduction and enzyme function are speculative since intermediates in
nitrogenase catalysis are very difficult to characterize. For this reason, kinetic studies
have been key to uncovering the secrets of nitrogenase catalysis and relevance of
potential intermediates in catalysis (7). The importance of modeling kinetics, which is
the ultimate goal in this work, is therefore put into context.
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1.5. Nitrogenase
There are four families of nitrogenase. A recently discovered nitrogenase family
(36) from Streptomyces thermoautotrophicus contains a CO-dehydrogenase component
that catalyzes electron transfer from CO to O2 to make O2– superoxide, which transfers an
electron to the MoFeS active site of a dinitrogenase component where N2 is reduced.
Interestingly, this nitrogenase is not inactivated by oxygen and is also more efficient with
ATP consumption than the other families of nitrogenase. Unfortunately, it also requires
high temperatures to function.
The other three families of nitrogenase also have two components. They are
much more widespread in nature and operate under mild conditions. Component 1, or
dinitrogenase, has α2β2 structure with each αβ dimer possessing both an [8Fe-7S] cluster
(P-cluster) and an Fe-M cofactor [7Fe-9S-M-X-homocitrate]. The identity of the metal,
M, determines the family of nitrogenase (M = Mo, V, Fe). X is a recently discovered
interstitial ligand, probably N3–. Mo nitrogenase is the best studied family of
nitrogenases since its expression is favored over V and Fe nitrogenases because of its
higher efficiency at reducing N2 instead of H+ in the overall reaction:
N ase
N2 + 8 H+ + 8 e– + 16 ATP ⎯⎯
⎯→ 2 NH3 + H2 + 16 ADP + 16 Pi.
2

(1-2)

This reaction contrasts with the reaction in the Haber-Bosch synthesis (Equation 1-1) in
several respects. Most notably, nitrogenase reduces N2 at ambient temperature and
pressure. Still, the reaction is very expensive in terms of energy consumption and
reducing equivalents. Therefore, the penalty for a plant to supply energy as a host to
diazotrophs is very large.
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2 MgADPAlF4–

Av2
Fe
protein

[4Fe-4S]
–

e transfer

P-cluster
FeMoco

E
NH3

N2

Av1
MoFe
protein

Av2

Figure 1-3. Structure and function of the nitrogenase complex. From PDB (62)
structure 1M34 (63) rendered in PyMol (64). Av1, or MoFe protein from Azotobacter
vinelandii has α2β2 structure, with two, essentially independently operating halves, E,
each of which is capable of binding Fe protein, or Av2. In the protein structure, metal
clusters and nucleotides are shown in orange. These are again shown in the cutaway at
the right, this time with coloring corresponding to the color of the protein subunit they
can be found in at left. The [4Fe-4S] cluster of Av2 and the P-cluster of Av1 are located
at the interface of two protein subunits, and so retain their orange color in the cutaway.
The general electron pathway from Av2 to the P-cluster and then the FeMoco of Av1 is
shown. Nitrogenase catalysis culminates with N2 reduction to NH3 at the FeMoco.
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The nitrogenase complex is shown in Figure 1-3. Component 1 of Mo
nitrogenase is called MoFe protein and contains the site of substrate reduction. The
convention is to name component 1 according to which organism it comes from. Thus
MoFe protein from Azotobacter vinelandii is called Av1. Component 1 is also sometimes
referred to as dinitrogenase.
Component 2 (e.g. Av2) is also called dinitrogenase reductase or Fe protein. Fe
protein is the site of MgATP binding and contains a redox-active [4Fe-4S] cluster that is
reduced by either flavodoxin and/or ferredoxin in vivo, or a strong reducing agent (low
negative reduction potential) in vitro. The reduced Fe protein bound to two MgATP can
form the nitrogenase complex with MoFe protein. Complex formation greatly alters the
Fe protein conformation, which leads to hydrolysis of the two ATP bound and electron
transfer from the [4Fe-4S] cluster Fe protein to the P-cluster of MoFe protein and
ultimately to the FeMoco (see Figure 1-3).
In the nitrogenase complex, Fe protein cannot be reduced sequentially for
productive catalysis, but with MgADP bound, Fe protein assumes a different
conformation that can dissociate much more readily from the MoFe protein. Free of the
complex, Fe protein is reduced. Reduction alters its affinity for nucleotides, promoting
MgADP dissociation and its replacement with MgATP. Fe protein then can bind MoFe
protein again in the catalytic cycle. This sequence of events continues, with electrons
accumulating on the FeMoco where substrates are reduced. Thorneley and Lowe first
outlined the kinetic description of this process. Their views are reviewed and critiqued in
the next chapter, which addresses my efforts to duplicate their model (10).
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Chapter 2
Duplication of the Thorneley-Lowe Kinetic Model
of Nitrogenase Catalysis

This chapter is based on a portion of a manuscript authored by myself, A. C.
Nyborg and G. D. Watt and published in Biophysical Chemistry (10), but most of this
chapter is newer, unpublished work that greatly expands upon the earlier work.

In the early 1980s, the nitrogenase research effort was progressing well, but there
was still much controversy about the details of the mechanism of catalysis and the
physical properties of the individual component proteins. Work with mutant or
genetically engineered nitrogenase had begun, but had not yet yielded many insights.
The x-ray crystal structures for the nitrogenase component proteins and the proteinprotein complex were still over a decade away from being solved. By today’s standards,
it was a time of uncertainty and unawareness. It is remarkable that the most dominant
view of nitrogenase catalysis today was developed during this period by R. N. F.
Thorneley and D. J. Lowe.
The Thorneley-Lowe (T&L) model was comprised of kinetic schemes and
computer simulator used to fit both pre-steady-state and steady-state kinetic data for H+
and N2 reduction by nitrogenase. The model in its original form was developed over the
course of several studies (2-7). Even this preliminary model is impressive in its scope,
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sound logic and wide applicability. Yet its complexity has made its application to the
field of nitrogenase research somewhat limited. Historically, the authors have not shared
their computer program with others in the field, insisting instead that other research
groups send in their data to be fit to the model. More recently, Thorneley and Lowe have
consented to share their program with other groups, including myself, but Lowe has told
me that the code is “not at all user-friendly.” Having seen the code, I can attest that this
is the case.
By the time Lowe sent me his code, I had already begun the task of duplicating
his model in the Mathematica software platform (65) using his published kinetic schemes
and assumptions. Our correspondence by email continued for some time, and Lowe
clarified some of the finer points of the model one needs to know in order to encode its
assumptions into a strictly mathematical framework. Lowe was, for the most part, very
helpful. However, the last email I sent him detailed some discrepancies between my
simulations and his published simulations that I had digitized using UN-SCAN-IT
software (66). I sent him my computer program and asked him if he had any further
insights about what could cause the discrepancies. He has not responded since that time.
Meanwhile, I have performed consistency checks on my program. These efforts
convinced me that my program is bug-free. However, I discovered that I implemented
my program incorrectly in my own publication (10). The essence of this publication is
correct, but one detail is not. This error has been corrected for the analysis in this
chapter.
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The value of the study in this chapter can be gauged in several respects:
•

The issue of applicability of the T&L model has been solved. Since Lowe’s
computer program is unavailable and/or not user-friendly, the only recourse for
research groups wanting to apply the model to their data is to defer to the authors
of the model, or to write their own computer program. Not only have I taken the
latter route, but I have also made my program available to the scientific
community as supplementary material to my published manuscript (10).

•

In duplicating the original model, I gained an intimate understanding of its
assumptions because they must be characterized quantitatively in the
mathematical framework of my computer program. These assumptions are
summarized in this work for ready reference.

•

My analysis in this chapter suggests that the model does not fit the data as
perfectly as Thorneley and Lowe indicate in their publications. Rather, it seems
that the model is sometimes misapplied and inadequate to explain all the data.

•

Some discussion points and conclusions in the T&L publications are made
without strict testing by the model. I have tested some of these and discuss which
of these conclusions are correct and which are not.

•

The correct aspects of the model are reaffirmed, and should be included in
subsequent kinetic studies.
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2.1. Assumptions and Overview of the T&L Model
In order to duplicate the T&L model in its mathematical form for a computer
simulation, I found it necessary to understand unambiguously all of its assumptions. At
times, however, the specific details of the T&L model are not clearly stated in the
literature. I was fortunate to have an ongoing correspondence with Lowe about such
vague points, and I hope that my compilation of the assumptions of the T&L model is an
accurate reflection of the intentions of the original authors.
These assumptions are summarized in Table 2-1 and organized into broad
categories for greater clarity. Scheme 2-1 is a kinetic scheme for the Fe protein cycle,
and should be viewed in conjunction with the assumptions of the Fe protein cycle
outlined in Table 2-1. Similarly Scheme 2-2 describes most of the mathematics behind
the MoFe protein cycle, and should be considered alongside the corresponding category
in Table 2-1. Table 2-2 lists the rate constants used for Schemes 2-1 and 2-2.

2.1.1. Protein Activities
Thorneley and Lowe are meticulous about correcting for active vs. inactive
protein so that their simulations match their experimental reaction stoichiometry. The
nitrogenase enzyme system can be particularly susceptible to inactivity because both the
Fe and MoFe proteins are very oxygen-sensitive (59, 67-74). Additionally nitrogenase
proteins require post-translational insertion of metal cofactors for activity (7).
Incomplete insertion leads to the formation of inactive apoprotein. Natural enzyme
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Table 2-1. Fundamental assumptions of the T&L model.
Specifics

Category
Protein Activity

• Only Kp nitrogenase is modeled by the T&L model. It may be shown that
Schemes 2-1 and 2-2 describe nitrogenase from other organisms, though with
different rate constants.
• Only irreversible effects of protein inactivation are taken into account, not
reversible effects from such sources as salt and CO.
• Kp1†, KpE, or simply E, refers to independently operating MoFe protein active
sites, taken from the Mo content of a Kp1 solution. The Kp1 used by Thorneley
mol Mo
[Kp1].
and Lowe has 1.4 ± 0.1 atom Mo per molecule Kp1 (3), so [KpE] = mol
Kp1

• Inactive KpE (about 30% of the total Kp1) does not interact with Kp2.
• Inactive Kp2 competes with active Kp2 for KpE, binding with the rate constants k3
and k–3.
• Kp2 used by Thorneley and Lowe is 45% active.
• [KpE] and [Kp2] are each allowed to vary ±10% in silico, to allow for fair
comparison to experimental data with its accompanying error (3, 7).
Reductant Source
• Dithionite (DT) is modeled as the reductant source to Kp2.
○ Kp2 functions only in the [Fe4S4]2+/[Fe4S4]1+ redox couple with DT as
reductant.
○ The actual reductant of DT solutions is the SO2- radical, so the Kobs of
reducing Kp2 is proportional to the square root of DT concentration.
• The reduction of Kp20(MgADP)2 is the only significant DT-Kp2 interaction.
• Nucleotide exchange following reduction is rapid compared to k4.
○ [ATP] is far in excess compared to [ADP].
○ The rate constants k5 and k–5 (binding of Kp21(MgADP)2 to KpE) are not
relevant to catalysis.
Fe Protein Cycle
• All explicit assumptions of Scheme 2-1, a modified version of schemes from refs
(2, 3, 7).
○ Of particular note, the k–3 pathway is irreversible for the transition of En+e to
En+1.
○ The k–3 pathway is rate-limiting in catalysis, except under conditions of very
low protein concentration, in which case the k1 pathway is rate limiting.
• Only free Kp2 (not bound to Kp1) is capable of being reduced.
• Kp2(MgATP)2 is the only known reductant of Kp1.
• One completion of the Fe protein cycle accounts for the transfer of a single
electron to KpE.
MoFe Protein Cycle • All explicit assumptions of Scheme 2-2, a modified scheme from separate schemes
from refs (3-5, 7). Straight dashed arrows represent a single Fe protein cycle.
○ Of particular note, E4N2H2 derived only from E4H4 is allowed to back-react
with H2 to form E4H4 in the k–11 pathway.
• The rate constants of the Fe protein cycle are assumed to be independent of the
level of reduction of KpE.
• Only free KpE is capable of binding substrate and releasing product.
• Henry’s Law determines the concentration of aqueous gas substrates.
• Quench releases a single H2 from all E2H2 and E3H3 species, and two H2 from
E4H4. N2H4 is released from E4N2H2 species upon quenching. Two NH3
equivalents are released from E5 and E6, and E7 releases one NH3 upon quenching.
• Natural NH3 release is from E6 and E7.
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En
k1

Kp21(MgATP)2

En Kp21(MgATP)2

k–1
2 MgADP
rapid

k2

2 MgATP

2 Pi

Kp21(MgADP)2
k4
Kp20(MgADP)2
k–3

k–3

Ej

En+e Kp20(MgADP)2

En+1

k3
Ej Kp20(MgADP)2
Scheme 2-1. The Fe protein cycle. Adapted from refs (2, 3, 7).
degradation (75) and destruction at high temperatures (above about 60 oC) can also
irreversibly inactivate nitrogenase proteins.
Certain inhibitors reversibly inhibit protein activity. One category of reversible
inhibitors act by binding at the FeMoco of MoFe protein (76-79). For example, CO binds
FeMoco and directs all electron flux to H+ reduction—effectively negating C2H2 and N2
reduction (8, 77, 80-89), or even inhibiting electron flux altogether in certain mutants (90,
91). Salt inhibition of Fe-MoFe protein complex formation is another type of reversible
inhibition (92, 93).
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Scheme 2-2. The MoFe protein cycle. Adapted from refs (3, 7).
While there are a number of effects contributing to enzyme inactivity,
corresponding to a variety of types of protein inactivation, it is simplest to consider
overall effects of inactive proteins that apply to all cases. Specifically, only irreversible
inactivation is accounted for in the T&L model. Apo Kp1 is assumed not to interact with
Kp2 at all (7). The empirical evidence behind this assumption is that the maximum
specific activity of Kp1 is proportional to the Mo content. Oxygen-inactivated Kp1 is not
directly addressed by the T&L model. This omission may not be a serious oversight
since general oxidation by ferricyanide has been shown to lead to loss of FeMoco from
Cp1 (94). Oxygen-inactivated Kp1 may also end up as apo Kp1, though this has not been
tested. In particular, what if inactivation of the P-clusters of Kp1 occurs without
affecting the FeMoco?
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Table 2-2. Rate constants for Schemes 2-1 and 2-2. Measured for Kp nitrogenase at
23 oC and pH 7.4 (3, 7).
Rate
Constant
k1
k–1
k2
k3
k–3
k4
k5
k–5
k6
k–6
k7
k8
k9
k10
k–10
k11
k–11

Value
7

5 X 10 / M s
15/ s
200/ s
4.4 X 106/ M s
6.4/ s
3.0 X 106/ M s
4.4 X 106/ M s
6.4/ s
1.2 X 109/ M s
1.75/ s
250/ s
8.0/ s
400/ s
4 X 105/ M s
8 X 104/ M s
2.2 X 106/ M s
3 X 106/ M s

}

Comment
Determined from stopped-flow studies
Determined from the dilution effect
Determined by difference in ε for Kp21 and Kp20
Responsible for inhibition at high [Kp1]
Rate limiting step in catalysis
Reduction by SO2– and nucleotide exchange
Used when MgATP but not reductants is limiting
—not in any of the simulations of the present work

k⎯
−6
⎯⎯⎯
⎯
→ 2 SO2–
S2O42– ←
k6

Subject to errors of a factor of about two
–

Determined from Km of N2 at low e flux
–
Determined from Ki of H2 at low e flux
–
Determined from Km of N2 at high e flux
–
Determined from Ki of H2 at high e flux

With one FeMoco per active site, the Mo content of Kp1 is taken as a measure of
active sites, a value twice the molar protein concentration for fully active MoFe protein.
The whole MoFe protein is distinguished from individual active sites by the notation
difference Kp1 vs. Kp1†, and the latter also represents Mo content, and not molar MoFe
protein concentration.
This notation was confusing to me since the symbol “†” is often used to denote a
footnote. Consequently, I did not understand that there was a difference between “Kp1”
and “Kp1†” upon publishing my duplication of the T&L model (10), so corrections were
necessary for the fully redone analysis in this chapter. To help future researchers avoid
any confusion in the matter, I have adopted a different notation for an active site of MoFe
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protein. That is, “E” is used to refer to the enzyme Kp1† in the MoFe protein cycle (see
Schemes 2-1 and 2-2), so I will call “Kp1†” by “KpE” in the future.
Both active and inactive forms of Kp2 possess a [4Fe-4S] cluster. Active Kp2
uses the [Fe4S4]2+/[Fe4S4]1+ redox couple. Inactive Kp2 (Kp2i) is assumed to compete
with active Kp2 for Kp1, binding with the same affinity as Kp20(MgADP)2 (2, 7). The
T&L model assigns active Kp2 a specific activity of 3500 nmol C2H4 min–1 mg–1 at 30
o

C, consistent with 45% active protein, an assignment that was necessary for Thorneley

and Lowe to simulate pre-steady state progress curves for H2, N2H4 and NH3 product
formation (7). The remaining 55% Kp2i is assumed to compete with the active Kp2 for
Kp1.

2.1.2. Direction of Electron Flux
The overall kinetics of nitrogenase catalysis proposed in the T&L model requires
three interdependent sets of redox reactions involving interactions of different types of
electron carriers and the directional flux of electrons from one type of carrier to another.
These interactions are in the order of: (1) electron source → Fe protein, (2) Fe protein →
MoFe protein, and (3) MoFe protein → substrates.

2.1.2.1. Reductant Requirement: Electron Source → Fe Protein. Nitrogenase
requires a low potential source of electrons, such as dithionite (DT), titanium (III) citrate,
or methyl viologen in vitro, and flavodoxin or ferredoxin in vivo. The choice of electron
source can have a significant impact on the overall kinetics of nitrogenase because both
the [Fe4S4]2+/[Fe4S4]1+ and [Fe4S4]0/[Fe4S4]2+ redox couples can function during catalysis
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(95-97), and which couple is active is dependent upon the reductant type and its
concentration. The T&L model was developed using DT as reductant. For reasons that
are still not clear to the nitrogenase community, DT makes Fe protein function only in the
[Fe4S4]2+/[Fe4S4]1+ redox couple. Because commercial sodium dithionite is only partially
pure (50-85%), it is standardized optically or by titration against known concentrations of
oxidants such as FMN or K3Fe(CN)6 (7). Also, the ionic strength of a solution with DT
concentration in excess of about 20-30 mM (98) can be inhibitory to nitrogenase protein
interactions and activity.
The rate of Fe protein reduction is proportional to the square root of DT
concentration, indicating that the actual reductant of Fe protein in DT solutions is not
S2O42– but the SO2– radical formed by dissociation (99). The rate of Fe protein reduction
by SO2– is dependent on several factors. Most notably, it is slowed by the presence of
nucleotides. Reduction of Kp2 bound to two MgADP is the relevant reaction in the T&L
model:
k⎯
−6
⎯⎯⎯
⎯
→ 2 SO2–
S2O42– ←

(2-1)

k 4 HSO – + Kp2 (MgADP) .
SO2– + Kp20(MgADP)2 ⎯⎯→
3
1
2

(2-2)

k6

Once the Fe protein is reduced, it is assumed that nucleotide exchange occurs
rapidly compared to the reduction of Kp2:

fast

Kp21(MgADP)2 + 2 MgATP ⎯⎯⎯→
Kp21(MgATP)2 + 2 MgADP.

(2-3)

The affinity of reduced Fe protein for MgATP is smaller than that for MgADP (1, 100102), so for nucleotide exchange to be complete, it is implicit that the amount of MgATP
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is in large excess compared to MgADP. This condition is satisfied to a large extent for in
vitro reactions conducted in the presence of the ATP regenerating system

(phosphocreatine and creatine kinase), as well as for early time scales of in vitro assays
lacking a regenerating system but large initial ATP/ADP. In either case, the effect of
varying ADP concentration cannot be gauged within the strict framework of the model,
as this violates the condition of rapid nucleotide exchange.
While the rate of Fe protein reduction by DT is proportional to the square root of
[DT], this is not always the case for the rate of product formation, as shown in Figure 2-1.
Here, total product in the given assay times is reported. For limiting [DT], the
relationship between product formation and [DT]½ is linear, but this relationship changes
if [DT] is in excess (compare data points in Figure 2-1a vs. 2-1b). This detail highlights
the complexity of the nitrogenase reaction, which is largely concerned with the
interaction of the component proteins, as described in the following section.

2.1.2.2. Fe Protein Cycle: Fe Protein → MoFe Protein. The Fe protein is the

only known reductant to the MoFe protein. The association of Kp21(MgATP)2 and KpE
is the first in a series of pathways leading to substrate reduction which is exclusive to the
component proteins of nitrogenase. The relationship of this k1 pathway with its
complement k–1 is measured by varying k–1/k1 to get a best-fit simulation of Schemes 2-1
and 2-2 to “dilution effect” data in Figure 2-2, having already determined all the other
rate constants in Table 2-2. In the dilution range, the k1 pathway becomes rate limiting,
so this data set is primarily concerned with the association of catalytically activated Kp2
with KpE.
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Figure 2-1. H2 evolution as a function of dithionite concentration. T&L data (● and
■) at pH 7.4 and 23 oC, and with 9 mM ATP; linear fit to data (— — —); T&L
simulations (▬ ▬ ▬); and duplication attempts at reported and adjusted conditions
(▬▬▬ → ——, respectively). T&L data and simulations are from ref (6). (a) Total
product formation after 5 min with Mo content = 1.4 Mo/Kp1, [Kp1] = 1.7 μM and [Kp2]
= 1.8 μM. (b) Total product formation after 1 min with 1.3 Mo/Kp1.
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Figure 2-2. Dilution effect at a constant Kp2/Kp1 molar ratio of 4/1. T&L data (●)
at pH 7.4 and 23 oC, and with 9 mM ATP and 10 mM DT; T&L best-fit curve to data to
solve for k–1/k1 (▬ ▬ ▬); and duplication attempts at reported and adjusted conditions
(▬▬▬ → ——, respectively). T&L data and simulation are from ref (7). Attempts at
duplication used 1.3 Mo/Kp1 and protein concentrations as indicated in the table inset.

The next step in catalysis, the k2 step, involves both electron transfer and
hydrolysis of two ATPs. When Kp21(MgATP)2 is added to Kp1, there is a positive
change in the absorbance of the system during turnover at around 430 nm. This
absorbance change is attributed to oxidation of Kp2, mirroring the drop in absorbance
upon reduction of Kp2. So the value of k2 can be measured spectroscopically in a
stopped-flow apparatus.
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Figure 2-3. Kp1 specific activity titration curve. T&L data (●), with [Kp1] held
constant at 0.53 μM and [Kp2] varied at pH 7.4 and 23 oC, and with 9 mM ATP and 10
mM DT; T&L simulation (▬ ▬ ▬); and duplication attempts at reported and adjusted
conditions (▬▬▬ → ——, respectively). T&L data and simulation are from ref (7). Mr
of Kp1 taken as 218 000 (3). The effect of simulating error in Kp2 is the same as scaling
the independent variable of a simulation without error by the same error after the fact.

The type of nucleotide bound to the Fe protein affects the stability of the
KpE-Kp2 complex. After ATP hydrolysis and phosphate release, Kp20(MgADP)2
dissociates from KpE. This k–3 step is rate limiting in the Fe protein cycle when protein
concentrations are not in the dilution range (2). Once freed from KpE, Kp20(MgADP)2
has less affinity for KpE than does Kp21(MgATP)2, so that under equal concentrations of
component proteins, and when Fe protein is in excess, catalysis proceeds rapidly as
shown in Figure 2-3, a specific activity curve for MoFe protein.
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Figure 2-4. Kp2 specific activity titration curve. T&L data (●), with [Kp2] held
constant at 0.92 μM and [Kp1] varied at pH 7.4 and 23 oC, and with 9 mM ATP and 10
mM DT; T&L simulation (▬ ▬ ▬); and duplication attempts at reported and adjusted
conditions (▬▬▬ → ——, respectively). T&L data and simulation are from ref (7). Mr
of Kp2 taken as 68 000 (3). The conditions given in the inset assume a Mo content of 1.4
Mo/Kp1.

On the other hand, reduction of Kp2 by DT is inhibited for excess KpE/Kp2 ratios
because Kp2 can only be reduced by DT when not bound to KpE. This phenomenon is
referred to as “MoFe inhibition” and is shown in Figure 2-4, a specific activity curve for
Fe protein. The amount of Kp20(MgADP)2 bound to KpE is determined by the absolute
and relative concentrations of these, plus the binding affinity (k3 vs. k–3) of the complex.
These rate constants were measured by determining the effect of varying [Kp1] on
the rate of Kp2 reduction by DT (2). Since these experiments were performed in the
presence of ADP and not ATP, it was also determined that Kp21(MgADP)2 binds KpE
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with the same affinity as Kp20(MgADP)2, so that k5 = k3 and k–5 = k–3 as in Table 2-2. As
noted previously, however, one of the important assumptions of the T&L model is that
ATP concentration must be in excess compared to ADP concentration so that nucleotide
exchange on reduced Kp2 is rapid. Therefore, the rate constants k5 and k–5, for the
interaction of Kp21(MgADP)2 with KpE, do not actually enter in to any of the kinetic
schemes presented in this work.
Only free Kp20(MgADP)2 is capable of being reduced in the k4 pathway. This
point deserves special emphasis as it has been debated in the literature since the time the
T&L was published, and will be discussed further in later chapters. The reasoning behind
this assumption in the T&L model comes from the T&L explanation of MoFe inhibition.
Namely, if Kp20(MgADP)2 is bound to KpE, then its Fe-S cluster is unexposed to
reductant in the solvent. We can also deduce that the Fe-S cluster must be the site of both
Kp2 reduction as well as the site of electron transfer to KpE. After Kp2 reduction, the Fe
protein cycle starts over.

2.1.2.3. The MoFe Protein Cycle: MoFe Protein → Substrate. One completion

of the Fe protein cycle accounts for the transfer of one electron from Kp2 to KpE.
However, all nitrogenase substrates require 2n electrons, n > 1. For example, the
reduction of N2 to 2NH3 (with obligatory reduction of at least 2H+ to H2) involves the
transfer of at least eight electrons (or eight Fe protein cycles). The MoFe protein cycle
accounts for various reduction levels of KpE-substrate complex before a particular
substrate is released as product, as in Scheme 2-2.
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In this scheme, En represents KpE operating independently of its counterpart on
the Kp1 molecule. The subscript, n, indicates the level of reduction of KpE relative to
n = 0 for KpE isolated in the presence of DT. By assuming that the constants of the Fe

protein cycle are independent of the level of reduction of KpE (3, 103), the T&L model
has the potential to be applied easily to any possible substrate (7), though this was
originally done only with H+, and N2, as in Scheme 2-2.
In the absence of alternative substrates, nitrogenase reduces H+ to H2. After the
first reduction of KpE by Kp2 and subsequent dissociation of Kp20(MgADP)2 from the
protein-protein complex, the FeMo cofactor of KpE interacts with solvent, and a metal
hydride is formed: E1H (8). Subsequent reduction cycles result in the binding of more
hydrides. After the second reduction, KpE is in the E2H2 reduction state and is capable of
evolving H2.
This mechanism was inferred from nitrogenase behavior during the lag phase
experiment of Hageman and Burris (104). The reaction conditions for a lag-phase
experiment include a large excess of Kp1/Kp2, so that only after several minutes product
is released at steady state rates. This is the case for several reasons. Under these
conditions, the k1 step is rate limiting because of the low [Kp2]. Also, equal populations
of both E0 and E1 are built up slowly until the steady state, with relatively insignificant
amounts of E2 (103), assuming that H2 release from E2 is rapid compared to the relatively
rare event of Kp2-KpE interaction.
Under normal catalytic conditions, where Kp1 is not in excess, higher redox states
of KpE become important. This is true because only free KpE is capable of evolving
product. For instance, if reduced Kp2(MgATP)2 binds E2H2 before H2 is released, E3H3
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Figure 2-5. Kp1 relative activity as a function of nitrogenase concentration.
Simulations of H2 product evolved naturally (no quenching) when [Kp2]/[Kp1] = 4/1 and
[Kp1] = (a) 1.0 μM, (b) 10.0 μM, and (c) 100.0 μM. T&L simulations digitized from ref
(3), though only up to 1.25 s due to physical distortions beyond this point. T&L
simulation (▬ ▬ ▬) and final duplication attempts at adjusted conditions (——)
indicated in the table inset.

can be generated, followed by the possible formation of E4H4 by the same means. The
framework of the T&L model can generate simulations to help explain this concept.
Figure 2-5 shows that the lag preceding steady-state product formation actually increases
upon simultaneously increasing Kp2 and Kp1 concentrations. Steady-state simulations of
actual data reinforce this concept in Figure 2-6. Note that Figure 2-6 is an extension of
Figure 2-2 to higher protein concentrations where Kp1 specific activity is inhibited by the
increase in the relative populations of bound Kp2-KpE species.
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Figure 2-6. Kp1 specific activity as a function of nitrogenase concentration. T&L
data (●), with [Kp2]/[Kp1] held constant at 4/1, pH 7.4 and 23 oC, and with 9 mM ATP
and 10 mM DT; transformed T&L simulations from Figure 2-5 (○); T&L simulation (▬
▬ ▬); and duplication attempts at reported and adjusted conditions (▬▬▬ → ——,
respectively). T&L data and simulation are from ref (7).

The data sets involving product release from KpE described so far have been
predominantly steady-state kinetics. They involve quenching with acid to halt the
reaction. There is a minute amount of product bound to KpE intermediates released upon
quench, but this is inconsequential compared to the large amount of natural product
evolution over the time course of a steady-state assay. One of the strengths of the T&L
model, however, is its ability to fit both steady-state and pre-steady-state data.
Unfortunately, pre-steady-state product formation cannot neglect product
produced from acid quenching. Specifically, Thorneley and Lowe used a rapid acid
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Figure 2-7. Pre-steady state reduction of H+ in the absence of N2. T&L data (●), pH
7.4 and 23 oC, and with 9 mM ATP and 10 mM DT; T&L simulations (▬ ▬ ▬); and
duplication attempts at reported and adjusted conditions (▬▬▬ → ——, respectively).
T&L data and simulation are from ref (7). Both (a) and (b) represent the same fit, but at
different time scales. In (a) we see total product, product from natural release from
enzyme, and release from various KpE species (see Table 2-1) upon acid quench. In (b)
data and simulations relating only to total H2 product are shown. The conditions given in
the table inset assume a Mo content of 1.3 Mo/Kp1.
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quench technique to obtain their data (3, 7, 105), and then determined empirically from
simulations what products would have to be released from the various En and Kp2-En
intermediates upon quenching to match the data. It was determined that all E0 and E1H
species release no product upon quenching, even though the latter has one electron
equivalent present. The quenching of all E2H2 and E3H3 intermediates, on the other hand,
releases a single H2 molecule, and E4H4 releases two H2. Figure 2-7 illustrates this
concept, with total product derived from both natural and quenched sources. Only total
product can be used to fit data in Figure 2-7b, as no isotopic experiments were performed
in an attempt to distinguish between natural versus quenched product evolution.
One complication of determining product from quenching is to know exactly
when one class of intermediate becomes another. Specifically, the question arises
whether KpE is considered E2 after E1 receives an electron from Kp2. This is important
because E1 does not release product, while E2 does. It turns out that upon electron
transfer to KpE, E1 does not become E2. Rather, E1H-Kp21(MgADP)2 becomes
E1+eH-Kp20(MgADP)2. The T&L model assumes that immediately after the release of
Kp20(MgADP)2 from KpE, E1+eH becomes E2H2. This idea is made explicit in Scheme 21, where En+e represents an En species that has been reduced, yet has not had its Kp2
released so as to allow its FeMo cofactor to interact with solvent. Once this dissociation
occurs, En+e is considered an En+1 species rather than an En species. From this we see that
the T&L model emphasizes the idea that only free MoFe protein can interact with and
reduce substrate, as already mentioned in the context of Figure 2-6.
The hydrogenase activity of the FeMo cofactor of KpE is a necessary
consequence of the ultimate protonation required to reduce N2 to NH3, so it is important
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Figure 2-8. Pre-steady state reduction of H+ in the presence of 100% N2. T&L data
(●), using the rapid acid quench technique at pH 7.4 and 23 oC, and with 9 mM ATP and
10 mM DT; T&L simulations (▬ ▬ ▬); and duplication attempts at reported and
adjusted conditions (▬▬▬ → ——, respectively). T&L data and simulation are from
ref (7). The conditions given in the table inset assume a Mo content of 1.3 Mo/Kp1.

to see how nitrogenase minimizes H2 evolution relative to N2 reduction. Comparing
Figure 2-7b with Figure 2-8, we see that at the same protein concentrations the presence
of N2 decreases the electron flux going towards H2 evolution. This hydrogenase activity
can never be abolished experimentally, even under extremely high pressures of N2 (106).
The T&L model explains this nicely with the idea of N2 binding free E3 and E4 via
displacement of H2 as in Scheme 2-2. Thus the limiting stoichiometry of the nitrogenase
reaction (Equation 1-2) is explained: a minimum of one H2 is produced for every two
NH3 molecules.
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Figure 2-9. Pre-steady state NH3 release from natural release and acid quench of
nitrogenase in the presence of 100% N2. T&L data (●), pH 7.4 and 23 oC, and with 9
mM ATP and 10 mM DT; T&L simulations (▬ ▬ ▬); and duplication attempts at
reported and adjusted conditions (▬▬▬ → ——, respectively). T&L data and
simulation are from ref (7). The conditions given in the table inset assume a Mo content
of 1.3 Mo/Kp1.

The NH3 response to N2 is shown in Figure 2-9, at similar protein concentrations
as in Figure 2-8. For NH3 release, the T&L model is not definitive on which
intermediates naturally release NH3, though one possibility (chosen for my simulations)
is that NH3 is released from E6 and E7 (7), so that two NH3 equivalents are bound to E5
and E6 species for release upon quenching, and that E7 species release one NH3 upon
quenching. Scheme 2-2 is appropriately non-committal on this point because of other
possibilities for NH3 release.
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Quenching of the nitrogenase reaction under N2 yields an intriguing product:
hydrazine. Unlike H2 and NH3 products, N2H4 comes completely from quench, so there
is no ambiguity about the relative contributions to total product from natural vs. quenched
sources. Rather, the ambiguity resides in which intermediates yield product. It was
determined that all E4N2H2 species are responsible for hydrazine release upon quenching,
but only if E4N2H2 derived from E3H3 is not allowed to back-react with H2 to form E4H4
(the k–11 step). This detail has been made explicit in Scheme 2-2. The reasoning behind
this assumption is that protonation of E3N2H1 is irreversible because of attack onto the
nitrogen substrate intermediate, rather than further binding to the FeMo cofactor.
Interestingly, N2H4 release upon quenching was determined in both the absence and
presence of H2, as shown in Figure 2-10. The back reaction of E3N2H1 and E4N2H2 with
H2 accounts for the experimental observation that for all times N2H4 release upon
quenching is higher in the absence of H2. One final note about N2H4 release from
E4N2H2 is that it could only be possible through super-oxidation of the MoFe protein.
Two aspects of Scheme 2-2 stand out that can be explained from experimental
observation, rather than just empirical fit to random schemes. Specifically, why does N2
only bind to KpE only after three Fe protein cycles, and why is E4H4 necessary at all?
The first query is answered by the observation that under lag phase conditions of very
large Kp1/Kp2 ratios, only H2 product is produced, even in the presence of N2. So N2
must not be able to bind E2H2.
The second query is answered by the data in Figure 2-11. The apparent Km for N2
changes with the Kp2/Kp1 ratio. This change is partially explained by the fact that at
higher Kp2 concentrations, relative Kp2-KpE species predominate. Within the
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Figure 2-10. Pre-steady state N2H4 release upon acid or base quench of nitrogenase
in the presence of N2. T&L data under 50% H2, 50% N2 (▲), or 100% N2 (●), pH 7.4
and 23 oC, and with 9 mM ATP and 10 mM DT; T&L simulations (▬ ▬ ▬); and
duplication attempts at reported and adjusted conditions (▬▬▬ → ——, respectively).
T&L data and simulation are from ref (7). The conditions given in the table inset assume
a Mo content of 1.3 Mo/Kp1.

framework of the model, only free KpE binds or releases substrate, so an increase in
relative concentrations of Kp2-KpE species decreases the availability for N2 binding and
the apparent N2-Kp1 binding affinity. The corresponding increase in apparent Km is
obvious in the data in Figure 2-11, but it is even more pronounced when the value of k11
in silico is changed. If k11 = k10 = 4 x 105, then the effects of changing the relative

population of free KpE can be gauged more accurately, as in Figure 2-12. In this
example, the value of the apparent binding affinity of N2 is not at all dependent on k–10
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Figure 2-11. Determination of the apparent Km for N2 reduction as a function of the
[Kp2]/[Kp1] ratio. T&L data from NH3 formation rates (●) and ΔH2 rates (▲), pH 7.4
and 23 oC, and with 0.57 μM Kp1, 9 mM ATP and 10 mM DT; T&L simulation (▬ ▬
▬); and duplication attempts at reported and adjusted conditions (▬▬▬ → ——,
respectively). T&L data and simulation are from ref (7). The conditions given in the
table inset assume a Mo content of 1.5 Mo/Kp1, and 0.57 μM Kp1.
.

nor k–11 because the amount of H2 available in solution to displace N2 in the back reaction
is zero. Therefore, the eventual flattening of the curve at high [Kp2]/[Kp1] where the
regular values for k10 and k11 are used is due to the fact that k11 is about five times larger
than k10, leading to tighter binding of N2.
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Figure 2-12. Effect of changing the value of k11 on the apparent Km for N2 as a
function of the [Kp2]/[Kp1] ratio. Simulation at reported conditions, as in Figure 2-11
(▬▬▬); for comparison to a simulation that only differs by a change in the value of k11
set to the value of k10 (——).

2.2. Duplicating the T&L Model
With a thorough understanding of the assumptions of the T&L model, I have been
able to duplicate published simulations of the T&L model. This has been accomplished
using the information in Tables 2-1 and 2-2 and Schemes 2-1 and 2-2, in the strictly
mathematical framework of a computer program I have written in the Mathematica
programming language (65). This program is capable of simulating a wide variety of
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experimental conditions, and the code itself is available in the form of either an HTML or
Mathematica file as supplementary electronic material to my published version of this

work (10). For very specific details not included in Table 2-1, this supplementary
material is a ready reference, and an adapted version of it has been included in Appendix
B of this work.
Selected original published data and simulations of the T&L model were digitized
using UN-SCAN-IT software (66). These were then used as targets for my Mathematica
simulations. Original T&L data in all figures are plotted as points, and original T&L
simulations are given as dashed lines. Thick solid lines are used for my Mathematica
simulations for the same conditions (protein component concentrations or ratios,
reductant concentrations, etc.) stated in the original publications. In all cases, the in silico
protein concentrations needed to be adjusted to duplicate original T&L simulations, and
such simulations are indicated by a thin solid line. An arrow indicates the direction of
activity change required to adjust initial simulations to better-fit simulations, and a table
insert to each figure indicates the percent deviation from “reported” to “adjusted”
conditions. As indicated in Table 2-1, the allowable variation for each protein
component is ±10%.
An added level of complexity is introduced by the fact that the Mo content of Kp1
prepared by Thorneley and Lowe is not known precisely. In the series of papers
presenting the bulk of their model (3-7), the Mo content is 1.4 ±0.1 Mo per Kp1, while an
earlier effort (2) related directly to establishing the model reports a slightly different
value: 1.3 ±0.1 Mo per Kp1. For this work, I have used the former value, first allowing
the Mo content to vary strictly within these limits (e.g. a range of 1.3 to 1.5 Mo/Kp1) to
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obtain a better fit to T&L simulations at reported protein concentrations, even before
attempting to vary the in silico protein concentrations to obtain a match.
It should be noted again that in my published version of this work (10), this issue
of Mo content was poorly understood: reported [Kp1] was thought to be equal to [Mo].
This error stemmed from the curious distinction between “Kp1” and “Kp†” made by
Thorneley and Lowe; the “†” was overlooked because of its more common usage as a
footnote indicator. This error has been corrected for the analysis in this chapter.
In this section, we will see cases in which my computer program successfully
duplicates T&L simulations within the allowable variation of error limits in Mo content,
and ±10% variation of each protein component. Sometimes large deviation from these
error limits is required to get a match. In some cases, adjustment of protein
concentrations is insufficient to obtain a match, illustrating that the original authors likely
used curve-fitting techniques outside of the parameters of the model. This becomes
apparent after considering some logical contradictions between the T&L simulations and
the assumptions of the model. At times it is obvious that human error and/or
inappropriate tweaking of the model is responsible, while at other times it is most
plausible to consider that there are errors in Lowe’s computer program itself.
Because of the varied nature of the methods used to obtain a match, the most
logical way to present my analysis is to follow the conceptual framework presented in the
previous section. That is, we will look at the case in Figure 2-1 and proceed through each
figure in sequential order. Additional cases in this analysis prove enlightening and raise
additional questions as to the application of the T&L model to experimental data.
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2.2.1. H2 Response to DT
In Figure 2-1a, my simulation at reported protein concentrations uses a Mo
content of 1.4 Mo/Kp1. Note that for all values of [DT]½, the T&L simulation is more
active than mine. Decreasing the Mo content raises activity in this case because there is
some MoFe inhibition at these protein concentrations. A change in [Kp1] affects the
curvature and activity of the simulation, while the major effect of a change in [Kp2] is to
change the overall slope of the simulation. With these various effects, I can alleviate the
difference between my simulation and the T&L simulation only at middle to high [DT]½,
but never at low [DT]½. Because the DT concentration is sometimes limiting in this case,
my simulation uses initial values of Kp20(MgADP)2 equal to the total active Kp2, while
Kp21(MgATP)2 at t = 0 is set to zero. Reversing these initial concentrations could not
eliminate the fact that my simulations never approach the origin linearly as the T&L
simulation does. The question arises whether the model predicts that the simulation
ought to approach the origin, in which case my program would be erroneous. The answer
to this question lies in understanding the effects of low [DT].
Let us first consider the more general case of limiting electron flux, then see how
this applies to low [DT]. The lag phase experiment provides one of the most extreme
examples of limiting electron flux through MoFe protein. Using a Kp1/Kp2 ratio of
100/1, there is a substantial lag on the order of minutes before product is formed at a
steady-state rate (103). Even though Kp2 transfers electrons to KpE, H2 product cannot
be formed until a second electron is transferred to KpE (see Scheme 2-2). The effect of
low electron flux is to tie up electrons in KpE so that product formation is limited
compared to the number of catalytic turnovers.
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For the case of limiting DT, the same issue applies. In the extreme that a single
SO2– ion is present in an assay, an electron will be transferred to a single KpE, but no
product will be formed. As the DT concentration is increased, but still kept very low,
E1H becomes more populated relative to E0, but E2H2 is rarely formed before the assay
runs out of reductant. With still more DT, the relative population of E2H2, and possibly
beyond, becomes significant, leading to a somewhat linear relationship between [DT]½
and activity. Even at high [DT]½, the number of electrons transferred to KpE, yet not
evolved into product, would be between half the number of KpE—which is the case
under lag phase conditions (103)—and the total number of KpE sites, the maximum
possible under excess Kp2. So at low [DT]½, activity cannot extrapolate to zero linearly.
My simulations in Figure 2-1 show this, and so do the T&L data. Note that a
linear fit to the data in Figure 2-1a crosses the horizontal axis at 0.0367 mM½, while a
linear fit to my simulation at the lower end of its primary curvature intercepts the
horizontal axis at 0.029 mM½. The nature of the T&L simulation is not in concordance
with the model, nor the experimental data. Rather, a complete vertical shift of 5.9 μM H2
in all data points of my simulation above 0.0316 mM½, followed by the addition of a
point at the origin, was required to obtain a match to the T&L simulation. Obviously,
this method is outside of the bounds set by the model.
The question is raised whether Lowe’s computer program actually encodes this
mistake, or whether he tweaked his simulation beyond the limits of the model to fit
preconceptions about nitrogenase activity, which commonly neglect the effects of
limiting electron flux as recently discussed. The latter explanation is likely because of
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the nature of the T&L simulations in other cases, though we should not rule out the
possibility of program errors from this example.
In Figure 2-1b it should be noted that a linear fit to the data below 1.25 mM½ does
not extrapolate to cross the horizontal axis above 0 mM½, even though it should, given
the same logic used to describe the behavior of the data and my simulation in Figure 21a. More data at even lower [DT]½ would undoubtedly show that this is the case.
The effect of decreasing the Mo content for the conditions in Figure 2-1b is to
lower the activity, so my simulation at reported concentrations in this figure has a Mo
content of 1.3 Mo/Kp1. The effect of changing Mo content in this case is a different
effect than in Figure 2-1a because MoFe inhibition is an issue in Figure 2-1a, while there
is excess Kp2 in Figure 2-1b.
Changing [Kp1] and [Kp2] have similar effects as in Figure 2-1a, but in this case
large deviations from the ±10% protein variation limits were necessary to obtain a match.
This is startling because absolutely no variation was necessary in Figure 2-1a. The likely
explanation for this discrepancy is that Thorneley and Lowe had to go well beyond their
own limits of ±10% to fit their data. If this is the case, the applicability of the T&L
model is brought into question. In the literature, it is presented as a completely
successful model, but it may in fact fall short in some respects.

2.2.2. Dilution Effect
Figure 2-2 displays the dilution effect of Kp nitrogenase at a constant
[Kp2]/[Kp1] ratio. The Mo content was set to 1.3 Mo/Kp1 for my simulations. My first
simulation of the dilution effect at the reported [Kp2]/[Kp1] ratio of 4/1 shows a [Kp1]-
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dependent deviation from the T&L simulation. Because this particular simulation varies
the protein concentrations while keeping the protein ratio constant, any error in
component protein concentrations is propagated as an error in protein ratio. From a
starting ratio of 4/1, the error rates in both numerator and denominator give us a range of
possible ratios from 3.27 to 4.89 if we are to stay within the ±10% limits of the model:
4 (0.9) / 1 (1.1) = 3.27, and
4 (1.1) / 1 (0.9) = 4.89.
Since the activity of my first simulation is too high, the lower Kp2/Kp1 ratio (more MoFe
inhibition) is likely to match the T&L simulation best. This is indeed the case. Note that
my second simulation at a ratio of 3.27 is a not a best fit curve, but rather, was achieved
as the limit of staying within the framework of the model.
Staying within the limits is particularly important in this case because the T&L
simulation is actually a best-fit curve used to solve for the value of k–1/k1, having already
determined the other rate constants in Table 2-2. Still, a completely objective fit of the
value of k–1/k1 should be independent of anything else. If Thorneley and Lowe actually
had to adjust the in silico protein ratio—not to mention Mo content—before performing a
best fit simulation, then the error inherent in the value of k–1/k1 is even more suspect.
This is especially true after considering that the multiplication/division rule for
propagation of errors involves a Pythagorean calculation, not the procedure used here that
actually allows for more error than the standard statistical approach.
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2.2.3. Specific Activity
Because there are numerous causes of protein inactivation, specific activity curves
for the Fe protein and MoFe protein are routinely performed by nitrogenase researchers.
Figure 2-3 shows a specific activity curve for MoFe protein, and Figure 2-4 shows a
specific activity curve for Fe protein. The T&L simulation in Figure 2-3 could not be fit
within the parameters of the model. The key difference between my simulation at
reported and adjusted conditions is the maximum specific activity. The effect of
changing the Kp1 concentration has no effect because the dependent variable is specific
activity. This problem can only be overcome by raising the Mo content of the MoFe
protein slightly above the error limits indicated for Mo content. The percent deviation of
+6.7% reported in the figure is with reference to the upper limit of Mo content (6.7%
above 1.5 Mo/Kp1). As with Figure 2-2, the error inherent in protein concentrations can
scale the protein ratio from 0.82 to 1.22:
(0.9)/(1.1) = 0.82, and
(1.1)/(0.9) = 1.22.
So the scaling of 0.91 in the figure is well within this range. The scaling is used to
multiply all values of [Kp2]/[Kp1] in this case, shifting the curve to the left.

The methods requisite to match the T&L simulation in Figure 2-4 are perhaps the
most unreasonable of all cases in this chapter. Because Thorneley and Lowe assume Kp2
to be 45% active, there is no simple adjustment available to change the maximum
specific activity, as was the case for Kp1 specific activity. If conventional fitting
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methods are chosen, e.g. changing parameters of the model and running simulations, then
the only way to get a match to the T&L simulation is to change a non-simulated factor:
the molecular weight of the protein. In my opinion, this is bad science.
Even adjusting the value of the rate-limiting step, k–3, is ineffectual for two
reasons. First, Thorneley and Lowe do not state that this method is used for fitting any
data. Specifically, they repeatedly state that their simulations use rate constants as
indicated in one of two tables (3, 7), neither of which give error limits for the values of
the rate constants. The implication is that the values of rate constants are not varied to
obtain a match to data, though Thorneley and Lowe specifically refer to the error limits of
k–3 in their discussion of Kp2 specific activity—the value of this rate constant is given as
k–3 = 6.4 ± 0.8 s–1 (6).

Second, when the possibility of varying the value of k–3 is explored, specific
activity cannot be matched within these error limits, and when these limits are exceeded,
specific activity can be matched for a particular [Kp1]/[Kp2] ratio, but not over the entire
domain of ratios. The reason for this is that an increase in the value of k–3 affects the offrate of Kp20(MgADP)2 from KpE for both higher rates of catalysis and relief of MoFe
inhibition. Hence, the slope of the specific activity curve is more horizontal after specific
activity reaches a maximum, and MoFe inhibition is less of an influence.
So adjusting the value of k–3 does not work. In fact, the only way to get one of
my simulations to match the T&L simulation in Figure 2-4 is vertical scaling of the result
of a simulation. Thorneley and Lowe give hints that scaling was indeed used. Upon
reading their explanation on p. 907 of ref (6) in context of the discoveries in this chapter,
it is likely that they scaled their simulation according to the expected specific activity.
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Their logic involves taking the maximum value of Kp2 specific activity to be
2860 nmol H2 min–1 mg Kp2–1 at 23 oC, derived from the rate constant of the ratelimiting step k–3 = 6.4 s–1. Assuming that only 45% of Kp2 is active, the maximum
expected specific activity for Kp2 in the T&L model would then be 1290 nmol H2 min–1
mg–1. The data in Figure 2-4 show that the actual specific activity is around 800 nmol H2
min–1 mg–1, where the lower-than-expected activity is explained by the inactive 55% of
Kp2 inhibiting the reaction. Though they do not specifically state that scaling was used,
their discussion of these details would be unnecessary unless they did indeed scale their
simulations in this case.
In any case, their reasoning seems sound upon cursory reading, but in actuality
this method belies a blatant circumvention of the framework of their own model to fit the
data, and I can prove that this logic is in fact not sound at all but an attempt at handwaving.
Consider first that scaling the specific activity lies outside of the framework of the
model because it is the dependent variable. The model admits that variation is allowed in
the independent variable—protein ratios—in this case, but not in the dependent variable.
Even so, I can prove that the logic used by Thorneley and Lowe to scale their simulation
is not sound through a comparison of the simulations in Figure 2-13. Here we see the
effects of increasing the in silico activity of Kp2 from 50% to 100%, a maximum specific
activity for Kp2 of around 1400 nmol H2 min–1 mg–1 is obtained, whereas in the logic
used by Thorneley and Lowe, a maximum specific activity for 100% active Kp2 of 2860
nmol H2 min–1 mg–1 is used. Thorneley and Lowe erroneously assume that basing the
maximum specific activity on some derivation from the rate-limiting step is accurate.
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Figure 2-13. Effects of Kp2 activity on the Kp2 specific activity titration curve.
Simulated curves with in silico [Kp2] held constant at 0.92 μM and [Kp1] varied. Mo
content is 1.4 Mo/Kp1, and Mr for Kp2 is 68 000 (3). Kp2 activity was simulated as
either 50% (▬▬▬), or 100% (——).

They are off by about 2-fold from the true simulated prediction because the system is
operating under conditions of MoFe inhibition. The k–3 step results in dissociation of the
En+e-Kp20(MgADP)2 complex, but the [KpE] concentration is high enough that the k3
step for reassociation of Kp20(MgADP)2 with KpE competes significantly with the k4
step (see Scheme 2-1).
It is true that for low Kp1/Kp2 ratios, MoFe inhibition is insignificant, but the
peak Kp2 specific activity represents the turning point for increasing activity through
increased FeMo cofactor concentration, and decreased activity through inhibition of
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further Kp2 reduction. Clearly then, MoFe inhibition is an issue at the peak for Kp2
specific activity.
Furthermore, Thorneley and Lowe assume that the inactive protein would inhibit
the specific activity under MoFe-inhibited conditions. This is not entirely correct.
Addition of inactive Fe protein under MoFe inhibited conditions increases the population
of KpE-Kp2i species, necessarily lowering the concentration of free KpE that can bind to
and inhibit Kp20(MgADP)2 from being reduced. This is shown in Figure 2-13 by the fact
that the maximum specific activity at 100% active Kp2 is only 2.0 times the maximum
specific activity for 50% active protein. Based on the arguments of Thorneley and Lowe,
we would expect 100% active Kp2 to be higher than 100/50 = 2 times more active than
50% active protein, because of the inhibiting effects of inactive protein that Thorneley
and Lowe claim is significant in this case.
At first, it may seem counter-intuitive that by adding inactive Kp2, activity is
actually increased. In reality, this is true for the reasons discussed above only to a certain
point. Upon addition of excess inactive Fe protein, the population of available KpE for
catalysis also decreases, and activity does decline. So the effect of addition of Kp2i is
similar to the effect of MoFe inhibition, where both represent a balance of competing
trends, one favoring catalysis, the other tending towards inhibition of Kp2 reduction. But
for the conditions in Figure 2-4, the results from Figure 2-13 clearly show that the
assumptions Thorneley and Lowe use to scale their simulation are wrong. Their scaling
method is tantamount to changing the molecular weight of Kp2 to match the data.
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Time courses for relative activity are shown in Figure 2-5. Since there are no data
accompanying this set of T&L simulations, we are given the impression that these are
theoretical simulations. If this is so, it is surprising that in silico assay conditions must be
adjusted to obtain a match to these simulations. Upon further inspection and comparison
with Figure 2-6, it is apparent that these two figures show essentially the same thing,
though pre-steady-state simulations are shown in Figure 2-5, and steady-state simulations
are shown in Figure 2-6. For greater ease of comparison, adjusted conditions in Figure
2-5 are reported as changes in Mo content and [Kp2]/[Kp1], though comparable matches
could be gained by adjusting [Kp1] and [Kp2].
The similarities between Figures 2-5 and 2-6 suggest that the progress curves are
in fact attempts to fit data similar to that in Figure 2-6, explaining why different adjusted
conditions are required for a match to each separate T&L simulation (a) through (c).
Curves (a) and (b) are performed at protein concentrations comparable to those in Figure
2-6, and transforming these curves into specific activity points for direct comparison to
the T&L simulation in Figure 2-6 yields the two open circles in Figure 2-6. Clearly,
these two points do not lie on the dashed line in Figure 2-6, but do have rather similar
curvature to my first attempt at duplication. It is likely that the curves in Figure 2-5 were
used as checkpoints to determine the response of the model to changes in input
parameters to fit the data in Figure 2-6, explaining their individual variation required for
me to get a match in Figure 2-5.
The simulation in Figure 2-6, on the other hand, is matched rather well with a
single adjusted Mo content and Kp2/Kp1 ratio, and varying the total nitrogenase
concentration. This match is not perfect, however. A perfect match could only be
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obtained using a different approach, largely based on varying Mr for Kp1 by close to
50%, so the match displayed in the figure is the lesser of two unsatisfactory approaches,
in spite of very large deviation from the established parameters of the model.
It is interesting that in both Figures 2-3 and 2-4, my first simulations at reported
concentrations are well below the activity of the T&L simulations, whereas in Figure 2-6
this trend is reversed. Perhaps including Figure 2-4 in this comparison is not valid since
vertical scaling was performed there. Still, the differences between Figures 2-3 and 2-6
suggest that the methods used to fit these graphs were indeed deviations from the
framework of the model, and not due to systematic differences between my computer
program and Lowe’s, especially when we consider that what each of these figures reports
is Kp1 specific activity.

2.2.4. Nitrogenase Response to N2
In order to gauge the response of nitrogenase to N2, we must first characterize
nitrogenase activity in the absence of N2. In Figure 2-7 we see progress curves for H2
release, representing sources of natural evolution and release upon quenching with the
rapid acid quench technique. This technique requires the use of large amounts of protein,
tending towards concentrations to the right in Figure 2-6. In that case, large deviations in
in silico reaction conditions were required to get a match to the T&L simulation, so it is

not very surprising that this trend should continue in Figure 2-7, where activity at
reported conditions is much too high. Note that the poor match of my simulation in
Figure 2-7a is partly a consequence of focusing primarily on obtaining a fit in Figure
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2-7b, where the two seconds showed in Figure 2-7a are valued less when compared to the
whole 10 seconds.
Still, an independent fit to the T&L simulations in the first two seconds was
ineffectual in obtaining a perfect match, or even one much better than the one shown,
unless the value of k–3 was varied. In this procedure, Mo content was set to 1.3 Mo/Kp1,
and k–3 was set to 5.6 s–1 (the lowest value allowed within the error) before adjusting
protein concentrations. Even so, the best fit simulation still gives [Kp1] outside the
allowed ±10% error: [Kp1]adj = 25.5 μM (–25% deviation); and [Kp2]adj = 119.7 (–10%
deviation).
Interestingly, the deviation in [Kp2]adj is greater after lowering the value of k–3.
This illustrates the sensitivity of the model to changes in the values of the rate constants.
The only way to get logically comparable simulations is to limit variation of parameters
to protein concentrations, while keeping the same values for rate constants. If Thorneley
and Lowe indeed varied the value of k–3 to obtain their simulations in Figure 2-7a, as
suggested by this analysis, then this goes beyond the explicit framework of the T&L
model, as I have explained above in the discussion about Kp2 specific activity. For the
case of fitting the T&L simulation of Kp2 specific activity, it was obvious that the value
of k–3 was not changed, but my analysis in this case strongly suggests that this was done
for the simulations in Figure 2-7a.

Figure 2-8 shows H2 evolution under the same protein component concentrations
as in Figure 2-7, though under 100% N2. This case is remarkable for the low variation of
protein concentrations required to obtain a match to the T&L simulation. However,
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closer inspection of the data at low t shows that the match is not perfect. Likewise, the
slope of my simulation at high t is off when compared to the T&L simulation. The
problem at early t is the more significant finding because my simulation’s lag is too short,
no matter what concentrations of Kp1 and Kp2 are used. In fact, the only way to match
the lag in the T&L simulation is to change the value of k–3, as was the case in Figure 2-7a.
In this case, Mo content was set to 1.4 Mo/Kp1, and k–3 was set to 5.6 s–1 before adjusting
protein concentrations. The best fit simulation still gives protein concentrations within the
allowed ±10% error: [Kp1]adj = 35.7 μM (+5% deviation); and [Kp2]adj = 133 (0%
deviation). Again, this analysis suggests that Thorneley and Lowe adjusted the value of
k–3 in their simulation in Figure 2-8.

Figure 2-9 is a pre-steady state progress curve for NH3 evolution from nitrogenase
under 100% N2, with total product originating from both natural and quenched sources.
It is most telling for the accuracy of the match at both low and high time scales, without
changing the value of k–3. This is especially important considering the error at early time
scales in Figures 2-7 and 2-8, performed with the unadjusted value of k–3 given in Table
2-2. Still, the quality of the match belies a large deviation from the allowed variation of
protein concentrations. In fact, the data were obtained with similar protein concentrations
to those in Figures 2-7 and 2-8, so we should be able to observe similar behavior of total
electron flux. However, my simulation at reported protein concentrations in Figure 2-9
predicts a much greater activity than that actually measured or even simulated originally
by Thorneley and Lowe.
In order to evaluate this large discrepancy further, I performed an internal
consistency check on my program by executing progress curves equivalent to those in
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Figures 2-7 through 2-9, comparing the total electron flux in the presence of N2
(2 H2 + 3 NH3 electrons) and absence of N2 (2 H2 electrons). This analysis revealed that
in silico nitrogenase is about 7% more active in the presence of N2 and with the reported

protein concentrations in Figures 2-7 and 2-8. While this may contradict the observed
phenomenon for Av nitrogenase that electron flux through nitrogenase is actually 13%
decreased in the presence of N2 (107), this 7% theoretical increase is intuitive in terms of
the original T&L kinetic schemes according to the following logic.
First consider that in the presence of N2 there are additional pathways that release
product faster than in its absence. For instance, there is obligatory release of H2 upon
binding of N2 in the k10 and k11 pathways. Also, there is no indication of extra rate
constants for the release of product NH3 from nitrogenase in addition to the rate constants
of the Fe protein cycle, e.g. k–3. On the other hand, H2 release must correspond to the
additional rate constants k7, k8, and k9, whereas NH3 release in Scheme 2-2 is assumed to
be automatic (fast) with the completion of an Fe protein cycle upon Kp20(MgADP)2
release.
This behavior is built into the T&L schemes to increase the electron flux through
nitrogenase in the presence of N2 gas and is consistent with a higher activity for NH3
formation, such as in my initial simulation at reported concentrations in Figure 2-9. It
would seem, therefore, that the data and published T&L simulation reflect a lower
enzyme activity than corresponds to the expected activity from Scheme 2-2, upon
consideration of the higher error rates than in Figure 2-7 necessary to lower activity until
the match is made.
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So far, it has been possible to match every T&L simulation, albeit outside of the
parameters of the model. There is, however, evidence that my program is actually
different from Lowe’s in some fundamental way, and it becomes my task to show that the
error lies in Lowe’s program, not mine. The case in Figure 2-10 vindicates my program
and exposes crucial errors in Lowe’s program. Here, pre-steady state production of N2H4
formed by acid or base quench of nitrogenase under 100% N2 is monitored. Of particular
note is that in my simulations, at both reported and adjusted concentrations, the quantity
of N2H4 released upon quenching levels off after about four seconds, whereas the original
T&L simulations, particularly the one in absence of H2, display a notable negative drift.
This is true regardless of variation of the value of k–3. In fact, decreasing the
value of k–3 to mimic the procedure in the analysis of Figures 2-7a and 2-8 exacerbates
the already large deviation in adjusted protein concentrations and creates a discrepancy in
the lag time before product formation, suggesting that Thorneley and Lowe adjusted the
value of k–3 only in the particular cases of Figures 2-7 and 2-8.
For Figure 2-10, the fit to the peak at 1 s is not shown because, interestingly, these
same protein concentrations fit the peak of second simulation in the figure, that of H2
inhibition of N2H4 production, rather well.
The question arises whether the negative drift in Figure 2-10 is present, yet
undetected at earlier t. Notice that the best-fit simulation at adjusted concentrations fails
to match the peak of N2H4 production. It is possible to fit this peak, as we will see in
Figure 2-14, but this comes at the expense of the fit at later t, indicating that the drift is
indeed present at earlier t, and propagated through time. In fact, the expected difference
between our respective simulations at 1 s should be –0.108 μM if the negative drift in the
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Figure 2-14. Determination of which nitrogenase intermediates are responsible for
N2H4 release upon acid or base quench. T&L data under 100% N2 (●), pH 7.4 and 23
o
C, and with 9 mM ATP and 10 mM DT; T&L simulations (▬ ▬ ▬); and duplication
attempts at reported and adjusted conditions (▬▬▬ → ——, respectively). T&L data
and simulation are from ref (4). The conditions given in the table inset assume a Mo
content of 1.3 Mo/Kp1. Of particular note, an error was detected in Fig. 2 of ref (4): the
expected E3N2H simulation was actually determined to be E3H3 plus E3N2H species.

T&L simulation manifests at early, as well as later, t. This value is determined from a
linear fit to the T&L simulation after 5.4 seconds and getting a negative slope of –0.0492
μM/s (R2 = 0.999). Working towards earlier time, the highest time of comparable N2H4
concentrations between our respective simulations is at the peak at 3.2 s. Going back to 1
s corresponds to –0.108 μM = ((3.2 s) – (1 s))(–0.0492 μM/s), the expected difference
between the simulations at the 1-s peak. The actual difference is –0.123 μM, which is
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very close to the expected value, considering the likelihood of slightly different protein
concentrations in our respective simulations.
It cannot be determined whether a correction should be made to each of the T&L
simulations to account for this negative drift because the drift is likely dependent on a
variety of factors, including protein concentrations, and the presence or absence of N2 or
extra H2, for example. If there is an error in Lowe’s program for a particular state of the
enzyme, then we should only expect to see problems when that state of the enzyme is
formed. In short, there are too many factors that complicate this issue to attempt a fullscale correction.

It is also possible that the drift is not accountable for the differences between our
simulations in Figures 2-7 and 2-8. Evidence for this conclusion is found in Figure 2-14.
Thorneley and Lowe ascertained which MoFe protein intermediates would release N2H4
upon quenching by considering the likely possibilities—E3N2H, E4N2H2, and E5N2H3
species—and comparing simulations to the data (same in both Figures 2-10 and 2-14).
Starting with what was concluded as the answer, I performed a best-fit simulation to the
E4N2H2 T&L simulation.
Note that the peak at one second can be fit quite well if we disregard high time
scales present in Figure 2-10. A fair comparison of these three classes of intermediates to
the data ought to be done with equivalent simulated protein concentrations. Note that the
reported E3N2H T&L species is actually higher in amplitude than the other two
possibilities. At these reported conditions, my initial simulation was very different.
Conceptually, my simulation makes sense because both E3N2H and E4H4 feed into
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E4N2H2, so the amplitudes of individual E3N2H and E4H4 species must be smaller than
the E4N2H2 amplitude.
I considered it unlikely that this gross difference in our respective E3N2H
simulations could be due to program differences because the cause of this difference
would then affect other fits by a large degree as well. Rather, I considered likely human
errors.
My adjusted curve to match the T&L E3N2H simulation shows that I solved this
problem. This curve represents the sum of E3H3 and E3N2H species, at the exact same
protein concentrations as my best fit for the T&L E4N2H2 simulation. This gross human
error can be forgiven; and yet it shows an important point—there is little drift between
the E3H3 & E3N2H curve and E4N2H2 curve for Lowe’s program.
On the other hand, my match for the T&L E5N2H3 simulation requires a 3.3%
increase in each protein component, with the concentrations used to fit the E4N2H2 curve
as reference. The difference between my expected and adjusted simulations for this case
shows time dependence towards higher than expected activity in E5N2H3 populations.
Perhaps the negative drift observed in Figure 2-10 is an error that converts E4N2H2 into
E5N2H3 too much, accounting for the decrease in E4N2H2 activity in Figure 2-10 and a
relative increase in activity in E5N2H3 in Figure 2-14.
If this is true, then we can also gain insights into the Lowe program in general.
Specifically, the relative behaviors of E3 and E4N2H2 species show very good correlation
in Figure 2-14. So if E4N2H2 experiences a negative drift as early as one second (as
observed in Figure 2-10), then the E3 species (both free and bound to N2) must also
experience a comparable negative drift.
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Still, as mentioned above, the exact nature of the error in the Lowe program
cannot be characterized completely because Lowe does not report adjusted concentrations
as I do. Rather, we do not know the extent of the deviation of protein concentrations
used to arrive at published simulations.

One of the best ways to characterize the response of nitrogenase to N2 is by the
change in Km vs. [Kp2]/[Kp1] as in Figure 2-11. In context of our recent discussion
about drift probably affecting En species for n < 4, including N-bound species, and in
some way changing drift patterns by n = 5, it is very interesting that my match in Figure
2-11 is not very difficult to attain. Rather, it hearkens back to the method of vertical
shifting used in Figure 2-1. Though this falls outside the framework of the model, the
amount of vertical shifting required is minimal. Whereas in Figure 2-1, the vertical
shifting is clearly wrong, probably because of tweaking of the model beyond its
framework, in this case there is uncertainty whether it was actually performed by
Thorneley and Lowe, or whether the vertical difference between our respective
simulations is due to the errors in the Lowe program discussed above.

2.2.5. Theoretical Product Distribution Studies
So far, the attempts at matching the T&L model have met with few successes
within the framework of the model. Reasons for this include the possibilities of program
errors and wrongful application of the model by going beyond its set framework, such as
exceeding limits on the allowed variation of the concentrations of component proteins,
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Figure 2-15. Theoretical product distribution as a function of relative activity
varied by changing [DT]. T&L simulations (▬ ▬ ▬) and duplication attempts (——)
under conditions of 100% N2, 50% active Kp2, 1.2 Mo/Kp1, and at either high protein
concentrations ([Kp1] = 80 μM, [Kp2] = 240 μM; k–3 = 6.4 s–1; reference time tref = 15 s)
or low ([Kp1] = 2 μM, [Kp2] = 6 μM; k–3 = 7.1 s–1; reference time tref = 60 s). T&L
simulations are from ref (7).

changing the value of set rate constants, vertical scaling, vertical shifting or simple
human error.
Fortunately, Thorneley and Lowe provide a single theoretical figure that ought to
minimize the complications of finding a match. In Figure 2-15, we see the theoretical
product distribution (% electrons) as a function of relative activity (electron
pairs/Kp1/min) varied by changing the DT concentration. Thorneley and Lowe provide
many in silico input parameters for this example (7). However, they do not elaborate on
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two very important details: the method for determining 2e– Kp1–1 min–1, and the method
used to adjust the specific activity of Kp2.
First, activity can be measured in a variety of ways, and it is not mentioned
whether instantaneous rates (derivatives of products with time) are used, or whether
product evolution in a given amount of time is used. Attempts at finding a match with
the former method were ineffectual; the general shapes of my simulations with this
method are very different from the T&L simulations. Assuming Thorneley and Lowe
used the second method, there is no indication of the reference time for determining
activity. My simulations in Figure 2-15 use different reference times for either high or
low protein concentrations: 15 s and 60 s, respectively. The reference time is the most
important factor to get the curves for product distribution at high protein concentrations
to cross each other at around 50 2e– Kp1–1 min–1, though there are striking differences
between my simulations and the T&L simulations at lower 2e– Kp1–1 min–1 for this
reference time.
Second, Thorneley and Lowe state that the simulations assume a specific activity
for Kp2 at 23 oC of 1430 nmol H2 min–1 mg Kp2–1, or 50%. Recall from the discussion
of Figures 2-4 and 2-13 that this high of a specific activity is impossible to simulate
without drastic departure from the framework of the model, involving scaling of specific
activity to some degree. It is not surprising, then, that my simulations—at 50% activity,
but with a Kp2 specific activity closer to 700 nmol H2 min–1 mg Kp2–1—fail to match the
T&L simulations, especially at low 2e– Kp1–1 min–1. I was not able to determine
conditions to match the T&L simulations at high protein concentrations, though changing
the value of k–3 from 6.4 to 7.1 s–1 (within the error limits for k–3) was necessary to match
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the curvature of the T&L simulations at low protein concentrations. Of these two values
for k–3, 6.4 s–1 fit better in general at high protein concentrations, but not so well at low
ep/Kp1/min. As stated previously, changing the value of k–3 was also necessary to match
the T&L simulations in Figures 2-7a and 2-8, and is a violation of the framework of the
model since Thorneley and Lowe repeatedly state that their simulations use the rate
constants as given in tables that show no error limits.
This case is disappointing considering the largely theoretical nature of the T&L
simulations in Figure 2-15, though my failure at obtaining a match is somewhat
reminiscent of another example in this study with limiting DT concentrations. Namely,
in Figure 2-1 it is clear that there is a mistake in the T&L simulation, either in Lowe’s
program or methods of implementing the model. Recall that the problem with Figure 2-1
is that the model should not extrapolate activity as a function of [DT]½ to the origin,
whereas the T&L simulations do. The problem is the same in Figure 2-15.
To see why this is so, consider that there must be a threshold for [DT] below
which H2 release dominates because of the low probability of forming N2-binding
species. This is the case for the lag phase experiment of Hageman and Burris (104),
where no NH3 evolution is detected from nitrogenase under N2 and low flux conditions.
The protein ratios are different in this case, but the crucial detail of low electron flux has
the same effect. Clearly, then, the curves in Figure 2-15 should not extrapolate to the
origin from their primary curvature, but rather from a secondary curvature as manifest in
my simulations. The evidence of vertical shifting is absent in this case, however,
considering the good agreement of my simulations to the T&L simulations at high
concentrations above 50 2e– Kp1–1 min–1, and considering the impossible task of
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matching the slopes of the T&L simulations at low protein concentrations. It is more
likely that this example is further evidence for differences between my program and
Lowe’s, including possible errors in Lowe’s program that defy the logic of the model.
By the same arguments used to show the flaws in the T&L simulations of Figure 2-1, the
T&L simulations in Figure 2-15 are likely flawed as well, as no evidence is shown of
their recovery from direct extrapolation to the origin as is indicated in my simulations.
Care should be taken in an analysis of Figure 2-15 not to associate the T&L
simulation for NH3 product at high protein concentrations with true Michaelis-Menten
kinetics, even though a Lineweaver-Burk plot fits the simulation surprisingly well (R2 =
0.9996). If this curve did in fact follow Michaelis-Menten behavior, then its Vmax would
fit to 78%. From the limiting stoichiometry of the nitrogenase reaction (Equation 1-2),
there is at least one H2 produced per N2 reduced, or two electrons out of eight to complete
the MoFe protein cycle (Scheme 2-2), or 25%. Clearly, N2 production cannot exceed
75% of the total electron flux, so the 78% from the Michaelis-Menten fit must somehow
be inaccurate. The key to understanding why this is the case is that the relative activity
reaches a maximum beyond which higher [DT] does nothing because of the rate limiting
step in catalysis. This prevents the horizontal axis from reaching values that would
correspond to a product distribution exceeding the limiting stoichiometry for product
distribution.

One of the interesting questions about nitrogenase is why it is such a slow
enzyme, with a rate-limiting step of 6.4 ± 0.8 s–1. Thorneley and Lowe conjecture that
this is so to minimize the evolution of H2 relative to NH3 (2, 3, 7). It is thought that the
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hydrogenase activity of nitrogenase is inevitable since protic attack is necessary for the
production of NH3, and according to Scheme 2-2, necessary for the initial binding of N2
as well. The release of H2 is therefore minimized kinetically to avoid wasting reductant
and ATP resources. Attempts to increase the value of k–3 by mutating the Fe protein
should not continue, therefore, because the result would be a nitrogenase inefficient at
reducing N2. To compensate for the slow rate of efficient nitrogenase with low k–3,
diazotrophic species produce massive amounts of nitrogenase, as much as 10% of the
total protein in vivo (7).
This summarizes the views of Thorneley and Lowe on this matter, but with the
power of their model, they make no attempt to test this conjecture. I have done so in
Figure 2-16. In these simulations, the value for k–3 is varied at a particular DT
concentration. The product distribution is affected by the value of k–3, and reaches
theoretical peak efficiency for NH3 production (% of electrons going to NH3 production)
that varies from one simulated DT concentration to another. Note that the theoretical
nature of these simulations neglects the salt inhibition of DT at high concentrations, so
the concept behind the DT values cited in the Figure caption ([DT] = 10-80 mM) is that
reducing power is increased in silico. This discussion is relevant considering the high
rates of nitrogenase catalysis using in vivo reductants such as flavoprotein.
Two important conclusions can be drawn from Figure 2-16. First, Thorneley and
Lowe have a perfectly valid argument for why nitrogenase is such a slow enzyme. It
does indeed appear that, for any given level of reducing power, increasing the value for
k–3 beyond a certain point leads to inefficient catalysis with reference to N2 reduction.

This conclusion is at least consistent with their model.
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Figure 2-16. Theoretical effects of the speed of the rate-limiting step, k–3, on product
distribution. Original simulations with input parameters 100% N2, 50% active Kp2, 1.2
Mo/Kp1, [Kp1] = 80 μM, [Kp2] = 240 μM, and various [DT]/mM: 10 (▬▬▬), 20 (▬
▬ ▬), 40 (▬▬▬), and 80 (▬ ▬ ▬). Product distribution was determined from natural
product release at 15 s, with no initial Kp21.

The fact that efficiency peaks in each of these simulations answers an additional
question: If slow catalysis minimizes H2 release in favor of N2 reduction, then why is the
value of k–3 not even smaller? Prior to performing these simulations, answers to this
question would have undoubtedly centered on reaching a compromise between
maximizing NH3 production efficiency versus the need to generate sufficient NH3 to
maintain cell physiology. These considerations are still certainly valid, yet Figure 2-16
gives us a much higher level of insight—if the value of k–3 is too low, then NH3
production efficiency actually declines.
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The second valuable insight gained from Figure 2-16 is that there may be an
optimum level of catalysis in vivo, corresponding to the value of k–3. Notice that for the
simulation at [DT] = 40 mM, the peak NH3 production efficiency is centered within the
error limits for the value of k–3 = 6.4 ± 0.8 s–1. If this value were accurate, along with the
other rate constants in the T&L model, then it would be interesting to see if the reducing
power in Klebsiella pneumoniae at 23 oC is equivalent to 40 mM DT, disregarding the
effects of salt inhibition inherent at such high [DT].

2.3. Summary and Conclusions
The T&L model is the dominant model for nitrogenase catalysis. In this chapter, I
have reviewed the assumptions of the model (Table 2-1) and the kinetic schemes
(Schemes 2-1 and 2-2, with rate constants in Table 2-2) that form the basis of a computer
program for simulating nitrogenase kinetics. We have seen how the qualitative behavior
of the model matches data. We have also seen how my attempts at duplication of the
T&L model come only after extensive deviation from the parameters of the model.
Logical contradictions between the T&L model and T&L simulations have been exposed
through this effort, proving that the T&L model was misapplied to data.
Unfortunately, it has been unknown until my efforts that the model does not
describe nitrogenase behavior so well as Thorneley and Lowe would have us believe.
Interestingly, only one duplication effort in this chapter manages to match a T&L
simulation within the strict framework of the model: Figure 2-2. It is interesting that of
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all the simulations, this is the only one that absolutely had to match because it is an
attempt to measure the value of k–1/k1. Even so, this match is stretched to the limit. A
cursory glance at Figure 2-8 suggests that it is successful as well, but upon closer
scrutiny, it is shown to be suspect. Other attempts are considered failures because of:
exceeding the allowable limits of variation of protein concentrations; curve-fitting
methods that lie outside of the framework of the model, such as vertical shifting, vertical
scaling (scaling of the dependent variable), varying rate constants, and/or human error;
and apparent errors in Lowe’s program.
We would be perfectly justified to conclude that the T&L model is more
qualitative than quantitative just from the analysis in this chapter, but I have additional
evidence from Lowe himself. In our personal correspondence, he admitted to me that
simulating the effects of the [ADP]/[ATP] ratio could only be done “unsatisfactorily and
not quantitatively,” whereas in publications, Thorneley and Lowe repeatedly claim that
they are capable of modeling the effects of ADP inhibition of nitrogenase (2, 7).
Similarly, it is clear from the study in this chapter that in general the model is
unsatisfactory and not quantitative. Rather, it is more of a qualitative model, and its
value should be considered as such.
Over the years a number of manuscripts have faced hurdles to be published from
presenting material contrary to the T&L model, and belief in the T&L model has stifled
many research efforts because some things in the model are taken for granted and not
questioned. Now that evidence has been presented to show that the T&L model is not so
correct as generally thought, a new attitude for vindicating research that does not support
the T&L model can be nurtured. The availability and usability of my program has the
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potential to give a number of groups the means to evaluate the T&L model in terms of
their own data. The assumptions of the model have been clearly laid out in this chapter,
giving researchers the opportunity to challenge their validity, discard false assumptions
and validate correct ones. In this chapter I have challenged the very applicability of the
model at the source. I have also validated the assertion of Thorneley and Lowe that the
value of k–3 is likely slow to maximize the efficiency of NH3 production, at least within
the framework of their model. In subsequent chapters, core assumptions of the model
itself will be challenged.

75

76

Chapter 3
Extension of the Thorneley-Lowe Model Through the
Years: Applications, Additions and Simplifications

Some of this chapter is based on a manuscript authored by myself, A. C. Nyborg
and G. D. Watt and published in Biophysical Chemistry (10), but most of this chapter is
newer work and a very focused literature review.

Over the years Thorneley and Lowe have used their model to explain new data.
In some cases, the T&L model in its original state is used. In other cases, the model must
be appended or even simplified to fit data. When such changes are made, their effects on
the original model were not determined, until now. In this chapter, I will critique such
additions and simplifications and their impact on the original T&L model.

3.1. Are Rate Constants Independent of the Reduction of En?

3.1.1. A Look at k1
In their original model, Thorneley and Lowe point out that it may be possible that
the rate constants for the Fe protein cycle change with the level of reduction of En (4).
Understandably, determining how these rate constants might vary was never attempted
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because of the complexity in having to account for a multitude of E-Kp2 intermediates in
reducing N2 (see Scheme 2-2). However, for the simplest case of product evolution—H2
evolved from E2H2—it is very easy to check whether there are differences between rate
constants for the first and second Fe protein cycles.
When [KpE]/[Kp2] is large, electron flux through nitrogenase is limiting, and
electrons tend not to accumulate on KpE. Because products are released from KpE when
Kp2 is not bound, having very little Kp2 compared to KpE means that products can
escape easily. The soonest this can happen is at E2H2. Upon formation of this species,
H2 is promptly evolved compared to the rate of Kp2 binding that would prevent its
evolution, and so E3H3 is not formed to any significant extent.
So under these conditions, the only significant species are E0 and E1. Because
only two Fe protein cycles are involved in this case—one to reduce E0, and one to reduce
E1—any differences in the rate-limiting steps of these two Fe protein cycles would show
up in a disproportionate relative population of either E0 or E1. On the other hand, if both
the rate-limiting steps in these Fe protein cycles are identical, then the equilibrium
concentrations of E0 and E1 will be identical.
As shown in Figure 3-1, the latter case is true. Here, the EPR intensity of KpE
diminishes to a limit of 50% of its initial value. Given that E0 has an EPR signal whereas
E1 is EPR-silent, it is clear that this limit of 50% is evidence that the equilibrium E0 and
E1 concentrations are identical. Additionally, the amounts of E0 and E1 are correlated
with H2 evolved, as shown in Figure 3-1. This result shows that the rate-limiting steps
under these conditions are the same to within 10% for these two Fe protein cycles. So
what is the rate-limiting step? It is k1, the association of KpEn with Kp21(MgATP)2.
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Figure 3-1. Is k1 for E0 → E1 the same as for E1 → E2? H2 evolution and EPR signal
as a function of time under low-flux conditions. T&L H2 data (●) and EPR intensity
(○) followed from the EPR spectrum (inset) between the arrows, pH 7.4 and 23 oC, and
with 9 mM ATP and 10 mM DT; T&L simulations (▬ ▬ ▬ for product formation, and
▬ ▬ ▬ for %En); and duplication attempts at reported and adjusted conditions (▬▬▬
→ ——, respectively). T&L data and simulation are from ref (103). The conditions
given in the inset tables assume a Mo content of 1.5 Mo/Kp1. The Adjusted
concentrations from [H2]/ μM were used as the Expected concentrations of the
corresponding EPR data for %En.

For both H2 activity and relative EPR intensity, the T&L simulations are easy to
duplicate (as shown in Figure 3-1). The reported and adjusted conditions are off by less
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than 10%, and so fall within the parameters of the T&L model. As for the data, they are
consistent with one of Thorneley and Lowe’s assumptions that the rates of the Fe protein
cycle do not vary with the level of reduction of KpEn. However, it should be noted that
Thorneley and Lowe originally thought that differences in rates from one Fe protein cycle
to another were responsible for the poor fit of their simulation to N2H4 upon quenching
on E4N2H2 (4). This could still be true for E2 → E3 and/or E3 → E4.

3.1.2. A Look at k2
It is also possible to measure any difference in the rate of k2—electron transfer in
the KpEn-Kp21(MgATP)2 complex. It is easy to measure k2 optically in the stopped-flow
apparatus because there is an increase in the extinction coefficient of Kp2 going from the
reduced to the oxidized state. Upon mixing Kp21(MgATP)2 to E0, the optical change
corresponding to inter-protein electron transfer fits to a single exponential curve—see
Fig. 3a of ref (103). If k2 is the same for the first two Fe protein cycles, then data
showing the oxidation of Kp21(MgATP)2 by a mixture of E0 and E1 would also fit to a
single exponential. Such a mixture is easily obtained from a low level of Kp21(MgATP)2
as is the case in Figure 3-1. On the other hand, if k2 is different for these two Fe protein
cycles, a double exponential fit is expected. The first case was shown to be correct in
Fig. 3b of ref (103), and so k2 does not vary for the first two Fe protein cycles.
While it appears that k1 and k2 for the first two Fe protein cycles are identical,
nothing can be concluded about the other rate constants, nor the other Fe protein cycles
associated with states of En where n > 2. Of particular concern are what effects other
substrates might have on the rates of the Fe protein cycle. Recall from the previous

80

chapter that the theoretical nitrogenase activity (assuming that Scheme 2-2 is correct)
predicts greater activity under N2, whereas the opposite is true experimentally (107, 108).
Such a drop in activity in the presence of substrates other than H+ may very well be due
to changes in the rates of the Fe protein cycle for En intermediates that are difficult to
characterize except kinetically, and even then only to a limited extent. In fact we see in
the next section how the addition of acetylene does indeed change the rates of the Fe
protein cycle in an addition to the T&L model.

3.2. Reduction of Alternative Substrates

3.2.1. Acetylene Reduction
The most commonly used substrate in nitrogenase research is C2H2. Two reasons
for this are that: the product of C2H2 reduction, C2H4, is easily detected by gas
chromatography; and C2H2 is reduced at the same site on the FeMoco as N2. Scheme 3-1
shows the MoFe protein cycle for C2H2 reduction (8). Of note, C2H2 binds to a more
oxidized state of En than does N2, namely E1H and E2H2.
This scheme is consistent with the mechanism of Ashby et al (109), but the
additional binding of C2H2 to E2H2 is required for Lowe et al (8) to simulate C2H2
reduction when the nitrogenase concentration is low, as shown in Figure 3-2. Eady &
Postgate reported that a with increasing MoFe inhibition, the percentage of flux going to
C2H2 reduction compared to H+ reduction decreased (110). The value of Scheme 3-1 is
to account for this behavior quantitatively. One caveat of Scheme 3-1 is that Lowe et al
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Scheme 3-1. Acetylene reduction by nitrogenase. Adapted from ref (8), with added
rate constants as follows in Table 3-1:
Table 3-1. Rate constants for Scheme 3-1. Measured for Kp nitrogenase at 23 oC and
pH 7.4 (8).

Rate
Constant
Value
k12
107/ M s
k–12
100/ s
k14
400/ s

Comment
Determined from
Ks for C2H2
C2H4 release

could not definitively show that C2H2 binds to E1H. Furthermore, binding of C2H2 to E0
could not be excluded.
While Scheme 3-1 works when the nitrogenase concentration is low, there is
some peculiar inhibition of nitrogenase by C2H2 under high protein concentrations. This
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Figure 3-2. Decreased relative flux to C2H2 reduction with MoFe inhibition. T&L
H2 data (●), pH 7.4 and 23 oC, and with 9 mM ATP and 10 mM DT, assumed 1.3
Mo/Kp1; T&L simulation (▬ ▬ ▬); and my simulations at reported and adjusted
conditions (▬▬▬ → ——, respectively), with product concentrations (▬ ▬ ▬) at
adjusted concentrations. T&L data and simulation are from ref (8).

behavior is shown in Figure 3-3. It was assumed when the T&L model came out that the
flux through nitrogenase did not change with the substrate (7). Whereas this might be the
case at low protein concentrations, it is clearly not so at higher concentrations. Activity
is more and more inhibited in the presence of C2H2 relative to activity in the presence of
Ar with increasing protein concentration. Therefore, there are critical problems when
Lowe et al try simulating C2H2 reduction from data garnered with the rapid quench
technique that requires high protein concentrations. Scheme 3-1 predicts a much more
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Figure 3-3. C2H2 inhibits total nitrogenase activity at high protein concentrations.
Total specific activity under 30% C2H2 (●) compared to H2 evolution under 100% Ar or
with 5% CO (●), with [Kp2]/[Kp1] held constant at 4/1, pH 7.4 and 23 oC. Source data
from Figs. 2 & 3 of ref (8); averaged for presentation in this figure. Note similarities to
Figure 2-6, except for the different units on the y-axis and more prominent curvature
here.

active rate of catalysis than is actually observed. Lowe et al solve this problem by
proposing a simplified scheme, Scheme 3-2, which assumes a baseline Kp2 concentration
and allows for different binding constants of Kp20(MgADP)2 to EnHn intermediates in the
H2-releasing pathway (Ka), as opposed to EnCnHn intermediates in the C2H4-releasing
pathway (Kb). The simulated values of Ka and Kb were determined from a fit to the data
in Figure 3-3. Scheme 3-2 also substitutes a single rate for the complete Fe protein
cycle—k1. The value of k1 is set to the value of the rate limiting step of k–3 of the original
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Scheme 3-2. Simplified scheme for acetylene reduction. Adapted from ref (8). *EnHn
species are bound up by Kp20(MgADP)2. Added equilibrium and rate constants and
assumptions as follows in Table 3-2:
Table 3-2. Rate constants and additional assumptions for Scheme 3-2. Measured for
Kp nitrogenase at 23 oC and pH 7.4 (8).

Rate
Constant
Value
k1
6.4/ s
Ka
4.0 × 103 M–1
Kb
2.4 × 104 M–1

Kc

2.5 × 106 M–1

}

Comment on Rate Constant OR Additional Assumption
Set to the value of k–3, the rate-limiting step in catalysis
Estimated by assuming that [Kp20] binding up *EnHn is
equal to [Kp2]tot. Underestimate real values.
• At high protein concentrations, acetylene-bound Kp1
intermediates have different rate constants for binding Fe
protein.
Kc is an overestimate of K12 = k12/k–12 = 105.
• Other rate constants, e.g. k7, k8, k9 and k14, are
unaccounted for.
• Quench releases a single H2 from free E2H2C2H2, not
*E2H2C2H2 All E3HC2H4 species yield C2H4 product
upon quenching.
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Figure 3-4. C2H4 vs. H2 production under high protein conditions. T&L C2H4 data
(●) and simulation (▬ ▬ ▬) and H2 data (●) and simulation (▬ ▬ ▬) from ref (8), pH
7.4 and 23 oC, and with 31 μM Kp1 (1.3 Mo/Kp1), 124 μM Kp2, 9 mM ATP and 10 mM
DT; my simulations at initial and adjusted k3,C2H2 for C2H4 (▬▬▬ → ——, respectively)
and H2 (▬▬▬ → ——, respectively), with my H2 simulations repeated in (b).
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T&L model. Fitting this simplified scheme to their rapid quench data led Lowe et al to
postulate that the decreased activity at high protein concentrations is due to an increase in
the association rates of component nitrogenase proteins in the C2H4-releasing pathway,
k3, not in their dissociation in the k–3 step (8).

This hypothesis should have been tested against the more rigorous and thorough
Scheme 3-1, but it was not. My efforts to do so are shown in Figure 3-4. The addition of
k3,C2H2, which is k3 specific to the C2H2 reduction pathway, was added into my
Mathematica program to observe the effects of increasing the affinity of C2H2-bound

KpE for Kp2. By increasing the value of k3,C2H2, I am able to bring the simulated activity
of C2H2 reduction down to experimental levels of data under the high protein conditions
of Figure 3-4a. Unfortunately, this occurs at the expense of H2 evolution, which is also
inhibited by the increase in k3,C2H2—see Figure 3-4b. This only worsens the simulation of
H2, which is much less active than it is experimentally in Figure 3-4a.
Figure 3-2 may hold the key to an alternative means to increase H2 production
while decreasing C2H4 production—by inhibiting total flux through nitrogenase. For
instance, by decreasing the value of k1 by 33-fold I obtain a fit of the C2H4 simulation and
an increase in H2 evolution, though only up to 1.5 nmol H2 at 10 s, compared to almost
63 nmol H2 at 10 s for the T&L simulation of H2 production. Likewise, varying k–3 also
could not produce a satisfactory fit to the data.
Clearly, varying rate constants could continue with the full nitrogenase scheme,
but the rationale behind such changes must be questioned. A mechanism of nitrogenase
inhibition by C2H2 should first be determined so that the model is rationally designed.
Without such rationale, a simplified scheme was implemented by Lowe et al. It is clear

87

that the mathematical responses of Scheme 3-2 to changes in constants are different than
they are for Scheme 3-1. Attributing the different inhibition under C2H2 in Figure 3-3 to
an increase in k3,C2H2 is simply wrong. The use of a “simplified scheme” appears to be an
attempt at hand-waving. It fits the data, but with absolutely no rationale. The added
assumption of Scheme 3-2 that H2 is not released upon quenching of *E2H2C2H2 species,
only the free E2H2C2H2 intermediate—see Table 3-2—also appears to be irrational
because it goes contrary to the conclusions of the original model that quench products are
released on the KpE2-Kp20(MgADP)2 complex.

3.2.2. Cyanide
A subsequent study by Lowe et al (111) used this same approach of implementing
a simplified scheme to fit nitrogenase under HCN-reducing and CN–-inhibited conditions.
Based on my experience with C2H2 above, I feel that the experimental data are good, but
the data analysis is specious whenever a simplified scheme akin to Scheme 3-2 is used.

3.3. Tracking the MoFe Protein Cycle

3.3.1. Spectroscopic Studies
Reverting back to the original T&L scheme, Lowe et al tackled the problem of
accounting for optical changes associated with KpEn in a stopped-flow study (112). I
will not attempt a duplication of their simulation. Rather, it is interesting that a
subsequent study by Duyvis et al with Av nitrogenase in 100 mM NaCl at 20 oC reported
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Figure 3-5. Stopped-flow assessment of the MoFe protein cycle. Lowe et al (112)
(▬▬▬) ΔAbs430 data pH 7.4 and 23 oC, Kp nitrogenase; Duyvis et al (113) (▬▬▬)
ΔAbs430 data pH 7.4, 100 mM NaCl, 20 oC, Av nitrogenase. En intermediates (▬ ▬ ▬)
corresponding to the fit of Av data by Duyvis et al.

similar data but with a very peculiar feature (113). These two studies are contrasted in
Figure 3-5. The rapid initial increase in ΔAbs430 is due to oxidation of R1 to R0, finishing
at about 25 ms. However, the long-term trend of increasing absorbance is due to the
progression of En through the MoFe protein cycle. Each of these studies reports the
change in extinction coefficients associated with this progression. The primary
difference in the data of these two studies is the sharp decrease of absorbance between
0.05 and 0.15 seconds in Av nitrogenase. There is some question about what this
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Scheme 3-3. Electron transfer precedes ATP hydrolysis. Adapted from ref (113),
with rate constants for Av nitrogenase in 100 mM NaCl at 20 oC.

difference is due to the species difference or the lower temperature and/or increased
ionic strength.
In any case, the Av data could not be fit to the T&L model because of this
peculiar drop in absorbance. Interestingly, by a simple addition to the Fe protein cycle to
account for ATP hydrolysis—see Scheme 3-3—this drop could be modeled. It was
determined that ATP hydrolysis occurred at a rate of 14 s–1 and must precede nitrogenase
complex dissociation (113). However, it was observed that the rate-limiting step of
catalysis was very low at 3.3 s–1, much lower than the rate of complex dissociation for Kp
nitrogenase. Perhaps this decrease is due to experimental conditions of the Av data,
which were performed at a lower temperature and a higher ionic strength. Both of these
differences would decrease activity, and both together may inhibit synergistically.
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3.3.2. A Rapid-freeze EPR Study
The preferred organism for the study of the biochemistry of nitrogenase has
become Azotobacter vinelandii (114), in large part because of the much higher protein
activity observed for Av nitrogenase compared with nitrogenase from other organisms.
Kp2, for instance, is only 45% active as discussed in Chapter 2. It was determined that
the reason for this is that Kp2 has an inactive conformation that is in equilibrium and
interchangeable with the active conformation (115). Av2 is more in the active
conformation, estimated at about 60% of Av2 by some (K. Fisher, as expressed at the
2002 Gordon Conference). The Mo content of Av1 (usually 1.8-1.9 Mo/Av1) is also
considerably higher than that of Kp1 (1.3-1.5 Mo/Kp1).
In spite of these differences, one would hope that the T&L model would be just as
applicable to Av nitrogenase as it is to Kp nitrogenase. The comparison of data in Figure
3-5 shows that this is generally the case, but the two data sets were done under such
different conditions that a fair comparison is not possible in this case. Rather, a better
approach has been to duplicate some of the same experiments for measuring rates of the
Fe protein cycle for Av nitrogenase. Importantly, the rate-limiting step of k–3 has been
measured at 6 s–1 (116), 6.6 s–1 (117) and 7.0 s–1 (118) for Av nitrogenase at 23 oC,
consistent with the T&L value of 6.4 s–1 for Kp nitrogenase.
For this reason, it is baffling that in a rapid-freeze study by Fisher, Newton and
Lowe (119), a novel EPR signal could only be simulated by the T&L model if the value
of k–3 “was increased from 6.4 to 11.2 s–1 to reflect the higher maximum specific activity
of the A. vinelandii proteins.” This significant deviation from reality catches my
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attention. Just as with the use of a “simplified scheme,” this irrational change to the T&L
model would appear to take the place of some potentially interesting phenomenon of
nitrogenase that is explained away with the wave of a hand.

3.4. ATP Hydrolysis versus Electron Transfer
Perhaps the most significant addition to the T&L model is the distinction between
electron transfer and ATP hydrolysis in a study by Lowe et al (9). This study employs a
kinetic scheme remarkably similar to Scheme 3-3, but with an additional intermediate of
EnKp20(MgADP·Pi)2 after ATP hydrolysis but before inorganic Pi release—see Scheme
3-4. Additionally, this scheme accounts for reductant-independent ATP hydrolysis,
which is that ATP hydrolysis proceeds in the complete absence of reductant, but at a
much reduced rate compared to ATP hydrolysis during catalysis. This occurs because of:
nucleotide exchange on the nitrogenase complex in the k2,cycle step, and subsequent ATP
hydrolysis.
In this study, Lowe et al follow Pi release in the stopped-flow by its rapid
interaction with a fluorescence probe (120). In Figure 3-6a, we see that the additional
intermediate in Scheme 3-4—EnKp20(MgADP·Pi)2—is observed in the lag in Pi release
after electron transfer but before Pi detection. It is also apparent that Pi release occurs
before complex dissociation.
Duplicating the simulation of Pi release turned out to be a challenge. Two phases
in Pi release are expected: a pre-steady-state phase corresponding to the total amount of
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En
k1

Kp21(MgATP)2

En Kp21(MgATP)2

k–1

k2,e-

2 MgADP

En+e Kp20(MgATP)2

rapid

2 MgATP

k2,ATPase

Kp21(MgADP)2
k4
k3

Kp20(MgADP)2

En+e Kp20(MgADP·Pi)2
k2,Pi
2 Pi

2 MgADP

k2,cycle
2 MgATP

En+e Kp20(MgADP)2

k–3
En+1
Scheme 3-4. Electron transfer, ATP hydrolysis and a non-dissociating Pi-bound
nitrogenase complex. Adapted from ref (9), with added rate constants as follows in
Table 3-3:
Table 3-3. Rate constants for Scheme 3-4. Measured for Kp nitrogenase at 23 oC and
pH 7.4 (8).

Rate
Constant
k2,ek2,ATPase
k2,Pi
k2,cycle

Value
176/ s
50/ s
22/ s
1.5/ s

To Simulate the Classical Model With Added Pathways
Set to 200/ s
Set to 109/ s
Set to 109/ s
Set to 0/ s

active Kp2, plus a steady-state phase from subsequent Kp2 reduction and rounds of the
Fe protein cycle. From the given concentration of Kp2 = 6 μM, we expect the presteady-state Pi release to be:
⎛ e − ⎞ ⎛ 2 ATP ⎞ ⎛ Pi ⎞
⎟⎟ ⎜
⎟⎜
⎟ = 5.4 μM Pi .
−
⎠ ⎝ ATP ⎠
⎝ Kp2 ⎠ ⎝ e

(6 μM Kp2)(45% active) ⎜⎜
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2
e– transfer
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1
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0
0
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0.2

0.3

0.4
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Time/ s

b

7

Concentration/ μ M

6
5.4 μM

5

no DT

4

Reported
Adjusted
%dev

3

[Kp1]/μM [Kp2]/μM
2
6
3.08
2.083
53.8
-65.3

2
1
0
0

0.1

0.2

0.3

0.4

0.5

Time/ s
Figure 3-6. Stopped-flow fluorescent probe for phosphate. In (a) reproduction of Fig.
2 of Lowe et al (9); data (▬▬▬) with simulations (▬ ▬ ▬) with assumptions
described in the text. In (b), reproduction of T&L simulation from (a) (▬ ▬ ▬), with
my simulations at reported and adjusted concentrations (▬▬▬ → ——). Original
conditions assume 1.3 Mo/Kp1, 0.52 mM DT (0 ▬▬▬), 2 mM MgATP, 23 oC, pH 7.4.
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34
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Figure 3-7. Lag phase induced by the addition of ATPase steps in the T&L model.
Application of Scheme 3-4 to the T&L data (●) and simulation (▬ ▬ ▬) of Figure 2-7.
Experimental: 1.3 Mo/Kp1, pH 7.4 and 23 oC, and with 9 mM ATP and 10 mM DT.
Duplication attempts at reported conditions with the original model and the modified
model and the modified model adjusted to fit the T&L simulation (▬▬▬ → ▬▬▬ →
——, respectively). T&L data and simulation are from ref (7). The figure exaggerates
the poor fit for early time from an increased lag in product formation induced by the
additional steps in Scheme 3-4, whereas the fit over the entire time course is very good as
shown in the inset.

This level of Pi production of 5.4 μM is demarcated in Figure 3-6b, and
corresponds to Pi production in a simulation given the reported conditions but without
any DT and with k2,cycle = 0 so that there is no reductant-independent ATP hydrolysis. In
order to duplicate the T&L simulation with DT present, a 65.3% drop in [Kp2] was
necessary. The [Kp2] parameter most significantly affects the overall absorbance at the
time activity makes a transition to the steady state. The 53.8% increase in [Kp1] is
required to match the curvature at early time.
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In spite of the poor fit of the simulations to the data in Figure 3- 6, the
development of ATP hydrolysis pathways is a significant advance to the T&L model.
However, adding steps in Scheme 3-4 may affect how well the adapted T&L model can
model the data used to fit the original T&L model. Such considerations were not taken
into account at the time that Lowe et al proposed the additional steps, but they are
considered now in Figure 3-7. The data from Figure 2-7 were used by Thorneley &
Lowe to determine what intermediates in the MoFe protein cycle evolve H2 (7). It was
concluded that H2 must not be released before two slow dissociation steps and formation
of free E2H2. However, the addition of steps for ATP hydrolysis slows down the Fe
protein cycle sufficiently that there is a prominent lag in the simulation with these added
steps in Figure 2-7 compared to the simulation without them. Thus, Scheme 3-4 allows
for an excellent fit to the T&L simulation overall (inset), but at low time this lag could
not be improved under any circumstances. It is important that both the original T&L
simulation and the data have a much shorter lag.

3.5. Summary and Conclusions
A focus of Chapter 2 was to determine whether the T&L model was reproducible.
This chapter has reaffirmed that implementation of the model goes beyond its own
parameters. Since the time that the T&L model was first designed, new data have pushed
the limits of the model. Sometimes, the model does well. For instance, it is likely that
the rates of the Fe protein cycle do not vary significantly with the level of reduction of En
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under Ar. However, the model fails to be broadly applicable. Another focus of this
chapter has been that the original T&L schemes are often unsuccessful even after going
beyond the ±10% change in protein concentrations and using other faulty methods to fit
data discovered in Chapter 2. We first saw this with C2H2 reduction in this chapter, for
which the rates of the Fe protein cycle change at high protein concentrations. A method
for fitting these data could not be found with the original T&L scheme, and the rationale
for fitting the data with a simplified scheme is tenuous.
The more detailed characterization of the k2 step into separate events of electron
transfer and ATP hydrolysis is a welcome improvement to the model made by different
research groups. However, I have shown that these additions greatly affect the lag in
product formation when applied to the data originally simulated by the T&L model. This
is significant because these data were instrumental in developing one of the core
assumptions of the T&L model that substrates and products only bind to the free MoFe
protein, not on the nitrogenase complex (7).
Perhaps we should not be critical of the added events of electron transfer vs. ATP
hydrolysis. Perhaps the real problem lies in the core assumption of substrate and product
binding. Since this is one of the absolutely fundamental assumptions of the MoFe protein
cycle in the T&L model, a revision of this assumption would not just be a change of the
T&L model in the same way that adding pathways does in this chapter. It would be a
complete overhaul of the model. It would be a new model entirely. In the next chapter, I
review and critique the literature as it relates to developing such a model to replace the
T&L model.
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Chapter 4
In the Aftermath of Thorneley and Lowe: A Review and
Critique of the Literature for Developing a New
Model of Nitrogenase Catalysis
While the T&L model answers a lot of questions about nitrogenase catalysis, it
was nevertheless conceived before a detailed portrait of nitrogenase was revealed. In this
chapter I review the literature that relates to structural perspectives of the mechanism of
nitrogenase and kinetic phenomena that push beyond the limits of the T&L model. In
light of this review, I introduce the framework of a new model to replace the T&L model.
First, I propose a convenient generalized shorthand notation. Each αβ half of
MoFe protein is called “En” for enzyme reduced by n electrons as per the T&L model. Fe
protein is called “RnXm” for enzyme reductase reduced by n = 0, 1 or 2 electrons beyond
the [4Fe-4S]2+ state and bound to m = 0, 1 or 2 nucleotides where X is T for MgATP or D
for MgADP. Thus, the Fe protein cycle of Scheme 2-1 becomes:
En
Kp21(MgATP)2

En
k1

k1

R1T2

En Kp21(MgATP)2

k–1

En R1T2

k–1

2 MgADP

2 MgADP
rapid

rapid

k2

2 MgATP

2 Pi

Kp21(MgADP)2

k2

2 MgATP

→

k4

2 Pi

R1D2
k4

Kp20(MgADP)2
k–3

Ej

k–3

k–3

R0D2

En+e Kp20(MgADP)2

k–3

En+1

k3

Ej
k3

Ej R0D2

Ej Kp20(MgADP)2
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En+1

En+e R0D2

4.1. Three Dimensions of the Fe Protein Cycle
This RnXm notation is interesting because it reveals an underlying pattern of the
different states of Fe protein, where the level of reduction and nucleotide binding could
be considered different dimensions of catalysis. Adding a third dimension of complex
formation with En, we obtain a three-dimensional view of catalysis in Scheme 4-1:

R1T2
rapid
En

k1
k1

R1T2

En R1T2

R1D2

k–1
2 MgADP

k4

rapid

k2

2 MgATP

2 Pi

R1D2

EnR1T2

→

R0D2

k4
k–3

R0D2
k–3

Ej

En+e R0D2

k2

En+1

k–3

k3
Ej R0D2

En+eR0D2
Scheme 4-1. The three-dimensional T&L Fe protein cycle. Only T&L steps shown.

Viewing the Fe protein cycle in three dimensions, it is apparent that the major
intermediates correspond to corners of a cube. I am, to my knowledge, the first person to
think of the intermediates of nitrogenase in this way. The advantage of this paradigm is
that it is easy to see gaps in the Fe protein cycle of Thorneley and Lowe. What about
R0T2, ER0T2 and ER1D2? Leaving out just three corners of the cube eliminates eight
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reaction pathways between the corners—more than the number of major pathways
described by Thorneley and Lowe. Could these intermediates be important under certain
conditions? Could such conditions have relevance in vivo? Are there other intermediates
that are unaccounted for that might also be important under certain conditions? How do
the intermediates relate and interchange with each other? What is the effect of one
dimension of catalysis on the others? How can the T&L model expect to be
comprehensive without accounting for all intermediates in catalysis?
These critical questions will be addressed in this chapter and throughout the
remainder of the nitrogenase chapters in this dissertation. The relevance of each
intermediate should be critiqued, and the assumptions used to eliminate certain
intermediates in the T&L model should be challenged. A structural perspective of the
nitrogenase proteins should help to solidify our understanding of nitrogenase catalysis
and help us rationally address shortcomings of the T&L model for the development of a
new model.

A more complete set of the nitrogenase intermediates of the three-dimensional Fe
protein cycle is shown in Scheme 4-2. This compilation does not including any possible
transition states. The general trends of how the dimensions of catalysis—redox
properties, nucleotide binding, and nitrogenase complex formation—impact each other
are shown. This scheme describes many more intermediates than are in Scheme 4-1.
These will be addressed in this chapter.
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nucleotide
binding
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R2T2

R2

R1T2

R2D

R1T

R2D2

R1

R0T2
R0T

R1D

Increasing
reduction
potential

R1D2
ER2T2

R0
R0D
R0D2

ER2T
ER2

ER1T2

ER2D

ER1T

ER2D2

ER1
ER1D
ER1D2

ER0T2

Increasing
nitrogenase
complex stability

ER0T
ER0
ER0D

ER0D2

Scheme 4-2. Trends in electron transfer, nucleotide binding and nitrogenase
complex stability in the three dimensions of the Fe protein cycle. Electron transfer
events are in green; nucleotide exchange events are in gold; and nitrogenase complex
formation events are in blue. Corresponding trends are shown by arrows in the same
colors. Increasing reduction potential refers to the magnitude of Em (increasingly
negative). Only the most straightforward intermediates and connections are shown; no
transition states. For simplicity, connections between RnX species are not drawn. An
arbitrary level of reduction of E is implemented because reduction of En in the MoFe
protein cycle is an additional dimension of catalysis.

4.1.1. Redox States and Reduction Potentials
The [4Fe-4S] cluster of active Fe protein can exist in three oxidation states:
•

Oxidized, R0, [Fe4S4]2+, i.e. [2Fe2+-2Fe3+-4S2–]2+

•

Reduced, R1, [Fe4S4]1+, i.e. [3Fe2+-Fe3+-4S2–]1+

•

All-ferrous, R2, [Fe4S4]0, i.e. [4Fe2+-4S2–]0

The R0/R1 redox couple is relevant to the T&L model, which came out before the
discovery of the all-ferrous Fe protein by Watt and Reddy in 1994 (121). The

102

[4Fe-4S]
R2T2

Av: Em = –430 mV

R1T2

Kd = 10 μM
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Nitrogenase complex
ER2T2

ER1T2

ER2T

ER1T

ER2

ER1

ER2D

ER1D

ER2D2

ER1D2

Av: R0 → R1, Em = –620 mV
ER0T2
Av: P1+ → PN, Em = –390 mV

ER0T
Av1-Cp2: R0 → R1, Em = –510 mV
2+

N

Av1-Cp2: P → P , Em = –320 mV

ER0
ER0D

Av1-Cp2: R0 → R1, Em = –510 mV
2+
N
Av1-Cp2: P → P , Em = –300 mV

ER0D2

P-cluster
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Av: Em = –300 mV

P1+

Av: Em = –300 mV*

P2+ or POX
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Em = –465 mV
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Em = –42 mV

MOX

Scheme 4-3. Nitrogenase reduction potentials and nucleotide binding constants.
Midpoint reduction potentials, Em, compiled from several sources in ref (114) for Av
nitrogenase and from ref (122) for Cp nitrogenase; and nucleotide dissociation constants
for Av nitrogenase, Kd, from ref (101) between intermediates corresponding to Scheme
4-2. Nitrogenase complex formation alters the reduction potentials of both the [4Fe-4S]
cluster and the P-cluster. PN and MN states as isolated in the presence of DT.
*Value at pH 8.0; changes –53 mV/pH.
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characterization of the all-ferrous Fe protein is an exciting development, most notably
because the ATP requirement of catalysis is cut in half. Indeed, a signature of formation
of this all-ferrous Fe protein is that ATP/2e– = 2. DT cannot reduce Fe protein to the allferrous [Fe4S4]0 state. Rather, reductants such as methyl viologen (MV) or Ti(III) citrate
must be used.
The standard midpoint reduction potentials of RnXm species vary somewhat from
study to study and with the organism. For Azotobacter vinelandii nitrogenase,
representative values are shown in Scheme 4-3 from values compiled in ref (114). The
reduction of R0 to R1 requires about Em = –300 mV (123-125). Fe protein isolated in the
presence of DT is in the reduced [Fe4S4]1+ state. As noted in Schemes 4-2 and 4-3, the
addition of nucleotides shifts the midpoint reduction potential dramatically. An Em =
–430 mV is required for reduction of R0T2, and an Em = –440 mV is required for
reduction of R0D2 (123, 124, 126, 127).
Another trend for reduction potentials shown in Schemes 4-2 and 4-3 is that
further reduction of R1 to R2 is more difficult. However the degree of difficulty has been
debated. Watt & Reddy first reported the formation of R2 requiring a potential of about
Em = –460 mV with methyl viologen as reductant (121). However, the more recent

measure of Em = –790 mV reported by Guo et al (128) coincides with density functional
theory (DFT) (129). If this value is correct, it would suggest that the all-ferrous state
could not be achieved in vivo (114). However, when using the in vivo reductant for Av
nitrogenase, AvFldHQ (Em = –500 mV), the ATP/2e– ratio drops to 2 (96). This
observation warrants an ongoing investigation of the physiological relevance of the allferrous Fe protein in spite of the debate over its reduction potential.
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ERT2: R0 → R1
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–500
–400
–300

RT2: R0 → R1

ERT2: POX → PN
E: POX → PN

R: R0 → R1

–200
–100
0

E: MOX → MN

P-cluster

[4Fe-4S]

FeMoco

Figure 4-1. Thermodynamics of electron transfer—reduction potentials of the metal
clusters of nitrogenase. Graphical representation of the effects of nucleotides and
complex formation on the reduction potentials of the metal clusters in the nitrogenase
proteins. Adapted from ref (130).

A final consideration of the trend in reduction potentials is that complex
formation makes both the [4Fe-4S] and the P-cluster better reductants (114, 130), e.g.
from conformational changes affecting either/both clusters and/or desolvation of
[4Fe-4S] in the nitrogenase complex. These changes work to favor inter-protein electron
transfer and reduction of the FeMoco. Figure 4-1 illustrates this concept.
But how is the reduction potential measured for ER0T2 → ER1T2? The L127Δ
Av2 mutant locked into the MgATP-bound conformation (131) forms a tight complex
with Av1 in the ER1T2 and ER0T2 redox states (118). The EPR signal of Fe protein is
distinctive in the R1T2 state, but silent in the R0T2 state. Reduction of ER0T2 can be
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followed by EPR after the addition of some external reductant, e.g. AvFldHQ, the in vivo
reductant to nitrogenase in A. vinelandii. Additionally, the FldSQ formed after electron
transfer has a distinctive absorbance at 580 nm in UV-vis spectroscopy. Tracking both of
these changes, Lanzilotta and Seefeldt were able to assess the redox potential of R0T2 on
the ER0T2 complex (130). Similarly, the tight AvE-CpR±D2 complex was studied (122).
This is in direct contrast to the T&L model in which only free Fe protein can be
reduced by an external reductant. Is there any kinetic evidence to support this proposal?
Duyvis et al proposed that the AvER0D2 complex is reduced by AvFldHQ based on
kinetic considerations in a stopped-flow study (132). They go so far as to propose that
even DT will reduce Fe protein on the AvER0D2 nitrogenase complex as well. In their
model, complex dissociation still occurs for more rapid nucleotide exchange, but MoFe
inhibition would appear not to compete so effectively with reduction of Fe protein. For
this reason, when I simulate their model in Mathematica, I see that MoFe inhibition
suddenly disappears to an extent that does not accurately reflect actual data. I believe
there are problems with the Duyvis paper. One possibility is that they use a very high
NaCl concentration in their experiments. This would lead to more dissociation of the
nitrogenase complex and give abnormally high observed levels of Fe protein reduction.
It may actually be that Fe protein is reduced on the nitrogenase complex, but it must
occur much more slowly than proposed by Duyvis et al.
The Fe protein is the only reductant to the MoFe protein. This is very curious
since the metal clusters of MoFe protein are accessible by small reductants (133). Even
when using reductants with a much lower potential than Fe protein, catalysis does not
proceed. So while it appears that MgATP binding and nitrogenase complex formation
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affect the reduction potentials of the nitrogenase metal clusters to favor electron transfer
to the FeMoco, Fe protein must contribute more to catalysis than just electrons.
In addition to elucidating the role of reduction potential of the various
intermediates in the Fe protein cycle, it is important to determine actual rates of reduction
for Scheme 4-2. In the T&L model, reduction of R0D2 is dominant. Is this always true?
Or are there experimental conditions that favor reduction of a different intermediate?

4.1.2. Nucleotide Binding
The absolute requirement of ATP hydrolysis for N2 reduction in wild-type
nitrogenase has led to the extensive study of Fe protein bound to nucleotides. The T&L
model is unable to describe nitrogenase catalysis when ATP is not in excess. Thus, the
T&L model breaks down under conditions where ATP is limited and where ADP is
prominent. This is a serious shortcoming of the T&L model because the in vivo
ADP/ATP ratio is significant at 0.83-1.47 under N2-fixing conditions, depending on the
organism (134, 135). It is noteworthy that the ADP/ATP ratio increases under nitrogenlimiting conditions because of the high ATP turnover rate of nitrogenase activity.
As a starting point to model nucleotide effects we consider all possible Fe protein
species bound to nucleotides. Schemes 4-2 and 4-3 show how these forms interconvert.
The traditionally characterized forms of Fe protein are RnD2, Rn and RnT2. It is more
difficult to characterize RnD and RnT. Schemes 4-2 and 4-3 do not show the possibility
of intermediates of the form RnDT. A study in 1977 by Thorneley and Cornish-Bowden
suggested that RnDT is not formed (136), but the evidence for this conclusion was
somewhat tenuous given the high degree of uncertainty in their data. RnDT may need to

107

be included if its presence is necessary to account for observed rates of nucleotide
exchange in the presence of both ADP and ATP as opposed to the off-rates of MgADP by
itself vs. the on-rates of MgATP by itself.
It is possible to determine which intermediates predominate given the various
nucleotide dissociation constants in Scheme 4-3 first reported by Lanzilotta et al
measured at 30 oC in 100 mM Tricine buffer at pH 8.0 by isothermal titration calorimetry
(101). Even with this normally very precise technique, the reported binding constants
have errors of about 50%. Nucleotide binding constants for Fe protein also vary
significantly in the literature. However, there are some important findings still to be
learned from a comparison of these dissociation constants for the various RnXm species
summarized visually in Figure 4-2:
•

Nucleotides bind cooperatively to Fe protein. Note the relative populations of R0,
R0T and R0T2.

•

Nucleotides bind more strongly to R0 than to R1 so that nucleotide exchange is
more likely after reduction of Fe protein, as per the T&L model.

•

However, MgADP binds more strongly than MgATP to Rn, even on R1,
explaining why ADP inhibition of nitrogenase is so potent.

Another trend of Scheme 4-2 is that nucleotides bind more tightly to the
nitrogenase complex than to free Fe protein. MgATP bound approximately three-fold
stronger to the tight Av1-Cp2 complex than to free Cp2 (137). This was confirmed for
the Av1-Av2 combination based on the nitrogenase salt effect (93) (see Figure 4-13).

108

Relative Abundance Rn Xm

1

R0D2

0.9

R0T2

0.8

R1D2

0.7

R1

R1T2

0.6
0.5
0.4
0.3
0.2

R1T

0.1
0
0

0.2

0.4

0.6

0.8

1

[MgAXP]/ mM
Figure 4-2. Profile of nucleotide binding in RnXm. Graphical representation of the
binding of MgATP (▬ ▬ ▬) and MgADP (▬▬▬) to R1 (blue) and R0 (green) from
the dissociation constants in Scheme 4-3. The x-axis refers to free nucleotide not bound
by Fe protein. All R1Tm and RnX2 species are shown for comparison. Populations of
RnXm were calculated from the solution to the system of equations:

K d1 =

[R n ] [MgAXP]
,
[R n X]

R nX =

K d2 =

[R n X] [MgAXP]
,
[R n X 2 ]

[R n X]
, and
[R n X 2 ] + [R n X] + [R n ]

[R n X 2 ]
,
[R n X 2 ] + [R n X] + [R n ]

R n + R nX + R nX2 = 1.

The solutions calculated in Mathematica are:
K d1 K d2
Rn =
,
2
[MgAXP] + [MgAXP] K d2 + K d1 K d2
R nX =

R nX2 =

[MgAXP] K d2
, and
[MgAXP] + [MgAXP] K d2 + K d1 K d2
2

[MgAXP]2
R nX2 =
.
[MgAXP]2 + [MgAXP] K d2 + K d1 K d2
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What is notable about Scheme 4-3 is that there are so many gaps in what has been
measured. Nucleotide binding is really understood only for a very select portion of the
Fe protein cycle. Furthermore, Schemes 4-2 and 4-3 require actual on- and off-rates of
nucleotides for input into a kinetic model. In the absence of measurable rates, such as
may be the case on the nitrogenase complex, a ballpark estimate may have to do.
Nevertheless, it is hoped that by modeling nucleotide binding on each intermediate in
Scheme 4-2 that ADP inhibition can be modeled quantitatively.
Comparing nucleotide exchange rates to the other rates of the Fe protein cycle
would determine whether ADP inhibition is controlled on species of R1, R0, or even ER1.
Nucleotide dissociation rates would, for instance, determine how fast R0D2 is converted
to R1T2, depending on which pathways predominate. That is, nucleotide dissociation
would affect which R0Xm species is reduced by an external reductant. In the T&L model,
only R0D2 reduction is modeled, but in reality it may just predominate. How much of a
contribution comes from reduction of R0 and R0T2? What would be the effect of
lowering the concentration of reductant to the point where nucleotide exchange occurs
before electron transfer? (From this question, it is apparent that the T&L model does not
just require excess ATP; it also requires excess reductant compared to the off-rate of
MgADP and subsequent addition of ATP!) Only by determining rates of steps in the full
Fe protein cycle can we resolve some of these issues. For that matter, how do
experimental conditions—e.g. temperature, pH and ionic strength—affect these rates?
There is a complex interplay in the interconversion of intermediates in the Fe protein
cycle that has not been characterized sufficiently in the literature.
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4.1.3. The Nitrogenase Complex
Fe protein associating with the MoFe protein is required for inter-protein electron
transfer and subsequent substrate reduction on MoFe protein. On the other hand,
dissociation of the nitrogenase complex is also required for nitrogenase catalysis.
Given the evidence for reduction of Fe protein on the nitrogenase complex (130,
132), and that nucleotide exchange can also proceed on the complex (9, 138), it is not

entirely clear why the complex must dissociate at all. Actually, it may be that the
complex is reduced, but not at a high enough rate for productive catalysis. Indeed, tight
nitrogenase complexes made from mutants and certain heterologous crosses are
invariably inactive because the complex does not dissociate. The overwhelming evidence
supports the T&L model that productive reduction of the nitrogenase complex by an
external reductant is not kinetically significant (114).
Therefore, the interplay between forming a stable nitrogenase complex on ER1T2
and then undergoing ATP hydrolysis to achieve a conformation favoring complex
dissociation on ER0D2 is of fundamental importance. How do the dimensions of Fe
protein reduction and nucleotide binding affect the stability of the nitrogenase complex?
The answer is shown in Scheme 4-2. Oxidized Fe protein binds more strongly to MoFe
protein than reduced Fe protein. Therefore, if Fe protein is to dissociate after electron
transfer, achieving the MgADP-bound conformation that dissociates more readily must
overcome the effects of the tighter binding of oxidized Fe protein.
Much about our understanding of nitrogenase complex stability comes from an
ultracentrifugation study in a report by Burns et al (92). With this method, only a weak
association between Av1 and Av2 was observed for the AvE-AvR0 combination. These
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formed a 1:1 complex, leaving an estimated 35% of the Av2 free in solution. This
complex was stable to the addition of 250 mM NaCl. On the other hand, the addition of
DT disrupted complex formation. Because of the stability of the complex in the presence
of NaCl, it is likely that the mechanism of DT weakening the nitrogenase complex is that
AvER1 is weaker than AvER0. The addition of 1 mM MgADP to AvER0 weakened the
nitrogenase complex, but not to the same extent as DT. An estimated 80% of Av2 was
free in solution.
From the trend in Scheme 4-2, we would expect the addition of MgATP to ER0 to
produce an even stronger complex than AvER0. Curiously, the addition of 1 mM
MgATP in the ultracentrifugation study resulted in no nitrogenase complex being
observed, as per the addition of DT. This result is very curious given the kinetic data of
the T&L model that says that KpER1T2 is tighter than KpER0D2. Being in the reduced
state ought to weaken KpER1T2, but the presence of MgATP strengthens it. Additionally,
the L127Δ Av2 mutant locked into the MgATP bound conformation (131) forms a tight
complex with Av1 in the ER1T2 and ER0T2 redox states (118).
Burns et al offer the following explanation to the interesting result that MgATP
weakens the nitrogenase complex in the ultracentrifugation study: k–3 is different for
ER0D2 when this complex forms from E and R0D2 as opposed to E and R0T2 followed by
ATP hydrolysis. This explanation would resolve the conflicting data in this study with
that of other research. It would also be consistent with the much higher value for k–3 used
for Av nitrogenase in the EPR study of Fisher et al (119)—see Section 3.3.2.
Unfortunately, a rational mechanism for such a difference in k–3 rates has not been
proposed.
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4.2. Structural Perspectives of the 3-D Fe Protein Cycle
Each of the dimensions of the Fe protein cycle affects the other two. How? What
is the structural mechanism for these changes? The crystal structures of nitrogenase
clearly put the nucleotide binding sites on the opposite end of the Fe protein from the
[4Fe-4S] cluster—see Figure 4-3. Yet nucleotide binding affects the redox properties of
the protein, and the level of reduction of the [4Fe-4S] cluster affects nucleotide binding.
There must be some structural mechanism that communicates the status of one site to the
other. Additionally, nucleotide binding and redox properties change upon complex
formation with MoFe protein. ATP hydrolysis is a property of the nitrogenase complex;
it does not proceed on the Fe protein alone at any appreciable rate. What is the structural
trigger for ATP hydrolysis? There are also very different rates for ATP hydrolysis on
ER0T2 as opposed to ER1T2. Complex formation does not abolish communication
between the [4Fe-4S] cluster and nucleotide binding sites. In this section we will explore
the structural features of nitrogenase, particularly the Fe protein, that intimately connect
the three dimensions of the Fe protein cycle in some very striking ways.

4.2.1. Molecular Switches on the Fe protein
The Fe protein falls into a broad class of nucleotide-binding proteins, which
includes myosin, adenylate kinase, ras p21, recA, etc. (139). Sequence analysis suggests
that Fe protein is the ancestral protein from which basic structural machinery was utilized
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for a diverse range of biological functions (140). In particular, from the first crystal
structure of Fe protein (141), it was clear that two regions of Fe protein corresponded to
molecular switches in ras p21 that control major conformational changes (139)—Switch
I and Switch II. Additionally, there is a phosphate-binding loop (P-loop). The P-loop
and a portion of Switch II are homologous to Walker’s motifs A and B from G-proteins
that have important contact points to nucleotides, esp. MgADP (131, 142).
These molecular switches control the three dimensions of the Fe protein cycle
through significant conformational changes shown in Figure 4-3. Representative
structures are R0D2, R0T2, and E●R0T2. The “●” in E●R0T2 indicates a transition state
activated at some stage of ATP hydrolysis. In this case, AlF4– stabilizes ER0D2 to
become a tight complex by taking the place of the γ-Pi of ATP (143, 144).
There is tremendous variability in the structures in Figure 4-3 from the Fe
protein’s switches and their response to nucleotides and complex formation. The redox
state of the [4Fe-4S] cluster can have a much more subtle influence on the Fe protein
conformation. A comparison of the crystal structures of AvR1 and AvR2 in ref (145)
revealed only very minor differences.
A more dramatic redox-dependent structural change occurs with R0T2 in the
presence of glycerol, for which the [4Fe-4S] cluster actually splits apart into two
[2Fe-2S] clusters, as shown in Figure 4-4. From resonance Raman, it was determined
that the [4Fe-4S] cluster reforms upon reduction to R1T2 (146). Reduction must thus be
accompanied by some very dramatic structural changes because of the general orientation
of ligands to a single [4Fe-4S] cluster in Figure 4-4.
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ADP
Mg2+

AlF4–

Asp125

R0D2 E●R0T2
R0T2

Asp39
Asp129
[4Fe-4S]

Cys132
P-cluster

Major structural changes
upon complex formation

P-loop Av2 residues 11-16
Switch I residues 39-67
glycerol

Switch II residues 125-132

Figure 4-3. Fe protein, a complex molecular machine. Structural changes in response
to nucleotide binding and complex formation coordinated by the molecular machinery of
the Fe protein’s switch regions and P-loop spanning indicated residues, with particularly
important ones labeled individually. Upper left, Av2(MgADP)2 from PDB structure
1FP6 (147), probably in the R0D2 conformation. Lower left, L127Δ Av2 from 1RW4
(146) in the R0T2 conformation. Upper right, AvE-Av20(MgADP·AlF4–)2 from 1M34
(63) in the E●R0T2 conformation.
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Cys132

Cys97

Cys97

Cys132

R0T2

glycerol

R1T2
Cys97

Cys132

Cys132

Cys97

Figure 4-4. Cluster splitting of R0T2. The oxidized L127Δ Av2 crystal structure from
PDB 1RW4 (146) shows two separate [2Fe-2S] clusters, with Fe atoms in green and S
atoms in yellow. The reduced form of R1T2 has not been crystallized, but it is known that
the clusters recombine to form a single [4Fe-4S] cluster. The [4Fe-4S] cluster from PDB
1G5P (145), probably in the R1 conformation, is shown to represent the radical
reconfiguration of cluster ligands that would have to occur on R1T2. Notice that Cys97
and Cys132 switch places up-and-down while maintaining their location in-and-out of the
page. Cys97 is always more head-ward (near), whereas Cys132 is more tail-ward (far).
As an endpoint of Switch II, Cys 132 could relay information about the redox state of the
cluster to the nucleotide-binding site.

However, using the crystal structure of R1 to represent the [4Fe-4S] cluster of
R1T2 in this figure is not very satisfactory. Rather, 1H NMR studies (see Figure 4-5)
implicate changes in Cys-132 and Cys-97 α-CH and β-CH2 protons in R1T2 when
compared to R1 and R1D2 (148, 149). Additionally, the EPR and CD spectra of Fe
protein (see Figures 4-6 and 4-7, respectively) reveal striking electronic differences
between RnT2, Rn, and RnD2.
These results suggests that perhaps the single [4Fe-4S] cluster of R1T2, though
still dramatically different from the split clusters in R0T2, is very different from the
representation in Figure 4-4. Indeed, the unique susceptibility of Fe chelation of the
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Figure 4-5. 1H NMR of AvR1Xm. Adapted from Fig. 2 of ref (149), in which the
labeled peaks are attributed to the milieu of the [4Fe-4S]1+ cluster.

g = 1.92

S = 3½

S= ½

Figure 4-6. Perpendicular-mode EPR spectra of AvR1Xm. The [4Fe-4S]1+ cluster of
Fe protein is in a mixed spin state of S = ½ and 3⁄2. Adapted from Fig. 1 of ref (102).
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Figure 4-7. CD spectra of AvR0Xm. From Fig. 5a of ref (125).

[4Fe-4S] cluster (e.g. by bipyridine) only when MgATP is bound (150-152) (see Figure
4-8) is suggestive of some peculiar properties of R1T2. That the [4Fe-4S] cluster is
capable of radical reorientation of geometry is supported by the observation that after Fe
chelation, an Fe protein with a single [2Fe-2S] cluster is formed (153).
Figures 4-3 through 4-8 demonstrate that significant structural changes occur
upon reduction, nucleotide binding and complex formation. The switches of Fe protein
are responsible for communicating changes in one dimension of catalysis to the others.

4.2.1.1. Nucleotide Binding vs. Redox State. The most direct link between the

[4Fe-4S] cluster and the nucleotide binding sites is Switch II. In Av2, it runs from
Asp125 to Cys132 (131). Residues 125-128 coordinate Mg2+ (139), and Asp125 also
interacts with the backbone amide of Gly14 that is part of the P-loop region that includes
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Figure 4-8. MgATP-dependent Fe chelation. From Fig. 1a of ref (152).

residues 11-16. These residues are particularly sensitive to changes in nucleotide
binding. Together, the P-loop and residues 125-128 in Switch II detect the nucleotide
binding status of Fe protein. At the other end of Switch II, Cys132 is one of the ligands
that bind directly to the [4Fe-4S] cluster, so there is a direct connection between the
[4Fe-4S] cluster and the nucleotide binding sites. The [4Fe-4S] cluster itself plays a
critical role in communication between the Fe protein subunits, contributing to the
cooperative nature of nucleotide binding (154). Thus when one subunit binds nucleotide,
the signal is transmitted through Switch II to the [4Fe-4S] cluster to Switch II of the other
subunit, and finally to the nucleotide binding site of the other subunit. Once the other
subunit is also bound by nucleotide, the signal is reinforced in the first subunit.
Consequently, R1T is not even halfway to the conformation of R1T2.
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4.2.1.2. Nitrogenase Complex Formation and Stability. Switch I spans Av2

residues from Asp39 that coordinates Mg2+ (155) to the α-helix in the 50-60’s that
interacts with Av1 in nitrogenase complex formation. Switch I is an attractive
mechanism for communication between docking to Av1 and nucleotide binding sites (1).
One of the effects of complex formation is that the nucleotide-binding region is
more closed in terms of the accessibility of solvent than the Fe protein is when it is free
of the complex (see Figure 4-3). This structural change rationalizes the observation that
nucleotides bind more tightly to the nitrogenase complex than to the free Fe protein (see
Scheme 4-2).
The positioning of nucleotides on the nitrogenase complex could then be relayed
to the [4Fe-4S] cluster by Switch II. The result is that the [4Fe-4S] cluster is projected 45 Å more towards Av1 in the Av1-Av2(MgADP·AlF4–)2 complex than in a rigid-body
docking model of Av1 and Av2(MgADP)2 (155).
This communication between Switch I and Switch II may occur indirectly through
nucleotides, but there is evidence for the direct interaction between Asp39 of Switch I
and Asp125 of Switch II. The Asp39Asn mutant locks into a tight complex with Av1, but
only following inter-protein electron transfer (156). From the crystal structure of
Asp39Asn-Av2, it was determined that Asn39 forms a hydrogen bond with Asp125 (142).
It appears that electrostatic repulsion between wild-type Asp39 and Asp125 is required
for complex dissociation (142). The positioning of these two residues based on changes
in both Switch I and Switch II could control the stability of the nitrogenase complex,
rationalizing the connection between the three dimensions of the Fe protein cycle.
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4.2.1.3. Inter-protein Electron Transfer and ATP Hydrolysis. Complex formation

of Av1-Av20(MgADP·AlF4–)2 projects the [4Fe-4S] cluster towards Av1 by 4-5 Å. This
would increase the rate of inter-protein electron transfer by a factor of ~103, all other
factors being equal (155).
Complex formation favors inter-protein electron transfer and promotes ATP
hydrolysis. The reason ATP hydrolysis only occurs on the nitrogenase complex is that
only in the complex is the structure able to bring Asp129 in one subunit into proximity
with the γ-Pi (157) in the opposite subunit for ATP hydrolysis (125, 158). In Figure 4-3,
the interaction between Asp129 and AlF4–, which substitutes for the γ-Pi, is shown by a
dotted line. Additionally, Met156 (not in any switch region) interacts with Asp43 and
MgATP in the opposite subunit to stabilize the conformation for ATP hydrolysis (159).
While Asp129 and Met156 are absolutely required for ATP hydrolysis, there may also be
some contribution from Asp39 of Switch I since the Asp39Asn mutant hydrolyzes ATP
much slower than the wild type (156).

4.2.2. Triggers on the MoFe protein
Two Phe residues on Av1 (Pheα125 and Pheβ125) appear to be crucial MoFe
protein triggers that induce Fe protein to proceed with inter-protein electron transfer and
ATP hydrolysis. When one Phe is mutated to Ala, the result is a sharp drop in both ATP
hydrolysis and inter-protein electron transfer. When both Phe residues are mutated to
Ala, all ATP hydrolysis and inter-protein electron transfer are completely disrupted, and
no stable nitrogenase complex formation is detected (117).

121

Asp125
Asp125

Pheβ125
Valβ124

Cys132

Cys132
Cys97

Pheα125

Cys97
Valα124

Arg100
Gluβ120

Arg100

Gluα120
P-cluster

Figure 4-9. Av1 triggers in the AvE-Av2(MgADP·AlF4–)2 complex. Taken from PDB
structure 1M34 (63), cartoon of αβ Av1 with Av2, with a cutaway of critical Av1-Av2
interactions with colors corresponding to the overall protein structure. The interactions
between Av1 Valα124 and Valβ124 and Av2 Cys97 residues are communicated to the
[4Fe-4S] cluster, which connects to Switch II via Cys132 residues. In the
Valα124Ala/Valβ124Ala mutant, there is absolutely no inter-protein electron transfer nor
ATP hydrolysis (117). Similarly, the interactions between Av1 Gluα120 and Gluβ120
and Av2 Arg100 residues could be communicated to the nearby Cys97 residues and on to
Switch II. In the Arg100His-Av2 mutant, ATP hydrolysis is relatively high, but there is a
very low level of inter-protein electron transfer (160). Substituting Gluα120 or Gluβ120
with Gln partially reverses this uncoupling of ATP hydrolysis from electron transfer (1).

The side chains of Pheα125 and Pheβ125 interact with Ile103 residues on Av2 at
very early stages of docking in a rigid-body docking model of L127Δ Av2 in the R0T2
conformation onto Av1 (146). See Table 4-1. However, Pheα125 and Pheβ125 do not
interact significantly with Av2 on the stable Av1-L127Δ-Av2 complex in the ER0T2
conformation. However, the slight movement of bulky Pheα125 and Pheβ125 side chains
that occurs on complex formation brings the backbone carbonyls of Valα124 and
Valβ124 residues into position to interact with Cys97 residues on Av2. See Figure 4-9.
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Table 4-1. Av1-Av2 interactions. Adapted from Table 4 of ref (146). Interactions can
derive from either side chain moieties or main chain groups.

Av1-L127Δ-R0T2
PDB 1G21 (138)

Av1-AlF4–-R0D2
PDB 1M34 (63)

Cys97-Valα124
Arg100-Gluα120
Arg100-Glyα157

Cys97-Valα124
Arg100-Gluα120
Arg100-Glyα157
Arg100-Gluα184

Cys97-Valα124
Arg100-Gluα120
Arg100-Glyα157

Thr104-Gluα120

Thr104-Gluα120

Av1-L127Δ-R0
PDB 1G20 (138)

Av1-L127Δ-R0
docking model (146)

Ala62-Lysα121
Asp68-Lysα129

Ile103-Pheα125
Gly133-Ileα159
Arg140-Glyα160
Glu141-Lysα168

Glu141-Argα187
Gln145-Argα203
Lys170-Aspα162
Lys170-Aspα161
Ala172-Ileα158
Ala172-Ileα159

Asp68-Lysβ132
Cys97-Valβ124
Arg100-Gluβ120
Arg100-Gluβ156

Cys97-Valβ124
Arg100-Gluβ120
Arg100-Gluβ156

Cys97-Valβ124

Thr104-Gluβ120

Thr104-Gluβ120
Glu111-Lysβ303
Gly133-Ileβ158

Thr104-Gluβ120

Arg100-Gluβ156
Ile103-Pheβ125

Gly133-Ileβ158
Arg140-Glyβ159

Lys170-Asnβ168

Glu141-Hisβ185
Gln145-Argβ206
Lys170-Aspβ160
Ala172-Ileβ158

On the other hand, several residues at the Av1-Av2 interface are known to
uncouple ATP hydrolysis from electron transfer when mutated. Notably, the effects of
one such mutation, Arg100His-Av2 (160), are partially reversed when other residues are
mutated in Av1 (Gluα120Gln or Gluβ120 Gln) (1). There may be other Av2 mutants that,
like Arg100His, are offset by mutations in Av1.
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4.2.3. Structural Accounting of 3-D Fe Protein Cycle
From all of these considerations, it becomes clear that the switches and triggers
that control conformational changes in nitrogenase are intimately connected, just as the
three dimensions of the Fe protein cycle are connected. However, the details are
complex, and there is not a full understanding at this time. To attribute certain trends in
Scheme 4-2 principally to either Switch I or Switch II individually would be to deny the
intimate relationship between these switches. Perhaps on the free Fe protein, Switch II is
the most compelling mechanism of communication that accounts for:
•

The Fe protein reduction potential changes with nucleotide binding; and

•

Nucleotide binding constants change with the redox state of Fe protein.

It is not clear what influence Switch I would have on these phenomena. Once on the
nitrogenase complex, however, both Switch I and Switch II likely contribute to the
observations that:
•

Nucleotide binding is enhanced on the nitrogenase complex;

•

There are changes in nitrogenase complex stability with nucleotide binding;

•

The Fe protein reduction potential changes with nitrogenase complex formation;

•

There are changes in nitrogenase complex stability with redox state of the
[4Fe-4S] cluster;

•

The Asp39Asn-Av2 mutant forms a tight complex with Av1, but only after interprotein electron transfer;

•

ATP hydrolysis is unique to the nitrogenase complex, not the free Fe protein; and

•

ATP hydrolysis is slower on the ER0T2 complex than on the ER1T2 complex.
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4.3. ATP Hydrolysis vs. Inter-protein Electron Transfer
During nitrogen fixation, both ATP hydrolysis and inter-protein electron transfer
occur in a concerted manner. In the original T&L model, the relationship between the
two was termed “concomitant.” However, in Chapter 3, we saw how Lowe et al
developed the k2 step to include separate steps in Scheme 3-4 (9). Stopped-flow data put
Pi release following a delay step after electron transfer. In three dimensions, Scheme 3-4
would become:
R1T2
rapid
En

k1
k1

R1T2
2 MgADP

k–1

EnR1T2

En+eR0T2

rapid
2 MgADP

k2,ATPase

2 MgATP

R1D2
k4
R0D2

R1D2

k2,e-

k2,cycle
2 MgATP

k3

k4

→

EnR1T2

R0D2

k2,e-

En+eR0(D·Pi)2

k2,ATPase

k2,Pi
2 Pi

En+eR0T2

En+eR0(D·Pi)2

En+eR0D2

k–3

k–3
En+1

k2,Pi

k2,cycle

En+eR0D2

Scheme 4-4. Electron transfer vs. ATP hydrolysis in three dimensions. Scheme 3-4
of Lowe et al (9) is reproduced using the condensed notation RnXm, and then put into
three dimensions. In the T&L scheme, both ER0T2 and ER0(D·Pi)2 are a non-dissociating
complexes.
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Because these events are especially important to catalysis, it is important to
understand how they are coordinated. Did Lowe et al get it right? There is actually a lot
of debate in the literature about: Which comes first, ATP hydrolysis or electron transfer?
Lowe et al point out that several studies have tried to ascertain the order of ATP
hydrolysis vs. electron transfer by using different techniques (9):
•

“Pre-steady-state rapid quench of turning over enzyme to monitor formation of
phosphate” (161, 162), which shows that Pi release matched electron transfer, but
is unable to distinguish between “on-enzyme cleavage of ATP and subsequent
phosphate release”.

•

“Pre-steady-state proton production using pH indicators” (163, 164), which shows
that Scheme 3-3 is correct—electron transfer followed by ATP hydrolysis and Pi
release without any delay step. The problem with this technique is that it is
“difficult to assign (pH changes) to a particular partial reaction”.

•

“Stopped-flow calorimetry” (165), which shows that ATP hydrolysis occurs
before electron transfer. Again, with this technique, it is “difficult to assign (heat

changes) to a particular partial reaction”. And finally:
•

Rapid, real-time assay for inorganic phosphate using a fluorescent probe (120)
used by Lowe et al (9), which is the basis for Scheme 3-4.

The technique used by Lowe et al may have fewer problems associated with
unambiguously assigning steps to experimental observations. Nevertheless, the data were
less than satisfactory in Figure 3-6. In a critical review of the literature, discussed below,
we will see how the Scheme 4-4 has certain flaws and important omissions.
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4.3.1. Electron Transfer on the Complex
In the decade since Lowe et al described the details of ATP hydrolysis vs.
electron transfer in Scheme 4-4, there have been significant findings that push far beyond
the limits of the T&L model.

4.3.1.1. Alternative Pathways to ER1T2. In the T&L model, only the interaction

between E and R1T2 lead to formation of ER1T2 for inter-protein electron transfer and
catalysis. This may be the most relevant pathway to ER1T2 under their experimental
conditions, but a three-dimensional view of the Fe protein cycle suggests alternative
pathways to ER1T2, especially the addition of MgATP to ER1. In fact, several studies in
the literature use the addition of MgATP to initiate catalysis of assays already containing
ER1 with no measurable lag in product formation, e.g. the stopped-flow study of ref
(166). The inclusion of ER1Xm intermediates other than ER1T2 in Schemes 4-2 and 4-3
would seem to be important.

4.3.1.2. Gating of Inter-protein Electron Transfer. So is attaining the ER1T2

conformation all that is required to attain inter-protein electron transfer? This is the
suggestion of Scheme 4-4. If so, the mutant L127Δ Av2 locked into the MgATP-bound
conformation should be able to transfer an electron to Av1 just as quickly as the wildtype Av2, which can be monitored by the optical change in Av2 in the stopped-flow. It
turns out that in a study by Lanzillota et al, L127Δ Av2 does indeed transfer an electron
to Av1, but about 1000 times slower than wild-type Av2 (167), as shown in Figure 4-10.
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Figure 4-10. Arrhenius plot of inter-protein electron transfer. The temperature
response of the rate of electron transfer to Av1 is illustrated for wild-type and L127Δ
Av2. Adapted from Fig. 3 of ref (167).

Furthermore, there is some fundamental difference between wild-type and L127Δ
Av2 in the mechanism of inter-protein electron transfer. The Arrhenius plot of the kobs
for this reaction with the L127ΔAv2 is linear, but the Arrhenius plot with the wild-type
Av2 has a break at 18.5 oC (167, 168). Interestingly, there is a break in the Arrhenius
plot of overall nitrogenase activity at about this same temperature (169).
Lanzillota et al analyzed these data according to Marcus theory of electron
transfer, which assumes that electron transfer is a non-adiabatic event. The fit of L127Δ
Av2 electron transfer data to this theory yielded reasonable values for fit parameters, e.g.
distances that match the protein structure, and appropriate values for the coupling
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constant in water and decay factor. This would be called a true, or coupled, reaction.
However, the wild-type Av2 data yielded wholly unrealistic or even impossible values
based on other known observations and common sense (167). Rather, it was concluded
that electron transfer from wild-type Av2 is not rate-limiting, and that the rate-limiting
step is some adiabatic step (e.g. conformational change) so that the steps leading up to
electron transfer take the form:
kc
k1
k⎯
ET
⎯⎯
⎯→
⎯⎯
⎯→
⎯⎯
⎯
En + R1T2 ←
⎯⎯ EnR1T2 ←
⎯⎯ En●R1T2 ←
⎯→
⎯ En+1●R0T2,
k −1
k −c
k − ET

(4-1)

where the kc step is some adiabatic conformational change, and the kET step is actual
electron transfer (167). In such cases, electron transfer is said to be “gated” by the
adiabatic event. In three dimensions, this would contrast with the L127Δ Av2 as such:

R1T2
rapid

R1D2

R0T2

k1

k4

very
slow

ER1T2
kC
(fast)

slow

R0D2

E●R1T2
k–3
kET E●R0T2

ER0T2

(very fast)

ER0D2
Scheme 4-5. The gating of electron transfer in three dimensions. Interpretation of
Equation 4-1 proposed in ref (167) and the dominant catalytic pathway in the Fe protein
cycle (blue), and the pathway of catalysis exemplified by the Av1-L127Δ-Av2
combination (orange) where inter-protein electron transfer is very slow compared to
electron transfer induced by the activating step (see Figure 4-10). No product formation
is detected with Av1-L127Δ-Av2 because ERnT2 is a tight complex.
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Lanzillota et al attribute the opening of the gate to electron transfer to some early
stage of ATP hydrolysis. The rationale for this argument is that electron transfer is so
much slower on AvE-L127Δ-Av2, for which there is no ATP hydrolysis, than on wildtype AvER1T2. ATP hydrolysis could increase the driving force for electron transfer by
shortening the distance between the [4Fe-4S] cluster and the P-cluster, and/or by altering
the pathway of electron transfer to the P-cluster, e.g. by shortening the gaps for electron
jumps through space as shown in Figure 4-11.

[4Fe-4S] cluster

Leuα158
Valβ157

Cysα154
Cysβ153

P-cluster

Figure 4-11. Putative electron transfer pathway from the [4Fe-4S] cluster to the Pcluster. Taken from PDB structure 1M34 (63), cartoon of αβ Av1 with Av2, with
cutaway of electron transfer pathway based on theoretical calculations presented in Fig. 6
of ref (114). Two major jumps of 3.2 and 2.8 Å are shown. Gating of electron transfer
could involve slight alterations in this pathway.

130

Upon completion of ATP hydrolysis, however, the gate would be closed,
preventing the reverse reaction of electron transfer. The rationale for this argument is
that electron transfer on AvE-L127Δ-Av2 is reversible—there is a temperature
dependence to the degree of electron transfer on the nitrogenase complex (167). Similar
behavior observed for the wild-type Av2 is complicated by ongoing ATP hydrolysis
which decreases the absorbance of the complex—see Figure 3-5. Since the L127Δ Av2
does not induce ATP hydrolysis, equilibrium is unambiguously established, and Av1 is
reduced more at higher temperatures.

4.3.1.3. Why Does Nitrogenase Consume Two ATP per e– Transferred? To assess

the influence of separate subunits of Fe protein binding to nucleotides, a heterodimeric
[Asp39/Asn39] Fe protein was generated by Chan et al by site-directed mutagenesis and
some very creative isolation procedures (170). The Asp39Asn mutation prevents normal
signal transduction of MgATP binding. It was concluded that the changes in the
conformation of Fe protein upon binding MgATP are the result of additive contributions
from the individual subunits.
With the MgATP-bound conformation in only one subunit, can the
[Asp39/Asn39] Av2 transfer an electron to Av1? Yes, and the reaction would be En +
R1T → EnR1T → En•R1T → En+1•R0T, as shown in Scheme 4-6. However, this only
occurs at a very slow rate of 2.2 s–1, or 1.8% of the rate of wild-type Av2. However, no
product formation was detected with the [Asp39/Asn39] Av2 because it forms a tight
complex with Av1.
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E●R1T

ER0T

ER1D
E●R0T

ER0

ER1D2

ER0D

ER0D2
Scheme 4-6. Inter-protein electron transfer independent of ATP hydrolysis. Partial
uncoupling of electron transfer from ATP hydrolysis with the catalytic pathway
exemplified by the [Asp39/Asn39] Av2, at only 1.8% of wild-type nitrogenase (green).
Complete uncoupling of electron transfer from ATP hydrolysis in even slower pathways
(red). For clarity, several conceivable pathways are not shown: the dissociation of any
ERnXm species, reduction of any R0Xm species, and all pathways associated with the allferrous Fe protein, R2Xm.

4.3.1.4. ATP-independent Inter-protein Electron Transfer. It appears that

attaining the MgATP-bound conformation is sufficient for electron transfer, but ATP
hydrolysis greatly speeds the reaction. L127Δ Av2 transfers an electron to Av1, but it
does not hydrolyze any ATP. Even ATP hydrolysis on Av1-[Asp39/Asn39]-Av2, which
only partially attains the MgATP-bound conformation in the presence of MgATP, is
sufficient to accelerate electron transfer much faster than in Av1-L127Δ-Av2.
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So while N2 fixation requires high rates of nitrogenase turnover—and
consequently high rates of ATP hydrolysis—what about very slow inter-protein electron
transfer and/or nitrogenase turnover of alternative substrates, such as H+? Schemes 4-2
and 4-3 are interesting not just for illustrating alternative pathways in the Fe protein cycle
leading to ER1T2. They also suggest that inter-protein electron transfer can occur for
EnR2Xm → En+1R1Xm or EnR1Xm → En+1R0Xm. This is, in fact, correct, as shown in
Scheme 4-6. There is now overwhelming evidence that for inter-protein electron transfer,
attaining the R1T2 state is not required. Very low rates of H2 production are seen in the
complete absence of MgATP in a process called ATP-independent electron transfer.
The heterologous cross Av1-Cp2 forms a tight complex (68, 171, 172). Since Fe
protein must be released from the complex to be re-reduced and restart the catalytic
cycle, nitrogenase combinations that result in a tight complex do not reduce substrates
requiring at least two electrons before product turnover. This is the case for the Av1L127Δ-Av2 and Av1-[Asp39/Asn39]-Av2 tight complexes. Hence, it was long believed
that no product formation occurred with Av1-Cp2 in the presence of ATP (AvE-CpR1T2),
but Clarke et al showed recently that AvE-CpR1T2 does supports H+ reduction
accompanied by complex dissociation at a very slow rate (0.032 s–1 at 30 oC) (173).
Inter-protein electron transfer, on the other hand, is readily detected in the
heterologous Av1-Cp2 cross, and Chan et al showed that ATP hydrolysis accelerates this
reaction almost 10,000-fold to approach the rate in the homologous cross at 100 s–1 at
23 oC (122). In the complete absence of MgATP, there is inter-protein electron transfer
in the AvE-CpR1 complex at a rate of 0.007 s–1, and in the AvE-CpR1D2 complex at a
rate of 0.018 s–1 (122).
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Yousafzai and Eady found that even the homologous cross of Kp nitrogenase very
slowly evolved H2 in the presence of MgADP, which must involve electron transfer,
EnR1D2 → En+1R0D2. This H2 evolution could not be attributed to low levels of
contaminating ATP (174). Yousafzai and Eady point out that similar behavior is
observed for Av nitrogenase under similar conditions in a study by Watt et al (123).
Lower levels of H2 were detected even in the complete absence of nucleotide (EnR1 →
En+1R0) with Kp nitrogenase (174).

4.3.2. ATP Hydrolysis on the Nitrogenase Complex
Just as electron transfer can occur in the complete absence of ATP hydrolysis, so
too can ATP hydrolysis proceed in the absence of electron transfer. In fact, this is often
the case. ATP hydrolysis proceeds without electron transfer through several means.

4.3.2.1. FeMoco Inhibitors. Certain inhibitors (e.g. CN– and CH3NC) bind the

FeMoco (175, 176) and prevent electron transfer without affecting ATP hydrolysis (177,
178). The most straightforward explanation that combines this observation and the

gating of electron transfer discovered by Lanzillota et al (167) is to assume that the
E•R1T2 conformation achieved by activation by the adiabatic conformational change is
indeed attributable to an early stage of ATP hydrolysis. If so, then the gate that enables
electron transfer to proceed can close before electron transfer even occurs, and the
uncoupling of ATP hydrolysis from electron transfer in the presence of FeMoco
inhibitors takes the form: ER1T2 → E•R1T2 → ER1D2. See Scheme 4-7.
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Scheme 4-7. ATP hydrolysis uncoupled from electron transfer/ Putting it all
together. A self-consistent mechanism to account for both: (a) the concept of gating of
electron transfer in the dominant pathway of catalysis (blue); and (b) uncoupling of ATP
hydrolysis from electron transfer (orange). This scheme brings together concepts from
Schemes 4-2, 4-3, 4-5 and 4-6 for completeness. Dashed lines show pathways more
important under certain low-flux conditions. All pathways are expected to be somewhat
reversible.

4.3.2.2. Reductant-independent ATP Hydrolysis. Nitrogenase still hydrolyzes

ATP in the absence of reductant in the reaction: ER0T2 → E•R0T2 → ER0D2. This is the
kind of uncoupling covered by Lowe et al in Scheme 4-4. The unfortunate aspect of
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putting their scheme in two dimensions is that it appears that reductant-dependent and
reductant-independent ATP hydrolysis are essentially equivalent. Indeed, a quench study
by Cordewener et al showed that pre-steady-state Pi release from ER0T2 was the same as
from ER1T2 (179). This result is curious given the trends in Scheme 4-2 and the
structural changes that affect the three dimensions of the Fe protein cycle. However, it
has been shown that ATP hydrolysis is about 20 times faster in the steady state when
reductant is present than in its absence (180, 181), and only reductant-independent
nitrogenase hydrolyzes ADP as well as ATP (182). Hence, there is a fundamental
difference between reductant-independent and reductant-dependent ATP hydrolysis.
Perhaps the observation of Cordewener et al is attributable to the distinction of
nucleotide exchange on the nitrogenase complex for ongoing ATP hydrolysis, as per
Scheme 4-4 of Lowe et al, and nucleotide exchange on the free Fe protein after
dissociation from the nitrogenase complex. Indeed, it is not required that the nitrogenase
complex dissociate for nucleotide exchange and further ATP hydrolysis (ER1/0D2 →…→
ER1/0T2 → E•R1/0T2 → ER1/0D2) (9, 97). For example, the heterologous cross Av1-Cp2
forms a long-lived tight complex that hydrolyzes several ATP before complex
dissociation (173, 182).

4.3.2.3. Coupling Efficiency of Fe Protein Subunits. The coupling efficiency of

ATP hydrolysis vs. electron transfer is diminished when the signal from only a single
subunit hydrolyzing MgATP is transduced to the [4Fe-4S] cluster of Fe protein in the
heterodimeric [Asp39/Asn39] Av2 (ER1T → E•R1T → ER1D) (170). Earlier this mutant
was discussed in terms of partial uncoupling of electron transfer from ATP hydrolysis,
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but in reality Av1-[Asp39/Asn39]-Av2 uncouples ATP hydrolysis from electron transfer
more than the other way around. Specifically, the rate of ATP hydrolysis for this mutant
on the nitrogenase complex is 8.4% of the wild-type rate, but the rate of electron transfer
is relatively slower, at only 1.8% of the wild-type rate.

4.3.3. Dissociation of the Nitrogenase Complex
Just how tight is the nitrogenase complex? In the T&L model, the values of k1
and k–1 predict a dissociation constant in the μM range. However, the value of k–1 in the
T&L model of Kp nitrogenase is rather substantial—15 s–1 at 23 oC (5)—compared to the
off-rate of L127Δ Av2 from Av1—less than 0.02 s–1 at 23 oC (118). If the latter is a
better measure of the affinity of the ER1T2 complex, then it would have a dissociation
constant in the nM range. Indeed, the catalytic ER1T2 complex would be a tight complex.
It is interesting that ER0T2 in Scheme 4-4 shows no pathway for complex
dissociation. If electron transfer is competent on several nitrogenase complexes in the
complete absence of ATP, then why did nature not evolve some mechanism to do away
with expensive ATP hydrolysis altogether. The answer, again, comes from these same
complexes. They show high rates of ATP-independent electron transfer, but they do not
dissociate. Even if the complex is reduced by an external reductant, this reduction is
somehow not potent in producing ongoing electron transfer to the FeMoco. Complex
dissociation appears to be absolutely required for catalysis. So one of the primary roles
of ATP hydrolysis appears to be to attain the MgADP-bound conformation of ERnD2 that
can dissociate readily.
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Another tight complex in Scheme 4-4 of Lowe et al is the ER0(D·Pi)2 complex
bound by inorganic phosphate, Pi. The Pi must dissociate in Scheme 4-4 before
achievement of the ER0D2 conformation and dissociation of Fe protein. However, Pi
effectively competes away formation of the tight Av1-Av2(MgADP·AlF4–)2 complex
(183) stabilized in a transition state conformation, e.g. E●R0T2. Thus AlF4– binds to the
same site as the γ-Pi on MgATP, a key location in the nucleotide-binding site.
Furthermore, activity is not inhibited by the amount of Pi that competes away AlF4–
inhibition (183), suggesting that the analogous nitrogenase complex with Pi in place of
AlF4– is not stabilized, but can dissociate normally. Thus, the data in Figure 3-6 could
represent contributions from Pi release from the ERn(D·Pi)2 complex and from Rn(D·Pi)2
after complex dissociation.

My critique of the literature here in Section 4.3 shows why Scheme 4-4 of Lowe
et al is deficient and inaccurate. I could sense that, somehow, everything in the Fe

protein cycle should fit together into a rational three-dimensional scheme. At last I
devised Scheme 4-7 from a literature review and considerations of symmetry. This
represents my best effort to describe a new model for the Fe protein cycle of nitrogenase
catalysis to replace the T&L Fe protein cycle. Some of my earlier sketches are laughable
in retrospect. The biggest stumbling block to achieving perfect symmetry was where to
put ERn(D·Pi)2. I achieved a breakthrough when I came across the study of the effects of
Pi on the formation of the Av1-Av2(MgADP·AlF4–)2 complex. The presence of Pi should
not alter the nitrogenase complex at all. ERn(D·Pi)2 simply becomes ERnD2±Pi, so that
ERn(D·Pi)2 is equivalent to ERnD2. Symmetry achieved!
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But is Scheme 4-7 accurate? It is complex enough to account for several
observations that push beyond the limits of the T&L model. All the pathways make
rational sense. Its symmetry simplifies much of its apparent complexity. But it is largely
untested. It cannot be considered quantitative until:
•

The Fe protein cycle is conceived in proper context with the MoFe protein cycle;

•

Ongoing experiments confirm the qualitative accuracy of pathways;

•

The rates of elementary steps are determined; and

•

The model quantitatively predicts nitrogenase behavior.

4.4. Cooperativity between MoFe Protein αβ Active Sites
In the T&L model, the two αβ halves of MoFe protein are independent of each
other. The maximum specific activity of Kp1 was determined to be proportional to the
Mo content of Kp1. It seems reasonable that if the two halves of MoFe protein were not
independent, that the Mo content of Kp1 should cause specific activity to deviate from
proportionality. However, there is mounting evidence that there is actually some
crosstalk between the halves of MoFe protein (173, 184).

4.4.1. Crosstalk Between αβ Active Sites
Clarke et al showed that the heterologous Av1-Cp2 cross forms a stable 1:1
complex (173). It appears that the Cp2 that is bound exerts a long-range influence to
decrease slightly the binding affinity of the other half of the MoFe protein for Cp2. The
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1:1 Av1-Cp2 complex can be isolated. Interestingly, the free half of MoFe protein on the
1:1 Av1-Cp2 complex is fully active upon addition of Av2 (173). The bound Cp2
apparently has no significant influence on catalysis of the other half of Av1 with Av2. It
would appear that the crosstalk between halves of MoFe protein does not play a
significant role in catalysis, but future studies may show otherwise. If there is significant
crosstalk, it would greatly complicate how the steps of the Fe protein cycle on one half of
the MoFe protein coordinate with the steps of the Fe protein cycle of the other half.

4.4.2. Sigmoidicity of Specific Activity
Early on in my studies of nitrogenase I coauthored a couple of papers by Johnson
et al (185, 186). Steady-state kinetic data revealed an underlying pattern of sigmoidicity.

For instance, the Av1 specific activity titration in Figure 4-12 appears not to extrapolate
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Figure 4-12. Underlying sigmoidicity of Av1 specific activity. Standard specific
activity titration with [Av1] held constant at 2.16 μM. Data from Fig. 4a of ref (185).
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linearly to the origin. Rather, the gradual initial increase in activity with added Av2 is
reminiscent of cooperative behavior, or could be thought of as evidence for crosstalk
between the halves of MoFe protein in the homologous cross. However, the model that
Joe Johnson proposed and used to fit the data was very different than that of Clarke et al
and the 1:1 Av1-Cp2 complex. Joe based his model on the cooperative addition of two
Fe proteins binding to a single αβ site, not just to a single MoFe protein. The hypothesis
was that ATP hydrolysis could occur with only one Fe protein bound, but that two Av2
were required for effective electron transfer to Av1. Thus, in the dilution range where
only one Av2 was bound, the ATP/2e– ratio increased because ATP hydrolysis continued
without electron transfer (186). Joe’s model does not actually even attempt to model
ATP hydrolysis. Rather, focusing exclusively on product evolution, this mechanism led
to the derivation of a very simple kinetic model that could be solved analytically.
However, within a week of working on my Mathematica models of nitrogenase, I
proved that Joe’s model was incorrect. It could not even fit the simplest pre-steady-state
kinetic data in the literature of the lag phase experiment for Av nitrogenase (104) similar
to the H2 evolution data in Figure 3-1. This was a case of having a model that could fit
some good steady-state data much better than Thorneley and Lowe. But the new model
could not fit pre-steady-state data; and it did not make any sense in terms of the x-ray
crystal structure of nitrogenase available at the time (158), which was consistent with the
solution x-ray structure of the day (187, 188).
My role in these two studies was to soften the language a bit from saying that
Joe’s model was correct to saying that we had some good data that could not be
rationalized in terms of the T&L model. Could cooperativity between αβ halves of MoFe
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protein be responsible for the observed sigmoidicity? The data favored either some kind
of cooperative mechanism, or the notion that rates of the Fe protein cycle were changing
with the level of reduction of the MoFe protein.
I could not conceive at the time that I would actually figure out the real
explanation for this sigmoidicity, and that it had nothing to do with either of these
possibilities. Rather, this sigmoidicity is caused by the nitrogenase salt effect, which will
be covered in detail in Chapter 7. For now, a brief introduction will suffice.

4.5. The Salt Effect
Several studies have looked at the inhibitory effects of salt on nitrogenase. These
will be discussed in some detail in Chapter 7. A model for salt inhibition was devised by
Deits and Howard (93) in which salt bound cooperatively to Av2, as shown in Scheme
4-8. Several lines of evidence suggest that salts bind to Av2. For starters, there are small
reversible effects of salts on the EPR and NMR spectra of Fe protein (93).
Recall from Figure 4-8 that chelators such as 2,2'-bipyridyl remove the Fe of the
[4Fe-4S] cluster of Fe protein, but only when MgATP is bound (93). The [4Fe-4S]
cluster is exposed in the splayed conformation of RnT2 (see Figure 4-3); and its geometry
may also be unique, even in R1T2. Adding MgADP or MoFe protein inhibits the Fe
chelation reaction (137, 151, 152). As it turns out, so do salts (93), presumably by
competing away the binding of MgATP to Av2 (see Figure 4-13).
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Scheme 4-8. The Deits-Howard salt effect. From Scheme 1 of ref (93), but using the E
and RTm notations, plus the cooperative binding of n effective particles of inhibiting salt,
In. It was determined that when R is inhibited by In, the ERTmIn complex is not stable
(▬ ▬ ▬). Only ERT2 results in activity, and only RT2 results in Fe chelation.

There is also some evidence that salts bind to the MoFe protein, according to the
ultracentrifugation experiments of Burns et al (92). However, Scheme 4-8 of the DeitsHoward model was sufficient to describe salt inhibition with salts binding on Av2 alone.
Figure 4-13 illustrates the very prominent apparent cooperativity of this salt inhibition of
activity, with a Hill coefficient of l = 3 in the inverse Hill equation:
1 K m + [I]l
.
=
v v max − [I]l

(4-2)

From the simulation of the data in Figure 4-13, Deits and Howard concluded that the saltinhibited nitrogenase complex, ERXmIn, is not stable, and they made the rate of complex
dissociation very large. Consequently, salts inhibit complex formation as well as
nucleotide binding. Both types of inhibition would lead to a decrease in nitrogenase
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Figure 4-13. Salt inhibits nitrogenase activity and MgATP-dependent Fe chelation
of the [4Fe-4S] cluster. The addition of NaCl inhibits the percent activity of Av
nitrogenase (relative to zero added salt) in standard assays at 30 oC. Data from ref (93):
from Fig 1 (● H2, and ●, C2H4); and transformed from Fig 4 (● H2). A global fit of all
these data to the inverse Hill equation and to a Hill coefficient of 3 is also shown
(▬▬▬). In the same scale of [NaCl], salt is more effective at competing 4.0 mM
MgATP away from 10 μM Av2, manifest in the decreasing rate of Fe chelation of the
[4Fe-4S] cluster by 1.2 mM 2,2'-bipyridyl. Data (▲) from Fig. 8b of ref (93), fit to the
inverse Hill equation and to a Hill coefficient of 1.05 (▬▬▬).

activity, and it could not be shown which is most responsible for salt inhibition.
However, it is clear from a comparison of inhibition of activity vs. inhibition of Fe
chelation in Figure 4-13 that nucleotides bind more tightly to the nitrogenase complex
than to free Fe protein because of the much sharper drop in Fe chelation with salt than
activity. Salts competing away even a single MgATP would produce a drastic drop in
both activity and Fe chelation. Interestingly, many research groups add a rather high salt
concentration to assays because activity is so high at 100 mM NaCl in Figure 4-13.
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4.6. Inactive Protein
There are several kinds of inactive nitrogenase proteins, as discussed in Section
2.1.1. In particular, the O2 sensitivity of both components is partly to blame for the
widely varying results from lab to lab. Results are generally not considered definitive
until reproduced in separate labs (139). Properly accounting for inactive protein, then, is
a major stumbling block to achieving a quantitative description of nitrogenase.

4.6.1. Inactive Fe protein
In the T&L model, inactive Fe protein, Ri, competes with active Fe protein for
MoFe protein, with binding affinity K3, the same as R0D2. This assumption was derived
from fitting data to Schemes 2-1 and 2-2, not from an independent determination of its
value. But such fits of data deviated from the model as shown in Chapter 2. Just how
accurate are the assumptions surrounding Ri? We begin to answer this question by
discussing the different possible types of inactive Fe protein.

4.6.1.1. An Inactive Conformation of Fe Protein. While Thorneley and Lowe

suggest that 55% of Kp2 is inactive (see Table 2-1), Ashby and Thorneley determined
through a stopped-flow study that all the KpR0 and KpR0D2 was active to reduction by
DT (115). In fact, they could not determine that there was a stable population of Ri
distinguishable from active R. Rather, Ri appears to be a protein conformation that is
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interchangeable with active R. The populations of R0 and R0D2 are almost completely
homogeneous with respect to this critical conformational change. That is, almost all R0 is
in a single conformation, and almost all R0D2 is in a single, different conformation.
Ashby and Thorneley propose that the conformation dominant in R0 still exists in R0D2,
and vice versa. This is perfectly reasonable considering the nature of protein folding and
conformational change in a complex landscape of semi-stable energy states. However,
the suggestion is made that the conformation assumed by R0D2 is actually Ri. Direct
evidence for this link to Ri is very tenuous; it would appear that this assumption is based
exclusively on Ri binding to E with the same affinity as R0D2.
However, Ashby and Thorneley do not discuss reduction of R0T2. We have
already seen how R0T2 has some peculiar properties. In particular, the Fe chelation data
in Figure 4-8 could only be fit to a double exponential, suggesting that the binding of
MgATP traps Fe protein into one of two conformations (152), perhaps one active and one
inactive with respect to both inter-protein electron transfer and ATP hydrolysis. This
possibility has never been considered before.
I propose that if binding of some inactive conformation of Fe protein, Ri, is
actually necessary to fit data once all other considerations of Scheme 4-7 have been
explored, then Ri is likely linked to the binding of MgATP. Because both conformers of
RT2—RnT2 and RiT2—would be susceptible to Fe chelation, they would be similar to
each other and very different from Rn and RnD2. Therefore, both RnT2 and RiT2 are
expected to bind to E strongly in the nitrogenase complex. The combination of inhibition
from 55% of Fe protein according to the binding affinity of ERi of K3 in the T&L model
would seem to be an arbitrary selection, especially considering that the T&L model is not
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quantitative. A different value for percent Fe protein activity with a different value for
the binding affinity of Ri may work just as well.

4.6.1.2. Oxidative Damage and/or Chemical Modification. Whether or not a

conformation of Fe protein is actually inactive, there are certainly inactive forms of Fe
protein caused by general protein degradation or more especially by alteration of the
[4Fe-4S] cluster.
For instance, the Fe chelation reaction results in conversion of the [4Fe-4S]
cluster to a single [2Fe-2S] cluster (153) that has some unique physical properties (189).
This [2Fe-2S] Fe protein is not very active, if at all.
More importantly, Fe protein is very sensitive to O2 inactivation. Actually,
oxidation is a general mechanism of Fe protein inactivation, also seen with NO inhibition
(190) and dyes. Oxidation to the [4Fe-4S]3+ state causes irreversible inactivation (97)
accompanied by loss of Fe content from the cluster.
It has been shown that the enzyme rhodanese (a sulphurtransferase)—in the
presence of thiosulfate, ferric citrate and reduced lipoate—restores activity in the
[2Fe-2S] Fe protein (191). Might the repair of the [4Fe-4S] cluster be a general feature
of diazotrophs? The nifH gene encodes the NifH gene product—the individual subunits
of Fe protein (192). Synthesis of the [4Fe-4S] cluster into Fe protein is more complex,
requiring the supply of inorganic sulfide from NifS (desulfurase of cysteine) to NifU for
formation of transient [2Fe-2S] clusters (193). Incorporation of these clusters into Fe
protein may require the rnf1 and rnf2 genes; the Δrnf1/Δrnf2 genotype accumulates Fe
protein with variable, deficient amounts of Fe, including an apo-Fe protein (194).
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There is compelling evidence that the [4Fe-4S] cluster of Fe protein is in constant
flux in a study of Azotobacter vinelandii cells by Curatti et al (194). A pulse-chase
experiment was set up starting with 55Fe in the [4Fe-4S] cluster of in vivo nitrogenase;
then cells were incubated in non-radioactive Fe for a variable amount of time, followed
by cell lysis and protein purification on α-Av2 beads. It was determined that the half-life
of 55Fe in Fe protein was only about five minutes! Perhaps because A. vinelandii is an
obligate anaerobe, there is a significant amount of oxidative damage and a mechanism to
repair Fe protein rapidly. This example highlights the importance of inactive Fe protein
and the in vivo mechanism to minimize its effects.
The [4Fe-4S] cluster of Fe protein under anaerobic conditions is not expected to
be so prone to destruction, but there is certainly some Fe protein in nitrogenase assays
that has been inactivated, especially by O2. The question is how much, since the specific
activity of Fe protein varies significantly from sample to sample. In fact, O2-inactivation
of Fe protein is the most reasonable explanation for this variability. The alternative of
some inactive protein conformation mentioned above would not be able to account for
such variability because that inactive conformation was proposed to interchange with the
active one.

4.6.1.3. Protein Regulation. Diazotrophs tightly regulate nitrogenase activity

because nitrogen fixation is such an expensive reaction. Thus, when ATP levels are low,
NH4+ levels are high, and/or O2 levels are too high (especially for obligate anaerobes), it
is not favorable to fix nitrogen.
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Nitrogenase expression is controlled at the transcriptional level by the products of
nifA and nifL genes (195, 196). NifA is a transcriptional activator of the nif promoter.

The purpose of NifL is to inhibit NifA when conditions for nitrogen fixation are not
favorable. Thus, NifL actively inhibits NifA when it is oxidized (197) and/or bound to
MgADP (60, 198). GlnK senses the cell’s amount of fixed nitrogen (glutamate and
glutamine). When there is an insufficient amount of fixed nitrogen, GlnK antagonized
NifL from inhibiting NifA (53, 199).
There is also very tight regulation of nitrogenase that has already been
synthesized. Several organisms possess a dinitrogenase reductase ADPribosyltransferase (DraT) and a dinitrogenase reductase-activating glycohydrolase (DraG)
(200). See Scheme 4-9. While A. vinelandii does not possess such a system, it is still
sensitive to the system from Rhodospirillum rubrum. DraT from R. rubrum ADPribosylates only one subunit of Fe protein, at Arg101 in RrR or Arg100 in AvR (see
Figure 4-9). The DraT-DraG system is sensitive to the presence of nucleotides bound to
Fe protein (201), as well as the redox state of Fe protein (200). DraT inactivates R0D2 to
ADPR-R0D2

whereas DraG activates ADPR-R1T2 to R1T2, reinforcing the concept that Fe

protein changes conformation for both nucleotide binding and redox state.
There is evidence that ADP-ribosylation prevents the nitrogenase complex from
forming. CpR normally forms a tight, inactive complex with AvE. However, ADPR-CpR
does not inhibit AvE (202). Using a heterologous cross is not always reflective of the
homologous cross, so it is interesting that even at a 66-molar excess of ADPR-KpR, activity
was not at all diminished in an assay containing KpR and KpE (203).

149

ADPR-

R1T2
ADPR-

ADPR-

R1D2
DraG

ADPR-

R0T2

R0D2

2+

Mn

nicotinamide
ADP-ribose

R1T2
rapid

R1D2

k1

DraT

NAD

+

R0T2

k4

ER1T2
kC

R0D2

k–3
E●R1T2
kET E●R0T2

ER0T2

ER1D2
ER0D2
Scheme 4-9. Post-translational regulation of Fe protein by ADP-ribosylation. The
three-dimensional Fe protein cycle with added pathways from Fig. 6 of ref (200) for
ADP-ribosylation (gold) of R0D2 and reactivation of R1T2 (red).

The regulation of nitrogenase transcription by the NifA-NifL system and
nitrogenase activity by the DraT-DraG system are intrinsically sensitive to the redox and
nucleotide energy states of the cell. However, both systems require additional input from
GlnK for responding to the nitrogen status of the cell. In addition, the DraT-DraG system
requires GlnB and AmtB to respond to the addition of NH4+ (204, 205).
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While several organisms employ the DraT-DraG system, alternative posttranslational modifications are emerging. For instance, there is modification by
palmitoylation in the cyanobacterum Gloeothece (206). While modifications of some
kind are common, it is interesting that certain organisms employ very different
mechanisms of shutting down nitrogenase activity. Whereas there is evidence for ADPribosylation in Azotobacter chroococcum, there is also evidence that there is an even
faster, unknown mechanism of nitrogenase inhibition upon the addition of NH4+ (207).
In its close cousin, Azotobacter vinelandii, there is no evidence for ADP-ribosylation.
Rather, A. vinelandii is famous for its FeSII protein that confers significant protection
from O2 inactivation of nitrogenase (208) by forming a tripartite FeSII0-ER0D2 complex
(209). Reduction of FeSII to the [2Fe-2S]+ state results in release of the FeSII protein
and resumption of nitrogenase activity.
The topic of inactive Fe protein and how cells shut down and restore nitrogenase
activity is of great importance. Because of the variable causes of inactivation, it is
unlikely that all inactive Fe protein behaves the same, as is the case in the T&L model.
However, inactive protein is not expected to change the pathways in Scheme 4-7. Rather,
accounting for the important intermediates of Ri could probably be accomplished by
adding in ancillary pathways to Scheme 4-7 that describe effects of inactive protein.

4.6.2. Inactive MoFe protein
In the T&L model, the amount of active E is taken as the Mo content of the MoFe
protein solution. For Kp1, this is about 70% of the total number of αβ MoFe protein
units, or about 95% for Av1. The remaining inactive apo-MoFe protein, Ei, is said not to
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interact with Fe protein at all. The first assumption seems reasonable. Without a
complete FeMoco, substrate reduction could not be accomplished. However, there is
compelling evidence that Fe protein actually does bind to apo-Ei.
The first indirect evidence for involvement of Fe protein with Ei was determined
from the discovery of alternative roles for Fe protein other than just nitrogenase catalysis.
Fe protein also participates in FeMoco synthesis (210-212) and insertion (213, 214). It is
not known exactly how Fe protein accomplishes these alternative roles. Its [4Fe-4S]
cluster is not required (215), but its ability to bind MgATP is (216). There is evidence
that distinct but overlapping regions of Fe protein participate in nitrogenase catalysis vs.
FeMoco synthesis vs. FeMoco insertion (216). The first residue that, when mutated, was
shown not to affect either catalysis or FeMoco synthesis but to be involved in FeMoco
insertion is Glu146 (217), which is located on the lateral surface of the Fe protein,
midway between the head and tail of the protein.
The crystal structure of the ΔnifB Ei was determined (218). The α subunit is open
to reveal a positively-charged pocket large enough to accept the mature FeMoco for
insertion. However, the domain of apo-Ei that binds to Fe protein is practically
unchanged.
Direct evidence for the interaction of Fe protein with apo-Ei has also been
observed in a study of a ΔnifB strain of A. vinelandii by Christiansen et al (219). The
binding of R0D2 to MoFe protein is observed by a slowing of R0D2 reduction by DT in
the stopped-flow (see Section 2.1.2.2 and ref (2)). Using this approach, Christiansen et al
determined that active AvE slowed down AvR0D2 reduction by 4.7-fold, whereas apoAvEi slowed down the reaction by 3.8-fold, or 80% of the effect of active AvE.
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Christiansen et al show that apo-Ei even supported ATP hydrolysis on R1T2 at
60% of the wild-type catalytic rate. Inter-protein electron transfer to the P-cluster
absolutely required ATP hydrolysis since there was none in the Ei-L127Δ-Av2 complex.
However, electron transfer to the P-cluster could not be sustained in the long-term
because electron flux requires the electron sink of substrate reduction on the FeMoco.
Thus, the most important ramification of formation of an EiR1T2 complex is uncoupling
of ATP hydrolysis from electron transfer to increase the ATP/2e– ratio. Considering that
reductant-independent ATP hydrolysis on EnR0T2 is only 20% of catalytic ATP
hydrolysis on EnR1T2 (181), the rate of ATP hydrolysis on EiR1T2 of 60% of the
catalytic rate would seem to be significant.
About 30% of Kp1 is Ei that binds to Kp2 to inhibit nitrogenase catalysis.
Thorneley and Lowe assumed that this Ei did not interact with Kp2 because the
maximum specific activity of a sample of Kp1 is proportional to the Mo content (7).
However, Thorneley and Lowe ignored the fact that at a high enough Kp2/Kp1 ratio, the
amount of Kp2 bound up by Ei is insignificant compared to saturating levels of free Kp2.
At lower Kp2/Kp1 ratios where Kp2 is not saturating, Ei would inhibit nitrogenase
activity. But how much? We can infer much from the drop in ATP hydrolysis with Ei.
The observed steady-state rate of ATP hydrolysis on EiR1T2 is 60% of that of
EnR1T2, but in the steady-state, this would involve all rates together:
5 X 107/ M s

200/ s

fast

14-50/ s

6.4/ s

With En: [R1T2 → EnR1T2 → En●R1T2 → En+1●R0T2 → En+1R0D2 → R0D2] and
8.0/ s

Ei: [R1T2 → EiR1T2 → Ei●R1T2

→ EiR1D2

→ R1D2]. (4-3)

Which pathways could account for the 60% difference in ATP hydrolysis on EiR1T2?
Because EiR0D2 dissociates only slightly faster than EnR0D2, it is reasonable to assume
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that EiR1T2 dissociates only slightly faster than EnR1T2, so that EiR1T2 is probably a tight
complex by analogy to the active EnR1T2 complex and in accord with the Ei crystal
structure. If so, then ATP hydrolysis would be required for complex dissociation. It is
highly unlikely that the value of k1 drops seven orders of magnitude for Ei + R1T2 to
account for the drop in ATP hydrolysis. Similarly, whatever causes the drop in ATP
hydrolysis on EiR1T2 must more than compensate for the increased rate of complex
dissociation of EiR1D2 compared to En+1R0D2.
Is the redox difference between the pathways important? Recall that in the
presence of inhibitors that bind the FeMoco and uncouple ATP hydrolysis from electron
transfer, e.g. CN–, the rate of ATP hydrolysis stays the same or even goes up slightly. So
the rate of [E●R1T2 → ER1D2 → R1D2] may be just slightly faster than [E●R0T2 →
ER0D2 → R0D2] because the ER0D2 complex is more stable than ER1D2 (see trends in
Scheme 4-2). This allows a fair comparison between EiR1T2 and EnR1T2, even though
there is electron transfer in the steady state for EnR1T2 and not for EiR1T2.
That leaves only some pathway in [EiR1T2 → Ei●R1T2 → EiR1D2] that could
account for the drop in ATP hydrolysis. Perhaps both of these rates are slowed by
inactive Ei compared to active En. Note that the value for En+1●R0T2 → En+1R0D2 is
kATPase = 14-50 s–1. This large range of values stems from fitting data measured at

different temperatures to different schemes (see Schemes 3-3 and 3-4). This kATPase step
is still closer to the value of k–3 = 6.4 s–1 than kc = 200 s–1, so it is more likely to be
slowed sufficiently to drop the rate of ATP hydrolysis on EiR1T2 to 60% of the rate on
EnR1T2. Thus it appears that the rate of ATP hydrolysis is slowed because Ei forms a
longer-lived complex with Fe protein than En does.
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Thus, MoFe protein can be 70% active in terms of Mo content when Fe protein is
saturating, but more than 30% inhibitory when Fe protein is not saturating because the
inactive Ei binds Fe protein 40% longer than does En. From preliminary simulations, I
estimate as much as 42% inhibition occurs for very dilute Fe protein, not even counting
increased MoFe inhibition from considering Ei! This level of inhibition begins to
approach the 55% inhibition attributed to inactive Fe protein in the T&L model. Thus, a
more detailed characterization of inactive nitrogenase proteins—both Fe protein and
MoFe protein—is desired for a more quantitative model of nitrogenase catalysis. The
important conclusion of this section is that inactive Ei is much more important than
previously thought, making Ri correspondingly less important than previously thought.

4.7. Substrate Reduction on the MoFe Protein
The Fe protein cycle is the heart of the MoFe protein cycle, but catalysis of
substrate reduction is most intimately tied to the MoFe protein. The MoFe protein cycle
can be thought of as a fourth dimension to catalysis; reduction of each substrate that can
bind at the FeMoco can be its own dimension. It may even be possible that multiple
substrates bind FeMoco at the same time. We have only scratched the surface so far in
this chapter as to the level of complexity of nitrogenase catalysis. Indeed, the complexity
of substrate reduction is inadequately understood in the literature. Nevertheless, in this
section I will discuss the relationships between the structure and function of MoFe
protein to make rational inferences about how the MoFe protein cycle functions.
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4.7.1. P-cluster Function
Recall from Scheme 4-3 that the P-cluster can exist in several redox states. MoFe
protein isolated in the presence of DT has a P-cluster in the PN state. Oxidation of the Pcluster by one electron to the P1+ state has a potential of +300 mV. It has not yet been
possible to isolate MoFe protein in this redox state for crystallography because further
oxidation to the P2+ state has a potential of +300 mV (at pH 8) +53 mM/pH (smaller with
lower pH) (220). Further oxidation to the P3+ state by thionine or O2 exposure
irreversibly inactivates the P-cluster (221).
The P-cluster is an electron relay point between the [4Fe-4S] cluster of Fe protein
and the FeMoco of MoFe protein. Direct evidence of a redox change in the P-cluster is
the loss of a novel EPR signal of a Serβ188Cys Av1 mutant during catalysis (222).
However, the exact mechanism of P-cluster function during catalysis is not known. Two
possibilities for changes in redox states of the P-cluster that could explain the loss of this
novel EPR signal are:
•

PN → PR → PN,

•

or PN → POX → PN.

In the first possibility, the P-cluster acts as a capacitor, charging from the PN state
to the PR state upon reduction by Fe protein. The thermodynamic considerations in
Figure 4-14 illustrate the appeal for the existence of the PR state. Specifically, substrate
reduction requires reduction of FeMoco to the MR state. Figure 4-14 illustrates that when
the reduction potential of the FeMoco to the MR state in Scheme 4-3 is added to the
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layout in Figure 4-1, it is clear that the PR state of the P-cluster is required for favorable
electron transfer to the FeMoco in the MN state. Evidence that is most consistent with
reduction of the P-cluster to the PR state is that when an Av1 is constructed with a
FeMoco lacking homocitrate, reduction by R1T2 results in a new EPR signal attributed to
the P-cluster, perhaps a PR state stabilized by the absence of homocitrate (223).

–600

ERT2: R0 → R1
ERT2: PN → PR

Em/ mV

–500
–400
–300

RT2: R0 → R1

R: R0 → R1

?

ERT2: MN → MR

ERT2: POX → PN
E: POX → PN

–200
–100
0

E: MOX → MN

[4Fe-4S]

P-cluster

FeMoco

Figure 4-14. Thermodynamic appeal for the existence of the PR redox state of the Pcluster. The significant difference from Figure 4-1 is the addition of the FeMoco
reduction potential of Em = –465 mV for MN → MR (133). The MR state probably
represents multiple AvEn states. Electron transfer from the PN state of the P-cluster to the
MN state of the FeMoco is not favorable. Favorable reduction of the FeMoco to the MR
state requires the existence of the PR state of the P-cluster, but the reduction potential
required to reduce the P-cluster to the PR state is not known.
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It may be that the P-cluster normally functions as a capacitor through reduction to
the PR state, and that P-cluster oxidation is also used when additional electrons are
required by the FeMoco. If it were ever favorable for the FeMoco to transfer electrons to
substrates to form the MOX state, then electron transfer to the FeMoco from the P-cluster
in the PN state would be favorable. Interestingly, there is spectroscopic evidence for Pcluster oxidation during catalysis that Lowe et al attribute to irreversible protonation of
N2 at the FeMoco (112). Thus, oxidation of the P-cluster could be mechanistically
important. Figure 4-15 suggests that the P-cluster structure is designed to accommodate
P-cluster oxidation, since drastic structural changes are observed for this process.

2 e–
PN

2 e–

POX

Figure 4-15. Structural changes of P-cluster oxidation. Cartoon of αβ Av1 with detail
of PN and POX (a.k.a. P2+) from PDBs 3MIN and 2MIN, respectively (224). Significant
structural differences upon oxidation require conserved residues in the P-cluster
environment (Serβ188 and Cysα88) suggesting a role for P-cluster oxidation in catalysis.
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In any case, deviations from the PN state during catalysis appear to be very
transitory. Alberty presents some thermodynamic considerations that suggest that ATP
hydrolysis is closely coupled to substrate reduction (225). ATP hydrolysis may be
intimately tied to electron transfer to the FeMoco, not just electron transfer to the Pcluster. In this sense, subtle changes in MoFe protein structure with Fe protein binding
and ATP hydrolysis may affect the pathway of electron transfer from the P-cluster to the
FeMoco according to Figure 4-16. In this light, it is interesting that the distance from
Alaα65 to homocitrate varies considerably in the literature.

Cysα62

Cysα88
Alaα65
Valα70

Argα96

Figure 4-16. Electron transfer from the P-cluster to the homocitrate of the FeMoco.
Theoretical calculation of the pathway of electron transfer. Electron jumps through space
of 3.54 Å and 3.36-5.15 Å (varies considerably in the literature) are predicted. Adapted
from Fig 8 of ref (114) using PDB 3MIN (224). Electron transfer through Valα70 and
Argα96 may be minor (226).
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4.7.2. FeMo Cofactor
The FeMo cofactor, FeMoco, is the site of substrate reduction on MoFe protein.
The FeMoco has a composition of Fe7MoS9-X-homocitrate, where X is a recently
discovered feature (227), most likely a N atom (227-229). Labeling of Fe and S atoms is
shown in Figure 4-17. The FeMoco is coordinated to the α subunit of Av1 by Cysα275 at
Fe1 and by Hisα442 at Mo. The Fe-Mo-S components of FeMoco can be circumscribed
by an outer sphere that intersects Fe1, all nine S atoms, and the Mo atom. An inner
sphere intersects Fe2 through Fe7.
Experimental (80, 230) and theoretical (228, 231-233) evidence puts the resting
state of FeMoco in E0 at [Mo4+, 3Fe3+, 4Fe2+, 9S2–], which is most consistent with N3– as
the central ligand to FeMoco: [MoFe7S9N]0.

R-Homocitrate

Cysα275
Hisα442
Figure 4-17. FeMoco coordination in the α subunit of Av1. From PDB structure
1M1N (227) with hydrogens added in PyMOL. Modeled after visual themes from refs
(79, 227), emphasizing: (a) the spherical geometry of the Fe-S-Mo region; (b) the
coordinating ligands in Av1; and (c) the numbering scheme employed to Fe (green) and
S (yellow) atoms.
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4.7.3. Site of Substrate Reduction on the FeMoco
A mechanism for N2 reduction in the inner core of the FeMoco has been proposed
(229), but it has been shown that the central N atom is not exchangeable with other N
atoms during N2 reduction (234). Rather, it is likely that a virgin cofactor reduces N2
through a unique mechanism, releasing a single NH3 and retaining a N atom (228).
Subsequent rounds of catalysis by this mature cofactor could involve either a similar
mechanism of opening of the FeMoco cage (235)—where the central N atom adds
flexibility to the FeMoco by providing additional bonds to Fe atoms—or a completely
separate mechanism at the FeMoco surface (236).
Theoretical studies suggest several different mechanisms reviewed recently by
Sra et al (237). The consensus on the theoretical work is that bridging S atoms of the
outer sphere of the FeMoco, not Fe atoms, are protonated (235, 238). Addition of H+ to
FeMoco must be controlled (i.e. directed to S instead of Fe sites) to minimize hydride
formation at Fe sites, which leads to H2 loss (226).
However, emerging experimental work is not compatible with these theoretical
studies. Rather, an ENDOR study of the Valα70Ile Av1 suggests that two hydrides in E2
actually bind to Fe (239). One possibility that accounts for both viewpoints being
compatible is that hydrides on Fe may be unique to a long-lived E2H2 state in the
Valα70Ile mutant protein and not characteristic of the wild-type. In wild-type Av1, H2 is
rapidly released from E2H2. More work is needed to reconcile the experimental and
theoretical studies.
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Still, Fe plays an important role in reduction of other substrates such as C2H2 and
N2 in both theoretical (235, 238, 240) and experimental (241) studies. Most importantly,
a series of studies on alkyne reduction have located substrate reduction at Fe6 of the
FeMoco. First, α70-substituted Av1 was shown to reduce longer-chain alkynes more
easily (242). Later, propargyl alcohol (HC≡CCH2OH) reduction in a Valα70Ala mutant
pinned its binding site to the face of the FeMoco capped by Valα70, or Fe atoms 2, 3, 6
and 7, and S atoms 2A, 2B, 3B and 5B (243). Further characterization of the specific
binding site showed that the propargyl alcohol reduction product binds to Fe6 of the
FeMoco, and is trapped on the FeMoco because of a stabilizing hydrogen bond to
Hisα195 (244), as shown Figure 4-18.

Hisα195

Valα70Ala

allyl-OH

Figure 4-18. Trapped substrate reduction product on FeMoco Fe6. Adapted from
ref (244). The allyl alcohol product of propargyl alcohol reduction by the Valα70Ala Av1
mutant bonds η2 to Fe6 of the FeMoco and hydrogen bonds to Hisα195. There is also a
significant electrostatic attraction between the H on the –OH group of allyl-OH and S2B
of the FeMoco.
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Localization of propargyl alcohol reduction at Fe6 has important implications for
both alkyne and N2 reduction based on DFT (245). Furthermore, N2H4 competes
effectively as a substrate in the Valα70Ala mutant (246), whereas N2H4 competes poorly
in the wild-type against H+, C2H2, and N2 reduction. Hence, N2H4 reduction is enhanced
by access to Fe6. Since hydrazine is an important intermediate in N2 reduction (7, 247250), it appears that at least part of the catalytic conversion of N2 to NH3 is accomplished

at Fe6. Additional insight should come from mutagenesis studies. Recently, a N2H4
reduction product was freeze trapped on the FeMoco in a Valα70Ala/Hisα195Gln mutant
(251). Further characterization of the intermediate should yield important information
about the binding site for N2H4 reduction, so long as the mutant reduces N2H4 at the same
site as wild-type Av1.
However, localization of a N2H4 reduction product to a certain site does not
exclude binding of intermediates to other sites. In particular, there is some debate over
the initial site of binding of N2 to the FeMoco. For example, a DFT study by Schimpl et
al suggests that binding of N2 to Mo is only transitory, and binding that ultimately leads

to catalysis occurs at Fe (235). On the other hand, Durrant’s theoretical work suggests
that the initial binding of N2 to Mo is essential (236). One of the limitations of all the
theoretical studies is that only a partial or approximate FeMoco is modeled, and never the
protein environment. The FeMoco can be extracted from MoFe protein by dissolution in
NMF (252). Isolated FeMoco can reduce C2H2 and H+ to a very limited extent, so the
protein environment of the native FeMoco is essential for active catalysis (79).
Therefore, better theoretical models and more direct experimental evidence are needed to
elucidate the site(s) and mechanism of N2 fixation at molecular resolution (79).
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4.7.4. Substrate Access
While the protein environment restricts substrate access to the FeMoco to a
certain extent, it is more interesting to consider the ways that nitrogenase facilitates
access to substrates. One of the hallmarks of most enzymes is a high degree of substrate
specificity. Interestingly, nitrogenase promiscuously reduces a multitude of substrates.
Natural reduction of H+ and N2 are perhaps most important, but reduction of C2H2 by
nitrogenase in the Jovian period was likely key in the evolution of earth’s early
atmosphere (253). In addition, detoxification of HCN in the environment continues to
this day (254, 255). A list of notable substrates to nitrogenase includes: H+, N2, N2H4,
N3–, CH3N≡C, HC≡N, C2H2, C2H4, N2O and CS2 (76, 97, 114). There are various types
of competition between these substrates because of reduction at different sites on and/or
redox states of the FeMoco, but reduction of each involves the addition of hydrides to the
FeMoco. How is this accomplished? In addition, N2 enters MoFe protein as a non-polar
molecule, but leaves as polar NH3 or ionic NH4+. Therefore, it is expected that MoFe
protein can accommodate the flux of both non-polar and polar molecules into and out of
the protein. Finally, this section deals with substrate access to the nitrogenase complex.

4.7.4.1. Proton Wires—the Delivery of H+/e– to the FeMoco. Fe6 is a focal point

for C2H2 reduction, and probably at least some steps in N2 reduction. The central S atoms
by Fe6 (S2B and S5B) are strategically positioned in Av1 to accept H+ via proton wires
that lead from the FeMoco to the protein surface (see Figure 4-19). Alternatively, there is
access of H2O to Fe7 and Fe3 bridged by S5B. Thus, bulk solvent could also be a source
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of H+ to the FeMoco, and/or regenerate H+ in the proton wires. Alternatively, the proton
wires may be more important for reduction of certain substrates other than H+. In the
Hisα195Gln Av1, the proton wire to S2B is altered. This mutant binds but does not reduce
N2, whereas C2H2 reduction continues unhindered (256-260). It also appears that
Hisα195 facilitates N2H4 reduction because a N2H4 reduction product is trapped in
Valα70Ala/Hisα195Gln Av1 (251) but not in Valα70Ala Av1 (246).

Figure 4-19. Controlled H delivery to the FeMoco of Av1. Cartoon of αβ Av1 from
PDB 3MIN (224), with close-up of electron transfer to the FeMoco coordinated with
delivery of H+ to the FeMoco. From an analysis of the protein structure, H+ delivery
could be accomplished via proton wires to S2B and S5B, and/or via bulk solvent to S5B,
whereas the H milieu around S3A appears to be structurally stabilizing only (226).
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4.7.4.2. Channels. Bulk solvent appears to have very limited access to the

FeMoco. Only the edge with Fe7, S5B and Fe3 reveals three waters in the crystal
structure. This small water pool is continuous with a more substantial water pool around
homocitrate (261) that connects to a permanent channel to the protein surface (226), as
shown in Figure 4-20. This water-filled channel could allow for transport of bulk solvent
to the Mo end of the FeMoco, including all substrates and products such as N2, H+, NH4+
and H2. Additionally, Igarashi and Seefeldt identify a hydrophobic channel that could
conduct small non-polar molecules such as N2 (114), as shown in Figure 4-20.

Figure 4-20. Channels to the FeMoco of Av1. From PDB 1M34 (63). Cartoon
structure of α2β2 Av1 with a single Av2. In the close-up, the relative positions of the gas
channel, the water channel and the docking site of Av2 are emphasized. The water
channel is composed of residues in the α, β and β' subunits as reported by Durrant (226).
Only waters in the water channel are shown. The gas channel is in the α subunit, with
residues reported by Igarashi and Seefeldt (114), plus Thrα177, Serα178, Valα206,
Ileα259 and Serα254 determined by visual inspection. The entrance to the gas channel at
the protein surface is comprised of Thrα177, Ileα259 and Lysα209. The appeal of this
hydrophobic gas channel is that with influx of N2 at one site and outflux of NH4+ at a
different site, there is one-way trafficking through Av1.
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4.7.4.3. Substrate/Product Flux on the Nitrogenase Complex. One of the striking

features of the crystal structure of the nitrogenase complex is that Av2 binds far from the
opening to either channel to the FeMoco, as shown in Figure 4-20. However, Burgess
and Lowe state (97): “It is an essential feature of the Thorneley-Lowe scheme that
substrates bind only to, and products are released only from, free MoFe protein, and that
the site(s) at which this occurs is protected from access by solvent in the relatively longlived complex between the Fe and MoFe proteins.” However, it is obvious from Figure
4-20 that Fe protein cannot physically block the channels. Preventing access to the
FeMoco on the nitrogenase complex according to this T&L assumption must be
accomplished by an alternate mechanism.
We begin to address this issue by comparing free and complexed structures of
MoFe protein. Durrant previously compared the water channel in crystal structures of
free and complexed MoFe proteins (Kp1 and Av1) and found no significant difference
(226). Igarashi and Seefeldt made no such structural comparison with their work on the
gas channel. Figure 4-21 shows comparisons of both gas and water channels in free and
complexed Av1 from PDBs 1M1N (227), 1G20 (138) and 1M34 (63). Capping the gas
channel, the side chain of Lysα209 swings over the opening into the channel significantly
from structure to structure. This behavior was investigated further in Figure 4-22, which
shows that only in 1G20 (ERT2 from Av1-L127Δ-Av2) is there any concern of covering
the channel. However, further investigation revealed that the side-chain of Lysα209
swings over the opening but does not form a seal with other residues. Rather, there is
ample room for gas substrate to go around this side-chain.
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Figure 4-21. Comparison of channels to the FeMoco in free and complexed
structures of Av1. PDBs 1M1N (227), 1G20 (138) and 1M34 (63) were aligned in
PyMOL according to main-chain atoms of the residues comprising gas and water
channels in the α subunit (chain a). At the opening of the gas channel there are
significant differences in Lysα209 between all three structures. See Figure 4-22. Durrant
showed that there is not a significant difference between structures in the water channel
(226), but Argα96 caps a face of the FeMoco, so minor structural differences may be
significant. See Figure 4-24.

In summary, the channels are essentially unchanged in free vs. complexed MoFe
protein. To accommodate the T&L assumption of substrate and product flux only on free
MoFe protein, Durrant proposes that Hisα195 only releases its proton to S2B upon
dissociation of the nitrogenase complex (226). However, with no direct evidence for this
structural change, and with the possibility of proton addition to S5B, there is a lack of
compelling structural evidence for this critical T&L assumption.
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Figure 4-22. Swinging of the side chain of Lysα209 over the gas substrate channel
of Av1. Space-filling view of αβ Av1 with Av2 of PDB 1M34 (63) with the same color
scheme as in Figure 4-20 except that: (a) surface residues of the gas channel are shown
in orange; and (b) Lysα209 is shown in red. Close-up views of PDBs 1M1N (227),
1G20 (138) and 1M34 aligned in PyMOL as in Figure 4-21 with a view into the gas
channel all the way to the FeMoco (white at end of arrows). Lysα209 is rendered as
semi-transparent and colored according to PDB structure as in Figure 4-21. Even in
1G20, there is ample room for substrates to go around the side-chain of Lysα209.

4.7.4.4. Kinetic Considerations of Flux on the Nitrogenase Complex. The

assumption of limiting flux to free MoFe protein was used to explain two observations
(97): “(a) dihydrogen is only released from nitrogenase, on quenching in acid, after two
protein-protein dissociations had occurred, even though two electrons had been
transferred to the MoFe protein before the second dissociation; and (b) the percentage of
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electron flux diverted from ammonia formation into dihydrogen evolution depends on the
electron flux through the MoFe protein.” In short, the assumption of substrate and
product flux only on the free MoFe protein is based purely on kinetics and product
distribution, not on structural considerations. Given the extensive problems with the
T&L model as shown in Chapters 2 and 3, the kinetic analysis of the T&L model comes
into question. Therefore, this assumption of substrate and product flux also comes into
question.
Even before my structural analysis of free vs. complexed MoFe protein, there was
other evidence against this limited assumption of substrate and product flux. Ironically,
this evidence is derived from kinetic concerns of the spectroscopic study of Lowe et al
discussed in Section 3.3.1 (112): “… C2H2 bound to E3 is reduced to C2H4 in the protein
complex…” This short statement contradicts the finer points of the assumption of
substrate and product flux. Recall from Scheme 2-1 that Thorneley and Lowe assumed
that the redox state of En+e in En+eR0D2 does not advance to En+1 until after dissociation of
the nitrogenase complex. However, the above statement implies that C2H4 is formed as
early as E2+eR0D2 instead of E3. If there is no electronic barrier to C2H4 formation on the
nitrogenase complex, and no physical barrier to prevent C2H4 release, then there ought to
be product flux on the nitrogenase complex.
This point deserves special emphasis. The addition of intermediates and
pathways I have made to the Fe protein cycle in this chapter are significant, but Lowe and
co-workers have tweaked it a couple times already. However, if substrate and product
flux occur on the nitrogenase complex, then this would be a much more significant
change because it is at the heart of how the Fe and MoFe protein cycles communicate
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mathematically. This is why Burgess and Lowe call this assumption “an essential
feature” of the T&L scheme.
Additional evidence for substrate/product flux on the nitrogenase complex comes
from the very source of the kinetics Thorneley and Lowe used to derive the limited
assumption of flux only on the free MoFe protein. Specifically, the quench data in Figure
2-7 were used in simulating the formation of intermediates on MoFe protein plus
natural product evolution. However, in Figure 3-7 we saw how the additional pathways
of ATP hydrolysis lengthened the lifetime of the nitrogenase complex, slowing down
catalysis. These points are reiterated in Figure 4-23. Upon closer inspection of the very
same kinetic data used to derive the limited flux assumption, it appears that it actually
supports a mechanism whereby flux occurs even on the nitrogenase complex!

Figure 4-23. Kinetic evidence for product flux on the nitrogenase complex. Original
T&L simulation (Figure 2-7, red) supports a mechanism of H2 release only on free MoFe
protein after two dissociation steps. Simulating the same data using the additional steps
of ATP hydrolysis in Scheme 3-4 slows the lag phase before product evolution (Figure
3-7, cyan). In order to regain activity in the lag phase, product evolution must occur
before complex dissociation, as shown in the inset.
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4.7.4.5. Considerations of Product Distribution. The only other observation that

formed the basis of product/substrate flux only on the free MoFe protein is product
distribution. Specifically, with increased electron flux through nitrogenase, there is an
increase in the proportion of NH3 formed relative to H2 (262). However, it is easy to
show that this observation is not a basis for the assumption, but is only consistent with
the Thorneley-Lowe paradigm.
Specifically, if you first assume that product is not released on the nitrogenase
complex, then you come to the conclusion that binding up MoFe protein with Fe protein
prevents decay of reducing power through H2 evolution until En is reduced sufficiently to
bind and reduce N2.
However, if you first assume that product evolution occurs regardless of complex
formation, then H2 evolution would have a slower over rate for k7, k8 and k9, which would
apply over all time instead of at discontinuous intervals when En is free of Fe protein.
Attaining the E3 state to bind N2 before H2 evolution becomes a matter of the rate of
electron flux through En before slow decay of electrons to H2 evolution. The more Fe
protein there is relative to MoFe protein, the greater the flux through nitrogenase, and so
the greater proportion of NH3 formed relative to H2, accounting for product distribution
just as easily as in the Thorneley-Lowe paradigm.

4.7.4.6. Gating Substrate Access to the FeMoco. A final consideration of the

access of substrates to the FeMoco is the position of Argα96 that caps the FeMoco and
changes slightly from structure to structure in Figure 4-21. Figure 4-24 shows these
changes in greater detail. Benton et al found evidence that this key residue is positioned
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as a gate over the FeMoco (176). There is no perturbation in the EPR signal of the
resting state AvE0 upon addition of C2H2 or CN–. However, in α96-substituted mutants,
there is a novel EPR signal that was correlated to binding of C2H2 or CN– to the FeMoco
through ENDOR analysis. Later, McLean et al characterized a very weak ENDOR signal
associated with C2H2 binding to the wild-type resting state E0 (81), confirming some
theoretical speculations (238, 240). However, binding of CO or CN– was not detected,
though both are known to bind to more reduced states of En, and despite the fact that CN–
binds E0 in α96-substituted mutants. The most straightforward explanation from these
considerations is that the electronic state of En is correlated to gating of Argα96.

Figure 4-24. Gating of Argα96 upon reduction of the FeMoco? Detail of structural
variations of Argα96 from Figure 4-21. Space-filling views reveal inversion of the
terminal end of the Argα96 side chain in 1G20 compared to 1M1N and 1M34. It appears
that this inversion results in increased exposure of the FeMoco. Of the three structures,
only 1G20 has the possibility of being in the E1H state, which may explain the inversion.
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But is there any structural evidence for this hypothesis? There may be. Figure
4-24 shows that there is inversion of the terminal end of the Argα96 side chain in 1G20
compared to 1M1N and 1M34. Possible causes of this inversion are: (a) nitrogenase
complex formation; (b) free rotation of the side chain; or (c) reduction of Av1.
Complex formation does not seem like a very plausible explanation since Argα96
is in essentially the same conformation in both 1M1N (E) and 1M34 (E●RT2). However,
it seems likely that neighboring residues should affect the conformation of Argα96.
There are only very subtle differences in the milieu around Argα96 in the PDB structures,
but I do not have the expertise to assess the effects of these differences on Argα96.
The validity of free rotation of the side chain can be gauged though an
examination of the b-factors for this residue in each PDB structure. PyMOL can color
structures according to relative b-factors (baseline for the structure subtracted out) so that
the error in position of Argα96 can be gauged visually, as shown in Figure 4-25. From
this figure, the position of Argα96 is apparently very stable, so free rotation of the side
chain is not likely responsible for the inversion in 1G20.

Figure 4-25. Stability of the positions of Argα96. The top row of structures in Figure
4-24 are re-drawn with a color scheme according to b-factors, where deep blue represents
a high degree of structure stability and accuracy of the position of atoms. The warmer
the color is, the more error is involved in the position of atoms. The position of Argα96
is fairly stable in each structure, so free rotation of the side chain is limited.
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As a final possibility, consider the potential of 1G20 being in the E1R0T2 state,
whereas the other structures represent an E0 state. First, it is important to note that in the
absence of Fe protein, 1M1N is definitely E0. Structure 1M34 represents E0●R0T2 from
EPR analysis (183). The MoFe protein is not reduced because the stabilizing reaction in
the presence of MgATP and AlF4– takes several minutes to perform. The AlF4– does not
instantaneously bind, allowing for multiple rounds of catalysis. Also, an excess of Fe
protein is used, so the experimental set-up does not result in the build up of partially
reduced species as occurs when there is a large excess of MoFe protein (see Figure 3-1).
In contrast, the Av1-L127Δ-Av2 complex is stabilized instantaneously by the RT2
conformation of L127Δ Av2 (131), so that an excess of Fe protein does not result in
multiple rounds of catalysis. Furthermore, there is slow electron transfer to Av1 in this
complex (see Figure 4-10) that is accompanied by a drop in the EPR signal of L127Δ
Av2, as shown in Figure 4-26. Protein crystallization for preparation of sample 1G20

Figure 4-26. Electron transfer to Av1 in Av1-L127Δ-Av2. Modified from Fig. 7 of
ref (118). The signal of the FeMoco MN state is not diminished, so reduction of the Pcluster to the PR state is likely.
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over a period of time would accommodate this slow electron transfer. As long as the
decay of E1 back to the ground state in the resulting E1R0T2 complex is slow, PDB
structure 1G20 would actually represent the first crystal structure for a super-reduced
MoFe protein.
However, Figure 4-26 shows that the FeMoco of Av1 is not reduced in this
complex since the characteristic Av1 EPR signal persists after oxidation of L127Δ Av2.
Rather, it is likely that the P-clusters become super-reduced to the PR state. Recall from
Figure 4-16 that Argα96 leads from the P-cluster to the FeMoco. Perhaps the subtle
inversion of the side chain of Argα96 is a reflection of the P-cluster being in the PR state.
This discussion raises some interesting questions:
•

Does reduction of the P-cluster on the nitrogenase complex open the gate for
substrate access to the FeMoco through inversion of the Argα96 side chain?

•

Is access to the FeMoco by substrates and inhibitors (e.g. C2H2, CO and CN–)
limited to when the P-clusters are reduced, or does reduction of the FeMoco also
affect the conformation of the gate of Argα96 to allow substrate access?

•

Av1-L127Δ-Av2 is likely in a PRMN state, but free E1H is in the PNMR state; so
when is electron transfer from the P-cluster to the FeMoco completed?

•

Do different redox levels of the FeMoco affect gate-keeping behavior by Argα96
and/or other residues differently?

Clearly, there are some important issues that have not been addressed regarding
substrate access to the FeMoco. Nevertheless, the discussion of this section provides
compelling arguments that substrates and products access the nitrogenase complex.
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4.8. An Atomic-Level Mechanism of Substrate Reduction
As discussed in Section 4.7.3, several mechanisms for substrate reduction have
been proposed, based on kinetics, spectroscopy, DFT and model compounds (79). These
vary extensively, and emerging experimental evidence is not always bearing out
predictions. Thus, it must be noted that a discussion of the mechanism of substrate
reduction based on theoretical models is necessarily speculative.
Nevertheless, one theoretical model attempts to rationalize certain features of the
T&L model, and so it deserves special attention in this literature critique. In a series of
studies, Durrant describes an atomic-level mechanism of substrate reduction, including:
N2 reduction (236); H+ reduction, H2 inhibition of N2 reduction and HD formation (263);
and C2H2 reduction and CO inhibition (238). Key differences between Durrant’s model
and the T&L model will be emphasized and discussed in terms of the outlook of this
chapter.

4.8.1. Overview
Durrant’s atomic-level mechanism is necessarily very detailed. A simplified
schematic of the FeMoco facilitates an understanding of this high level of detail for
reduction of various substrates. This schematic FeMoco is described in Figure 4-27.
Unfortunately, this schematic FeMoco has not always been understood by others. For
instance, Igarashi and Seefeldt (114) assign Durrant’s intermediates to the wrong sites.
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Figure 4-27. Structure-schematic relationship of the Durrant theoretical model.
From PDB 1M1N (227). The view to S3A is obstructed behind the central N in the
FeMoco because it appears to be bound structurally (see Figure 4-19) and on the opposite
end of the FeMoco face from Valα70 which caps the catalytically relevant face. The
figure simplifies the view of the catalytically relevant face. Clear understanding of the
orientation of the schematic for the FeMoco is important because Igarashi and Seefeldt
(114) assign Durrant’s addition of substrates to the wrong sites. In the resting state E0,
Durrant assigns a non-specific association of a proton (lower-left corner of schematic)
with the FeMoco (238).

Consequently, the atomic-level mechanism was not understood. Figure 4-27 describes
the origin of the schematic FeMoco to avoid any confusion in this work.
Durrant began his theoretical work before the central ligand to the FeMoco was
discovered and characterized. Thus, his first studies describe FeMoco with a different
resting-state charge than his more recent study. To facilitate comparison, I have updated
the earlier work. Scheme 4-10 shows all the different intermediates that Durrant
describes. Pathways between these intermediates will be described in sub-sections in this
Section 4.8.
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Scheme 4-10. Compilation of intermediates used in Durrant’s MoFe protein cycle.
Pathways for N2 reduction (236) are shown in red; pathways for H+ reduction (263) are
shown in purple; pathways for HD formation (263) are shown in yellow; and pathways
for C2H2 reduction (238) are shown in slate blue. Some key intermediates participate in
multiple pathways, resulting in combination colors. Specifically, HD formation occurs
exclusively in the presence of D2 and N2, and necessarily involves pathways that overlap
with H2 evolution. Note: Durrant classifies these E5 species in the HD-forming pathway
as E3 species because they are electronically identical to E3.

179

4.8.2. H2 Evolution
As the simplest, default pathway for nitrogenase catalysis, there is a tendency to
think of H+ reduction as easy to characterize. However, this section reveals some
surprising complexity to the problem of understanding the mechanism of the FeMoco.

4.8.2.1. An E5H5 Intermediate. Before discussing the pathways of H2 evolution,

an intermediate of Scheme 4-10 deserves particular emphasis: E5H5. A major problem
with the T&L MoFe protein cycle is that there is no pathway for the formation of E4H4R1T2. However, there is simply no physical barrier that should prevent nitrogenase
complex formation in this case. Considering the high affinity of the EnR1T2 complex
compared to EnR0D2, the T&L assumption that only the free MoFe protein experiences
substrate/product flux is modified for the E4H4 intermediates differently than any other
set of intermediate in the MoFe protein cycle.
It is interesting that Durrant describes an E5H5 species in the pathway for HD
formation (intermediate C of E5 in the HD pathway). Durrant actually classifies this set
of intermediates as E3 species, but they are not, because release of D2 would result in an
E3 species. It is not clear whether Durrant explored the possibility of E5H5 formation via
H+/e– addition instead of direct addition of H2. Still, because it is theoretically possible to
form an E5H5 species, why is it not observed in the kinetics of Thorneley and Lowe? One
possible explanation is that it is actually formed, but not to any significant extent.
Another possibility stems from my previous discussion on substrate/product flux actually
occurring on the nitrogenase complex. The rate of H2 evolution from E4H4-R1T2 or
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Scheme 4-11. Pathways of H2 evolution. Detail of Scheme 4-10 showing intermediates and pathways for H2 production.
The presence of E5 is derived from the pathway for HD formation, but its presence in this set resolves a longstanding problem
with the T&L model.

E5H5-R0D2 would limit the amount of free MoFe protein in the E5H5 state, particularly if
E5H5 can only exist in a very reactive state that rapidly decays to E3H3. Thus, the
formation of E5H5 could be limited by kinetics rather than by some bogus barrier to
E4H4-R1T2 complex formation.

4.8.2.2. Mechanism of H2 Evolution. Durrant’s mechanism for H2 evolution

refines the level of detail of the steps in the T&L MoFe protein cycle, as shown in
Scheme 4-11. Reduction of E0 to E1H results in the addition of a delocalized H+/e–. At
E2H2, however, the addition of hydrogen to S2B from the proton wire from Hisα195 is
most likely (see Figure 4-19). The next H+/e– results in modification of the homocitrate
ring in E3H3, and further reduction to E4H4 results in addition of a second localized
hydrogen to the FeMoco—this time at S5B (see Figure 4-19). In this highly reduced
state, the homocitrate ring can open, resulting in a very reactive species that rapidly
releases H2.

4.8.3. C2H2 Reduction
As the best-characterized alternative substrate to nitrogenase, C2H2 is extremely
important. Durrant’s atomic-level mechanism approaches the level of a satisfactory
treatment of the complexities of both wild-type and mutant nitrogenases.

4.8.3.1. Mechanism of C2H2 Evolution. Durrant’s atomic-level mechanism for

C2H2 reduction is shown in Scheme 4-12. The binding of C2H2 to E0 is my own addition.
Neither Durrant’s theoretical considerations (238), nor the kinetic considerations of Lowe
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Scheme 4-12. Pathways of C2H2 reduction. Detail of Scheme 4-10 showing intermediates and pathways for C2H2 reduction
alongside H2 production (muted shading). Durrant’s original scheme does not include some of these pathways: there is direct
ENDOR evidence for C2H2 binding to E0 (81); C2H2 binding to E2 is based on the T&L model (see Scheme 3-1); and C2H2
binding to E3 was excluded by the T&L model, but is used to account for the behavior of the Glyα69Ser mutant (see text).

et al (8) were able to rule out this possibility, and very weak binding of C2H2 to E0 has

been observed directly through ENDOR methods (81). In Durrant’s model, C2H2 binds
weakly even to more reduced states. The schematic shows C2H2 bound to a single Fe
atom, Fe6, coinciding with the trapping of propargyl-OH and propargyl-NH2 at Fe6 of
the FeMoco (244). Actually, binding of C2H2 to Fe atoms 2, 3, 5, 6 or 7 is equivalent in
Durrant’s model from molecular mechanics (MM) calculations of steric hindrances from
the protein environment. Of the inner-sphere Fe atoms, only Fe4 is excluded outright.
Aside from the binding of C2H2, the electronic structure of the FeMoco in the
C2H2-reducing pathway mimics exactly the H+-reducing pathway in Durrant’s model.
However, Durrant seems to be more concerned with what all the intermediates are rather
than how they interconnect. Only the binding of C2H2 to E1 is explicitly described (238).
Therefore, the pathway showing binding of C2H2 to E2 is my addition based on the
kinetic findings of Lowe et al that C2H2 binds to E1 and E2—but not E3 (8) (see Scheme
3-1). Binding of C2H2 to E3 is made somewhat tentatively. It is an intuitive assignment
based on the similarities between E2 and E3 FeMoco structures, and it helps explain the
behavior of the Glyα69Ser mutant Av1 (see below). Perhaps it does not appear to be
kinetically relevant in the T&L model because the E3 state bound to C2H2 is expected to
be too short lived to model the kinetics of C2H2 binding accurately on intermediate A of
E3 in the C2H2-reducing pathway, given the paradigm that there is substrate/product flux
on the nitrogenase complex. Once intermediate B is formed, there is a different
electronic structure that irreversibly commits C2H2 to reduction. Transfer of the
-CH=CH2 reduction intermediate to a central sulfur results in intermediate C, which
releases C2H4 product.
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It should be noted that the side-on binding mode of C2H2 to the FeMoco in
Scheme 4-12 contrasts with an alternative theoretical mechanism of opening of the
FeMoco cage (240). Opening of the FeMoco cage results in a lower energy for binding
substrate, but Durrant points out that “any distortion of the FeMoco will also have an
attendant energy cost (from steric hindrance from the protein environment) that will
rapidly offset the moderate energy gain from” binding in a bridging mode (238). Hence,
the use of both DFT and MM calculations in his model has helped Durrant rationalize the
action of a number of mutant proteins.

4.8.3.2. Refining the Detail of C2H2 Reduction—Insights from Mutant
Nitrogenases. In large part, Durrant’s explanations of the behaviors of mutants derive

from understanding Scheme 4-12 in somewhat more detail than is explicitly described.
Specifically, reduction of S2B is preferred to that of S5B, but reduction of S5B is still
possible to some extent. Based on the relative amounts of each, there is an appearance of
two binding sites, one with high apparent affinity (S2B) and one with low apparent
affinity (S5B), as shown in Scheme 4-13.
When Glyα69 is substituted by Ser, C2H2 reduction is severely reduced, whereas
N2 is reduced normally. In this Glyα69Ser mutant there is steric hindrance for the
migration of the –CH=CH2 intermediate to S2B (238). However, the proportion of S2B
reduced before S5B is still maintained. Reduction of S5B that could accept the
–CH=CH2 intermediate is not predominant until the E4 state, but a very small amount is
likely reduced by E3. In the wild-type, C2H2 is a noncompetitive inhibitor of N2 because
C2H2 and N2 bind to FeMoco in different (though perhaps overlapping) redox states.
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Scheme 4-13. Two-site model for C2H4 evolution. C2H2 binding to Fe atoms 2, 3, 5, 6
or 7 is equivalent and weak. C2H4 evolution requires a hydrogen at S before or shortly
after binding the —CH=CH2 intermediate. There is much more S2B reduced (with a
hydrogen) than there is S5B at E2 or E3. Thus, binding S2B is more likely to release
C2H4 product, and so has a higher apparent affinity for C2H2.

However, in a mutant that needs a more reduced state to reduce C2H2 effectively, the
competition between these substrates may change. Indeed, C2H2 is a competitive
inhibitor of N2 in this Glyα69Ser Av1, (83, 241, 264). This is evidence that both
substrates bind to E3 to compete directly for the same redox state of the FeMoco, but the
apparent binding of C2H2 for this inhibition is weaker than in the wild-type since only a
small proportion of S5B is reduced in the E3 state.
In α277-substituted mutants, the presence of CO induces sigmoidicity in C2H2
reduction consistent with two C2H2 molecules binding cooperatively to the FeMoco (85).
This weaker binding is again attributed to the inability of S2B to bind the –CH=CH2
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intermediate, this time because the proton wire to S2B is obstructed in the α277substituted mutants (263).
Durrant also discusses α195-substituted mutants (238). In the Hisα195Gln mutant
there is still a hydrogen bond to S2B, but the proton relay is obstructed since Gln is not a
good proton donor. Consequently, C2H2 reducing activity in this mutant is reduced to
68% of normal (257). Furthermore, the Hisα195Asn mutant presumably does not even
form a hydrogen bond with S2B, and so activity is reduced to 8% of the wild-type rate
(257).
Importantly, Durrant can also account for novel EPR signals observed in the
Hisα195Gln Av1 (265, 266), one attributed to binding of C2H2 and/or adducts to the
FeMoco, and another attributed to a radical on homocitrate. Durrant explains (238) that
C2H4 release should follow rapidly after normal migration of the –CH=CH2 group to a S
atom that either has a hydrogen already or can receive one rapidly. However, there is no
proton channel to S2B in the Hisα195Gln Av1, so a –CH=CH2 intermediate in this
position should be “unusually long-lived”. Durrant continues: “Spontaneous migration
of –CH=CH2 from Fe to S results in a reduction of the formal electron count of the metal
centers of the FeMoco by two; this could leave the FeMoco in a highly reduced state not
normally encountered in the wild-type catalytic cycle …, perhaps resulting in the
formation of a radical anion on homocitrate.”
As a final example, Durrant discusses the NifV– mutant nitrogenase that has
citrate instead of homocitrate (238). This mutant reduces C2H2 at the normal rate (90),
suggesting that opening of the homocitrate ring is not involved in C2H2 reduction, and
binding of C2H2 at Mo is very unlikely.
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4.8.4. N2 Binding and HD Formation
A singular observation of nitrogenase is that HD can be formed exclusively when
both N2 and D2 are present (108, 267-270). Electron flux going towards HD formation is
taken away from N2 fixation, so it is not surprising that H2 is a competitive inhibitor of
N2, but of no other substrate (268). These two observations are essentially equivalent.
A scheme for HD formation was proposed by Thorneley and Lowe (7). However,
it does not rely on the Fe protein cycle, and no data were fit to the scheme. So the
mechanism of HD formation has remained elusive for some time. Durrant is the first to
describe an atomic-level mechanism for HD formation, as shown in Scheme 4-14.

4.8.4.1. N2 Binding. First, HD formation requires the presence of N2, which binds

to E3. In the T&L model, N2 also binds to E4, but Durrant does not reveal any attempt to
study binding of N2 also on E4, which may be required to model changes in the Km for N2
binding with varying protein concentrations.
Note that N2 binding does not result in the loss of H2 as occurs in the T&L model.
This is because N2 binds at Mo. While there is a consensus that Mo makes a poor site to
bind most substrates, there is considerable debate in the literature regarding the role of
Mo in binding N2 (79). Synthetic catalysts are now able to reduce N2 all the way to NH3
at a single Mo site (20, 22). Because Mo is saturated in the resting FeMoco, a bond has
to be removed for N2 to bind. Homocitrate is well suited to ring opening. Importantly, in
the NifV– mutant where citrate replaces homocitrate, N2 reduction is sharply diminished
(271).
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Scheme 4-14. Pathways of HD formation. Detail of Scheme 4-10 showing intermediates and pathways for HD formation
alongside H2 production (muted shading). All the E5 species shown are classified as E3 by Durrant (263). Durrant did not
explore the possibility of N2 binding to E4 and subsequent HD formation on a set of E6 species, but this probably occurs.

4.8.4.2. HD Formation. The important feature of N2 binding that allows for HD

formation is opening of the homocitrate ring. In the absence of N2, the homocitrate ring
is not opened until E4H4, and then only briefly before rapid H2 evolution. On the other
hand, stabilization of the homocitrate ring opening is accomplished by N2 binding as
early as E3. D2 should bind Fe irrespective of N2 binding to Mo (263), but when D2 binds
to E3, it is here classified as an E5 species. Protonation of the bound N2 adduct to
Mo–N=NH (intermediate B) results in loss of N2. N2 inhibition of HD formation is
competitive (270) because the pathway for N2 release is reversible. However, if N2 does
leave, a Mo–H adduct is sufficiently long-lived to scramble with D2 bound at a
neighboring Fe site. Note that the electronic signature of this E5 state for HD formation
is equivalent to the E3 state (which is why Durrant classifies it as E3). The loss of HD
forms a true E3 species with the second D bound at Mo. Again, this Mo-D adduct is
long-lived at this electronic signature. Subsequent reduction of the FeMoco produces a
Mo-D adduct that is very reactive since HD formation from scrambling is not observed in
the absence of N2; the E4 species rapidly decays to E2 through evolution of a second HD
molecule.

4.8.5. N2 Reduction
Once N2 has bound to the FeMoco, it can either be displaced through the steps of
HD formation/H2 competition or further reduced to NH3, as shown in Scheme 4-15. N2
can bind E3 head-on at Mo, or in a bridging mode between Mo and an unspecified Fe
(Fe5, Fe6 or Fe7). The orientation of N2 bound in such a bridging mode lowers the free
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Scheme 4-15. Pathways of N2 reduction. Detail of Scheme 4-10 showing
intermediates and pathways for N2 reduction in the context of HD production from
Scheme 4-14 (muted shading). Durrant proposes that the FeMoco is oxidized by release
of NH3 released at E5. There is no special pathway for obligatory H2 evolution.
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energy of irreversible protonation of the bound intermediate at the next reduction
sequence. H2 is a competitive inhibitor of N2 reduction because its binding to Fe sites
prevents N2 binding in a bridging mode. Thus, the binding of H2 favors proton reduction
according to the HD pathways. However, if N2 is allowed to bind in a bridging mode,
reduction ensues, resulting in a Mo=N–NH2 adduct in E4. Further reduction of E4 to E5
allows for complete cleavage of the bonds between the two nitrogen atoms, again via
binding in a bridging mode between Mo and an unspecified Fe site. Intermediate B of E5
is then able to draw upon the stores of reducing power of the FeMoco to release two NH3
molecules, oxidizing the FeMoco in the process. There is spectroscopic evidence for the
oxidation of metal clusters on MoFe protein during turnover, but Lowe et al attributed
this oxidation to the P-cluster, not the FeMoco (112). Given the thermodynamics of
Figure 4-14, it is clear that a FeMoco in the MOX state would be reduced by the PN state
of the P-cluster. So intermediate C of E5 with a PNMOX electronic configuration would
ultimately arrive at POXMN. Subsequent reduction to E0 restarts the catalytic cycle.

4.8.6. The Cage Effect
It is notable that in Durrant’s model, both C2H2 and N2 bind unspecified Fe atoms
over the course of substrate reduction. C2H2 binds to Fe atoms 2, 3, 5, 6 or 7; and N2
binds to Fe atoms 5, 6 or 7. Indeed, there is evidence that these substrates bind to the
same or overlapping sites at the FeMoco. For example, the Hisα195Gln Av1 reduces C2H2
at a reduced but substantial rate, as discussed earlier, but it reduces N2 very poorly (<2%
of wild-type) (257, 259). However, N2 is still as effective as in the wild-type at inhibiting
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C2H2 reduction. But since N2 is not reduced, it does not inhibit by taking electron flux
from C2H2 reduction, but through binding FeMoco.
This brings into question Durrant’s model of N2 binding at the Mo, which is the
only site for N2 binding relevant to reduction. But actually, Durrant does model N2
binding at Fe sites, and he concludes that Fe atoms 2, 3, 5, 6 and 7 could all be used to
concentrate N2 at the FeMoco so that when the FeMoco is sufficiently reduced, there is
a substantial pool of N2 ready for catalytic binding at Mo (236). With limited space
around the FeMoco, there is a cage effect of competition between substrates for space,
not necessarily a catalytic site. Thus, whereas there is evidence for competition between
H2 and N2 for binding sites aside from the pathway of HD formation (272), these sites
may not be catalytic sites, just the cage effect (263). Thus, the cage effect can be
responsible for patterns of competitive inhibition when substrates are not actually
competing for electrons, nor a catalytic site, but for space in the small cavity surrounding
the FeMoco.

4.8.7. Perspectives on Obligatory H2 Evolution
Durrant’s mechanisms of substrate reduction are collectively a singular advance
in the field, but his mechanism for N2 reduction is somewhat controversial because there
is no specific pathway for obligatory H2 evolution. With all alternative substrates other
than N2, H2 evolution is completely obliterated as the substrate concentration is
extrapolated to infinity, but not even 50 atm of N2 is able to overcome the limiting H2/N2
stoichiometry of 1:1 (273). For many years, there has been debate over the cause of this
obligatory H2 evolution.
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Burgess and Lowe point out the two explanations for obligatory H2 evolution that
require a limiting 1:1 H2/N2 stoichiometry (97):
•

N2 can only bind to nitrogenase by displacement of H2 (possibly bound as a
dihydride) to give H2 evolution; or

•

H2 evolution is intimately coupled to N2 reduction and is needed to achieve a
thermodynamically unfavorable, partially reduced, bound N2 intermediate (108).

The first option is perhaps the better known explanation popularized by the T&L
model. The best experimental evidence for this explanation is based on the stoichiometry
of HD formation. If H2 is released upon binding of N2, then for every two HD made,
there is a H2 released upon N2 binding that is required for HD formation in the first place;
thus the limiting HD/H2 = 2. Indeed, this is the same stoichiometry observed by Burris’
research group from extrapolation to infinity when using D2 pressures up to 4 atm (270).
However, if multiple scrambling events occur at still higher D2 pressures, then a
different theoretical limit of HD/H2 = 6 is reached (263). In a separate experiment by the
same research group, extrapolation of data using up to 50 atm D2, the measured HD/H2
stoichiometry is 6.0-6.8 (274). This result could be an argument either for or against
obligatory H2 evolution.
Burgess and Lowe also point out other explanations that do not require a limiting
1:1 H2/N2 stoichiometry. Rather H2 evolution represents (97):
•

A leakage of electrons from E2H2, E3H3 or E4H4;

•

Competition for H+/e– between Fe sites and a N2 intermediate; or

•

Decomposition of a partially reduced bound N2 intermediate to N2 + H2.
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Durrant subscribes to the first of these options. The major point brought up in favor of
these alternatives is that the alternative nitrogenases have a different limiting H2/N2
stoichiometry. While the limiting H2/N2 stoichiometry for Mo nitrogenase is 1, the V
nitrogenase (vnf genes) has a limiting H2/N2 stoichiometry of 3.5 (275), and the Fe-only
nitrogenase (anf genes) is even less efficient, with a H2/N2 stoichiometry of 4.0 (276).
So does the limiting stoichiometry for each alternative nitrogenase reflect a
difference in the fundamental mechanism of N2 reduction? This explanation does not
seem reasonable.
Alternatively, perhaps the underlying stoichiometry for each family of nitrogenase
is a limiting H2/N2 stoichiometry of 1, plus extra leakage of H2 in the alternative V and Fe
nitrogenases. The reduced overall activity of the alternative nitrogenases (275) would
certainly lead to an increase in H2 leakage.
However, the simplest explanation is that the observed H2/N2 stoichiometry for all
the nitrogenases is the result of unavoidable H2 leakage. Durrant points out that “this last
possibility is in line with Occam’s razor and also fits in best with the results from both
the present and other (277) theoretical studies, which failed to uncover any potential
constructive role” for obligatory H2 evolution (263). So the leakage of electrons from
E2H2, E3H3 and E4H4 would explain obligatory H2 evolution, the different limiting H2/N2
stoichiometries for the different nitrogenases, as well as the elevated HD/H2 ratios
discussed above.
The notion of unavoidable leakage of H2 is compatible with—but not dependent
upon—my proposition that H2 is released from the nitrogenase complex. Seefeldt et al
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point out (79): “The mechanism for N2 activation appears to be fundamentally different
from that required for activation of other substrates and inhibitors, indicating a probable
distinction between where and how substrates might bind to the active site.” I would add
that it may be important when N2 binds. Binding later in the MoFe protein cycle gives H2
more of a chance for release than occurs for any other substrate. Maybe N2 binds at the
kinetic limit for the lifetime of H2 on the cofactor. If so, product distribution may reveal
an underlying temperature dependence.

4.9. Connection between the FeMoco and the P-cluster
In Section 4.8.5, I describe Durrant’s mechanism for N2 reduction, for which
intermediate C of E5 has a FeMoco in the MOX state (236). Durrant draws comparisons
with this oxidation step and the oxidation observed through EPR/ UV-vis spectroscopy
by Lowe et al in ref (112), which they attribute to P-cluster oxidation. Both the Durrant
theoretical model and the T&L kinetic model are compatible in this regard since the
conversion of E5-MOXPN into E5-MNPOX is thermodynamically favorable (see Figure
4-14).
However, there are two critical differences between these models: (a) Lowe et al
observed cluster oxidation much earlier in the catalytic cycle than described by Durrant—
at the transition from E3 to E4, as shown in Figure 4-28a; and (b) the EPR signal and
corresponding absorbance change were seen under both Ar and N2 (but not under C2H2)
as shown in Figure 4-28b. In contrast, Durrant describes oxidation of the FeMoco only
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on E5, and only under N2. It is tempting to discard Durrant’s model outright because of
these two major discrepancies, but it is more intriguing to come with an explanation that
accounts for both models.

Figure 4-28. Kinetics of P-cluster oxidation under Ar and N2. (a) Adapted from
Figs. 3 and 5 of ref (112). Stopped-flow data of redox changes during catalysis (black
traces) with T&L simulations of the data (cyan) using the indicated changes in extinction
coefficients. Under both Ar and N2, the data and simulations are essentially equivalent,
except that E5-E7 would also be present under N2; and there is P-cluster oxidation
associated with the E3 → E4 transition. Under C2H2, the absorbance of E3 is the same as
E1, providing evidence for C2H4 production on the nitrogenase complex. (b) Adapted
from Fig. 6 of ref (112). EPR signal during turnover; evidence of P-cluster oxidation
under both Ar and N2 (arrows), but not under C2H2.
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4.9.1. No P-cluster Oxidation under C2H2
Figure 4-28 is significant in correlating the absorbance increase under both Ar and
N2 with the novel EPR signal. Both features are absent with CO and C2H2. Even without
the novel EPR signal, C2H2 reduction can be characterized in great detail from the
stopped-flow data. A striking conclusion from the kinetics of C2H2 reduction is (112):
“The binding of C2H2 has no effect on its absorption coefficient except that C2H2 bound
to E3 is reduced to C2H4 in the protein complex so that the absorption coefficient of this
species is the same as E1” (emphasis added), according to the reaction:
E2-C2H2-R1T2 → E3-C2H2-R0D2 → E1-C2H4-R0D2.
This point was discussed in Section 4.7.4 regarding substrate/product flux on the
nitrogenase complex. Lowe et al conclude that the absorbance and EPR data are
different in the presence of C2H2 because C2H2 does not allow the FeMoco to be reduced
so much as is possible under Ar or N2.

4.9.2. P-cluster Oxidation under Ar
Kinetically, the most oxidized state at which P-cluster oxidation could occur
would be the state just more reduced than occurs in the presence of C2H2—just after
E3PNR1T2 → E4PNR0D2. This step occurs just prior to the E3 → E4 transition (upon
complex dissociation) proposed by Lowe et al, but recall that the original T&L model
used to simulate the data in Figure 4-28 is actually too fast, as previously discussed in
Section 4.7.4.4 (see esp. Figure 4-23). Generally speaking, each Fe protein cycle is too
fast, so the later in time data is modeled, the further off the simulation and data become,
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Scheme 4-16. Proposed atomic-level mechanism for P-cluster oxidation under Ar. P-cluster oxidation takes place
following electron transfer and ATP hydrolysis in the E3R1T2 → E4R0D2 reaction, but on the nitrogenase complex. Once the E4
state is reached, further reduction of the FeMoco by the P-cluster in the E4PN → E3P1+ + H2 reaction is proposed.

as shown by the double arrow at 0.8 s in Figure 4-28a. Therefore Lowe et al could
conclude that C2H2 is reduced on the nitrogenase complex at E2-C2H2-R1T2 → E3-C2H2R0D2 and miss that P-cluster oxidation also occurs on the nitrogenase complex a few
steps later.
Under Ar, P-cluster oxidation may proceed according to the reaction E4H4PN →
E3H3P1+ + H2, as shown in Scheme 4-16. This reaction requires: (a) favorable electron
transfer from the P-cluster to the FeMoco; and (b) a stabilized intermediate at the
FeMoco that does not transfer an electron back to the P-cluster.
The first of these requirements cannot be addressed directly because an
experimental measure of the free-energy state of each intermediate in catalysis is not
available. Note that the MR state in Figure 4-14 could represent an average of potential
states, perhaps some that favor P-cluster oxidation and others that do not. In Durrant’s
model E4H4 readily decays to E2H2 through H2 evolution. Since this is such a favorable
reaction, the thermodynamics for electron transfer from the P-cluster to the FeMoco may
actually be favorable.
The second requirement is for a stabilized intermediate that does not readily decay
back to E2H2PN. One possibility for this intermediate is suggested by Durrant’s open-ring
structure for E3H3 in the HD-forming pathway, which represents E3 in Scheme 4-16.
Thus, the kinetics of P-cluster oxidation are rationalized in terms of Durrant’s structures
for intermediate states at the FeMoco. However, these considerations require more
experimental and theoretical development and follow-up.
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4.9.3. P-cluster Oxidation under N2
P-cluster oxidation under N2 occurs with the same timing as it does under Ar.
Since N2 is already bound at E3, Lowe et al attribute P-cluster oxidation to an extra
driving force needed to cleave the N≡N bond to form the Mo=NH–NH2 adduct of E4
(112). In contrast to catalysis under Ar where H2 is lost upon P-cluster oxidation, there
does not appear to be any structural reason for depletion of H2 from a N2-bound
intermediate. Rather, the E5 state must be formed, as shown in Scheme 4-17.
However, kinetic observations demand that a single Fe protein cycle after N2
binds, a species releases N2H4 upon quenching. Hence, N2H4 release is associated with
the E4N2H2 intermediate in the T&L model (see Scheme 2-2). With such a short-lived E4
Mo=NH–NH2 intermediate demanded by the kinetics of P-cluster oxidation, how is N2H4
released upon quenching? The structure of intermediate A of E5 reveals the answer. This
intermediate also possesses the Mo=NH–NH2 adduct that should release N2H4.
However, the T&L model also determined that in the Fe protein cycle following
Mo=NH–NH2 formation, N2H4 is not released upon quenching. They speculate that
E5N2H3 has the Mo=NH–NH3+ intermediate, which would release NH3 upon quenching,
instead of N2H4. Thus, gradual depletion of intermediate A of E5 occurs. Notably, the
data in Figure 2-10 suggest that N2H4 release is more long-lived than Thorneley and
Lowe can account for. Given additional insight that the original T&L model is too fast as
discussed above (see also Section 4.7.4.4), it becomes clear that an increase in the
duration for N2H4 release would be compatible with the long duration of E5 in two Pcluster states in Scheme 4-17.
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Scheme 4-17. Proposed atomic-level mechanism for P-cluster oxidation under N2. Multi-dimensional grid for the MoFe
protein cycle. H2 evolution from Scheme 4-16 (muted gray) is connected to pathways unique to N2 reduction through the
binding/release of N2 at E3. P-cluster oxidation takes place following electron transfer and ATP hydrolysis in the E3R1T2 →
E4R0D2 reaction, but on the nitrogenase complex. Once the E4 state is reached, further reduction of the FeMoco by the Pcluster in the E4PN → E5P1+ reaction is proposed. Additional P-cluster oxidation at E5 would also be possible.

This same lengthening of the duration of the E5 intermediate may also be
responsible for the difficulty in matching NH3 release (natural and quench) to any
specific intermediate (see Scheme 2-2). Other factors are that make it difficult to
pinpoint NH3 release kinetically are: (a) increased error in matching kinetic model to data
with time; and (b) the evolution of H2 somewhere in the kinetic cycle to account for the
limiting 1:1 H2/N2 stoichiometry.
Note that in Figure 4-15, it appears that the structure of the P-cluster is actually
designed to accommodate the P2+ state, not just the P1+ state as proposed in Scheme 4-17.
However, Scheme 4-17 is perfectly compatible with additional P-cluster oxidation,
especially once oxidation of the FeMoco at intermediate C of E5 is reached.
With an oxidized P-cluster at E5, electron transfer from the Fe protein should be
very favorable, so the states of substrate thermodynamics and proton transport to the
FeMoco should not adversely affect the number of Fe protein cycles required for interprotein electron transfer.
Therefore, the rate of turnover of NH3 would be more influenced by the chemistry
at the FeMoco than by the ongoing flux received from the Fe protein. This chemistry is
probably affected by the metal at the cofactor, so that the release of N2H4, which actually
occurs naturally to an appreciable extent in alternative V nitrogenase (249), must be
minimized for effective NH3 production.
As with P-cluster oxidation under Ar, the proposed mechanism in Scheme 4-17
rationalizes how Durrant and Lowe et al could both be correct, but more experimental
and theoretical work is clearly needed.
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4.10. Connection between the MoFe and Fe Protein Cycles
In Section 4.7.4.6, I argue based on Figure 4-26 that Av1-L127Δ-Av2 is in the
E1R0T2 state with a P-cluster in the PR state, but a FeMoco in the MN state. Some event
must trigger electron transfer to the FeMoco in the wild-type that does not occur in this
mutant.
Two possible triggers are: (a) ATP hydrolysis; and (b) dissociation of the
nitrogenase complex. Both may be correct, but in the context of gating of electron
transfer, ATP hydrolysis is probably the more important of the two.
In this section, I will discuss the importance of electron transfer vs. ATP
hydrolysis in communicating key information between the Fe protein cycle and MoFe
protein cycle.

4.10.1. A Thermodynamic Perspective
Recall the discussion of electron transfer from the P-cluster to the FeMoco in
Section 4.7.1; Alberty presents thermodynamic evidence for the coupling of ATP
hydrolysis to substrate reduction (225). This concept is applicable only if ATP
hydrolysis triggers electron transfer all the way to the FeMoco, not just the P-cluster.
The reasoning behind this conclusion is based on two observations: (a) the PR state of the
P-cluster has not been directly observed in the wild-type; and (b) ATP hydrolysis gates
electron transfer to the MoFe protein. Combining these two concepts, once the gate of
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ATP hydrolysis closes, the P-cluster relaxes to the PN state, with the electron either
transferred back to the [4Fe-4S] cluster or onto the FeMoco.
In this way, the P-cluster is a kinetic sensor between the [4Fe-4S] cluster and the
FeMoco to coordinate when electrons are actually transferred to the MoFe protein. The
way the Fe protein cycle and the MoFe protein cycle communicate kinetically is through
this electron sensing pathway and ATP hydrolysis.

4.10.2. A Kinetic Perspective
Recall from Section 4.3.2 that there are several causes of uncoupling of ATP
hydrolysis from electron transfer. The pathways in Scheme 4-7 can account for all of
these possibilities; and these pathways are reiterated in greater detail in Scheme 4-18.
Scheme 4-18 includes the state of the P-cluster to highlight the role of ATP hydrolysis
driving electron transfer from the P-cluster to the FeMoco. In the EnPR●R0T2 →
En+1PNR0D2 reaction, electron transfer and ATP hydrolysis are intimately connected.
On the other hand, Section 4.3.1.4, cases of ATP-independent electron transfer are
discussed; very slow rates of product formation are observed in the complete absence of
ATP, so at some point electron transfer to the FeMoco must be finalized. Any
explanation involves complex dissociation in some form or another. Complex
dissociation as a trigger for the EnPR → En+1PN reaction is reminiscent of the T&L model
where En+e does not become En+1 until after complex dissociation. However, it is
important to reiterate that this concept does not apply to normal catalysis because of the
kinetic evidence for product flux on the nitrogenase complex (see Section 4.7.4.4) that
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EnPNR1T2
EnPRR0T2
EnPN●R1T2
EnPR●R0T2
EnPNR1D2±2Pi
En+1PNR0D2±2Pi
Scheme 4-18. ATP hydrolysis vs. electron transfer. Detail of Scheme 4-7, with
EnPNR1T2 (boxed) as the starting point. The status of the FeMoco—its ability to accept
an electron from the P-cluster—is “sensed” kinetically far away at the [4Fe-4S] cluster in
the activated E●RnT2 complex. ATP hydrolysis closes the gate to electron transfer,
resulting in reduction of either the Fe protein or the FeMoco.

clearly would not be possible without electron transfer to the FeMoco in the nitrogenase
complex, not just the P-cluster.
The view emerging from all these considerations is that ATP hydrolysis is a
trigger for complete electron transfer to the FeMoco in the more catalytically relevant
pathways in Scheme 4-18 (blue), whereas complex dissociation is the trigger for electron
transfer to the FeMoco in the minor pathways.

4.10.3. Effect of Substrates at the FeMoco
The simple pathways in Scheme 4-18 are extremely powerful in connecting the Fe
protein cycle with the MoFe protein cycle. Traditionally, the Fe protein cycle is thought
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of as determining the rate of total electron flux through the FeMoco. However, Scheme
4-18 allows for a critical input from the MoFe protein cycle into the Fe protein cycle—
the variable ability of electrons to be transferred to the FeMoco.
ATP hydrolysis continues at the same rate regardless of electron transfer. If there
were ever a shift in the equilibrium of electron transfer (167), fewer electrons would be
transferred from Fe protein to MoFe protein before ATP hydrolysis. A full cycle of
complex dissociation and recharging of R1T2 again would have to occur for another
opportunity at electron transfer. Therefore, the Fe protein cycle has the rate-limiting step
of complex dissociation, but the MoFe protein cycle ultimately determines number of Fe
protein cycles required to successfully transfer an electron. In this way, the MoFe protein
cycle can actually determine the rate of total electron flux through nitrogenase.
But what could shift the equilibrium of electron transfer towards the Fe protein?
This could occur if a particular step in reducing a substrate is less favorable than others,
either because of the thermodynamics of this step, or because the intermediate physically
obstructs proton delivery at the FeMoco (258).

4.10.3.1. FeMoco Inhibitors. Recall from Section 4.3.2.1 that certain FeMoco

inhibitors (CN– and CH3NC) bind the cofactor and prevent electron transfer to any
substrate, but do not affect the rate of ATP hydrolysis. The ATP/2e– ratio is extrapolated
to infinity as the concentration of inhibitor is extrapolated to infinity. FeMoco inhibitors
are the most extreme case for the MoFe protein cycle and Fe protein cycle
communicating through electron transfer vs. ATP hydrolysis.
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4.10.3.2. Distinguishing Types of Inhibition. Could all substrates be FeMoco

inhibitors to some degree? How could we tell if they were? All causes of nitrogenase
inhibition lead to a drop in electron flux, but two groups of inhibition emerge based upon
whether an increase in the ATP/2e– ratio accompanies the drop in electron flux.
Causes of head-on inhibition, where only electron transfer is inhibited (an
increase in the ATP/2e– ratio), are:
•

FeMoco inhibitors, such as CN– and CH3NC, which inhibit electron transfer
directly in the En●R1T2 complex;

•

Excess MoFe protein or limiting reductant, which results in an increase in
reductant-independent ATP hydrolysis on the En●R0T2 complex;

•

Using inactive MoFe protein (see Section 4.6.2); and

•

Extremes in temperature or pH, which favor ATP hydrolysis over electron
transfer, i.e. through altering the rates of these steps.

In contrast to head-on inhibition, dead-end inhibition results in no change in the
ATP/2e– ratio because both electron transfer and ATP hydrolysis are inhibited. Cases of
dead-end inhibition are:
•

Inactivating Fe protein (note that this would ultimately lead to MoFe inhibition,
so this possibility implies a constant excess of Fe protein);

•

Increasing the ADP concentration;

•

Post-translational regulation of 4.6.1.3 Fe protein; and

•

Salt inhibition.
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Simply by controlling the experimental setup of assays, several causes of
inhibition can be excluded. To determine whether substrates are also FeMoco inhibitors,
we are required to determine the effects of variable substrate concentration on electron
transfer and ATP hydrolysis while maintaining constant all other assay conditions of
temperature, pH, ionic strength, and protein and reductant concentrations. Restoring full
activity with CO would show whether the proteins were inactivated or just inhibited.

4.10.3.3. The 15N Isotope Effect. Very recently, Sra et al observed a 15N isotope

effect with nitrogenase (237). This is an extremely important observation because an
isotope effect is generally only observable if it affects a kinetic step that is slow enough
compared to the rate-limiting step, or the rate-limiting step itself. Sra et al go on to
review a host of different theoretical molecular mechanisms in their supporting
information in hopes of elucidating a slow step that could account for the isotope effect,
but this review is fruitless in this regard.
The reason they could not elucidate a slow step is that they were looking in the
wrong protein cycle. The key lies in how the MoFe protein cycle connects to the Fe
protein cycle in the electron transfer and ATP hydrolysis steps, as discussed above. At
least one intermediate in N2 reduction must be more difficult to reduce than H+.
Note that this simple explanation requires no knowledge of the atomic-level
mechanism of N2 fixation, though it may be helpful now to try to rationalize theoretically
which intermediates may prevent electron transfer the most. The most
thermodynamically unfavorable reduction step would be cleavage of the N≡N bond in the
E3 → E4 step. Indeed, Lowe et al originally attributed this step to P-cluster oxidation
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(112). So in developing an atomic-level mechanism for N2 reduction, several things must
be compatible: the theoretical structures of intermediates; with quench products H2,
N2H4 and NH3 released according to known kinetics; and at least one step where
reduction of an intermediate should be very difficult thermodynamically or mechanically,
i.e. in the En(NxHy)PNR1T2 complex with a fully reduced P-cluster.
Importantly, Scheme 4-17 is compatible with all these considerations. The last
consideration was not previously discussed, however. That the step responsible for the
15

N effect (difficult reducing step) must also be associated with a reduced P-cluster pin-

points this difficult step to the reduction of the N≡N bond in the E3 → E4 step. It was not
possible to devise an alternative to Scheme 4-17 that satisfied all of these requirements.

4.10.3.4. Self Inhibition. The observation of an 15N isotope effect is evidence that

the total electron flux is diminished in the presence of N2. This makes sense if on
average slightly more than one Fe protein cycle is required to reduce the N≡N bond. This
kind of inhibition where the presence of a substrate inhibits its own reduction is known as
self-inhibition, as discussed by Burgess (76).
Early in the study of nitrogenase, it was determined that total electron flux and the
ATP/2e– ratio were not variable with added substrate (180, 262, 278, 279). This
assumption was incorporated into the T&L model. However, Hageman and Burris
reported a 35% reduction in total activity with N2 up to 1 atm (280). This inhibition was
reversed by adding CO, indicating that it was not due to inactivation of the nitrogenase
proteins or other type of inhibition. Likewise, Wherland et al (107) and Burgess et al
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(108) observed a 13% drop in electron flow under N2 using different methodologies.
Self-inhibition by N2 was also observed in other studies (269, 281).
Self-inhibition by C2H2 is even better characterized and established. Sha et al
noted that high C2H2 concentrations were required to observe self-inhibition (282). A
similar drop in activity was ultimately acknowledged in the T&L model (see Section
3.2.1 and esp. Figure 3-3) and was incorrectly attributed to an increase in the affinity of
the nitrogenase complex in the presence of C2H2 (8). More recently, Han and Newton
explored the modes of C2H2 inhibition quite extensively (283).
In summary, self-inhibition is now well established in the literature. However,
characterizing substrates as slight FeMoco inhibitors also requires an elevated ATP/2e–
ratio, as discussed below.

4.10.3.5. An Increase in the ATP/2e– Ratio? The observation of self inhibition

has not always been followed up in the literature with a correlation to an increase in the
ATP/2e– ratio. Other studies tally both activities and ATP/2e– values, but have never
described a kinetic framework for how these are related, such as in Scheme 4-18.
Occam’s razor suggests that if substrates increase the ATP/2e– ratio while diminishing
total electron flux, then they act in some small degree as FeMoco inhibitors by decreasing
the extent of electron transfer to the FeMoco.
On the other hand, inhibition of total activity by a substrate could be attributed to
a salt-like effect (dead-end inhibition) where the association between the Fe and MoFe
proteins or ATP hydrolysis is inhibited. If so, there would be no increase in the ATP/2e–
ratio with increased inhibition. Sorlie et al conclude that C2H4 is just such an inhibitor
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(266). Therefore, it is vital to compare both activities and the ATP/2e– ratio to determine
whether certain substrates are FeMoco inhibitors to some extent. It is even possible that
certain substrates exhibit self-inhibition through a mixture of patterns of both dead-end
salt-like inhibition and head-on FeMoco inhibition.
A brief review of the literature reveals great variability regarding a change in the
ATP/2e– ratio with substrate addition. With wild-type nitrogenase, Yousafzai et al
observed equal activities under both Ar and N2, but a higher ATP/2e– ratio under Ar (4.7)
than under N2 (4.0) (284). Peters et al observed approximately equal activities and
ATP/2e– values under Ar, N2 and C2H2 (285). In contrast, Kim et al observed an elevated
ATP/2e– value under N2 (5.5) compared to Ar (4.8) (257). With the variability of the
measured ATP/2e– value under different substrates, it appears that making a solid case for
substrates being slight FeMoco inhibitors will require some innovative experimental
design and precise measurements. It is particularly important to measure Pi or
nucleotides directly as accurately as possible.
In the meantime, there is actually compelling evidence for substrates being
FeMoco inhibitors in nitrogenase mutants and alternative nitrogenases. N2 being a strong
FeMoco inhibitor is exemplified in the Hisα195Gln Av1. Under Ar, the ATP/2e– ratio is
5.4, but under N2, it is significantly elevated to 23.0 (257). This great difference was
carefully analyzed over a range of added N2 for both Hisα195Gln Av1 (258) and
Hisα195Asn Av1 (272).
Similarly, the ATP/2e– ratio is elevated by the addition of N3– (258, 272). In
wild-type Av1, the addition of 10 mM NaN3 elevated the ATP/2e– ratio from 4.5 to 5.3;
but in Hisα195Gln Av1, N3– addition elevated the ATP/2e– ratio even more significantly—
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from 4.8 to 29.3 (258). This uncoupling of ATP hydrolysis from electron transfer was
relieved by the addition of CO.
Interestingly, some mutant nitrogenases are not inhibited by CN– the way the
wild-type is. Dilworth et al showed that Hisα195Gln Av1was not at all inhibited by CN–.
Upon closer inspection, CO was shown to relieve a partial inhibition of CN– in
Hisα195Gln Av1 (260).
Surprisingly, the addition of CO to relieve CN– inhibition in the Glnα191Lys Av1
greatly compounded the problem of inhibition and uncoupling of ATP hydrolysis from
electron transfer; the ATP/2e– ratio under Ar (5.5) was increased by CN– (6.0) and then
even more under both CN– and CO (16) (260).
Mixed substrate/inhibitor effects were also observed when C2H2 was added to
nitrogenase reducing HCN (260). In the wild-type and Hisα195Gln Av1, C2H2 did not
significantly alter the ATP/2e– ratio, but in the Hisα195Asn Av1, the addition of 2 kPa
C2H2 elevated the ATP/2e– ratio from 8.1 under 5 mM NaCN to 15.
It was also shown that in the NifV– mutant where citrate replaces homocitrate, CO
no longer just diverts electron flux to H+ reduction; it also acts as a FeMoco inhibitor,
decreasing total electron flux without affecting the rate of ATP hydrolysis (90, 91, 286,
287).

This series of results highlights the importance of multiple substrate-inhibitor
interactions and changes at the FeMoco in mutants. The mechanism of increasing the
ATP/2e– ratio is probably that in the mutants, the pathway of proton transport to the
FeMoco is changed. The arrival of a proton should greatly stabilize the arrival of an
electron, so in the absence of proton flux, the ability of Fe protein to reduce the FeMoco
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is greatly diminished. Ultimately, it is the presence of substrates, reduction intermediates
and inhibitors, in combination with the protein environment around the FeMoco, that
combine to produce some complex thermodynamic and physical potential for electron
transfer to the FeMoco.
Perhaps the best evidence that substrates act as FeMoco inhibitors is that in the
wild-type V nitrogenase, N2 actually increases the ATP/2e– ratio substantially. Eady

states (275) that ATP/2e– ratio “found for Mo and V nitrogenases of A. chroococcum”
were “4.32 ± 0.16 and 4.87 ± 0.03, respectively. However, under N2, significant
differences were seen when total electron flux into NH3 and H2 was used to calculate the
ratio. Under these conditions, the ratios were 5.71 ± 0.41 for Mo nitrogenase and 7.14 ±
0.14 for V nitrogenase.”
The difficulty in measuring a slight difference in the ATP/2e– ratio with added
substrate for wild-type Mo nitrogenase is overcome by the very large differences seen in
mutant and alternative nitrogenases. Alternatively, the alternative nitrogenase could
operate through a different mechanism than Mo nitrogenase. Occam’s razor suggests that
this possibility is very unlikely.
Scheme 4-18 provides a framework that unifies the various observations in this
work, that there is a simple mechanism for uncoupling ATP hydrolysis from electron
transfer that accounts for the thermodynamic connection between ATP hydrolysis and
substrate reduction, the 15N isotope effect, self-inhibition, and an elevated ATP/2e– ratio.
This simple mechanism serves as a vital connection between the Fe protein cycle and the
MoFe protein cycle.
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4.11. Summary and Conclusions
The Fe protein cycle has been greatly expanded in this chapter to include
intermediates and pathways that have been shown to be dominant under certain
circumstances. The original Thorneley-Lowe model approximates nitrogenase catalysis
by focusing on a limited set of intermediates that are important, but not comprehensive,
under conditions of high electron flux and N2 fixation. Notably absent in the T&L model
are pathways associated with the all-ferrous Fe protein, nucleotide binding and the
nitrogenase salt effect. The T&L treatment of inactive proteins is particularly deficient.
Inactive Fe protein is less important than previously thought, and inactive MoFe protein
is more important.
There is a tendency in considering the MoFe protein cycle to separate the effects
of the Fe protein cycle from the overall steps in catalysis, which is the case when using
“simplified” schemes such as Scheme 3-2. In Chapter 3, it was clear that this approach
presented several problems and deficiencies. Rather, the MoFe protein cycle is
intimately connected with the Fe protein cycle at the electron transfer and ATP
hydrolysis steps. The modified Thorneley-Lowe Fe protein cycle (see Scheme 4-4) does
not treat these steps correctly. The uncoupling of either event from the other is essential
to account for the intimate connection between the MoFe protein cycle and the Fe protein
cycle.
The MoFe protein cycle has been critiqued at a very high level of detail. It is
concluded that substrate/product flux occurs on the nitrogenase complex. An atomic-level
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sequence of events for N2 fixation is shown to involve the P-cluster as an intimate partner
in catalysis.
Over the past two decades the details of nitrogenase catalysis have become
clearer. The value of the critique of the literature in this chapter is to unify several
disparate studies into a workable framework for ongoing studies to develop a replacement
to the Thorneley and Lowe model. This chapter gives unique perspective to our
understanding of the structure and function of nitrogenase and gives insights into my
outline for future experimental work.
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Chapter 5
Reduction of Av2 by Dithionite: Quantitative and
Qualitative Effects of Nucleotides, Temperature,
pH and Reaction Buffer

This chapter is based on a manuscript authored by myself, J. Bunker, T. J.
Lowery, and G. D. Watt, and published in Biophysical Chemistry (288).

The comprehensive review and critique in Chapter 4 may be somewhat
overwhelming. In my endeavors to develop a new model for nitrogenase catalysis, there
are many things to do! One approach to tackling this ambitious task is to research what
are the different intermediates and pathways in catalysis, through literature search and
experimental work. This approach produces a qualitative model, whose basic
components are presented in Chapter 4.
However, I am trying to develop a quantitative kinetic model for nitrogenase
catalysis. To quantify nitrogenase catalysis requires careful measuring of each
elementary step. In developing a comprehensive model of nitrogenase, I want to be able
to unify not only the concepts of how nitrogenase works, but also what the different rates
are under different experimental conditions that would be important in vivo, such as pH,
ionic strength and temperature. Thus, measuring rates of nitrogenase catalysis becomes a
major effort for each step.
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The simplest of these steps is the reduction of Fe protein. In this chapter, I
discuss the surprisingly complex effects of experimental conditions on the rate of Av2
reduction.
The reduction of oxidized Fe protein in the presence and absence of nucleotides
and the relative binding strengths of nucleotides to both the oxidized and reduced forms
of the Fe protein have been important areas of study in attempts to understand how Fe
protein reduction, nucleotide binding, electron transfer, and nucleotide hydrolysis
influence nitrogenase catalysis (99, 115, 118, 219, 289, 290). This is the first attempt to
characterize Fe protein reduction over a broad set of conditions of temperature, pH and
buffers.

5.1. Theory
Two important reactions describe the reduction of Fe protein by dithionite (99,
291):
k⎯
− DT →
–
⎯⎯
S2O42– ←
⎯⎯
⎯ 2 SO2 ,

(5-1)

kr
SO2– + OH– + R0Xm ⎯⎯→
HSO3– + R1Xm,

(5-2)

k DT

and

in terms of the RnXm notation introduced in Chapter 4. Only R0 and R1 forms of Fe
protein are relevant when DT is present. In this study, several forms of the Av2 will be
studied: R0, R0T2 and R0D2, with corresponding reduction rates kr, free, kr, ATP or kr, ADP.
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An analysis of the differential equations describing Equations 5-1 and 5-2 yields
–

two useful limiting cases. The first of these cases is where kr [R0] >> 2 k–DT [SO2]. This
condition applies particularly to reduction of R0, whose kr is fast, and the following
equation can be used:

[R0] = [R0]0 – 2 k–DT [DT] t.

(5-3)

This linear equation applies for early t, until [R0] decreases enough that the first limiting
case no longer applies. To relate Equation 5-3 to the measured drop in absorbance, we
start with the relationship:

ΔAbs = ε0 Δ[R0] l + ε1 Δ[R1] l,

(5-4)

where the change in absorbance, ΔAbs, depends on the change in concentrations of R0
and R1, on their respective extinction coefficients, ε0 = 17.5 mM–1 cm–1 and ε1 = 11.5
mM–1 cm–1 at 400 nm (as shown in Figure 5-1), and on the path-length of the stoppedflow apparatus (l = 1 cm). The change in [DT] is assumed negligible. For every R0
reduced, an R1 is formed, so Equation 5-4 becomes

ΔAbs = ε0 Δ[R0] l – ε1 Δ[R0] l
= (ε0 – ε1) Δ[R0] l.

(5-5)

Combining Equations 3 and 5, we obtain the relationship

k− DT =

m
.
2 [DT] (ε − ε ) l
1

(5-6)

0

The second limiting case of the differential equations describing Equations 5-1 to 5-2
–

occurs when 2 k–DT [SO2] >> kr [R0], and applies at higher t to stopped-flow time courses
that initially have a linear portion. For time courses lacking an initial linear portion, this
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Figure 5-1. Extinction coefficients of Av20 and Av21. From D. Thiriot (WattLab).

second limiting case is true for all t. The consequence is that [R0] decays exponentially
according to the equation:

[R0] = [R0]0 e

(− kr

K

DT

[DT] t

),

(5-7)

where KDT = k–DT/ kDT. The observed rate constant of exponential decay is therefore equal
to kr KDT1/2 [DT]1/2. If [DT] is known, it is easy to calculate an adjusted rate constant, kr
KDT1/2, so that samples reduced at different [DT] can be compared.
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5.2. Materials and Methods

5.2.1. Solutions and Proteins
Av2 with specific activities between 1800-2000 nmol of H2 mg–1 min–1 was
isolated, purified and characterized as described (292). All sample preparation, solution
transfers and size exclusion chromatography were conducted in a Vacuum Atmospheres
glove box under nitrogen at oxygen levels below 1.00 ppm (Nyad O2-Monitor). All UVVis spectra were recorded on a Hewlett Packard 8453 UV Spectrophotometer, located
inside the glove box. Oxidized Av2 (Av20) concentrations were determined by
absorbance at 400 nm (ε400 = 17.5 mM–1 cm–1) (153).
Stock Av21 was oxidized with excess methylene blue and subsequently separated
using anaerobic G-50 Sephadex column chromatography. After separation, the R0 optical
spectrum was recorded to ensure complete separation from the methylene blue and to
determine protein concentration. Dithionite solutions were made inside the glove box
and were standardized by absorbance at 315 nm (ε315 = 8.1 mM–1 cm–1) (293).

5.2.2. Stopped-flow Instrumentation
Stopped flow measurements were conducted using an Applied Photophysics
Sequential SX-18MV Stopped-Flow Reaction Analyzer connected to a Neslab RTE-111
Refrigerated Bath/Circulator. The sample-handling unit of the stopped-flow was
contained inside the glove box. Reduction of the Fe protein was monitored at either 400
nm or 430 nm using the one-centimeter path length. AvR concentrations for all runs
were known to within ± 3 μM, and all temperatures were known to within ± 0.1°C. All
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concentrations reported are the concentrations in the reaction cell after mixing. All
reaction progress curves accounted for the complete reduction of all R0 present within our
experimental error. All reactions were conducted in 50 mM buffers: inorganic
phosphate, TES, Tris or HEPES. Progress curves were obtained in the stopped-flow for
the reduction of R0, R0T2 and R0D2 by averaging at least three consecutive runs under
various conditions of pH 7.0-8.0 and temperature 10.0-40.0 oC. Samples with
nucleotides had protein, magnesium, and nucleotides together in the same syringe prior to
protein reduction.

5.2.3. Data Analysis
Some kinetic traces were fit to an initial linear portion, and all traces were fit to an
equation of the form:

Abs(t) = A1 e–k1 t + A2 e–k2 t + … + An e–kn t + An+1,

(5-8)

where Abs(t) is the absorbance as a function of time, with contributions from different
exponential terms with apparent rate constants, kn, and amplitudes, An.
Adjusted rate constants k–DT and kr KDT1/2 were calculated from Equations 5-6 and
5-7, respectively. The activation energy of a reaction was obtained from the best-fit line
of ln(k) vs. 1000/T, according to the Arrhenius equation:

k = Ae

⎛ E
⎜− a
⎜ RT
⎝

ln(k ) = −

⎞
⎟
⎟
⎠

Ea ⎛ 1 ⎞
⎜ ⎟ + ln( A) ,
R ⎝T ⎠

(5-9)

where k is the adjusted rate constant (either k–DT or kr KDT1/2), Ea is the energy of
activation, R is the gas constant (8.314 J/mol·K), T is the temperature in Kelvin, and A is
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the pre-exponential factor. The activation energy, Ea, is calculated as –R times the slope
of the line to yield units in kJ/mol.
In a similar fashion, the activation enthalpy and entropy of a reaction was
obtained by fitting the data to the Eyring equation:
⎛
⎜ kh
ln⎜
⎜k T
⎝ B

‡
⎞
ΔH ‡ ⎛ 1 ⎞ ΔS
⎟
,
⎟ = − R ⎜T ⎟ +
⎟
⎝ ⎠
R
⎠

(5-10)

where k, T, and R are as before in Equation 5-9, and where h is Planck’s constant (6.626
×10-34 J s), kB is Boltzmann’s constant (1.380 × 10–23 J/K), ΔH‡ is the activation enthalpy
in kJ/mol (when plotting versus 1000/T), and ΔS‡ is the activation entropy in J/K·mol.
For better qualitative comparison of kinetic traces shown in figures, the data have
been modified to account for variations in protein concentrations between samples
according to the equation:

Relative Reaction Progress =

Abs(t ) − Absmin
,
Absmax − Absmin

(5-11)

where Abs(t) is the absorbance at a give time, and Absmin and Absmax are the minimum
and maximum absorbance values over the course of a kinetic trace, respectively. This
modification facilitates a qualitative comparison of traces at different temperatures and
pH values because all traces cross the y-axis at 1.0 and reach the x-axis at the same time.
For comparison of traces where the resolution of data points was different at early t, and
where the end times were different, care was taken to apply Equation 5-11 at coincident t
from one trace to another from start to finish of data manipulation.
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5.3. Results

5.3.1. Reduction of R0 by DT
Thorneley et al report that the reduction of free Ac20 consists of several distinct
kinetic phases whose time constants range from milliseconds to over 10 s (99). We also
report that the reduction of Av20 consists of several distinct kinetic phases, i.e. up to
n = 3 in Equation 5-8.

5.3.1.1. Temperature Effects on Av20 Reduction. Representative data for the

reduction of Av20 as a function of temperature in phosphate buffer are shown in Figure
5-2. Fast and slow phases of the reaction are evident. The fast phase of each kinetic
trace is completed within the first 0.2 s for all temperatures shown, and appears
superimposed on the y-axis in the figure. Interestingly, the amplitude of the fast phase
diminishes with increasing temperature, as should be clear by where the kinetic traces
appear to leave the y-axis. However, the rate of Av20 reduction in all three phases is
faster with increasing temperature.

5.3.1.2. pH Effects on Av20 Reduction. The effect of pH on the reaction also

shows a consistent trend at any given temperature over the range of 10-40 oC.
Representative kinetic traces are shown in Figure 5-3 for this effect at ~30 oC. The rate
of reduction for each exponential term decreases slightly with increasing pH, and the
amplitude of the fast reaction decreases with increasing pH.
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Figure 5-2. Temperature effect on Av20 reduction. The reduction of 20 ± 3 μM, free
Av20 by 0.25 mM DT at 10.8, 19.4, 29.0, and 38.5 oC; and pH held constant at 7.5 in 50
mM inorganic phosphate buffer. The data shown are representative of the temperature
effect on Av20 reduction at all pH values studied, and have been modified according to
Equation 5-11 to facilitate a qualitative comparison.

5.3.1.3. Quantitative Effects of Temperature and pH on Av20 Reduction. While

the comparison of traces in Figures 2 and 3 is largely qualitative, a more rigorous analysis
of temperature and pH effects was performed. After correcting observed rate constants
for small variation in the DT concentration, the raw data were further analyzed by
Equation 5-8 to yield best-fit apparent rate constants and amplitudes of exponential
terms. Arrhenius plots of the fast reaction (data not shown) at constant pH show that the
activation energy varies only slightly from one pH value to another. Table 5-1
summarizes the averages for the activation parameters—Ea, ΔH‡, and ΔS‡—for each
phase of Av20 reduction.
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Figure 5-3. pH effect on Av20 reduction. The reduction of 20 ± 3 μM, free Av20 by
0.25 mM DT at pH 7.0, 7.25, 7.5, 7.75, and 8.0 in 50 mM inorganic phosphate buffer;
and temperature held constant at 29.4 ± 0.6 oC. The data shown are representative of the
pH effect on Av20 reduction at all temperatures studied, and have been modified
according to Equation 5-11 to facilitate a qualitative comparison.

The effects of pH and temperature on kr, free, 1 KDT1/2 (the adjusted rate of reduction
of free Av20 in the fast phase, n = 1 in Equation 5-8) are shown in Figure 5-4. Note that
the rate varies essentially linearly with pH, and that this pH effect is more pronounced at
high temperatures. For a given temperature but varying pH, linear least-squares fits of
the data yield lines (not shown) with increasingly negative slopes (m) and higher
intercepts (s) that follow a predictable pattern. A plot of ln(–m) versus 1/T fits to a
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Table 5-1. Thermodynamic activation parameters for reduction of AvR0Xm.
Reduction of Av Fe protein species—R0, R0T2 and R0D2—occurs in different exponential
phases n = 1, 2, etc., in order of decreasing rate. Phases that correspond to previously
measured rates of reduction at ~23 oC and pH 7.4 are bolded for emphasis.

2

11.8 ± 1.8

47 ± 8

ΔS‡/ J/K·mol
105 ± 12
–76 ± 26

3

6.2 ± 1.5

24 ± 6

–201 ± 21

1

–0.4 ± 1.2

–4 ± 5

–204 ± 17

2

2.2 ± 1.2

7±5

–192 ± 18

3

12.4 ± 1.5

49 ± 6

–64 ± 22

4

14.7 ± 1.3

59 ± 5

–48 ± 18

1

12.9 ± 5.1

52 ± 21

2

23.4 ± 0.8

96 ± 3

119 ± 11

3

11.7 ± 3.0

47 ± 13

–78 ± 42

MgADP

MgATP

Free

n Ea/ kcal/mol
1 20.1 ± 0.9

ΔH‡/ kJ/mol
82 ± 4

4 ± 74

straight line with slope –a and intercept b; and a plot of ln(s) versus 1/T fits to a straight
line with slope –c and intercept b. Working backwards, one can derive the relationship:
½
k r K DT
= −e

⎡ a ⎤
⎢ − T +b ⎥
⎦
⎣

pH + e

⎤
⎡ c
⎢ −T + d ⎥
⎦
⎣

,

(5-12)

where T is in Kelvin. The values of a, b, c and d for each phase of the reduction of Av20
are given in Table 5-2. For comparison of rate constants measured in different buffers,
we accounted for a temperature-dependent pH change, where the ΔpKa/oC is –0.020 in
TES, –0.014 in HEPES, and –0.031 in Tris (294). The ΔpKa/oC for phosphate buffer is
negligible.
The procedure used to derive Equation 5-12 is useful for estimating the values of
a, b, c and d; but a global fit of Equation 5-12 on the original data yields a more accurate

determination of these constants, along with standard errors. The fitting method
implemented in Figure 5-4 uses weighted nonlinear least squares in Microsoft Excel
227

29.5 °C

k r, free, 1 K DT½

20000

24.9 °C

18000

19.5 °C

16000

10.6 °C

14.8 °C

14000
12000
10000
8000
6000
4000
2000
0
6.8

7

7.2

7.4

pH

7.6

7.8

8

8.2

Figure 5-4. pH effect on Av20 reduction. Effects of pH and temperature on the phase-1
rate constant for Av20 reduction, kr, free, 1 DT½, and fit to Equation 5-12 (straight lines).
Survey of data from reduction of 20 ± 3 μM free Av20 by 0.25 mM DT in inorganic
phosphate, TES, HEPES and Tris buffers over the temperature range ~10-40 oC and pH
~7.0-8.0. Average temperatures for the data within a general temperature range are
10.6 ± 0.5 oC, 14.8 ± 0.2 oC, 19.5 ± 0.5 oC, 24.9 ± 0.5 oC and 29.5 ± 0.7 oC.

(295). The straight lines in Figure 5-4 represent a simplified form of this data fit,
assuming a constant temperature for each line (the average temperature for data points in
a given general temperature range). So the actual fit of the data is better than that
portrayed because it accounts for subtle temperature and pH variations. However, a
significant trend in Figure 5-4 is the apparent worsening of the fit to the data with
increasing temperature. This is a consequence of weighting the fit according to the
reciprocal of the square of the standard deviation (295). The standard deviation of rate
constants within a general temperature range generally increases with temperature. For
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the 14.8 and 24.9 oC subsets of data points, the standard deviation was taken to be the
standard deviation of the rate constants. For the other data subsets that span a larger pH
range, we determined the standard deviation from a linear fit with pH.

Table 5-2. Kinetic parameters for reduction of AvR0Xm. Constants given to estimate
the value of kr, n DT½ for the reduction of Av Fe protein species—R0, R0T2 and R0D2—in
different exponential phases n = 1, 2, etc., in order of decreasing rate. The constants a, b,
c and d are generally applicable to Equation 5-12 over the temperature range 10-40 oC
and pH 7-8. Phases that predict traditionally accepted reaction rates at ~23 oC and pH 7.4
are bolded for emphasis. Compare with Table 5-3.
½

k r K DT = −e
n

Free

1

⎤
⎡ a
⎢− T +b⎥
⎦
⎣

a
7650.171
± 0.010

b
33.61
± 0.18

4700.015
± 0.037

11.12
± 0.26

11523.5437
± 0.0022

39.29
± 0.17

2
3

MgATP

1
2
3

4
MgADP

1
10223.89
± 0.13
11772.699
3
± 0.095
2

37.89
± 0.30
40.95
± 0.91
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pH + e

⎤
⎡ c
⎢− T + d ⎥
⎦
⎣

c
8172.451
± 0.039
5960
± 930
4339.982
± 0.042
–124
± 660
1130
± 620
9919.7485
± 0.0066
7390
± 640
6500
± 2600
10577.35
± 0.14
11445.608
± 0.087

d
37.72
± 0.13
21.4
± 3.1
12.12
± 0.21
6.2
± 2.2
7.4
± 2.1
36.31
± 0.14
24.7
± 2.1
30.9
± 8.9
41.57
± 0.19
42.05
± 0.78

5.3.1.4. Qualitative Considerations of Phase Amplitudes of Av20 Reduction. The

amplitudes of the different phases of Av20 reduction that accompany fits of Equation 5-8
to data did not follow as predictable a trend with temperature and pH as the rate constants
of the different phases. Still, the results using Equation 5-8 are in harmony with the
qualitative behavior of kinetic traces in Figures 2 and 3, as shown in Figure 5-5. The
relative amplitude of the fast reaction, A1 (see Equation 5-8), decreases with temperature
and pH. The slowest phase, A3, is responsible for the majority of the compensatory Av20
reduction with the loss of A1, while A2 remains relatively constant at only about 10% of
the total absorbance change. With declining amplitude at high temperatures and with a
rate approaching the dead time of the stopped-flow apparatus, it was difficult to
accurately measure kr, free, 1 KDT½ above 30 oC. Still, the phase-1 constants in Table 5-1
are consistent with the data up to 40 oC. The pH effect for phase 2 was too minor to
justify assigning constants for it, possibly because of difficulties in measuring the rate of
a phase of such low amplitude. In this case, the pH term in Equation 5-12 drops out,
leaving only constants c and d in Table 5-2 for an alternate form of the Arrhenius
equation (see Equation 5-9).
While the analysis in this study has focused on the effects of pH and temperature
on the exponential portions of Av20 reduction, a brief look at the linear portion predicted
by Equation 5-3 is in order. This equation is only valid for the condition kr [Av20] >> 2
–

k–DT [SO2], which is applicable to phase-1 reduction especially at low pH. There is

sufficient reduction in the fast phase in phosphate buffer to accurately measure the
activation energy of k–DT at pH 7.0 to be 24 ± 5 kcal/mol, in agreement with the value of
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Figure 5-5. Amplitudes of phases of reduction of Av20. Relative amplitudes for the
three phases of reduction of free Av20—A1 (●), A2 (■), and A3 (▲) from Equation 5-8—
as a function of temperature and pH: (a) pH 7.0; (b) pH 7.5; and (c) pH 8.0.
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24.1 kcal/mol determined previously by Lambeth and Palmer at pH 8.0 (291). One may
infer that the rate of monomerization of DT (Equation 5-1) is pH-independent because of
this agreement.
Unfortunately, k–DT measured from the linear portion above pH 7.0 was
significantly slower than expected, progressively worsening with increasing pH. This
should be attributed to a DT-independent mechanism. There is likely a breakdown in the
–

condition kr [Av20] >> 2 k–DT [SO2] because it is only true for large kr [Av20]. As the
amplitude of the fast reaction decreases at higher temperatures and pH values, phases
with slower kr predominate. Thus for temperatures above 30 oC and pH above 7, what
may appear as a linear portion (usually very short) should be accounted as a hybrid
between a line and an exponential that could only be fit accurately to the complete set of
differential equations describing Equations 5-1 and 5-2. This is because experimental
conditions present an intermediate state between the assumption used to derive Equation
5-3 and the assumption used to derive Equation 5-7. The less rigorous approach in this
work is satisfactory since a determination of k–DT versus temperature has been performed
elsewhere (291), and since our results are sufficient to show there is not likely a pH effect
on k–DT.

5.3.2. Reduction of R0T2 by DT
Figure 5-6 shows representative kinetic traces for the reduction of Av20(MgATP)2
as a function of temperature. A striking difference between Figures 5-2 and 5-6 is that
the traces in Figure 5-2 are encountered from left to right with increasing temperature,
while in Figure 5-6 traces are encountered from left to right with decreasing temperature.

232

Figure 5-6. Temperature effect on Av20(MgATP)2 reduction. The reduction of 20 ±
3 μM Av20 in 4.4 mM ATP and 5.0 mM Mg2+ by 0.25 mM DT at 10.8, 19.3, 29.0, and
38.6 oC; and pH held constant at 7.5 in 50 mM inorganic phosphate buffer. The data
shown are representative of the temperature effect on Av20(MgATP)2 reduction at all pH
values studied, and have been modified according to Equation 5-11 to facilitate a
qualitative comparison.

The reason for this difference is that the combined amplitude of phases 1 and 2 with
Av20(MgATP)2 reduction increases when the temperature rises from 10 to 40 oC (about
65% to 85% at pH 7.0, 55% to 80% at pH 7.5, and 40% to 75% at pH 8.0), while the
opposite trend is seen with Av20 reduction.
On the other hand, the effects of pH on the amplitudes of phases of
Av20(MgATP)2 reduction follow the trend seen with Av20 reduction (compare Figures 53 and 5-7). Table 5-1 summarizes the thermodynamic activation parameters of the
different phases of Av20(MgATP)2 reduction, and Table 5-2 gives constants a, b, c and d
for use with Equation 5-12. Note that only the rate for phase 3 actually demonstrates a
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Figure 5-7. pH effect on Av20(MgATP)2 reduction. The reduction of 20 ± 3 μM Av20
in 4.4 mM ATP and 5.0 mM Mg2+ by 0.25 mM DT at pH 7.0, 7.5, and 8.0 in 50 mM
inorganic phosphate buffer; and temperature held constant at ~29 oC. The data shown are
representative of the pH effect on Av20(MgATP)2 reduction at all temperatures studied,
and have been modified according to Equation 5-11 to facilitate a qualitative comparison.

pH effect on the rate of reduction, apart from the pH effect on the amplitudes of each
phase discussed above.

5.3.3. Reduction of R0D2 by DT
There are three phases of Av20(MgADP)2 reduction. In Figure 5-8, the rate of the
fast phases of reduction increase with increasing temperature as expected. In addition,
the combined amplitude of the two fast phases (n = 1 and n = 2) rises until 20 oC, and
then falls at higher temperatures.
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Figure 5-8. Temperature effect on Av20(MgADP)2 reduction. The reduction of 20 ±
3 μM Av20 in 4.4 mM ADP and 5.0 mM Mg2+ by 0.25 mM DT at 10.7, 19.2, 29.1, and
38.7 oC; and pH held constant at 7.5 in 50 mM inorganic phosphate buffer. The data
shown are representative of the temperature effect on Av20(MgADP)2 reduction at all pH
values studied, and have been modified according to Equation 5-11 to facilitate a
qualitative comparison.

Similarly, the combined amplitude of the two fast phases is maximum at pH 7.5,
and diminished at pH 7.0 and 8.0. The fast phases are favored, then, at 20 oC and pH 7.5.
While this effect is slight, it is nevertheless consistent over almost the entire range of data
in phosphate buffer.
The dominant phase of Av20(MgADP)2 reduction is the slower of the two fast
reactions (n = 2). Its amplitude is relatively constant at about 86% of the total absorbance
change over the range of experimental conditions. Phase 1 accounts for about 14% of the
absorbance change at all pH values but temperatures less than or equal to 30 oC. At
higher temperatures, the contribution from phase 1 is abolished—perhaps because at
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Figure 5-9. pH effect on Av20(MgADP)2 reduction. The reduction of 20 ± 3 μM Av20
in 4.4 mM ADP and 5.0 mM Mg2+ by 0.25 mM DT at pH 7.0, 7.5, and 8.0 in 50 mM
inorganic phosphate buffer; and temperature held constant at ~29 oC. The data shown are
representative of the pH effect on Av20(MgADP)2 reduction at all temperatures studied,
except at 10 oC where the peak in amplitude of A1 is not so obvious. The data have been
modified according to Equation 5-11 to facilitate a qualitative comparison.

higher temperatures, the rate of phase 2 overtakes the assumed rate of phase 1 so that the
two are indiscernible—and compensated for by phase 3, which is present only to a much
smaller extent at lower temperatures.
The thermodynamic activation parameters of the phases of Av20(MgADP)2
reduction and constants for determining the rate constants as a function of pH and
temperature are summarized in Tables 5-1 and 5-2. There is only a pH effect for the
dominant phase (n = 2). Perhaps the minor phases have a pH effect, but as with phase 2
of Av20 reduction, the low amplitudes of these phases contribute to difficulties in
measuring their corresponding rate constants accurately enough to discern a pH effect.
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5.4. Discussion

5.4.1. Protein Activity
The rates of reduction of Kp20 (45% active) and Ac20 (65-75% active) with DT
have been reported to have four distinct exponential phases (99, 296). The fast phase was
attributed to active protein, while the remaining slower phases did not manifest the
characteristic change in EPR signal upon reduction, and were assumed to originate from
reduction of O2-inactivated Fe protein. In the present study, we have observed only three
exponential phases of free Av20 reduction. The question remains whether the two slower
phases correspond to active or inactive protein.
Given the extinction coefficients of the reduced and oxidized forms of Av2 (see
Figure 5-1), the total absorbance changes for our runs accounted for all the Av2 present
within the limits of experimental error. This observation suggests that if there were
inactive protein present, at least one of two conditions must be true: either the extinction
coefficients of the forms of Av2 are not changed by inactivation (whether O2 inactivation
or some other kind); or the amount of inactive protein is small, so that it falls beyond the
limits of detection.
The specific activity was measured to be 1800-2000 nmol of H2 min–1 mg–1 in
standard activity assays (292) before being loaded into the stopped-flow apparatus and
after the completion of the kinetic measurements. The activity after the measurements
was only up to 10% less than the original activity, which is consistent with the possibility
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of only a small activity loss upon initial oxidation as reported previously (289). This
observation suggests that, given the highly active nature of Av2 when compared to Fe
protein of species other than Azotobacter vinelandii, the slower phases of Av20 reduction
actually represent active protein.
Furthermore the combined amplitude of the fastest reactions for Av20(MgADP)2
reduction was as high as 97% of the total absorbance change at pH 7.5 and 20 oC (see
Figure 5-8). If the slower phases of Av20 reduction could be attributed to inactive
protein, then the same protein should give similar amplitudes for slow reduction of
nucleotide-bound forms of protein. In the case of Av20(MgADP)2, the average relative
amplitude of the slow phase over the entire range of pH and temperature studied was
around 6% of the total absorbance change, while 15% of the absorbance change in
Av20(MgATP)2 reduction could be attributed to the slowest reaction in phosphate buffer.
We attribute the slower phases of Av20 reduction to different conformations of the
protein—the relative amounts of which change with pH, temperature, and solution
buffer—and not to inactive protein.
Azotobacter vinelandii nitrogenase is generally considered to be very active when

compared to nitrogenase of other species, but it was determined in one study of the Fe
protein cycle that Av2 is only 62% active (113), so it would be of interest to determine
whether the slower phases of Av2 reduction are attributable to active protein conformers
for each of the variants Av20, Av20(MgADP)2, and Av20(MgATP)2. Specifically, one
could measure the EPR change that occurs upon Av2 reduction under conditions where
such data could be obtained manually as described in this work. However, this is beyond
the scope of the present study.
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5.4.2. Populations of Different Conformers
While there is undoubtedly a continuum of conformations of Av2 in solution—
each with different rates of reduction—there are likely just a few that are important to
nitrogenase catalysis. Furthermore, it is likely that if a particular conformation favors
reduction of one Av2 species over another, then natural selection would have favored it
to dominate the relative absorbance change of Av2 reduction under physiological
conditions. Such appears to be the case for Av20(MgADP)2 reduction. From Figures 5-8
and 5-9, we noted how there is consistently a peak in the combined amplitude of the two
faster phases favoring reduction at pH 7.5 and 20 oC, at which point the fast phases
account for 97% of the total absorbance change. With higher resolution of temperature
and pH it should be possible to narrow the exact conditions favoring this reaction.
It has long been thought that Av20(MgADP)2 reduction is catalytically relevant
(7). Our data provide supporting evidence for this idea, as the other two possibilities—
Av20 and Av20(MgATP)2—only favor rapid reduction at a particular extreme.
Specifically, A1 for Av20 is highest at pH 7.0 and 10-20 oC (see Figure 5-5), while (A1 +
A2) for Av20(MgATP)2 is highest at pH 8.0 and 40 oC. Neither of these extremes

represents ideal physiological conditions. It may be, however, that reduction of Av20 and
Av20(MgATP)2 may be compensatory mechanisms for Fe protein reduction under
conditions of physiological stress.
Still, it is important to emphasize that the experimental conditions in this study are
not physiologically relevant because dye-oxidized Av2 was used, and it was reduced by a
non-physiological reductant. Therefore this study at most only lends supporting evidence
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to the notion that Av20(MgADP)2 reduction is catalytically relevant, but not definitive
proof that this is the case.
Ashby et al proposed that there are different conformers of the Kp20 protein in
both free and MgADP-bound forms (115). However, I discussed in Section 4.6.1.1 how
reduction of Kp20 and Kp20(MgADP)2 showed that almost all Kp20 is in the R0
conformation, and almost all Kp20(MgADP)2 is in the R0D2 conformation. An emphasis
on several distinct conformers was not made.
Different conformers of Kp2 were also seen by Miller et al, who report that
Kp20(MgADP)2 and Kp20(MgATP)2 transiently assume the Kp21(MgADP)2 and
Kp21(MgATP)2 conformations, respectively, in the absence of DT (297).
It is possible that Av2 has similar conformers. It has been suggested that Av2 has
different conformers when bound to MgATP (118), owing to the observation of a double
exponential for both the reduction of Av20(MgATP)2, as well as the chelation reaction of
Fe from the [4Fe-4S] cluster of the MgATP-bound Fe protein (152).
As noted previously, we have observed four exponential phases for the reduction
of Av20(MgATP)2, while Lanzilotta et al noted only two exponential phases (118).
There is also a difference of two between the number of exponential phases we report for
Av20(MgADP)2 reduction. However, with both nucleotides the amplitudes of the slowest
phases that we have observed are very small. Our respective protein activities are
comparable, so the differences are unlikely to be due to inactive protein. It may be that
the kinetic traces of Lanzilotta et al did not run so long as ours—200 s for
Av20(MgADP)2 and 500 s for Av20(MgATP)2—or that the minimal contribution of the
slowest phase was not evaluated. This seems likely because A2 for Av20(MgADP)2
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reduction is only 3% of the total absorbance change at pH 7.5 and 20 oC, very close to the
experimental conditions of Lanzilotta et al, though not in the same buffer. Furthermore,
it has been suggested that if slower phases are observed, they may be difficult to measure
if their amplitude is small (115). As this is the first study to investigate these reactions
over wide ranges of temperature and pH—under conditions where the amplitudes of
slower phases can be more pronounced—it may be that this is the first time the slower
phases have been seen as relevant.

5.4.3. An Accelerated Phase of Reduction
Interestingly, our analysis of both Av20(MgATP)2 and Av20(MgADP)2, reduction
revealed a previously uncharacterized faster phase in addition to the previously
uncharacterized slower phase described above. As this phase is also a minor contributor
to the total absorbance change, it may have been previously attributed to an anomaly of
instrumentation, or missed entirely if the time resolution were poor for early t. Only
when this very fast phase was fit as its own phase were we able to reconcile apparent
differences between rate constants from runs of high time resolution to runs of low time
resolution.
The rates of phase 1 for Av20 and Av20(MgADP)2 reduction are remarkably
similar, as determined by a comparison of rate constants in Table 5-2 and Equation 5-12.
One may postulate that there is a small population of Av2 in a sample of Av2(MgADP)2
that is unbound by nucleotide, and so is reduced at the rate of phase 1 for Av20, since that
is the dominant phase for Av20 reduction. However, MgADP binds Av2 more tightly
than does MgATP (97). If there is free Av20 in a sample of Av20(MgADP)2, then there
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should be more of it in a sample of Av20(MgATP)2 at the same nucleotide
concentrations. If this were the case, the fastest phase for both Av20(MgADP)2 and
Av20(MgATP)2 reduction would have the same rate, but a larger amplitude in the sample
of Av20(MgATP)2. This is not observed.
Rather, the fastest rate of Av20(MgATP)2 reduction is much slower than the
corresponding phase of Av20(MgADP)2 reduction. However, it is interesting that the
amplitude of the fastest phase of reduction is more prominent in Av20(MgATP)2 than in
Av20(MgADP)2, perhaps corresponding to a larger relative population of Av20MgATP in
a sample of Av20(MgATP)2 than Av20MgADP in a sample of Av20(MgADP)2. Indeed, it
is more difficult to rule out Av20MgATP and Av20MgADP as candidates for phase-1
reductions than it is to rule out Av20.
One way to confirm or disprove the presence of Av20MgAXP (Av20MgATP or
Av20MgADP) is to vary the concentration of nucleotides and observe the effect on the
amplitude of the phase-1 reductions. If Av20MgAXP reduction were responsible for
phase-1 reactions, then the phase-1 amplitudes would increase at lower nucleotide
concentrations and diminish at higher nucleotide concentrations. However, at our
concentrations of 4.4 mM MgAXP, there should be about 99.7% Av20(MgAXP)2, 0.3%
Av20MgAXP, and a very small quantity of free Av20, based on the most recently
determined values of dissociation constants Kd2 and Kd1 of MgAXP from Av20(MgAXP)2
and Av20MgAXP (101). Unfortunately, there is considerable disagreement in the
literature about the measurements of apparent Kd for the Fe protein and nucleotides, and
earlier estimates of the apparent Kd for Av20(MgAXP)2 (97) predict a much more
significant population of free Av20—9.1% of the total Fe Protein at our concentration of

242

MgATP, or 1.35% in our samples with MgADP. As mentioned above, there is not a
significant quantity of free Av20 in our nucleotide-containing samples, so values for an
apparent Kd are unlikely to be applicable to our analysis. An area of ongoing research in
our lab is to vary nucleotide concentrations to determine if phase 1 for Av20(MgATP)2
and Av20(MgADP)2 reduction can be attributed to Av20MgAXP species. If this is the
case, it should be possible to adjust nucleotide concentrations so that there are sufficient
populations of Av20, Av20MgAXP, and Av20(MgAXP)2 to measure Kd1 and Kd2 for
MgAXP in the stopped-flow apparatus as a function of temperature and pH.

5.4.4. Buffer Effects on Fe Protein Reduction
Depending on the buffer used to perform Fe protein reduction reactions, there is a
change in the amplitudes of the different phases. Figure 5-10 illustrates this buffer effect
for Av20 reduction. For the same conditions of pH 7.5 and temperature 24.0 oC, the fast
phase is favored in TES buffer. HEPES also heavily favors the fast phase (data not
shown). To a lesser extent, the fast phase is favored in Tris buffer; and in phosphate
buffer, it is favored the least of any buffer tested.
While the fast phase is not favored in phosphate buffer as much as it is in other
buffers, the reverse is true for the reduction of both Av20(MgATP)2 (Figure 5-11) and
Av20(MgADP)2 (Figure 5-12). In each case, phosphate favors rapid reduction. The next
best buffer is TES, then HEPES (data not shown for Av20(MgATP)2 reduction), and then
Tris.
Having performed Fe protein reduction reactions in buffers where certain phases
are more important than in others, we have been able to measure certain rate constants
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Figure 5-10. Buffer effect on Av20 reduction. The reduction of 20 ± 3 μM, free Av20
by 0.25 mM DT at 24 oC and pH 7.5 in 50 mM inorganic phosphate, Tris and TES
buffers. The data shown are representative of the buffer effect on Av20 reduction over
the range of experimental conditions in this work, and have been modified according to
Equation 5-11 to facilitate a qualitative comparison. The inset shows that reduction in
TES favors the fast phase.

more accurately than would have been possible from measurements in a single buffer
alone. In particular, phase 3 of Av20 reduction was an important phase in phosphate
buffer, while generally undetectable in each of the other buffers tested; and phase 4 of
Av20(MgATP)2 reduction, while minor in phosphate buffer, is a major contributor to the
overall reaction in Tris buffer. It should be noted that the data in Figures 11 and 12 are
compared over the same time scale, with poor resolution at early t, essentially truncating
off the fast phase-1 reactions, so the comparison is for phases of n > 2.
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Figure 5-11. Buffer effect on Av20(MgATP)2 reduction. The reduction of 20 ± 3 μM
Av20 in 4.4 mM ATP and 5.0 mM Mg2+ by 0.25 mM DT at ~19.3 oC and pH ~7.54 in 50
mM inorganic phosphate, Tris and TES buffers. Data modified according to Equation 511 to facilitate a qualitative comparison, particularly to compensate for time resolution
differences at early t.

An important observation with experiments done in different buffers is that the
general trends of how the amplitudes of the different phases of a reaction change with
temperature and pH are the same as they are in inorganic phosphate buffer. In addition,
the corresponding rates are unchanged with the buffer.

5.4.5. Effects of Nucleotides on the Reduction of R0
It has been observed previously that ATP does not affect the rate of Ac2 reduction
when compared to free Ac2 (289). On the contrary, Av2 showed a marked drop in the
rate of Fe protein reduction upon addition of MgADP, and an even greater drop in the
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Figure 5-12. Buffer effect on Av20(MgADP)2 reduction. The reduction of 20 ± 3 μM
Av20 in 4.4 mM ADP and 5.0 mM Mg2+ by 0.25 mM DT at ~19.2 oC and pH ~7.55 in 50
mM inorganic phosphate, TES, HEPES and Tris buffers. Data modified according to
Equation 5-11 to facilitate a qualitative comparison, particularly to compensate for time
resolution differences at early t.

rate in the presence of MgATP (118). The present work supports this view of Av2
reduction. It may be that incubation of protein with MgATP prior to protein reduction is
responsible for the apparent difference in ATP inhibition being present in Av2 reduction
(incubated) and absent in Ac2 reduction (not incubated). Even so, multiple phases of the
reaction must be considered.
Given the constants in Table 5-2, one may actually calculate a rate for phase-1
Av20(MgADP)2 reduction comparable to phase-1 Av20 reduction. However, there is
considerable error in the measurement of phase-1 Av20(MgADP)2 reduction. It is more
reasonable to assume that a more accurate measurement of phase-1 Av20(MgADP)2
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Figure 5-13. Nucleotide effect on R0X2 reduction under physiological conditions.
Nucleotides (4.4 mM AXP, 5 mM Mg) slow the initial phases of reduction of 20 ± 3 μM
Av20 by 0.25 mM DT at pH 7.5 and ~19.3 oC in inorganic phosphate buffer. But over the
entire course of the reaction, the secondary phases of Av20 reduction in the presence of
nucleotides are faster than the slower phases of Av20 reduction by itself. Overall,
reduction of Av20(MgADP)2 is best reduced under physiological conditions. Data
modified according to Equation 5-11 to facilitate a qualitative comparison.

reduction will yield results more in line with the overall effect of nucleotides shown in
Figure 5-13. Furthermore, the contribution from phase-1 Av20(MgADP)2 reduction is
very minor compared to the dominant phase 2. Figure 5-13 shows that at pH 7.5 and
~19.3 oC Av20 reduction is much faster for early t, but because a much slower phase 3 is
responsible for much of the overall reaction, Av20(MgADP)2 reduction overtakes it at
about 0.6 seconds.
Phase-1 Av20(MgATP)2 reduction is faster than phase-2 Av20(MgADP)2
reduction for all pH values and all temperatures less than or equal to ~35 oC, but it is
from 4 to 35 times slower than phase-1 Av20(MgADP)2 reduction over 10-40 oC. Since
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the amplitude of phase-1 Av20(MgATP)2 reduction is generally larger than the amplitude
of phase-1 Av20(MgADP)2 reduction, a progress curve for Av20(MgATP)2 reduction may
start slightly slower than one for Av20(MgADP)2 reduction, but may overtake
Av20(MgADP)2 reduction in overall reaction progress for a very short time, then falling
behind as slower phases of Av20(MgATP)2 reduction begin to take over.
Thus, in Figure 5-14, high temperature and pH combine to facilitate reduction of
Av20(MgATP)2, but over the course of the whole reduction, Av20(MgADP)2 is still
reduced more quickly.

Figure 5-14. Nucleotide effect on R0X2 reduction under high temperature and pH.
Nucleotides (4.4 mM AXP, 5 mM Mg) increase the overall rate of reduction of 20 ± 3
μM Av20 by 0.25 mM DT at pH 8.0 and ~38.7 oC in inorganic phosphate buffer. Data
modified according to Equation 5-11 to facilitate a qualitative comparison.
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Figure 5-15. Nucleotide effect on R0X2 reduction under low temperature and pH.
Nucleotides (4.4 mM AXP, 5 mM Mg) slow the reduction of 20 ± 3 μM Av20 by 0.25
mM DT at pH 7.0 and ~10.5 oC in inorganic phosphate buffer. Data modified according
to Equation 5-11 to facilitate a qualitative comparison.

At the other extreme of very low temperature and pH, the fast phase of Av20
reduction is dominant, and so the effect of nucleotides is to slow the reduction of Fe
protein, which is what is expected when comparing the rates of corresponding phases in
reduction of Av20, Av20(MgATP)2 and Av20(MgADP)2.
Clearly, a comparison of rate constants of the different phases of Fe protein
reduction is insufficient to assess which overall reaction (Av20, Av20(MgATP)2 or
Av20(MgADP)2 reduction) will proceed more quickly overall. An understanding of how
the amplitudes of each phase vary with temperature and pH is also important.
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5.4.6. Survey of Literature Values for kr
In light of novel observations in this work, it is important to assess in what ways
our work coincides with previously published results. Table 5-3 shows the rate constants
of reduction, kr, for various forms of the Fe protein from different organisms. Values
derived from the literature were either determined by the original authors, or calculated
from given values of kobs and [DT], where kobs equals kr KDT½ [DT]½. Values from this
work were derived from the constants in Table 5-2 with Equation 5-12 at pH 7.4 and
23 oC. The value of KDT = 1.46 nM was used, as determined previously at pH 7.4 and
23 oC (7).

MgADP

MgATP

Free

Table 5-3. Comparison of literature values for R0Xm reduction. Only certain phases
from this work are represented: phase 1 for Av20; phases 2 and 3 for Av20(MgATP)2;
and phase 2 for Av20(MgADP)2.

Organism

T/oC, pH

kr, fast/ (M–1 s–1)

Kp

23, 7.4

>1 × 108

(115)

Ac

23, 7.4

>1 × 108

(99)

1.7 × 108

(118)

1.9 × 108

This Work

~1 × 108

(289)

Av

23, 7.4

Ac

23, 7.4

kr, slow/ (M–1 s–1)

Reference

1.9 × 106

1.3 x 105

(118)

1.2 × 106

1.5 x 105

This Work

Av

23, 7.4

Kp

23, 7.4

3 × 106

(7, 115)

23, 7.4

2.9 × 106

(289)

23, 7.2

4.7 × 106

(290)

23, 7.4

3.7 × 106

(118)

22, 7.4

4.5 × 106

(219)

23, 7.4

3.5 × 106

This Work

Ac

Av
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One major discrepancy in the literature is shown in Table 5-3. For Ac20 and
Kp20, MgADP slows down Fe protein reduction while MgATP does not (289, 296). On
the other hand, this work and other recent studies (219, 298) show that MgATP inhibits
Av20 reduction even more than MgADP, particularly when taking into account the
relative amplitudes of the slower phases for the reduction of Fe protein bound to MgATP
(see Figures 5-13 through 5-15). Other than this detail, there is striking agreement in the
literature on the rate of reduction of free Fe protein and Fe protein bound to MgADP, as
in Table 5-3. Our results coincide well with previous work on Av20.

5.4.7. Activation Parameters of Av2 Reduction
In an attempt to understand the differences between the respective phases of Fe
protein reduction, we calculated the activation parameters (energies, enthalpies, and
entropies) for the component phases of the overall reduction processes, as summarized in
Table 5-1. With free Av20 the slower phases have progressively lower activation
energies and enthalpies, as well as more negative activation entropies. The exact reverse
is seen with Av20(MgATP)2 reduction. Av20(MgADP)2 reduction is mixed, with higher
activation energy, enthalpy and entropy going from phase 1 to phase 2, but then a drop in
these parameters going from phase 2 to phase 3.

5.4.8. The Break in the Arrhenius Plot for Activity
A break has been observed in the Arrhenius plot of both nitrogenase activity and
primary electron transfer from the Fe protein to the MoFe protein (167-169, 278, 299,
300). This break has been attributed to a conformational change in one or both
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components of nitrogenase, leading to a change in the affinity of the Fe protein-MoFe
protein complex (167, 168, 278, 299-301). It has been suggested that the MoFe protein is
a noteworthy candidate for this proposed temperature-dependent conformational change,
as its interaction with CO experiences a sharp increase above 15 oC in nitrogenase from
Klebsiella pneumoniae (299).

Still, it has been proposed that a change in both component proteins may be
required to explain breaks in both electron transfer and ATP hydrolysis (300). It is likely
that such a conformational change in the Fe protein is inherent in the formation of the
protein-protein complex. However unlikely, it may also be inherent in the Fe protein
itself. If a significant temperature-dependent conformational change were inherent in the
individual protein components of nitrogenase, and not just in the nitrogenase complex,
then we would expect it to influence a series of steps in the catalytic cycle, such as Fe
protein reduction. However, we have not observed any break in the Arrhenius plots of Fe
protein reduction in this study.
Still, relative contributions of different phases of reduction are also important.
Since phase-2 reduction of Av20(MgADP)2 is likely the catalytically relevant reaction,
any argument for the importance of relative amplitude must address this phase. We have
noted that it is dominant over the range of 10-40 oC and pH 7-8, and the effects of
temperature and pH on its amplitude are minimal.
However, the reduction of Av20 is far superior at low temperature and pH, so if
nucleotide binding constants favor dissociation and the presence of Av20 under these
conditions, then Av20 reduction could become very important. On the other hand,
Av20(MgATP)2 reduction is more important at high temperature and pH, so its
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reduction may be more important under the same conditions. The combination of the
complex considerations of both reduction rates and multiple phases of reduction
necessarily limit our ability to state with certainty that the break in the Arrhenius plot for
activity is not due to the Fe protein.
Nevertheless, given high concentrations of nucleotides in nitrogenase assays, and
the slow off-rate of MgADP from the R0D2 complex (115), it seems highly unlikely that
the break in the Arrhenius plot is attributable to the reduction of Fe protein. Rather, it is
likely due to the MoFe protein and/or the nitrogenase complex, and not some property
inherent in the Fe protein alone.

5.5. Summary and Conclusions
AvR0 was reduced by DT in the absence and presence of nucleotides, over the
temperature range 10-40 oC, over the pH range 7-8, and in various buffers—inorganic
phosphate, TES, HEPES, and Tris. The reduction of each species of Fe protein—R0,
R0T2, and R0D2—was resolved into at least three exponential phases, with relative
amplitudes of each phase varying over the range of experimental conditions, suggesting a
dynamic population shift of kinetically distinct species. The rapid phase of R0 reduction
predominated at low temperature and pH, and in Tris buffer; rapid R0T2 reduction was
favored at high temperature and pH, and in phosphate buffer; and R0D2 reduction was
favored under more physiologically relevant conditions of 20 oC, pH 7.5, and in
phosphate buffer.
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The rates of reduction of Fe protein species did not change with buffer, but
temperature and pH did have an effect on the rates. With the appropriate constants, an
empirically derived equation estimates the rate of Fe protein reduction at any temperature
and pH within the limits 10-40 oC and pH 7-8, for a given species of Fe protein, and a
given phase of the reaction. At 23.0 oC and pH 7.4, the rate of the dominant phase of
Av20 reduction is 1.9 × 108 M–1 s–1. Under the same conditions, the rates of the two
dominant phases of Av20(MgATP)2 reduction are 1.2 × 106 M–1 s–1 and 1.5 × 105 M–1 s–1;
and the rate of the dominant phase of Av20(MgADP)2 reduction is 3.5 × 106 in M–1 s–1.
Thermodynamic activation parameters for each phase of reduction were
calculated. No breaks in the Arrhenius plots for any Fe protein species were observed.
I have taken two approaches in my research: (a) determining the different
intermediates and pathways in catalysis; and (b) quantifying the rates of these pathways.
The detailed quantitative and qualitative description of Fe protein reduction in this
chapter illustrates the interplay between the two approaches. I was just trying to quantify
the simplest step in catalysis, but I uncovered some intriguing complexity to this step.
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Chapter 6
Formation of the All-ferrous Fe Protein in an S = 0 Spin
State from Reduction by Flavodoxin Hydroquinone

This chapter is based on a manuscript under preparation authored by T. J. Lowery,
myself, J. Bunker, B. Zhang, R. G. Harrison, A. C. Nyborg, D. Thiriot, and G. D. Watt.

My approach in Chapter 5 was to characterize in detail the simplest step in
nitrogenase catalysis—that of Fe protein reduction by DT. It was possible to build upon
earlier work that had established, in large measure, the complexities of studying this
pathway. However, in extending our understanding of Fe protein reduction to pathways
that generate the all-ferrous Fe protein, it is more important first to establish that such
pathways exist before quantifying their rates. Thus, in this chapter, the formation of the
all-ferrous Fe protein in a novel spin state is discussed.
For many years, Fe protein was thought to transfer a single electron to MoFe
protein using exclusively the R0/R1 ([4Fe-4S]2+/[4Fe-4S]1+) redox couple. The discovery
(302) and characterization (95, 96, 127, 145, 303-306) of the all-ferrous form of Fe
protein, R2, is an exciting development that has raised a number of questions about how
nitrogenase functions (307-309). This all-ferrous Fe protein uses the R0/R2 ([4Fe4S]2+/[4Fe-4S]0) redox couple, transferring two electrons to MoFe protein instead of one
(95, 96, 127). Consequently, the ATP requirement for nitrogenase catalysis is lowered by
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a factor of two or more. Capitalizing on this increased energy efficiency makes the study
of the all-ferrous Fe protein of particular interest.

6.1. Literature Preview on the All-ferrous Fe Protein
The initial description of the [4Fe-4S]0 cluster of Av2 using reduced methyl
viologen (MV1) reported a light brown species with no discernable absorption peaks or
shoulders, a spectrum analogous to that of Av21. During reduction of EPR-active [4Fe4S]1+ with MV1, the perpendicular mode EPR signal associated with [4Fe-4S]1+
disappeared, and an EPR silent [4Fe-4S]0 cluster was formed. Measurement of the redox
potential for the Av21 to Av22 reduction by MV1 gave an Em of –460 mV and an n value
of 1.0 (302).
Subsequent characterizations of Av22 have been made with other reductants, most
notably Ti(III) citrate (310). The Em for Av2 reduction by Ti(III) was measured during
turnover to be –480 mV (127). However, there is some question about whether this
measured potential is for the all-ferrous redox couple or the standard redox couple
because of the very low concentration of Ti(III) used (see Fig. 7 of ref (127)). Because
enzyme turnover by coulometry was utilized in this measurement, the quoted value of
–480 mV depends on the accuracy of Em = –510 mV for Ti(IV) reduction to Ti(III) as
reported in the literature (311). More recent research estimates a much more negative
value of Em = –790 mV (312), which is more in line with Em estimates of all-ferrous Fe-S
clusters using DFT calculations (129).
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Indeed, there has been some debate over whether Av22 can even be made in vivo
(114). If the value of Em = –480 mV for Av21 reduction to Av22 is correct, then there are
several in vivo redox proteins that would be candidates to reduce Av2 to the [4Fe-4S]0
oxidation state (312). If the more negative Em value is correct, then the all-ferrous Fe
protein is not likely to be physiologically relevant (114).
The question of whether the all-ferrous Fe protein is physiologically relevant may
hinge on what is the correct Em. On the other hand, the R0T2 conformation has two
separate [2Fe-2S]+ clusters (see Figure 4-4) that could conceivably be reduced
simultaneously, both with the easily accessible potential of –430 mV (see Scheme 4-3).
Upon consolidation of the separate Fe-S clusters into the [4Fe-4S]0 state, the kinetic
stability of the all-ferrous Fe protein may determine its lifetime and ability to interact
with MoFe protein for efficient catalysis. Another concern is whether the electron flux to
Fe protein is sufficiently rapid to sustain high levels of all-ferrous Fe protein for
nitrogenase catalysis.
In various species, flavodoxin hydroquinone is the in vivo reductant to nitrogenase
(132, 313-315). In Azotobacter vinelandii, flavodoxin II is not the only reductant to
support nitrogen fixation in vivo, but it is required for maximal nitrogenase activity (314).
It was shown previously that using AvFldHQ (Em = –515 mV (316)) in standard
nitrogenase assays, the ATP/2e– ratio dropped to 2, suggesting that FldHQ made
nitrogenase function in the Av20/Av22 redox couple (96). However, the distinguishing
characteristics of the Av22 protein made by reduction with Ti(III)—including a UV-vis
shoulder at 520 nm and a strong g = 16.4 EPR signal (303)—are absent with FldHQreduced Av2. Hence, there has been some uncertainty about whether FldHQ actually
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reduces Av2 to the Av22 state (312). Such concern based on the lack of physical
similarities to Ti(III)-reduced Av22 is understandable, but neglects the possibility of Av22
in other spin states.
Theoretically, an all-ferrous [4Fe-4S]0 cluster in Av22 can have spin states of
S = 0, S = 4 and S = 8 (129). Ti(III)-reduced Av22 is in the S = 4 spin state (303). Of the
other two possibilities, Av22 in an S = 0 spin state should be very close in energy to the
Av22 in an S = 4 spin state (129). In this study, we provide evidence that FldHQ reduces
Av2 to Av22 with an S = 0 spin state with different physical properties than Av22 with an
S = 4 spin state, accounting for the fact that the distinguishing characteristics of the
Ti(III)-reduced Av22 are absent with FldHQ as reductant. This conclusion is consistent
with the ATP/2e– ratio of 2.0 previously reported for FldHQ-reduced Av2. Furthermore,
the reduction of Av21 by FldHQ occurs readily, providing evidence for the physiological
relevance of Av22.

6.2. Materials and Methods

6.2.1. Instrumentation
All reactions involving air sensitive compounds were conducted in an argon filled
Vacuum Atmospheres glove box equipped with a Nyad O2 monitor and dual purifiers that
maintained O2 levels below 0.1 ppm. All optical spectra and absorbance changes were
recorded on an HP 8453 diode array spectrometer located inside the glove box.
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6.2.2. Reagent Preparation
Av2 was isolated and characterized as previously reported (292) and had activities
of 1885-2030 nmol H2 min–1 mg–1 Av2. Ti(III) citrate was prepared according to
established protocols (127, 310). Azotobacter vinelandii flavodoxin II, Fld, was isolated
during the nitrogenase isolation procedure and purified by passage through an ultragel
size-exclusion column (5 cm × 2.0 m). FldHQ was prepared by reduction of Fld with
excess sodium dithionite (DT) in 0.050 M Tris, 0.1 M NaCl, pH 8.0, then separated from
DT on a G-50 Sephadex column (1.0 × 20 cm) equilibrated with 0.05 M Tris pH 8.0 in
the glove box. Treating all solutions and proteins with chelex (Sigma) chelating column
and treating all glassware and syringes with sulfuric acid prolonged the lifetime of
FldHQ.

6.2.3. Reduction of Av20 and Av21 by FldHQ
Various concentrations of FldHQ from 0.25-0.50 mM were added to a 1.0 mL
quartz cell, the spectrum recorded and the stable, near-zero absorbance at 580 nm was
monitored for 1-5 minutes. Solutions of DT-free Av20, Av21, or Av22 (at a 3-20 fold
excess of FldHQ) were then added by syringe and the solution mixed. Reaction progress
was monitored optically by the conversion of FldHQ to FldSQ (Δλmax = 580 nm, Δε = 5.4
mM–1 cm–1 (313, 317)), and compared to controls with only the addition of buffer. From
the optical change and the known amounts of Fld and Av2, it was possible to determine
the stoichiometry of electron transfer. Identical reactions were conducted in the presence
of 2.0 mM MgATP and MgADP.
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6.2.4. EPR Analysis
EPR samples of FldHQ- and Ti(III)-reduced Av2 were prepared in the glove box
in 3.0-mm ID calibrated quartz EPR tubes, capped and then transferred outside where
they were frozen in liquid nitrogen. EPR spectra were recorded in both perpendicular
and parallel modes at 12-15 K with 10-50 scans per spectrum using a 9.2 GHz Bruker
EMX EPR spectrometer with a dual cavity.
In the case of Av22 prepared by reduction with Ti(III) citrate, excess Ti(III) was
removed by anaerobic G-25 Sephadex chromatography before EPR sample preparation.
A series of EPR spectra of this Av22 at g = 16.4 over the concentration range of 0.05-0.25
mM were examined to determine the detection limit of Ti(III)-reduced Av22 to give this
signal.
In the case of FldHQ-reduced Av2, EPR samples were prepared from Av21 (0.150.4 mM) plus an excess of FldHQ (2-10-fold excess). Independent EPR samples were
prepared by the addition of [Fe(CN)6]3– to FldHQ for comparison. Alternatively, some
EPR samples were prepared by first mixing DT, Av2, and Fld, then separating the protein
mixture from DT on a G-50 Sephadex column (1.0 × 20 cm) equilibrated with 0.05 M
Tris pH 8.0 in the glove box. The DT-free protein mixture was used for EPR
measurements.

6.2.5. Evans NMR Magnetic Susceptibility
Magnetic susceptibility measurements for standard metal ion or protein solutions
of known spin state were performed on 0.25-10 mM samples by the Evans NMR method
260

(318) using an INOVA 300 MHz or a Varian 500 MHz spectrometer. The reference
solution in the capillary insert and the sample solution in the 5 mm NMR tube was 20%
D2O, 40 mM TES at pH 7.4. Tertiary butyl alcohol, t-BuOH, was added to the reference
and sample solutions for a final composition of 7% and 0.6%, respectively. Additional
experiments were conducted under the same conditions using Tris as buffer except tBuOH was absent and the proton resonance of Tris was used as an internal standard. The
chemical shift of each protein sample was calculated by subtracting the measured proton
shift from the corresponding capillary reference. Protein standard curves were
constructed using Av20 (S = 0), Av21 (a mixture of S = ½ and S = 3/2), FldSQ (S = ½),
and Ti(III)-reduced Av22 (S = 8/2). The slope in Hz/mM obtained using Tris or t-BuOH
as frequency references for the protein or metal ion standards were identical.
Additional NMR samples were prepared under identical conditions as above
except Av21 was added to a 3-5 molar excess of FldHQ to give a final concentration of
~0.30 mM Av2. Independent NMR samples were prepared by the addition of
[Fe(CN)6]3– to FldHQ for comparison.

6.3. Results and Discussion

6.3.1. FldHQ Reduces Av2
An excess of dithionite (DT) at pH 8 reduces most Fld to the FldHQ state (319,
320). As expected, there was some residual FldSQ in FldHQ preparations. The optical

spectra of three forms of AvFld were first determined by Hinkson and Bulen (317).
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Figure 6-1. Extinction coefficients of the three forms of Av flavodoxin II. Calculated
from data in Fig. 9 of ref (317).

Their data were digitized and analyzed to produce Figure 6-1. FldOX is a yellow,
oxidized species (quinone); FldSQ is a blue radical species (semiquinone); and FldHQ is
a pale yellow, fully reduced species (hydroquinone). The FldHQ/FldSQ redox couple is
relevant to nitrogenase catalysis (313, 315), since the Em of AvFldOX reduction is too
positive (–245 mV), whereas the Em of AvFldSQ reduction is sufficiently negative (–515
mV) (316). The maximum optical change for oxidation of FldHQ to FldSQ occurs at 580
nm (Δε = 5.4 mM–1 cm–1 (313, 317)).
This optical change allowed for following Av2 reduction through monitoring
FldSQ formation. There was rapid production of FldSQ upon addition of Av20 or Av21
to excess FldHQ as shown in Figure 6-2. From the number of moles of Av2 added and
the optically observed number of moles of FldSQ formed, the number of electrons
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Figure 6-2. Formation of Av22 from reduction of Av2 by FldHQ. Monitored by the
formation of FldSQ at 580 nm. Av2 addition occurs at 9 s. Two electron equivalents are
transferred to Av20 (top curve), one to Av21 (middle curve), and none to S = 4 Av22
(bottom curve). A control for electron equivalents, [Fe(CN)6]3–, is also shown. Varying
degrees of slow oxidation of FldHQ is observed, most notably in the curve for S = 4 Av22
addition.

transferred to Av2 was determined. The viability of this approach was tested against the
addition of [Fe(CN)6]3– to FldHQ, which mirrored closely the reaction of FldHQ with
Av21 as shown in Figure 6-1. Based on four to seven independent Av2 preparations,
Av20 was rapidly reduced by 1.92 ± 0.13 electrons, Av21 by 0.95 ± 0.08, and Ti(III)reduced Av22 by none. These results suggest that Av20 and Av21 are reduced to Av22 by
FldHQ. The Fld/Av2 ratio was varied from 3-20 to assess whether complete reduction of
Av2 had occurred at the lowest ratio of Fld/Av2 tested. There was no statistically
significant difference in results between these different ratios. Presumably, then, the
electron transfer from FldHQ to Av2 to make Av22 is close to stoichiometric.
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The ability of FldHQ to make Av22 so readily is evidence for the Em of Av22
being closer to –480 mV, rather than –790 mV. The discrepancy in these values may
arise from an Av2 conformational change upon interaction with FldHQ that increases its
Em, or an Av2 conformational change in the presence of certain non-physiological

reductants (312) that decreases its Em. There is no precedent for an Av2 conformational
change increasing its Em. Rather, Av2 conformational changes—upon binding of
nucleotides and Av1, for instance—tend to decrease the Em of Av2 (114, 312). So the
true Em of Av21 reduction is more likely closer to –480 mV.
It has been shown that in Klebsiella pneumoniae a complex is formed between
KpFldSQ and Kp21(MgAXP)2, but not with free Kp21 (315). Similar results are seen in
Rhodobacter capsulatus (321). It has been suggested that the midpoint potentials for

Kp20(MgAXP)2 and/or KpFldHQ may be changed in such a complex (315). Indeed, a
decrease in the Em of AvFldHQ formation when in such a complex with Av21 could
account for the discrepancy between Av22 formation suggested here in spite of a very
negative Em suggested by others (312). It is not known what effect forming an Fld-Av2
complex has on the Em for inter-protein electron transfer from FldHQ to Fe protein.
Furthermore, it is not likely that complex formation occurs between nucleotide-free Av2
and AvFld if the Fld-Av2 interaction is similar to that of K. pneumoniae and R.
capsulatus.

In previous studies, it was shown that electrons can transfer back from Fe protein
to FldSQ (315, 321), e.g. in the Kp21(MgAXP)2–KpFldSQ complex. This cannot be
ruled out in the present study of A. vinelandii proteins. Any such effect is masked by the
slow formation of FldSQ that continues after the initial rapid phase of FldSQ formation
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(see Figure 6-2). Interestingly, FldHQ is stable for several minutes in the absence of O2
or other oxidizing agents—forming very little FldSQ—so slow formation of FldSQ is
observed only upon Av2 addition. In particular, note the pronounced FldSQ formation in
the trace for Ti(III)-reduced Av22 in Figure 6-2. Before Av22 addition to FldHQ, the
trace is stable, and no reaction is expected upon Av22 addition. However, a slow
formation of FldSQ is observed after the addition of Av22. The reactions of Av20, Av21,
and O2 with FldHQ are all rapid and can be ruled out as the source of this slow FldSQ
formation.
When buffer is added in place of Av2 solution, only a negligible amount of FldSQ
is formed, ruling out nonspecific oxidation. Analysis of the gas phase of a reaction vial
containing a Ti(III)-reduced Av22 and FldHQ mixture by gas chromatography revealed
that no H2 was formed, excluding this possibility as the product of electron loss from
FldHQ. Pre-treating all solutions with chelex resin diminishes the slow rate of FldHQ
oxidation, suggesting that free metal ions may be partially responsible for the slow
catalytic formation of FldSQ. In addition, inactive Av2 may be partly responsible for this
oxidation.

6.3.2. Optical Spectrum of FldHQ-reduced Av22
Flavodoxin (21 kD) was separated from FldHQ-reduced Av22 (63 kD) using a G75 Sephadex column (1.0 × 50-cm) in the glove box. Qualitatively, the spectrum of the
Av22 isolated in this manner did not have the shoulder at 520 nm typical of Ti(III)reduced Av22 and resembled the spectrum of Av21. Because these samples were dilute
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and prone to error in spectral measurements, a more accurate approximation of the
FldHQ-reduced Av22 optical spectrum was obtained through difference spectroscopy.
Figure 6-3a shows the derivation of the difference between two curves, which are
(1) the initial absorbance of FldHQ by itself, and (2) the final absorbance of a mixture of
excess FldHQ plus Av21. The final absorbance was taken after excess FldHQ and Av21
had reacted to form FldSQ and Av22 (at 1 electron equivalent as in Figure 6-2), and the
initial spectrum was corrected for dilution so it could be accurately compared to the final
spectrum. This difference curve represents the absorbance change from only the FldHQ
that reacted to FldSQ, plus the additional Av2 that is added. This essentially blanks
against excess FldHQ that does not react, so samples containing different concentrations
of FldHQ can be compared. This was better than blanking the spectrophotometer against
FldHQ initially because it allowed for correction for dilution of the sample upon addition
of a non-negligible volume of Av2.
In a similar fashion, the difference spectrum of a sample of FldHQ plus
[Fe(CN)6]3– was determined in Figure 6-3b as a control for the optical change when
FldHQ is converted to FldSQ. This curve was scaled to correct for a known difference in
actual concentration between [Fe(CN)6]3– and Av2 added for use in Figure 6-3c.
The difference between these two difference spectra from Figure 6-3a and b is the
spectrum of 0.043 mM FldHQ-reduced Av22 minus an equimolar amount of [Fe(CN)6]4–
(negligible in the visible range), as shown in Figure 6-3c. This Av22 spectrum is
consistent with that obtained from dilute Fld-free Av22 discussed above. It resembles
that of Av21 and lacks the shoulder at 520 nm present in Av22 in an S = 4 spin state. The
spectra of all forms of nucleotide-free Av2 are compared in Figure 6-4.
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Figure 6-3.
Determination of
the spectrum of
Av22. (a) The
difference spectrum
of the reaction of
FldHQ plus Av21 is
shown. The initial
spectrum contained
only buffer and
FldHQ, which was
subtracted from the
final spectrum
containing unreacted
FldHQ, FldSQ, and
Av22. The final
concentration of Av2
was 0.043 mM, and
the total
concentration FldHQ
plus FldSQ was 0.190
mM. (b) The
difference spectrum
for the reaction of
FldHQ plus
[Fe(CN)6]3– is also
shown. (c) Taking
the difference of
these two difference
spectra from a and b
yields the curve for
Av22.
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Figure 6-4. Extinction coefficients of the forms of Av2. All spectra except S = 0 Av22
are from D. Thiriot (WattLab). The spectra of S = 0 Av22 is calculated from Figure 6-3.

6.3.3. EPR-silent Av22
EPR samples of Ti(III)- and FldHQ-reduced Av22 were compared. The Ti(III)reduced Av22 has a strong g = 16.4 signal in the parallel mode (303) that reflects the
S = 4 spin state. EPR samples of FldHQ-reduced Av22 completely lacked this g = 16.4
signal, as shown in Figure 6-5. It is apparent from this figure that if the FldHQ-reduced
Av22 were in an S = 4 spin state, it should have been possible to detect a g = 16.4 signal
at the concentration of Av2 in the sample, which was equivalent to the concentration of
Av2 in the Ti(III)-reduced sample.
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Figure 6-5. Parallel-mode EPR spectra of all-ferrous Fe proteins. The signal from
0.05 mM Av22 reduced by Ti(III) is contrasted with an equivalent concentration of Av22
reduced by FldHQ. The g = 16.4 signal is only present in the S = 4 Av22.

The perpendicular-mode EPR signals arising from equimolar Av21 and Av21 plus
a two-fold excess of FldHQ are shown in Figure 6-6. The signal arising from FldSQ
made after [Fe(CN)6]3– addition to FldHQ was also determined. There is some overlap
between the g = 1.94 signal from Av21 (322) and the very intense g = 2.00 signal of
FldSQ (317), but the loss in intensity of the Av21 signal upon reduction by FldHQ is
readily apparent. This result suggests that FldHQ-reduced Av22 is in an EPR-silent S = 0
spin state. At this low Fld/Av2 ratio, the reduction of Av2 to Av22 is not complete. Still,
the data are consistent with 70-80% reduction of Av2 to the Av22 state.
A more effective method of S = 0 Av22 preparation was to combine DT, Av2, and
Fld, then separate the DT from the protein mixture. A representative trace is shown in
Figure 6-6, and is consistent with 89% reduction of Av2 to Av22. Upon coming off the
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Figure 6-6. Perpendicular-mode EPR spectra for the reduction of Av21 by FldHQ.
A sample containing 0.16 mM Av21 plus 0.33 mM FldHQ (▬▬) is consistent with 7080% reduction of Av21 to S = 0 Av22 when compared to a 0.16 mM Av21 sample (▬▬)
and a 0.16 mM FldSQ sample prepared by addition of [Fe(CN)6]3– to FldHQ (not shown).
A more effective means of preparing S = 0 Av22 (89% reduced to Av22) involved loading
a mixture of DT, Av2, and FldHQ together on a size-exclusion column for separation of
the protein from DT, and collection of the protein mixture effluent (▬▬). In this trace,
the strong signal for the FldSQ is delineated.

column, the protein mixture was brown in color, and turned slightly blue before the EPR
sample could be prepared. There is very little FldSQ in this sample, however. With the
corresponding drop in Av21 signal intensity, a dynamic equilibrium is likely in effect
between Av21 and FldHQ versus Av22 and FldSQ.
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6.3.4. Evans NMR Magnetic Susceptibility
The Evans NMR method is a viable means for evaluating the number of unpaired
electrons of inorganic substances and protein-bound metal clusters. There is a direct
correlation between the changes in chemical shift of a reference compound with the
electronic spin state of a substance. Figure 6-7 shows how this technique is applied to
various oxidation states of Av2 and FldSQ. The upper line, with a slope of 37.1 Hz/mM,
is for S = 8/2 Av22 prepared by reduction with Ti(III) citrate. With a slope of 11.2
Hz/mM, Av21 consists of a mixture of S = 1/2 and S = 3/2. FldSQ has a spin of S = 1/2,
with a slope of 4.6 Hz/mM; and Av20 has a spin of S = 0 with a slope of 0 Hz/mM.

Figure 6-7. Magnetic susceptibility of Av2 and FldSQ proteins. Determined by the
proton shift in reference solution as a function of protein concentration, according to the
Evans NMR method. The slopes for different protein species are proportional to their
spin state. Ti(III)-reduced Av22 (S = 4) has a slope 8.1 times larger than that of FldSQ (S
= ½) and 2.4 times that of Av21 (S = ½ and S = 3/2). Av20 has a zero slope (S = 0).
FldHQ-reduced Av22 is consistent with a [4Fe-4S]0 cluster in the S = 0 spin state.
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The ratios of the non-zero slopes of these species are 8.1/ 2.4/ 1.0, which correlate
with the number of unpaired electrons of each species. Ti(III)-reduced Av22 (S = 4) has a
spin 8.1 times that of FldSQ (S = 1/2). This result shows that the Evan’s NMR method
gives reliable results for paramagnetic proteins in known magnetic states. Av21 has an
overall spin 2.4 times that of FldSQ, consistent with a mixture of 47% S = 1/2 and 53%
S = 3 /2 .
The addition of Av21 to FldHQ under identical conditions to those in Figure 6-2
produces combined paramagnetic shifts arising from the formation of FldSQ and Av22.
The contribution of Av2 to this shift was determined by subtracting out the contribution
attributable to FldSQ, given its concentration determined optically times the slope
(Hz/mM) of its standard curve for proton-shift in Figure 6-7. The residual shift is due to
the magnetic contribution of FldHQ-reduced Av2. This is shown as a single point in
Figure 6-7—an average of 0.8 ± 1.4 Hz (1.0, -0.5, 0.0 and 2.6) at 0.3 mM, which would
correspond to a slope of 2.7 Hz/mM. The deviation among these data arises from errors
in measuring FldSQ. The FldSQ was determined optically before NMR sample
preparation, so before running of NMR samples, there was likely some variable, slow
oxidation of FldHQ (as in Figure 6-2) that would make these NMR data more positive
than they should be. Incomplete reduction of Av21 to Av22 could also contribute to the
data being more positive. Neglecting slow FldSQ formation, this average slope of 2.7
Hz/mM is consistent with 76% reduction of Av21 to S = 0 Av22. This corresponds well
with the EPR results in Figure 6-6. On the other hand, it can be argued that oxidation of
Av21 to Av20 would contribute to a lower NMR shift, accounting for this Evans NMR
result for FldHQ plus Av2. This possibility is excluded because the conditions of Evans
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NMR sample preparation were strongly reducing and because the spectrum of the
FldHQ-reduced Av2 (Figure 6-4) is not remotely close to that of Av20. In short, Evans
NMR data give evidence for the formation of S = 0 Av22.
Finally, the activity of the FldHQ-reduced Av22 gives an ATP/2e– ratio of 2. The
combination of nitrogenase activity, EPR, UV-vis, and Evans NMR results are consistent
with the formation of a previously uncharacterized Av22 species in an S = 0 spin state.

6.3.5. Effect of Nucleotides
The physiological relevance of the all-ferrous Fe protein is supported by the
characterization of a novel form of Av22 made by reduction with a physiological
reductant FldHQ. However, the reduction of nucleotide-bound forms of Av2 is
catalytically relevant (97, 114). Nucleotides decrease the reduction potential for
Av20/Av21 (114, 126, 131, 156, 323, 324), though it is unclear to what degree this occurs
for Av21/Av22. The L127Δ Av2 mutant locked into an MgATP-bound conformation
(131) can be reduced to the all-ferrous state by Ti(III) citrate (W. N. Lanzilotta and L. C.
Seefeldt, personal communication). This is interesting considering that the Em for the
L127Δ mutant in the Av20/Av21 redox couple is the same as wild-type Av2 bound to
MgATP (131). Additionally, nucleotide-bound Av2 can be reduced to Av22(MgAXP)2
by Ti(III) for two reasons: (1) this reductant makes nitrogenase operate in the Av20/Av22
redox couple (ATP/2e– = 2); and (2) reduction of the nucleotide-bound Av2 is
catalytically relevant. This reasoning also holds when FldHQ is the reductant, so
presumably FldHQ can also reduce Av2(MgAXP)2 to the all-ferrous state. This is not
surprising since Em = –515 mV for FldHQ is comparable to Em = –510 mV for Ti(III).
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We repeated experiments of Av2 reduction by FldHQ (as in Figure 6-2) in the
presence of 2.0 mM MgATP and MgADP. Rapid electron transfer to Av2 was not
prevented by nucleotides. However, while the stoichiometry of rapidly transferred
electron equivalents to free Av20 and Av21 was a near-integer value, this was not the case
with nucleotide-bound Av2. Only about 73% of Av2(MgATP)2 was reduced to
Av22(MgATP)2 in the rapid phase. The effect of ADP was more inhibitory—only about
40% of Av2(MgADP)2 was rapidly reduced to Av22(MgADP)2.
It is likely that the remaining Av2(MgAXP)2 was reduced to Av22(MgAXP)2 in
slower phases of reduction that could not be distinguished from the slow oxidation of
FldHQ described upon addition of Av2 (as in Figure 6-2). Pure all-ferrous activity
(ATP/2e– = 2) is observed with FldHQ as the reductant to nitrogenase. If only a fraction
of Av2 is ever reduced to the all-ferrous state, then there would also only be a mixture of
all-ferrous Av20/Av22 and traditional Av20/Av21 activity. This would give an ATP/2e–
ratio higher than 2—at least ATP/2e– = 3.2 in the case of ADP-bound Av2 where only
40% of the protein is rapidly reduced. But this is not observed, so the remaining
Av2(MgAXP)2 was likely reduced to Av22(MgAXP)2 in slower phases of reduction.
A change in reduction potential of Av21 upon nucleotide binding is likely to
influence the extent of reduction by FldHQ. However, the same 3- to 20-fold variation in
FldHQ/Av2 that was performed for the nucleotide-free Av2 experiments was performed
in the presence of nucleotides, ruling out incomplete reactions in the fast phase of
reduction. This suggests that the inhibitory effect of nucleotides is more of a kinetic
effect than a thermodynamic one. Nucleotides are known to lower the rate of reduction
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of Av20 by DT (115, 118, 219, 289, 290), providing some precedent for the proposed
slowed reduction of Av21(MgAXP)2 by FldHQ.

6.3.6. Physiological Relevance of Av22
This study offers evidence that Av22 can be made by one of its in vivo reductants,
flavodoxin II hydroquinone (Em = –515 mV), providing a counter-argument to claims that
the Em of Av21/Av22 is –790 mV as opposed to the earlier value of about –480 mV.
While the results of this study are consistent with Em = –480 mV, ongoing research will
show whether Av22 is indeed physiologically relevant.
It may be that nitrogenase catalysis proceeds with the Av21/Av20 and Av22/Av20
redox couples simultaneously, or it may be that one or the other predominates, depending
on several in vivo conditions, such as temperature, pH, ionic strength, FldHQ
concentration, ATP/ADP, and nitrogenase component protein concentrations.
Some of these considerations are summarized in Scheme 6-1. If the Av22 state is
achieved in vivo, then there are two likely pathways for its formation, either by reduction
of Av21(MgADP)2 or Av21(MgATP)2. Reduction of Av21(MgADP)2 would be favored
under conditions of limiting ATP. Under such conditions, electron transport to
nitrogenase would also be limited, so the low FldHQ/FldSQ ratio would not favor this
pathway. Interestingly, this study has shown that only 40% of Av21(MgADP)2 is rapidly
reduced to Av22(MgADP)2 by an excess of FldHQ. On the other hand, reduction of
Av21(MgATP)2 would be favored under conditions of excess ATP concentration, which
would coincide with active electron transport (high FldHQ/FldSQ) to nitrogenase.
However, binding of Av1 to Av21(MgATP)2 would compete with Av21(MgATP)2
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Scheme 6-1. Pathways to the all-ferrous Fe protein in the Fe protein cycle. Detail of
Scheme 4-7, showing the favorability of FldHQ reducing R1T2 as opposed to R1D2.

reduction by FldHQ, so reduction would have to be relatively efficient to compete
effectively with the Av21/Av20 redox couple. Interestingly, this study has shown that
about 70% of Av21(MgATP)2 is rapidly reduced to Av22(MgATP)2 by FldHQ.
It is interesting to speculate about the relevance of the all-ferrous Fe protein in
organisms other than A. vinelandii, where midpoint potentials are much more positive
and/or the concentration of flavodoxin/ferredoxin is very low. In previous studies of the
interaction of Fe protein with flavodoxin in K. pneumoniae (315) and R. capsulatus
(321), reaction progress was followed optically at the isosbestic point of flavodoxin so
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that the absorbance change of only Fe protein was monitored. If the all-ferrous Fe
protein was made, it was likely missed because the spectrum of S = 0 all-ferrous Fe
protein resembles that of the singly reduced Fe protein. It is unfortunate that reaction
progress did not focus on the oxidation of FldHQ as well.
While the midpoint potential of flavodoxin is about 100 mV more positive in K.
pneumoniae than in A. vinelandii, the midpoint potential of reduced Fe protein is

correspondingly more positive in nucleotide-free, MgATP-bound, and MgADP-bound
forms (315). Hence, the relative differences in redox potential between flavodoxin and
the three forms of Fe protein are the same in A. vinelandii and K. pneumoniae. While the
midpoint potential for Kp22 formation has not been determined, it is possible that it too
follows the same pattern. Hence, the physiological relevance of Kp22 is likely to be
comparable with Av22 if only midpoint potentials are considered.
However, the in vivo concentration of KpFld is very low compared to AvFld
concentration, and it has been suggested that flavodoxin-Fe protein complex formation is
a mechanism to maintain rapid Fe protein reduction in organisms with low flavodoxin
concentration (315, 321). Because two interactions with FldHQ are required for the
formation of the all-ferrous Fe protein, it seems unlikely that organisms with very low
flavodoxin/ferredoxin levels could maintain all-ferrous Fe protein levels relative to
consumption of Fe protein in the catalytic cycle.
However, there may be alternative mechanisms a cell uses to achieve the allferrous redox state for efficient catalysis in organisms with low flavodoxin/ferredoxin
levels. For instance, a high ADP/ATP ratio prevents catalysis from proceeding, giving
the cell more time to reduce Fe protein. Complex formation between Fe protein and
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flavodoxin could serve a similar purpose. Additionally, Kp2 has been extensively
characterized as having an inactive conformation (115) that explains why Kp2 is only
45% active in kinetic studies (7). This Kp2 is capable of being reduced but does not
hydrolyze ATP nor transfer electrons to Kp1. Because active and inactive conformers are
inter-convertible (115), all electron flow to Kp2 eventually progresses to Kp1. This
would provide K. pneumoniae with an additional mechanism to reduce Kp2 to the allferrous state before it enters catalysis.
However, there have been no direct measurements of an all-ferrous Fe protein in
vivo. This study shows that if the all-ferrous Fe protein is made in vivo, it is likely in an

EPR-silent S = 0 spin state, with an optical spectrum resembling singly reduced Fe
protein. Hence, this discovery gives information that may be useful in the search for an
in vivo all-ferrous Fe protein.

6.4. Summary and Conclusions
AvFldHQ reduces all of the iron atoms in the [4Fe-4S] cluster of Av2 to the
ferrous oxidation state. This all-ferrous Av22 has some unique physical properties that
distinguish it from the previously characterized Ti(III)-reduced Av22. Most notably,
magnetic susceptibility measurements using the Evans NMR method indicate that
FldHQ-reduced Av22 has an S = 0 spin state, not an S = 4 spin state that is characteristic
of Ti(III)-reduced Av22. Furthermore, the visible absorbance spectrum of this S = 0 Av22
lacks the shoulder at 520 nm that is present in the S = 4 Av22. Similarly, the EPR
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spectrum of the S = 0 Av22 does not have the g = 16.4 resonance that is present in the S =
4 Av22 EPR spectrum. Because of these unique physical properties, the S = 0 Av22 has
not been previously detected. This study provides information that may help us detect
the presence of the all-ferrous Fe protein in in vivo systems. The physiological
implications of an S = 0 Av22 made from this in vivo reductant were discussed, and
reduction of Av21(MgATP)2 by FldHQ is likely to be relevant.
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Chapter 7
Evidence for a Synergistic Salt-protein Interaction—
Complex Patterns of Activation vs. Inhibition of
Nitrogenase by Salt

This chapter is based on a manuscript coauthored by myself, A. C. Nyborg, J.
Kenealey, T. J. Lowery, K. Crawford, C. R. King, A. J. Engan, J. L. Johnson and G. D.
Watt, and being readied for submission.

Adaptive mechanisms to extracellular tonicity are prominent features of
diazotrophic bacteria (that all have nitrogenase) because they live in virtually all global
environments. For instance, an extracellular NaCl concentration is balanced by more
physiologically tolerable osmolytes intracellularly. Therefore, how the build-up of these
osmolyte salts affects nitrogenase activity is of great importance to these organisms.

7.1. Literature Overview and Preliminary Analysis
It is clear from the work of Deits and Howard (93) that salt inhibition of
nitrogenase can be modeled mathematically (see Scheme 4-8 and Figure 4-13).
However, Thorneley and Lowe do not have any pathways for salt inhibition in their
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model. In my efforts to incorporate salt effects into my model of the Fe protein cycle
(see Scheme 4-7), I came across an unusual pattern of salt effects in both the literature
and in my own lab work—that of salt activation of nitrogenase. In this study, we show
that salts have a profound effect on both inhibition and activation of nitrogenase, and
mechanisms for each are described.

7.1.1. Salt Inhibition
The series of protein and nucleotide interactions in Scheme 4-7 is reproduced here
for ready reference (see Scheme 7-1). These interactions are rather complex, and there
are several ways salts can influence them. Our lab (G.D.W.) and others have previously
described the inhibitory effects of salts on Azotobacter vinelandii nitrogenase (92, 93,
166, 181). Inhibition is universal to all salts, and both cations and anions have an effect.

Also, there is a high degree of apparent cooperativity in the inhibition (93, 160) (see
Figure 4-13).
The best characterization of salt inhibition to date was performed by Deits and
Howard, who modeled salt as a dead-end inhibitor, preventing both inter-protein electron
transfer as well as ATP hydrolysis by abolishing nitrogenase complex formation (93).
Only inhibition at nucleotide binding sites was directly modeled in their scheme. This
accounts for salt inhibition of MgATP-dependent Fe removal from the [4Fe-4S] cluster of
Av2 by certain chelators. To account for disruption of nitrogenase complex formation,
the Deits-Howard model makes the rate of dissociation of the complex large when the
nucleotide site is inhibited by salt. This indirect accounting of inhibition of complex
formation was sufficient to describe the data they observed.
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Scheme 7-1. Fe protein cycle. Reproduction of Scheme 4-7.

7.1.2. Salt Activation
In a subsequent study, however, a low concentration of NaCl (~25 mM)
increased nitrogenase activity under conditions of excess MoFe protein, followed by the
expected activity decrease at higher salt concentrations—see Fig. 8 of ref (160). The
low-salt activation could not be rationalized in terms of the Deits-Howard scheme, which,
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the authors admit, breaks down under conditions of low electron flux, such as when there
is an excess of MoFe protein (93, 160).
However, several studies even show a small low-salt activity increase under
conditions of high electron flux where the Deits-Howard model ought to apply. The
primary osmolyte in M. barkeri 227, potassium glutamate, activated nitrogenase activity
by about 15% at about 80 mM of this salt (325). This and other cases of salt activation in
the literature—where there is an excess of Fe protein to MoFe protein—are shown in

Figure 7-1. Literature survey of cases of salt activation of nitrogenase with an
excess of Fe protein. Compilation of data normalized to 100% activity at zero added
salt. The Fe protein/MoFe protein molar ratios and identities of nitrogenases are shown.
K143Q-Av2 (red) and wild-type Av2 (green) data are normalized from Fig. 3 of ref
(326); M. barkeri data (orange) is from Fig. 4 of ref (325); and normalized data for the
Av2/Cp2 hybrid protein (blue) is from Fig. 4 of ref (327). Another minor case of salt
activation under excess Fe protein is in Fig. 2b of ref (93).
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Figure 7-1. Because several cases of salt activation are induced by NaCl, it is concluded
that salt activation is a general ionic effect.
The Deits-Howard model does not account for salt activation under any
circumstances, necessitating either a study of the reproducibility of nitrogenase activation
under these high-flux conditions or a more accurate description of the nitrogenase salt
effect. Salt activation falls into the category of an effect requiring a thorough qualitative
characterization in this chapter. Future work should focus on a quantitative
characterization of salt effects.

7.1.3. Targets of Salt Effects
Salt effects are possible through interference of Av2-nucleotide interactions (93,
152) and Av2-Av1 interactions (2, 92, 93, 181, 328), so the logical starting point in

describing the nitrogenase salt effect is a thorough description of all of these interactions,
as shown in Scheme 7-1.
Catalysis begins with the association of MoFe protein with reduced Fe protein
bound to two MgATP according to the shorthand E + R1T2 → ER1T2. Formation of
ER1T2 leads to rapid electron transfer and ATP hydrolysis, so salts must prevent ER1T2
formation to inhibit catalysis—by inhibiting protein-protein and/or protein-nucleotide
interactions. Upon hydrolysis of MgATP there is a drastic alteration in complex
stability—ATP hydrolysis promotes complex dissociation, but dissociation is still very
slow and is usually the rate-limiting step in catalysis (7).
Dissociation is required because only Fe protein not bound to MoFe protein is
capable of being reduced in the k4 step by an external reductant (118)—such as
flavodoxin or ferredoxin in vivo, or dithionite (DT) in vitro. Fe protein binding to MoFe

285

protein again before it is reduced leads to MoFe inhibition, which is also a potential target
for salts. Reduction of Fe protein bound to MgADP is most relevant to catalysis (288).
Reduction of Fe protein decreases its affinity for binding nucleotides (97, 101) so that
nucleotide exchange is favored under conditions of ATP excess.
Salt effects may also be observed under non-optimal conditions. Of particular
interest, it is now established that electron transfer can even occur in the complete
absence of ATP. Yousafzai and Eady found that Kp nitrogenase very slowly evolved H2
in the presence of ADP (EnR1D2 → En+1R0D2), which could not be attributed to low
levels of contaminating ATP (174). They point out that similar behavior is observed for
Av nitrogenase under similar conditions in a study by Watt et al (123). Lower levels of
H2 were detected even in the complete absence of nucleotide (EnR1 → En+1R0) with Kp
nitrogenase (174).
Because inhibition of both protein-protein and protein-nucleotide interactions can
affect nitrogenase catalysis, competing or parallel effects of salts at these sites can
complicate nitrogenase behavior. The possibility of monitoring product formation in the
complete absence of nucleotides gives us the opportunity to assess the salt effect between
the nitrogenase proteins without a simultaneous salt effect on nucleotide inhibition. The
framework of Scheme 7-1, therefore, provides several ways of analyzing the salt effect,
including the conventional ATP-dependent point of view of inhibition, as well as a novel
analysis of ATP-independent salt inhibition.
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7.2. Materials and Methods

7.2.1. Protein Characterization
Nitrogenase proteins from Azotobacter vinelandii and Clostridium pasteurianum
were isolated, purified and characterized as described previously (292). Fe protein
preparations had specific activities between 1400-2000 nmol of C2H4 min–1 mg Av2–1 and
>3000 nmol of C2H4 min–1 mg Cp2–1. Samples of MoFe protein had a specific activity of
~1400 nmol of C2H4 min–1 mg Av1–1. We thank Dr. L. C. Seefeldt (Utah State
University) for a sample of L127Δ-Av2.

7.2.2. Assay Procedures
Nitrogenase activity was determined by either standard assays or novel titration
assays.

7.2.2.1. Standard Assays. Standard 1.0-mL assays were run for 10 minutes in a

temperature-controlled shaker bath at 30 oC as performed previously (185, 186). Vials
were made anaerobic and put under 100% Ar or 10% C2H2. The solution phase of the
assays contained an ATP generating system (with 1 mg/mL creatine phosphokinase and
30 mM creatine phosphate), 2.5 mM ATP, 5 mM MgCl2, 20 mM DT, and 25 mM TES
pH 7.4. Assays were quenched with trichloroacetic acid, and products H2 and C2H4 were
determined by gas chromatography. Deviations from these conditions are reported in the
text where applicable.
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7.2.2.2. Titration Assays. Titration assays were a variation of standard assays

changed repeatedly by addition from some stock solution, usually 3 M salt plus 1X of
other assay components except protein, under gas equivalent to the assay’s original
atmosphere. Assays were started by adding Av2. After some time, a small volume from
a stock solution plus a balance of gas to make a total of 200 μL was injected into the
reaction solution, followed by rapid mixing. With the syringe still in the assay vial, a
200-μL gas sample was taken for gas chromatography.
This series of steps took less than six seconds to perform. Usually ten activity
measurements over variable conditions with the same assay vial were taken over 2 to 6
minute intervals. The product present in the initial atmosphere was subtracted as a blank.
A mathematical correction was used for the addition of all fluids (gas and stock
solution) to the assay and subtraction of product gas from earlier sampling. For noisy
data, a three-point box-car average was applied to a cumulative product versus time
curve.
In general, only nitrogenase was diluted in the assay, but never more than to a
third of its initial concentration. Two to six titrations were performed for any given set of
conditions.
Titrations were started at different points along the variable component and
compared in the overlapping regions; they were also compared to standard assays.
Systematic deviations implied problems with protein dilution or consumption of vital
assay components over time (e.g. creatine phosphate), and were grounds for truncating
the data.
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7.3. Results

7.3.1. Salt Inhibition in the Dilution Range
The Deits-Howard description of salt inhibition of nitrogenase predicts increased
inhibition with protein dilution—see Fig. 6 of ref (93). We have applied this concept to
the dilution range. The dilution effect refers to the drop in total activity that occurs upon
nitrogenase dilution at a constant ratio of Fe protein to MoFe protein, as shown in Figure
7-2. The dilution effect is thought of as a mass-action effect of the Kp1-Kp2 interaction
in the Thorneley-Lowe model (6). However, the Thorneley-Lowe model was devised

Activity/ (nmol H2/min)
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Figure 7-2. Salt inhibition in the dilution range. Detail of Figure 2-2. The T&L
model is incapable of matching the data in the extreme dilution range. A finding of the
Deits-Howard model that salt inhibition is more potent with nitrogenase dilution could
explain why the date is less and less active with dilution than predicted by the T&L
model. T&L data (●) and T&L best-fit curve to data to solve for k–1/k1 (▬ ▬ ▬).
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Figure 7-3. Salt inhibition exaggerated in the dilution range. The activities of
titration assays in 30 mM NaCl (▲) and 102 mM NaCl (■) at 30 oC in 20 mM DT, pH
7.4. The variable component of the titrations was nitrogenase concentration using a stock
solution with an [Av1]/[Av2] ratio of 1/6 and activities of 1400 nmol min–1 mg Av1–1 and
1912 nmol min–1 mg Av2–1. Percent relative activity of nitrogenase (circles) in 102 mM
NaCl compared to 30 mM NaCl: points used in the linear fits to demarcate two regions of
the data (●); and data not used in these linear fits (○).

before salt inhibition was characterized, so it was of interest to assess the effects of salts
in the dilution range.
The percent activity of nitrogenase in 102 mM NaCl compared to nitrogenase in
30 mM NaCl is shown to change with protein concentration in Figure 7-3. The data
show that above about 2 μM Av1 at an Av1/Av2 molar ratio of 1/6, activity is equivalent
at these two salt concentrations, which is expected from the Deits-Howard study that
showed that activity begins to drop only at NaCl concentrations higher than 100 mM
(93). Below 2 μM Av1 in Figure 7-3, nitrogenase in 102 mM NaCl is progressively more
inhibited with dilution when compared to nitrogenase in 30 mM NaCl. This relative
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activity drop is attributed to enhanced salt inhibition with nitrogenase dilution, which was
expected from the Deits-Howard scheme in which Av1 and salts compete for Av2 (160).
Dilution leads to a second-order drop in Av1-Av2 association (dilution of both
component proteins), but only a first-order drop in salt-nitrogenase association—and
hence an enhanced salt inhibition. Thus, the dilution effect of nitrogenase cannot be
attributed exclusively to a mass-action effect, and salt inhibition contributes significantly
to the drop in total activity with dilution.

7.3.2. Salt Effect on MoFe Inhibition
The Deits-Howard scheme cannot model the salt effect under conditions of low
electron flux, including MoFe inhibition (93, 160), where it was shown that there is an
increase in activity when salt is added—see Fig. 8 of ref (160). MoFe inhibition refers to
the competition between reduction of R0D2 to R1T2 (Fe protein reduction favoring
nucleotide exchange) and formation of an inactive ER0D2 complex—a competition
between the k4 and k3 steps—as described by the Thorneley-Lowe model and Scheme
7-1. As the MoFe protein concentration increases, inactive complex formation dominates
(7). Thorneley and Lowe observed that salts disrupt complex formation in the k3 step,
leading to increased rates of Fe protein reduction in the k4 step (2). The consequences of
this effect on activity were not determined, however. In Figure 7-4, it is shown that salt
competes away MoFe inhibition at low salt concentrations and then k1 at higher salt
concentrations. Both H2 and C2H4 evolution are enhanced by this salt activation by the
increase in free reduced Fe protein because of salt inhibition of MoFe inhibition. We can
conclude from Figure 7-4 that at a high Av1/Av2 ratio k3 is initially predominant over

291

nmol min–1 nmol Av2–1

100

Total

90
80
70
60

H2

50
40
30

C2H2

20
10
0
0

100

200

300

400

500

600

[NaCl]/ mM
Figure 7-4. Salt activates MoFe-inhibited nitrogenase. Standard assays were used to
measure total activity (●) from the components of both H2 (■) and C2H4 (▲). Each
assay had only 8 mM DT, compared to 1.14 μM Av2 (1600 nmol min–1 mg–1) and 17 μM
Av1 (2143 nmol min–1 mg–1).

k1—in terms of how much protein is involved in each step—so that inhibiting both k1 and
k3 leads to an overall increase in activity at low salt concentrations.

7.3.3. Concentration Affects Specific Activity
There is ambiguity from Figure 7-4 as to whether salts exert a different influence
on k1 vs. k3. In the Deits-Howard model, salts affect these steps equally (93). However,
this is not compatible with the notion that there are different interactions involved in
complex formation when different nucleotides are present (146). Therefore, it was of
interest to determine whether salts affect k1 and k3 differently. In Figure 7-5, Av2
specific activity at 2.1 µM Av2 increases with MoFe protein, only to drop because of
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Figure 7-5. Concentration dependence of Fe protein specific. Standard assays measuring the specific activity of Av2.
An effect of increased Av1 causing MoFe inhibition is seen to depend on the dilution of Av2, with Av2 held constant at 2.1
μM (▲), 1.0 μM (■), or 0.05 μM (●). The activities of proteins used were 2000 nmol min–1 mg Av2–1 and 1900 nmol min–1
mg Av1–1.

increasing MoFe inhibition. However, MoFe inhibition is concentration dependent.
There is a specific activity drop with dilution at low Av1/Av2 ratios where MoFe
inhibition is not a factor and where inhibition of k1 predominates. At high Av1/Av2
ratios where MoFe inhibition is important, salt inhibits primarily k3. With each dilution,
the salt effect is more potent, and so k1 and k3 are increasingly inhibited. At the lowest
protein concentration shown, 0.05 μM Av2, not even an Av1/Av2 ratio of 300/1 produces
a drop in activity reflective of MoFe inhibition (data not shown). Therefore, k3 (E + R0D2
→ ER0D2) is almost completely suppressed. Otherwise, MoFe inhibition should have
overcome salt inhibition at this very high Av1/Av2 ratio. On the other hand, k1 (E + R1T2
→ ER1T2) must only be partially inhibited since product formation is high. Therefore,
salts exert a stronger inhibition on k3 than on k1.

7.3.4. Salt Activation under High Electron Flux
While considering salt inhibition at multiple intermediates in Scheme 7-1 is
sufficient to explain nitrogenase activation by salt under MoFe-inhibited conditions, there
is also evidence for salt activation, as shown in Figure 7-1, under high electron flux
conditions—excess MgATP, reductant and Fe protein.
In Figure 7-6, the salt effect on the percent activity of nitrogenase (relative to zero
added salt) is shown for assays at three different temperatures. At 12.5 oC, the smallest
addition of NaCl (9 mM) inhibits the activity of assays with 1 μM Av1 and 6 μM Av2 by
40%. A fit of the data to the Hill equation (not shown) displays no deviation at low salt
as occurs for the data at 30 oC, which maintains activity out to 100 mM NaCl before
inhibition occurs, consistent with the results of Deits and Howard (93). At 40 oC there is
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Figure 7-6. Salt activates nitrogenase under conditions of high electron flux.
Titration assays involving the addition of a 3-M NaCl stock solution to 1.0-μM Av1 and
5.8-μM Av2 at 12.5 oC (▲) or 30 oC (●). Titration assays performed at 40 oC (■) had
only a fifth of the protein. To facilitate comparison, the data are normalized to 100%
activity at zero added salt for a given temperature. The activities of proteins used were
1400 nmol min–1 mg Av1–1 and 1912 nmol min–1 mg Av1–1.

a dramatic salt activation of nitrogenase by NaCl under 50 mM. At this high
temperature, a dilute sample of nitrogenase (0.2 μM Av1 and 1.2 μM Av2) was used to
ensure that assays did not run out of ATP regenerating system, and to ensure a very large
excess of DT relative to protein concentration. This dilute nitrogenase is more
susceptible to salt inhibition, which is apparent from the more dramatic drop in activity
above 50 mM NaCl compared to nitrogenase at five times the concentration at 30 oC. As
Figure 7-6 suggests, a slight deviation above 30 oC would result in a small activation of
nitrogenase, which could account for the variability of whether or not salt activation of
nitrogenase is observed in the literature at a reported temperature of 30 oC.
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7.3.5. Salt Activates the Cross AvE-CpR1T2
The heterologous cross Av1-Cp2 forms a tight complex (68, 171, 172). Since Fe
protein must be released from the complex to be re-reduced and restart the catalytic cycle
(see Scheme 7-1), nitrogenase combinations that result in a tight complex do not reduce
substrates requiring at least two electrons before product turnover. Hence, it was long
believed that no product formation occurred with Av1-Cp2 in the presence of ATP (AvECpR1T2), but Clarke et al showed recently that AvE-CpR1T2 does supports H+ reduction
accompanied by complex dissociation at a very slow rate (0.032 s–1 at 30 oC) (173). The
rate of complex dissociation is clearly the rate limiting step in this case because electron
transfer approaches the rate in the homologous cross at 100 s–1 (122) and because ATP
hydrolysis is also relatively fast (173, 182).
One of the possible explanations for the salt activation in Figure 7-6 is that salts
accelerate the rate-limiting step of nitrogenase complex dissociation. We hypothesized
that AvE-CpR1T2 would be activated by salt if this were the case. Because dissociation
of AvE-CpR0D2 is by far rate limiting, the rate of product formation is essentially a
measure of this rate-limiting step. Figure 7-7 shows that AvE-CpR1T2 is indeed activated
by salt at a Cp2/Av1 ratio of 3/1 at 1 μM Av1. There is close to a five-fold activation of
H2 formation at 500 mM NaCl, followed by a drop in activity to near zero at 2 M NaCl.
There was only about 10% greater activity in assays with AvE-CpR1T2 by increasing the
Cp2/Av1 ratio from 3/1 to 8/1 (data not shown), so a 3/1 Cp2/Av1 ratio was sufficient to
achieve close to saturating conditions of high electron flux, i.e. MoFe inhibition is not a
factor. The inset to Figure 7-7 shows the controls of MgATP-dependent H2 evolution by
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Figure 7-7. Salt activates the tight complex Av1-Cp2 in the presence of MgATP.
Standard and titration assays with 3.4-μM Cp2 and 1.0-μM Av1 using 3-M salt as the
variable component in titrations. H2 measurements (●) were taken independently of

C2H4 measurements (○). The inset repeats the data from titration assays measuring C2H4
for comparison to H2 production from controls of three-hour standard assays with 3.4-μM
Cp2 with no Av1 (■squares) and 1.0-μM Av1 with no Cp2 (▲).

Av1 and Cp2 by themselves. The contribution of H2 from these sources represents less
than a tenth of the total activity when both components are present at zero added salt.
The low level of activity in each separate component is produced from a very low level of
contaminating Av2 and Cp1 in our samples of Av1 and Cp2, respectively. These were
inhibited by the addition of salt, whereas salt activated assays containing both Av1 and
Cp2. At zero added salt, the rate of AvE-CpR0D2 dissociation is about 0.068 s–1 at 30 oC,
or about twice as fast as previously reported by Clarke et al (173). This rate is calculated
from a simulation (10) where all rates are much faster than dissociation and assuming that
product H2 is only evolved from free Av1, not on the Av1-Cp2 complex, so that two
dissociation steps are required before product evolution (7).
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Clarke et al determined that acetylene was not a substrate (173). Therefore, this is
the first report that AvE-CpR1T2 supports acetylene reduction, but only upon salt
activation. The inset to Figure 7-7 shows how the initial drop in ethylene production by
the heterologous cross with added salt below 100 mM NaCl can be correlated to the drop
in activity due to contaminants in Av1 and Cp2. An increase in ethylene production
(about 8% of the total electron flux) at higher salt concentrations corresponds to the
increase in H2 evolution by the heterologous cross, so that it appears that ethylene
production is not supported by the heterologous cross to any significant extent below
about 100 mM NaCl.
We observed salt activation of AvE-CpR1T2 with several different salts at a
Cp2/Av1 ratio of 6:1. CsCl and NaCl-activated AvE-CpR1T2 peaked at about 20 and 10
nmol H2 min–1 nmol Av1–1, respectively, between 500-600 mM salt. KI and NaI and
NaBr-activated AvE-CpR1T2 peaked at about 20 nmol H2 min–1 nmol Av1–1 between 350
and 450 mM salt. It appears that the activating salt effect on AvE-CpR1T2 is a general
ionic effect.

7.3.6. Salt Activation in the Absence of MgATP
Scheme 7-1 includes pathways of MgATP-independent electron transfer.
Whereas the rate of electron transfer in the homologous Av cross has never been fast
enough to detect, electron transfer is detectable in the heterologous cross Av1-CpR1
(0.007 s–1) and Av1-CpR1D2 (0.018 s–1) in the absence of ATP at 24 oC (122). The rates
of complex dissociation of these heterologous combinations have never been measured
but are expected to be very slow in the catalytic cycles [En + R1 → EnR1 → En+1R0 →
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En+1 + R0] and [En + R1D2 → EnR1D2 → En+1R0D2 → En+1 + R0D2]. Similarly, the
L127Δ-Av2 mutant locked into the MgATP-bound conformation transfers an electron to
Av1 in a reaction homologous to EnR1T2 → En+1R0T2 (0.2 s–1 at 23 oC). The rate of
dissociation of the Av1-L127Δ-Av2 complex is less than 0.02 s–1 at 23 oC (118), and so
dissociation is rate limiting in the catalytic cycle [En + R1T2 → EnR1T2 → En+1R0T2 →
En+1 + R0T2].
Where dissociation is rate-limiting, an activity increase under excess Fe protein
suggests salt activation by enhanced complex dissociation. The effects of NaCl on H2
formation by AvE-CpR1, AvE-CpR1D2, and AvE-L127Δ-AvR1±D2 are shown in Figure
7-8. All of these combinations display salt activation. Activity by AvE-CpR1 is most
strikingly enhanced by salt addition. Between 0-100 mM NaCl, the level of activity

nmol min–1 nmol Av1–1

0.3

AvE-CpR1

0.25
0.2

AvE-CpR1D2

0.15
0.1
0.05

AvE-L127Δ− AvR1

0
0

500

1000

[NaCl]/ mM

1500

Figure 7-8. Salt activates nitrogenase in the absence of MgATP. An average of
standard and titration assays (using 3-M NaCl as the variable component) with 1-μM Av1
with 6-μM L127Δ-Av2 (▲). Titration assays with 1-μM Av1 and Cp2 with no
nucleotides (●) and with MgADP (■).
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corresponds to a dissociation rate of about 0.0004 s–1 at 30 oC. Between 500 and 900
mM NaCl, activity was about 25 times faster. MgADP enhanced activity in less than 400
mM NaCl but depressed activity for NaCl concentrations above 400 mM. Its peak
activity of AvE-CpR1D2 of 0.2 nmol H2 min–1 nmol Av1–1 between 250 and 350 mM
NaCl corresponds to a dissociation rate of AvE-CpR0D2 of 0.007 s–1 at 30 oC, or about
3.5 faster than at zero added salt. Product formation by AvE-L127Δ-AvR1 and AvEL127Δ-AvR1D2 was identical, with an apparent dissociation rate at zero added salt of
0.002 s–1, very similar to AvE-CpR0D2. This was enhanced to 0.004 s–1 between 200 and
500 mM NaCl. It is important to note that the actual rates of dissociation must be faster
than these apparent rates for two reasons: (a) there is equilibrium in electron transfer so
that not every complex formation contributes to catalysis; and (b) there is slow decay of
super-reduced En+1 back to the ground state En.

7.4. Discussion

7.4.1. Broad Application of the Salt Effect
An emphasis should be given to the description of salt inhibition by Deits and
Howard that salts and Av1 compete for Av2. Consequently, in any study where the
concentrations of the nitrogenase assay components are changing, there is a
corresponding salt effect. The extensive applications of this nitrogenase salt effect are
often overlooked. Taking it into consideration explains several phenomena of
nitrogenase that have baffled researchers in the past.
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7.4.1.1. Sigmoidicity. For example, there is apparent sigmoidicity in MoFe

protein specific activity curves where there is a change in Fe protein concentration vs.
constant MoFe protein (185), as shown in Figure 4-12. The salt effect can account for
this sigmoidicity. Salt inhibition is more inhibitory at low Fe protein concentrations—see
Fig. 7 of ref (93). With addition of Fe protein to a constant concentration of MoFe
protein, however, salt inhibition is competed away more effectively, and so activity
appears to increase dramatically, giving the appearance of sigmoidicity or cooperativity
in the MoFe protein specific activity curve. In particular, Av2 mutants that showed
enhanced susceptibility to salt inhibition also displayed greater sigmoid character in Av1
specific activity (e.g. R100H—compare Figs. 4 and 7 of ref (160); and R140Q and
K143Q—compare Figs. 2 and 3 of ref (326)). For example, see Figure 7-9.

Figure 7-9. Salt inhibition coincides with sigmoidicity of MoFe protein specific
activity. Adapted from Figs. 2 & 3 of ref (326). (a) R140Q and K143Q Av2 mutants
display increased sigmoidicity that (b) corresponds to an increased susceptibility to salt
inhibition at an Av2/Av1 ratio of 15:1, but a high degree of apparent cooperativity, n.
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7.4.1.2. Competition Studies of Fe Protein Mutants. The same argument applies

to sigmoidicity or apparent cooperativity in competition assays involving Av2 mutants
(e.g. D129E—Fig 8 of ref (125); and D39N—Fig 2 of ref (116)), where salt inherent in
the assay inhibits competition of the mutant at low mutant concentration, but not so much
at higher concentrations.

7.4.1.3. Effect of Salt Inhibition on the T&L Model. Another important

application of the salt effect is in modeling nitrogenase catalysis. Many of the key steps
in Scheme 7-1 are derived from the Thorneley-Lowe (T&L) model of nitrogenase
catalysis (2-9, 103, 112). It is the best description of nitrogenase kinetics to date, but we
have previously shown that it is not quantitative (see Chapters 2 and 3 and ref (10)). It
was developed years before Deits and Howard described salt inhibition, which has
important implications for the T&L description of the dilution effect.
The dilution effect is thought of as a mass-action effect in the T&L model. The
measure of the binding constant K1 = k1/k–1 (E + R1T2 = ER1T2) is performed in the
dilution range of 0-0.3 μM Kp1—see Figure 7-2. However, the fit is very poor for Kp1
concentrations less than 0.08 μM. The effects of salts in the dilution range—see Figure
7-3—bring into question the measurement of K1 by Thorneley and Lowe Salts inherent
in activity assays—e.g. reaction buffer, DT and NaCl (from the protein isolation
procedure)—are partly to blame for this poor fit.
Because the T&L model does not incorporate a salt effect into the simulation of
the dilution effect, the fit becomes worse with dilution as salt inhibition becomes more
potent. The dilution effect is more of a salt effect than a mass-action effect. Hence their
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measure of K1 at about ten times K3 is too low, where K3 = k3/k–3 (E + R0D2 = ER0D2).
Since the value of K1 is used on all subsequent simulations of the T&L model, it would
seem that ignoring the salt effect has skewed to some degree all of their simulations of
nitrogenase kinetics. This explains in part why the T&L scheme is not quantitative.

7.4.1.4. The Binding Affinity of the ER1T2 Complex. The value of k1 in the T&L

model was measured in stopped-flow studies, while K1 was measured by the dilution
effect. The value of k–1 was determined from these two constants. Thus, our analysis of
the dilution effect is not a criticism of the value of k1, but of k–1 (too high). The L127ΔAv2 mutant forms a tight complex with Av1 (118). This interaction is analogous to K1 of
the T&L scheme since L127Δ-Av2 is locked into the MgATP-bound conformation (118,
131, 138, 298). It is not clear how similar complex formation is for Av1 with either the

wild-type Av2(MgATP)2 or the mutant L127Δ-Av2. To date, one of the best arguments
against drawing comparisons between the two has been that the value of k–1 in the T&L
model of Kp nitrogenase is rather substantial—15 s–1 at 23 oC (5)—compared to the offrate of L127Δ-Av2 from Av1—less than 0.02 s–1 at 23 oC (118). However, since the
value of k–1 in the T&L model is too high, the dissociation of Av1-L127Δ-Av2 may
actually be more analogous to dissociation of Av1-Av2(MgATP)2 than previously
thought. This could be true in spite of the fact that nitrogenases from two different
organisms (Kp vs. Av) are being compared; the measured rates of elementary steps of
nitrogenases from different organisms have been remarkably similar. Therefore, if k–1
is less than 0.02 s–1 in the wild type, then K1 is at least a thousand times stronger than
previously thought.
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7.4.1.5. Needed Improvements to the Deits-Howard Salt Model. We have used

concepts from the Deits-Howard salt effect to explain, in part, why the T&L scheme is
incomplete. The reverse is also true—aspects of the T&L scheme help to explain
deficiencies in the Deits-Howard model. Specifically, the Deits-Howard model does not
account for MoFe inhibition. From Figures 7-4 and 7-5, inhibition of k1 vs. k3 can
explain nitrogenase activation under low-flux conditions where MoFe-inhibition is
competed away by salt more effectively than formation of the catalytic complex ER1T2.

7.4.2. A Mechanism for Salt Activation
The paradigm that emerges from the synthesis of Deits-Howard salt inhibition
with Scheme 7-1 can be a powerful tool in explaining several of the effects observed with
salt inhibition and activation. However, it cannot account for salt activation of
nitrogenase under high-flux conditions where competing away MoFe inhibition is not
relevant.
An alternative description of salt activation is sought. Indeed, the impetus for the
exhaustive description of nitrogenase salt effects in this study was that no one has
previously described the mechanisms for salt activation of nitrogenase. This is a
particularly important phenomenon to explain since it occurs under conditions relevant to
in vivo osmolytes and their concentrations (325). In this study, we have not examined the

effects of physiological osmolytes. Rather, salt inhibition is a general ionic effect (92,
93), and the results in Figure 7-1 and our results show that activation is also a general

ionic effect, though some salts are more activating than others. Therefore, we have
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favored the use of the Hofmeister-neutral NaCl in this study to minimize complications
with altering protein solubility vs. denaturation (329), and because of the general use of
NaCl in previous studies of salt effects.
NaCl activation of nitrogenase under high-flux conditions is observed in the
literature (see Figure 7-1) and in this study (see Figure 7-6). What could account for this
activation? Two reasonable possibilities are: (a) inactive protein could be competed
preferentially to active Fe protein; and (b) salts could increase the rate of complex
dissociation.

7.4.2.1. Competing Away Inactive Protein. Inactive Fe protein, Ri, interacts with

active MoFe protein with the same binding constant as R0D2 in the T&L model (7). As
much as 55% of Kp2 is in an inactive conformation (7). The proportion of inactive Av2
in equilibrium with the active conformation is not known, but is believed to be much
lower. Salts competing away Ri preferentially to R1T2 would enhance activity, but
limited to the extent that R1T2 is also inhibited and to the extent that a particular
organism’s Fe protein is in the inactive conformation. Because the inactive and active
conformations of Fe protein are interchangeable (115), there is no way to separate them
physically and assess the effects of salt on each individually.
Christiansen et al showed that there is an interaction between inactive apo-MoFe
protein, Ei, and Fe protein, though somewhat weaker than that of holo-MoFe protein for
Fe protein (219). Salt inhibition of complex formation is more likely to compete away
this weaker interaction of Fe protein for Ei as opposed to active E. The activating effect

305

on overall activity of releasing Fe protein bound up by Ei would be minimal under
conditions of excess Fe protein and/or when there is a low level of Ei.

7.4.2.2. Accelerating Complex Dissociation. Alternatively, salts could activate

nitrogenase by increasing the rate of dissociation of the nitrogenase complex by
weakening the complex through charge screening. This should both slow complex
formation and speed complex dissociation. Dissociation is rate limiting, so charge
screening affecting this step should be readily apparent under conditions of high electron
flux.
Similarly, the electron transport chain in plant mitochondria is stimulated by
charge screening that increases the rate of dissociation of cytochrome c from the
membrane (330).
This concept applied to nitrogenase is the best explanation for the activation in
Figures 7-6 through 7-8. The alternatives—e.g. preventing MoFe inhibition or inhibiting
inactive protein—either do not apply outright or could not account for the large degree of
activation: a 50% increase in Figure 7-6 at 40 oC; a 5-fold increase in H2 production and
the induction of C2H2 reduction in Figure 7-7; or the ~25-fold activation of ATPindependent AvE-CpR1 activity in Figure 7-8.

7.4.2.3. Charge Screening of the Fe Protein-MoFe Protein Interface vs. Inhibition
of Nucleotide Binding. That the MoFe protein-Fe protein interface is the likely site of

activation by charge screening is supported by the observation that individual
contributions to nitrogenase complex stability are found in key residues at the Av1-Av2
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interface that in Av2 mutants show an increased susceptibility to salt inhibition, including
R100H (160) and R140Q and K143Q (326).
With this new insight on the role of salts binding at the MoFe protein-Fe protein
interface, questions arise as to the importance of salt inhibition of nucleotide binding to
the nitrogenase complex. After all, screening of MoFe protein-Fe protein interactions is
sufficient to explain both activation and inhibition of activity in Figure 7-8.
The role of salt inhibition of nucleotide binding is best seen in a study in which
Duyvis et al determined the effects of salt on inter-protein electron transfer measured in
the stopped-flow (166). In one syringe were Av1, Av2 and DT. In the other were salt
and MgATP. This measure of salt inhibition targets nucleotide addition to ER1 rather
than formation of ER1 from E and R1. Disruption of ATP binding could only ever result
in nitrogenase inhibition since ATP-independent electron transfer is so slow.
Cooperative inhibition at this site is intuitive since nucleotides bind cooperatively to
nitrogenase (101). Duyvis et al determined that the Hill coefficient of salt inhibition of
primary electron transfer is 2.1 (166).
A Hill coefficient of two may be a signature of nucleotide inhibition on the
nitrogenase complex. If so, it is interesting that the data at 12.5 oC in Figure 7-6 fit to a
Hill coefficient of 2.0. Activation by charge screening that becomes more prominent at
higher temperature in Figure 7-6 would increase the apparent cooperativity, counteracting
nucleotide inhibition at low salt, then inhibiting with nucleotide inhibition at higher salt.
Thus, the Hill coefficient of salt inhibition of nitrogenase activity at 30 oC is 3.0-3.5 (93,
160).
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Interestingly, salts inhibit assays with R100H-Av2 at a reported Hill coefficient of
1.9 (160), suggesting that inhibition of nucleotide binding is targeted in this case and that
salt activation is no longer a factor. In addition, the nitrogenase recently characterized
from Gluconacetobacter diazotrophicus was very sensitive to salt inhibition (331), and fit
to a Hill coefficient of 2.0 (data analyzed from Fig. 6 of that reference).
On the other hand, the patterns of salt inhibition of the R140Q and K143Q Av2
mutants fit to Hill coefficients of 3.5 and 5.1, respectively (see Figure 7-9). Interestingly,
activation is still observed—see K143Q in Fig. 3 of ref (326).
That Arg-140 of Av2 appears to be required for salt activation under high-flux
conditions may be a consequence of its role, as stated by Wolle et al, to stabilize ER1T2
and destabilize ER0D2 (160). On the other hand, since mutating either Arg-140 or Lys143 does not abolish activation and/or have a high degree of apparent cooperativity, these
residues probably contribute only minimally to differences in complex stability in ER1T2
vs. ER0D2. Other clues may be found with differences between Av2 and Gd2.
Study of the nature of salts binding to nitrogenase to activate by charge screening
at the MoFe protein-Fe protein interface is difficult when nucleotides are present because
of the simultaneous effect of salt inhibition of nucleotide binding. This difficulty was
bypassed by the study of nucleotide-independent salt effects, such as with Av1-Cp2 and
Av1-L127Δ-Av2 in Figure 7-8. Charge screening is sufficient to account for both
activation and inhibition. The activation portions of all the curves in Figure 7-8 are
concave-up for low salt concentrations. This is particularly clear with Av1-Cp2 in the
absence of nucleotides, since activation occurs in dramatic fashion above about 250 mM
NaCl.
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There are two possibilities for why activation by charge screening is concave-up:
cooperative binding of salt particles; and independent binding of salt particles that exert a
synergistic effect to destabilize the nitrogenase complex. Cooperativity is difficult to
rationalize in terms of the structures of the nitrogenase proteins at the MoFe protein-Fe
protein interface (160).
On the other hand, synergistic charge screening can be rationalized in terms of the
structure of nitrogenase. Specifically, the dimeric structure of the Fe protein raises some
interesting questions as to the role of the individual subunits in complex formation. The
heterodimeric [Asp(39)/Asn(39)] Fe protein mutant forms a tight complex with MoFe
protein because of a mutation in only one subunit (170). Thus, there is the possibility that
salts modulating the interaction of a single subunit of wild-type Fe protein with MoFe
protein would not prevent complex formation, only modulate its stability. Thus, salt
inhibition of this system should be synergistic, and the activation portion of an activity
vs. salt curve should be concave-up, as is seen in Figure 7-8.

7.4.2.4. Unequal States of Fe Protein Intermediates through Charge Screening.

The nature of synergistic charge screening depends critically on the state of nitrogenase
when the complex is initially screened. Dissociation of AvE-CpR0D2 is rate-limiting in
two separate assay sets: the AvE-CpR1T2 data in Figure 7-7, and the AvE-CpR1D2 data
set in Figure 7-8. However, there is a huge discrepancy in the activities of each. This
difference is most easily attributed to the different charge screening interactions of AvECpR1T2 as opposed to AvE-CpR1D2.
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We use the notation AvE-Sj,ATP-CpR1T2 and AvE-Sj,ADP-CpR1D2 to distinguish
between the ways that salts screen the initial complex. Whereas only the level of
reduction of Fe protein changes with AvEn-Sj,ADP-CpR1D2 → AvEn+1-Sj,ADP-CpR0D2,
ATP hydrolysis on AvE-Sj,ATP-CpR1T2 produces more drastic conformational changes
upon formation of AvEn+1-Sj,ATP-CpR0D2. Hence, different AvE-CpR interactions are
screened in AvE-CpR0D2 depending on the initial formation of the complex.
This reasoning is readily applicable to the homologous Av cross as well. Burns et
al observed that AvER0 formed a complex in centrifugation studies in 200 mM NaCl

(92). The addition of MgADP weakened this complex somewhat, but the addition of
MgATP completely disrupted complex formation. This observation may seem
counterintuitive at first since AvER0T2 should be in one of several predicted states:
ER0T2, ER0, or ER0D2. ER0 and ER0D2 were both independently characterized, and
ER0T2 is a short-lived tight complex. However, when we consider the possibility of ESj,ATP-R0T2 → E-Sj,ATP-R0D2, then it is clear why MgATP disrupts complex formation; ESj,ATP-R0D2 is much more unstable than E-Sj,ADP-R0D2.
Thus, salts activate the homologous cross in Figure 7-6 effectively because the
low level of salt that only modulates the stability of E-Sj,ATP-R1T2 greatly disrupts the
stability of E-Sj,ATP-R0D2 formed upon ATP hydrolysis. So it is of particular importance
to note that temperature-dependent activation of nitrogenase in Figure7-6 is relevant to in
vivo conditions—very high flux, 30-40 oC, and low salt concentrations.
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7.5. Summary and Conclusions
Interactions between the nitrogenase components and between Fe protein and
nucleotides (MgADP and MgATP) are crucial to catalysis. It has been well established
that salts are inhibitors of nitrogenase catalysis that target these interactions. However,
the implications of salt inhibition are often overlooked.
We reexamined salt inhibition and identified patterns of activation of nitrogenase
by salt through two different mechanisms: (a) relief of MoFe inhibition; and (b)
accelerating the rate-limiting step in catalysis. The first of these is easily understood in
terms of Scheme 7-1, which is a useful framework for discussing gross interactions of Fe
protein with nucleotides and MoFe protein, trivializing many previously baffling
observations of nitrogenase behavior with new insights on the mechanisms of salt effects.
An emphasis has been placed on the importance of not only tracking salt effects when
there is a change in salt concentration, but also when any component of the nitrogenase
assay is changing concentration, whether by dilution, or variation of a single
component—MoFe protein, Fe protein, nucleotide, reductant, etc.
With the new insights from salt activation under high-flux conditions, a novel
mechanism of salt-protein interactions is proposed, which is that there are changes in the
rates of elementary steps in catalysis by synergistic charge screening of Fe protein-MoFe
protein interactions. This type of salt activation is such an important effect because it
occurs for sufficiently low salt concentrations that it is physiologically relevant and
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because it targets the rate-limiting step of nitrogenase complex dissociation, even under
high-flux conditions relevant to N2 fixation.
Further confirmation of this explanation was examined by demonstrating that
tight complexes that have previously displayed little or no activity due to the inability of
Fe protein to dissociate are activated by the presence of salt. This occurs for the
combination Azotobacter vinelandii MoFe protein with: (a) the L127Δ Fe protein; and (b)
Clostridium pasteurianum Fe protein. The curvature of activation vs. salt implies a

synergistic salt-protein interaction.
It is not our intention to provide a quantitative model of the nitrogenase salt effect
on Scheme 7-1 at this time. Rather, this study outlines features that are critical to such a
model. Aspects of both the Deits-Howard and Thorneley-Lowe models are critical to our
understanding of salt effects. A comprehensive kinetic model of nitrogenase must
account for salt effects to be quantitative under a variety of experimental conditions.
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Appendix A
The Nonlinear Nelder-Meade Simplex Curve-Fitting
Algorithm in Mathematica

A curve fitting function was encoded into Mathematica for fitting computer
models to data. It was equipped with a routine to estimate standard errors in the fitting
parameters, such as protein concentrations in T&L duplication simulations or rate
constants in simulations of new data.
The method chosen to fit the nitrogenase model to data was the Nelder-Mead
simplex method of nonlinear least squares (332). Many fitting algorithms require the
fitting function to be differentiable, whereas the simplex does not. Since the simulation
of nitrogenase is solved numerically, any fitting method that requires derivatives in terms
of each fitted parameter would not have been possible to implement. The simplex
method is also well characterized in the literature, and it is easy to estimate errors of fit
parameters.

A.1. The Simplex
The simplex is a geometric figure in curve-fitting space. The simplex algorithm
moves the simplex around in this space to minimize the differences between the curve fit
and the data, like an amoeba seeking lower ground.
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To initiate the simplex, the user inputs an initial guess for the values of each of
the fitting variables, and a value for the overall size of the simplex. The choices for these
parameters are crucial to the efficiency and success of the fit. An initial guess that is far
away from the actual minimum will require the simplex to take additional steps to find
the global minimum; or worse, the algorithm may become trapped in a local minimum.
If the initial guess for the simplex size is too large, it may take longer to find a minimum,
and a simplex that is too small may become more easily trapped in a local minimum.
The simplex algorithm will find a minimum, but there is no guarantee that the
minimum is the global minimum. To ensure that the minimum is global, the simplex is
restarted after it finds a minimum. If the subsequent minimum is within some userdefined threshold of the first, then it is accepted. Otherwise, the simplex is restarted
again, and so on until a viable solution is found, or a user-defined iteration limit is
reached. Once a viable solution is found, standard errors in the fitting parameters are
determined.
Let’s now take a more detailed look at the simplex method. The algorithm seeks
to minimize the function (333)

f (x ) =

ΣiN= 1 ( yi,obs − yi,calc )2
N −1

,

(A-1)

where f (x) is the residual between the N observed data points, yi,obs, and the calculated
points, yi,calc. The objective function, f, corresponds to coordinates, x, for the fitting
parameters, or independent variables. For a curve-fitting problem with n unknowns,
there are n dimensions in the curve fitting space. The simplex is an (n + 1) × (n + 1)
matrix with n + 1 vertices. Each vertex, xi, has an associated value for the objective
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function f (xi). For a problem in two dimensions—or two fitting parameters—the simplex
matrix, S, would appear as:

⎛ x1,1
⎜
S = ⎜ x2,1
⎜x
⎝ 3,1

x1, 2
x 2, 2
x3, 2

f ( x1 ) ⎞
⎟
f ( x2 ) ⎟.
f ( x3 ) ⎟⎠

(A-2)

Before the simplex algorithm can function, an initial simplex must be
characterized. This can be done manually in my Mathematica program by simply
inputting all the coordinates of the simplex, xi,j. Alternatively, an initiating function can
be used to automate this process. Specifically, the initiating function accepts a single
point for the user’s initial guess, x1, along with the size of the simplex. Then the function
automatically generates the rest of the vertices of the simplex matrix. A reasonable
choice for the simplex size is 0.2—that is, the function generates points within 20% of
the value chosen for the initial guess, estimating that the actual value of each fitting
parameter is within 20% of the estimate. So for a two-dimensional problem with a
simplex size of 0.2, the initiated simplex would look like

⎛ x1,1
x1, 2
⎜
S = ⎜1.2 x1,1
x1, 2
⎜ x
1.2 x1, 2
⎝ 1,1

f ( x1 ) ⎞
⎟
f ( x2 ) ⎟.
f ( x3 ) ⎟⎠

(A-3)

This simplex in two dimensions is shown graphically Figure A-1. It may be that
x1 is not so good a point as the others—f (x1) may be larger than f (xi >1)—so the vertices

are sorted from lowest to highest f (xi) such that in the sorted simplex,

f (x1) < f (x2) < · · · < f (xn+1).
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(A-4)

Initial Simplex

var-2

x1

x3

Sorting
Function

var-2

x2

Sorted Simplex

x3

var-1

x1

x2

var-1

Figure A-1. Sorting the simplex. Simplified representation of the automated generation
of simplex vertices and the result of sorting these in order of increasing f.

In the example in Figure A-1, the initial value of x2 turns out to be the worst point on the
simplex.
After the vertices of the simplex are sorted in order of decreasing value, the
simplex algorithm seeks to replace the worst point—x3 in this example in two
dimensions—with a point of the form

x(δ) = x̄ + δ ( x̄ − xn+1),

(A-5)

where x̄ is the centroid of all points from x1 to xn:

1 n
x = ∑ xi ;
n i =1

(A-6)

and where x(δ) is a function of some operation, δ, such as reflection, expansion, outside
contraction, or inside contraction with typical values

{δr, δe, δoc, δic} = {1, 2, ½, −½}
used on the right side of Equation A-5. The only requirement for these values is that
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–1 < δic < 0 < δoc < δr < δe.
The simplex algorithm consists of determining which δ operations are to be performed
under certain circumstances to move the simplex to minimize f (x). This is achieved by
comparing f values of x(δ) operations with each other and with f values of the current
simplex.

A.2. Remediation of Stagnation

During the course of these operations, it is possible for the simplex to stagnate to
a non-optimal point. An improvement to the Nelder-Mead simplex was devised to
monitor the progress of the simplex and restart in a new orientation if necessary (332). A
simplex gradient is determined for each iteration in the algorithm and compared to the
gradient of the initial sorted simplex. If the average of objective functions for a given
simplex is

1 n +1
f =
∑ fi ,
n +1i =1

(A-7)

where fi = f (xi), then we use the failure of condition

f k +1 − f k < −α

σ 0+
G0

Gk

2

(A-8)

to determine that the simplex is stagnating. Here, the current iteration is the (k + 1)th
iteration of the simplex algorithm; α is some constant (10−4 in my program); σ +0 is
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σ+ = Max[|| x1 − xi ||], 2 < i < n + 1

(A-9)

for the initial simplex, S0; ||v|| represents the norm of vector v, or ||v|| = √ (v · v) and
||v||2 = v · v; and Gi is the gradient of the ith iteration of the simplex. The simplex gradient
is derived from two additional terms: the n × n matrix of simplex directions, Di

⎛ x2 − x1 ⎞
⎟
⎜
x
x
−
⎟
⎜
Di = D( Si ) = ⎜ 3 1 ⎟;
...
⎟⎟
⎜⎜
x
x
−
n
+
1
1
⎠
⎝

(A-10)

and the vector of objective function differences, ϕ i

⎛ f 2 − f1 ⎞
⎜
⎟
−
f
f
⎜
⎟
ϕ i = ϕ ( Si ) = ⎜ 3 1 ⎟ .
...
⎜⎜
⎟⎟
−
f
f
⎝ n +1 1 ⎠i

(A-11)

From these we calculate the simplex gradient, Gi

Gi = Di−T ϕ i .

(A-12)

318

A.3. The Simplex Algorithm
The essence of the simplex algorithm is (332):

A.3.1. While fn+1 − f1 > τ

(A-13)

A.3.1.1. Compute x̄, xr = x(δr), and fr = f (xr).
x2
xr
x̄
Figure A-2. Computing a reflection.

x3

x1

A.3.1.2. Reflect. If f1 < fr < fn, then replace xn+1 with xr and go to step 6.
x2

xr
Figure A-3. Reflect.

x1
A.3.1.3. Expand. If fr < f1, compute xe = x(δe), and fe = f(xe). If fe < fr, then

replace xn+1 with xe and go to step 6; otherwise replace xn+1 with xr and go to step 6.
xe

x2

xr

xe

x2
Figure A-4. Expand.

x̄
x3

x1

x1
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A.3.1.4. Outside Contraction. If fn < fr < fn+1, compute xoc = x(δoc), and foc = f(xoc).

If foc < fr, then replace xn+1 with xoc and go to step 6; otherwise go to step 7.

x2

xr

x2

xoc

x̄

xoc
Figure A-5. Out Contract.

x3

x1

x1

A.3.1.5. Inside Contraction. If fn+1 < fr, compute xic = x(δic), and fic = f(xic). If fic

< fn+1, then replace xn+1 with xic and go to step 6; otherwise go to step 7.
x2

xr

x2
Figure A-6. In Contract.

x̄
xic
x3

xic
x1

x1

A.3.1.6. Oriented Restart. Test the condition in Equation A-8.

If f k +1 − f k < −α

σ 0+
G0

2

Gk , then go to step 8. Otherwise, calculate a new

simplex by keeping the best vertex, x1, and for i < 2 < n + 1,

xi = x1 + βi-1 ei-1,

(A-14)

where ej is the jth coordinate vector,

1 ⎧σ k− Sign[Gk [[ j ]]],
βj = ⎨ −
2 ⎩σ k ,
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Gk [[ j ]] ≠ 0
,
Gk [[ j ]] = 0

(A-15)

σ− = Min[|| x1 − xi ||], 2 < i < n + 1,

(A-16)

and Gk[[j]] is the jth element of gradient Gk. Note that only the sign of this value
is actually used in Equation A-15. As an example in two dimensions, the
simplex created by an oriented restart looks like

⎛
x1,1
⎜
⎜
S = ⎜ x1,1 ± 1 σ k−
2
⎜
x1,1
⎜
⎝

x1, 2
x1, 2
x1, 2 ± 1 σ k−
2

⎞
f ( x1 ) ⎟
⎟
f ( x2 ) ⎟ .
⎟
f ( x3 ) ⎟
⎠

(A-17)

Graphically, then, an oriented restart can take on several different looks as in
Figure A-7. Use this new simplex to calculate replacement values for σ+0 and
G0, essentially restarting the algorithm. Go to step 8.
Figure A-7. Oriented restart.

x2

OR
x3

x1

OR
OR

OR
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A.3.1.7. Shrink. Rarely, steps using operations on x(δ) fail to produce an

improvement to the simplex. If so, then a new simplex is generated by keeping the best
vertex, x1, and for i < 2 < n + 1, xi,new = x1 + ½ (xi,old − x1). Corresponding values of fi are
then computed to complete the new simplex. Go to step 8.
x2
x1 + ½ (x2 − x1)
x1 + ½ ( x3 − x1 )
Figure A-8. Shrink.

x3

x1

x1

A.3.1.8. Sort. Sort the vertices of the simplex matrix from lowest to highest f so

that Equation A-4 holds.

A.3.2. Conditions
The simplex algorithm concludes by satisfying some user-defined conditions:
when fn+1 − f1 exceeds some number (Equation A-13); when the total number of iterations
exceeds some number; or when the number of oriented restarts exceeds some number.

A.3.3. Restarting
There is no guarantee of the simplex finding the global minimum, only a local
minimum. Therefore, the algorithm is restarted using the initiating function, with x1 from
the previous run, and with a smaller initial simplex size for each restart. Once one run
differs insignificantly from a previous run, or the number of restarts exceeds some
number, the program is completely terminated.
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A.3.4. Errors
Estimate errors εi in the calculated values for each of the n fitting parameters, ai
(333):

ε i± =

f (ai )
(0.001 ai ), 1 ≤ i ≤ n.
f (ai ± 0.001 ai ) − f (ai )

(A-18)

The overall error for a given parameter, εi, is the average of the errors ε+i and ε−i .

A.4. An Example
Let’s look at how the simplex algorithm looks in a real example from one
iteration to the next. In this example, we seek to minimize the curve shown in three
dimensions in Figure A-9, and in density-contour style in two dimensions in Figure A-10.
Overlaid in Figure A-10 is the simplex from one iteration to the next. In Figure A-10,
the coordinates of the initial simplex were manually input. The algorithm proceeds to
find the function minimum.

Figure A-9. 3D view of
curve for optimization.
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Figure A-10. Two-dimensional simplex problem with arbitrary units. Initial simplex
in dark blue, and successive iterations in warmer, lighter colors. The smallest, white
simplex in the box is the same dark blue one in Figure A-11.
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Figure A-11. Continuation of the minimization. The same problem shown in Figure
A-10 until the simplex has solved the fitting parameters to within less than ± 0.6 standard
deviation.

325

A.5. Mathematica Code for the Simplex Algorithm
initialize x0_, size_ : Module i, n, adder ,
i 1;
n Length x0 ;
;
simprogress
;
x1 Flatten Append x0, f x0
While i n,
adder Table 0, j, n ;
adder ReplacePart adder, size x0 i , i ;
xi 1 Append x0 adder, f x0 adder ;
i
;
Table xi, i, n 1
;
sorter matrix_ : Module n, i, operatingtable, postop ,
n Length matrix ;
i 1;
While i n,
reversxi Reverse Extract matrix, i ;
i
;
operatingtable Table reversxi, i, n ;
postop Sort operatingtable ;
i 1;
While i n,
xi Reverse Extract postop, i ;
i
;
Table xi, i, n
;
newX _ : Module n ,
n Length simplex
1;
1
centroid
Take xn 1 , n
;

326

directions matrix_ : Module n, i ,
1;
n Length matrix
i 1;
While i n 1,
xi Extract matrix, i ;
i
;
i 1;
While i n,
Take x1, n ;
directi Take xi 1 , n
i
;
Table directi, i, n
;

diameters matrix_ : Module n, i ,
n Length matrix ;
i 1;
While i n,
directi Extract matrix, i ;
powerdiami directi .directi ;
diameteri
powerdiami;
i
;
Table diameteri, i, n
;

differences matrix_ : Module n, objfuncts, i ,
n Length matrix ;
objfuncts Part matrix, All, n ;
i 1;
While i n 1,
diffi objfuncts i 1
objfuncts 1 ;
i
;
Table diffi, i, n 1
;
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gradient matrix_ : Module v,
,
v Inverse Transpose directions matrix
differences matrix ;
v.
;

main

;

_, itermax_, restartmax_ :

Module

grad0, normgrad0, diam0, n, , gradf, norm2gradf, fx1, fxn,

fxnp1, differ, condition, xr, fxr, xe, fxe, xoc, fxoc, xic, fxic,
diamin, e2, f2, g2, restart, shrink ,
orientedrestart 0.;
iterations 0.;
refl 0.;
expan 0.;
outcon 0.;
incon 0.;
shk 0.;
grad0 gradient simplex ;
normgrad0
grad0.grad0 ;
diam0 Max diameters directions simplex
10 ^ 4 diam0 normgrad0;
gradf gradient simplex ;
norm2gradf gradf.gradf;
n Length simplex
1;
fx1 Extract x1, n 1 ;
fxn Extract xn, n 1 ;
fxnp1 Extract xn 1, n 1 ;
While fxnp1 fx1
,
restart 0;
shrink 0;
centroid 0;
i 1;
While i n,
coordinatesxi Take xi , n ;
centroid centroid coordinatesxi ;
i
;
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;

centroid centroid n;
xr newX 1 ;
fxr f xr ;
If fx1 fxr fxn,
differ fxr fxnp1;
norm2gradf ;
condition
If differ condition, restart 1; Goto e2 ;
;
xn 1 Flatten Append xr, fxr
spogressspog xn 1 ;
simplex Table xi, i, n 1 ;
refl ;
Goto g2 ;,
If fxr fx1,
xe newX 2 ;
fxe f xe ;
If fxe fxr,
differ fxe fxnp1;
condition
norm2gradf ;
If differ condition, restart 1; Goto e2 ;
;
xn 1 Flatten Append xe, fxe
spogressspog xn 1;,
differ fxr fxnp1;
norm2gradf ;
condition
If differ condition, restart 1; Goto e2 ;
xn 1 Flatten Append xr, fxr
;
spogressspog xn 1;
;
simplex Table xi, i, n 1 ;
expan ;
Goto g2 ;,
If fxn fxr fxnp1,
xoc newX 1 2 ;
fxoc f xoc ;
If fxoc fxr,
differ fxoc fxnp1;
condition
norm2gradf ;
If differ condition, restart 1; Goto e2 ;
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xn 1

Flatten Append xoc, fxoc
;
spogressspog xn 1 ;
simplex Table xi, i, n 1 ;
outcon ;
Goto g2 ,
shrink 1;
Goto f2 ;
;,
xic newX 1 2 ;
fxic f xic ;
If fxic fxnp1,
differ fxic fxnp1;
condition
norm2gradf ;
If differ condition, restart 1; Goto e2
xn 1 Flatten Append xic, fxic
;
spogressspog xn 1 ;
simplex Table xi, i, n 1 ;
incon ;
Goto g2 ,
shrink 1;
Goto f2 ;
;
;

;

;
;
Label e2 ;
If restart 1,
shrunkx1 x1;
coordinatesx1 Take x1 , n ;
diamin Min diameters directions simplex
;
i 1;
While i n,
gradientfi Extract gradient simplex , i ;
0, Sign gradientfi , 1 ;
i 1 2 diamin If Abs gradientfi
coordvecti PadLeft 1 , n, 0 , n i ;
newcoori 1 coordinatesx1
i coordvecti ;
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shrunkxi 1 N Flatten Append newcoori 1, f newcoori 1
spogressspog shrunkxi 1 ;
spog ;
i ;
;
simplex Table shrunkxi, i, n 1 ;
;
If orientedrestart restartmax 1, Break
grad0 gradient simplex ;
grad0.grad0 ;
normgrad0
diam0 Max diameters directions simplex
10 ^ 4 diam0 normgrad0;
orientedrestart ;
spog spog 1;
Goto g2 ;

;

;

;
Label f2 ;
If shrink 1,
i 2;
coordinatesx1 Take x1 , n ;
While i n 1,
coordinatesxi Take xi , n ;
shrinkcoori coordinatesx1 1 2 coordinatesxi
xi Flatten Append shrinkcoori , f shrinkcoori
spogressspog xi ;
i ;
spog ;
;
simplex Table xi, i, n 1 ;
shk ;
Goto g2 ;
;
Label g2 ;
simplex sorter simplex ;
iterations ;
If shrink 1, spog
;
fx1 Extract x1, n 1 ;
fxn Extract xn, n 1 ;
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coordinatesx1 ;
;

fxnp1 Extract xn 1, n 1 ;
gradf gradient simplex ;
norm2gradf gradf.gradf;
If iterations itermax 1, Break
;
;

x01

;

20., 20., 20. ;

f x_ : N

x

1

20 2

x

2

20 2

x

20 2

3

size 0.2;
simplex initialize x01, size ;
simplex sorter simplex ;
n Length simplex
1;
spog 1;
While spog n 1,
spogressspog xspog ;
spog
;
0.0000001;
j 1;
While j

5,

main , 500, 3 ;
x0j 1 Take x1 , n ;
diffx0 x0j 1 x0j;
normx0
diffx0.diffx0 ;
If normx0 0.00001, Break
;
size size 0.9;
simplex initialize x0j 1, size ;
j

;

i 1;
avesimplex x1;
While i n,
avesimplex avesimplex xi 1 ;
i ;
;
simplexprogress N Table spogressi,
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i, spog

1

;

;

MatrixForm N simplex
avesimplex
avesimplex
;
n 1
favesimp Extract avesimplex, n 1 ;
cooravesimp Take avesimplex, n ;
trialavesimplex Flatten Append cooravesimp, f cooravesimp
ftrialavesimp Extract trialavesimplex, n 1 ;
Abs ftrialavesimp favesimp
avesimptest
;
ftrialavesimp
, avesimplex, x1
avesimplex If avesimptest
favesimp Extract avesimplex, n 1 ;
i 1;
coorsx1 Take x1 , n ;
While i

n,

ai Extract coorsx1 , i ;
coordinatesai ReplacePart coorsx1 , 1.001 ai , i ;
coordinatesai ReplacePart coorsx1 , 0.999 ai , i ;
fai f coordinatesai ;
fai f coordinatesai ;
i

favesimp
fai favesimp

0.001 ai ;

i

favesimp
fai favesimp

0.001 ai ;

i

;

errors

i

i

, i, n
2
iterations, refl, expan, outcon, incon, shk, orientedrestart, j
20.
20.
20.
20.

Table

20.
20.
20.
20.

20.
20.
20.
20.

0.
7.77825 10 8
8.52919 10 8
9.5402 10 8

20. , 20. , 20. , 0.
0., 0., 0.
109. , 37. , 0., 30. , 40. , 0., 2., 1
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Appendix B
Mathematica Program for the Thorneley and Lowe Model
This material is from the supplementary electronic material from ref (10) and is geared
towards readers with at least preliminary experience with Mathematica. We have made
an attempt to use the most straight-forward terminology of variables possible (consistent
with the primary publication), along with commentary set off by (* commentary *) when
imbedded in code.

B.1. General Model Setup
The differential equations provided in this supplementary material are comprehensive of
the original/classical T&L model. The following cell loads the rate constants.
constants x_ :
k1 5. 107;
k 1 15;
k2 200;
k3 4.4 106;
k 3 6.4;
k4 3. 106;
k6 1.2 109;
k 6 1.75;
k7 250.;
k8 8.;
k9 400.;
k10 4. 105;
k 10 8. 104;
k11 2.2 106;
k 11 3. 106;
TK

273.15 23;
Note that all of the T& L simulations
at 23 o C.
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were performed

T

TK 100;
T is employed below in the calculation
of the solubility of N2 and H2 as a function of
temperature .
H2O 0.99821 0.000256 TK 293.15 ;
The following are terms for calculating the molar
concentration of gas in the reaction fluid ,
from the CRC Handbook of Chemistry and Physiscs .
67.3877;
N2
86.3213;
N2
24.7981;
N2

kHN2

N2
T

N2

XN2

XN2
1

XN2

N2 Log T
H2O

1000

;
1
;
18.0152

The corresponding Henry ' s Law constant at 23 o C is
0.0006737 M a. The less rigorous generic textbook
value is 0.0006399 M a. The differences between
simulations performed with one constant as opposed
to the other are miniscule to say the least .
H2
H2
H2

48.1611;
55.2845;
16.8893;

kHH2

H2
T

H2

XH2

XH2
1

XH2

H2 Log T
H2O

1000

;
1
;
18.0152

The next cell encodes a function with input variables for the most common types of
experimental parameters, e.g. initial molar concentrations of protein and DT; and

pressures of gases in atm. An exception to this is the variable active, which is
actually the ratio of active to total Fe protein, the default value for Kp2 being 0.45 for
45%-active Kp2. These variables to not include nucleotide concentrations, which are
assumed to be far in excess with ATP.
The function is instructed to take these initial values and solve a list a differential
equations describing the kinetic schemes of the model. There are so many differential
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equations that a single simulation may take several seconds to perform. Cutting down the

time variable tmax, also encoded here as an input variable, helps to decrease simulation
time.
Note that some of the differential equations are written in terms of conservation of mass
to constrain the system to realistic values.
All species that are generated during the course of the simulation are boxed. Note that
the box is part of the variable's name, which allows for more readable names. For

instance, Mathematica would read the notation H 2 D 0 as species H 2 times species

D

0. On the other hand,

H

2 D 0 is read as a single variable, representing the

complex formed between doubly reduced MoFe protein in the H2 -evolving pathway and
oxidized Fe protein bound to ADP.
simulation
CN2
CH2

0_,

0_,

active_, DT0_, PN2_, PH2_, tmax_ :

kHN2 PN2;
kHH2 PH2;

equations
HSO3 0
0 eD 0

D 0 0
0

0

H 1 0

H 1 eD 0 0

H 2D 0 0

H 2T 1 0

H 4 0
N 3D 0 0
N 4 0

N 4 i 0

N 4 eD 0 0
N 5T 1 0

N 5 eD 0 0

N 6D 0 0

N 6T 1 0

N 7 i 0
NH3 0

N 7D 0 0
H2 0

H 3 eD 0 0
N 3 0

N 5 i 0

N 5D 0 0

N 6 eD 0 0

0.0,
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N 3 4 eD 0 0

N 4T 1 0

N 6 0
N 7T 1 0

N 3 i 0
N 3 4 0

N 3 4T 1 0

N 4D 0 0

N 5 0

H 3 0

N 3 eD 0 0

N 3 4D 0 0

0

H 2 i 0

H 3T 1 0
H 4D 0 0

0T 1

H 1D 0 0

H 2 eD 0 0

N 3T 1 0

N 3 4 i 0

0

H 2 0

H 3D 0 0
H 4 i 0

0D 0

H 1 i 0

H 1T 1 0
H 3 i 0

0

i

N 6 i 0
N 7 0
N 7 eD 0 0

S2 O4 0

DT0

SO2 0

k 6
k6

0

0

0,

i

0

1

T 1 0

k 6 2
k6

k 6
k6
k 6 2
k6

active

2,

k 6
DT0 ,
k6

4

0,

active 0,

2

S2 O4 ' t

k6 SO2 t

SO2 ' t

2 S2 O4 ' t

HSO3 ' t

k4 D 0 t

i

k 6
DT0
k6

4

k 6 S2 O4 t ,
HSO3 ' t ,
SO2 t ,

' t
0

i

' t

H 1 i ' t

H 2 i ' t

H 3 i ' t

H 4 i ' t

N 3 i ' t

N 3 4

i

N 5 i ' t

N 6 i ' t

N 7

' t

i

' t

N 4

i

' t

,

D 0 ' t
T 1' t

0D 0

' t

0T 1

H 1D 0 ' t

H 1T 1 ' t

H 2T 1 ' t

H 2 eD 0 ' t

H 3 eD 0 ' t
N 3D 0 ' t
N 3 4T 1 ' t
N 4T 1 ' t
N 5 eD 0 ' t
N 7D 0 ' t

' t

0 eD 0

' t

H 1 eD 0 ' t

H 2D 0 ' t

H 3D 0 ' t

H 3T 1 ' t

H 4D 0 ' t
N 3T 1 ' t

N 3 eD 0 ' t

N 3 4 eD 0 ' t

N 3 4D 0 ' t

N 4D 0 ' t

N 4 eD 0 ' t

N 5D 0 ' t

N 5T 1 ' t

N 6D 0 ' t

N 6T 1 ' t

N 6 eD 0 ' t

N 7T 1 ' t

N 7 eD 0 ' t
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,

T 1 ' t
k 1

k4 D 0 t
T 1 t

0

SO2 t

H 1T 1 t

H 2T 1 t

N 3T 1 t

N 3 4T 1 t

N 6T 1 t

N 7T 1 t

H 3T 1 t

N 4T 1 t

N 5T 1 t

k1 T 1 t
t

0

H 1 t

N 4 t
0

H 2 t

N 5 t

N 6 t

N 3 t

N 7 t

N 3 4 t

,

' t
0

i

' t

0D 0

H 1 ' t

' t

0T 1

H 1 i ' t

H 1 eD 0 ' t

H 2 ' t

H 2

H 2 eD 0 ' t

H 3D 0 ' t

H 3T 1 ' t

N 4

N 4 eD 0 ' t

N 5D 0 ' t

N 5T 1 ' t

i

' t

k3

t

0

i

t

0

t

D 0 t

0T 1

' t

k1

0

t

T 1 t

k 3

k3 H 1 t

k2

0

0 e
i

i

' t

' t

i

N 3 4 ' t
N 4D 0 ' t

N 5 ' t

N 5

N 6T 1 ' t

k 3

k3

H 1 ' t

' t

i

' t

N 6 ' t
N 6 eD 0 ' t

N 7T 1 ' t

,

' t

' t

N 3

N 7D 0 ' t

0D 0

0 eD 0

i

H 4 ' t

N 5 eD 0 ' t

N 6D 0 ' t

N 7 eD 0 ' t

H 3

N 3 4T 1 ' t

N 4 ' t

N 7 i ' t

H 2D 0 ' t

N 3 eD 0 ' t

N 4T 1 ' t

N 6 i ' t

' t

N 3 ' t

N 3 4D 0 ' t

N 3 4 eD 0 ' t

N 7 ' t

i

' t

H 1T 1 ' t

H 3 ' t

N 3T 1 ' t

N 3 4 i ' t

0 eD 0

H 3 eD 0 ' t

H 4D 0 ' t

N 3D 0 ' t

' t

H 1D 0 ' t

H 2T 1 ' t

H 4 i ' t

0

H 3 t

t

T 1 t

D 0 t

k 3
k 1
k 3

k 3

D 0 t

0

0 e

H 1

i
0

t ,

D 0 t ,

k2

0

T 1 t ,

D 0 t ,
i

t

H 1D 0 t

k 1 H 1T 1 t

k8 H 3 t ,
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k1 H 1 t

T 1 t

H 1 i ' t

k3 H 1 t

i

t

k 3 H 1

H 1D 0 ' t

k3 H 1 t

D 0 t

H 1T 1 ' t

k1 H 1 t

T 1 t

H 1 eD 0 ' t

H 2 ' t

k2 H 1 T 1 t

k 3 H 1 eD 0 t

k3 H 2 t

i

k9 H 4 t

t

k 3 H 1D 0 t ,
k 1

k2

H 1T 1 t ,

k 3 H 1 eD 0 t ,

k 3

D 0 t

H 2

t

i

H 2D 0 t

k 1 H 2T 1 t

k3 H 2 t

i

t

k 3 H 2

H 2D 0 ' t

k3 H 2 t

D 0 t

H 2T 1 ' t

k1 H 2 t

T 1 t

H 2 eD 0 ' t

k2 H 2 T 1 t

k 3 H 2 eD 0 t

k3 H 3 t

i

k8 H 3 t

k1 H 2 t

T 1 t

t

D 0 t

k3 H 3 t

i

t

D 0 t

H 3T 1 ' t

k1 H 3 t

T 1 t

k3 H 4 t

k2 H 3 T 1 t

i

t

k 3 H 2D 0 t ,
k 1

k2

H 2T 1 t ,

H 3

t

i

H 3D 0 t
k1 H 3 t

k 10 CH2 N 3 t ,

k3 H 3 t

k 3 H 3 eD 0 t

t ,

k 1 H 3T 1 t

H 3D 0 ' t
H 3 eD 0 ' t

i

k 3 H 2 eD 0 t ,

k 3

k10 CN2 H 3 t

H 3 i ' t

H 4 ' t

t ,

k7 H 2 t ,

H 2 i ' t

H 3 ' t

i

k 3

D 0 t

k 3 H 3

i

t ,

k 3 H 3D 0 t ,
k 1

k2

H 3T 1 t ,

k 3 H 3 eD 0 t ,

H 4

t

i

H 4D 0 t

k9 H 4 t

k11 CN2 H 4 t

k 3 H 4

t ,

k 11 CH2 N 4 t ,
H 4 i ' t
H 4D 0 ' t

k3 H 4 t
k3 H 4 t

i

t

D 0 t

i

k 3 H 4D 0 t ,
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T 1 t

N 3 ' t

k 3

N 3

k3 N 3 t

i

k10 CN2 H 3 t
N 3 i ' t

t

i

t

N 3D 0 t

D 0 t

k 1 N 3T 1 t
t

i

k 3 N 3

N 3D 0 ' t

k3 N 3 t

D 0 t

N 3T 1 ' t

k1 N 3 t

T 1 t

N 3 eD 0 ' t

k2 N 3 T 1 t

k3 N 3 4 t

t

i

k 3 N 3D 0 t ,
k 1

k 3

D 0 t

N 3 4

k3 N 3 4 t

i

t

D 0 t

N 3 4T 1 ' t

k1 N 3 4 t

T 1 t

N 3 4 eD 0 ' t

k2 N 3 4 T 1 t

k 3

N 4

k3 N 4 t

i

k11 CN2 H 4 t

t

t

i

D 0 t

i

t

D 0 t

N 4T 1 ' t

k1 N 4 t

T 1 t

k2 N 4 T 1 t

k 3
i

N 3 4 eD 0 t
t

k 1 N 5T 1 t

k 3 N 3 4D 0 t ,
k 1

k2

N 3 4T 1 t ,

k 3 N 3 4 eD 0 t ,

k1 N 4 t

k 11 CH2 N 4 t ,

k3 N 4 t

N 4 eD 0 ' t

t ,

i

k 1 N 4T 1 t

k3 N 4 t

N 5

N 3 4D 0 t

N 4D 0 t

N 4D 0 ' t

k 3

t

i

k 3 N 3 4

k3 N 3 4 t

N 5 ' t

N 3T 1 t ,

k 1 N 3 4T 1 t

N 3 4D 0 ' t

N 4 i ' t

k2

T 1 t ,

N 3 4 i ' t

N 4 ' t

t ,

i

k 3 N 3 eD 0 t ,

k 3 N 3 eD 0 t

k1 N 3 4 t

T 1 t

k 10 CH2 N 3 t ,

k3 N 3 t

N 3 4 ' t

k1 N 3 t

N 5D 0 t
k1 N 5 t

k 3 N 4

i

t ,

k 3 N 4D 0 t ,
k 1

k2

N 4T 1 t ,

k 3 N 4 eD 0 t ,

N 4 eD 0 t
k3 N 5 t
T 1 t ,
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i

t

D 0 t

T 1 t

N 5 i ' t

k3 N 5 t

t

i

k 3 N 5

N 5D 0 ' t

k3 N 5 t

D 0 t

N 5T 1 ' t

k1 N 5 t

T 1 t

N 5 eD 0 ' t

N 6 ' t

k2 N 5 T 1 t

k 3 N 5 eD 0 t

k3 N 6 t

i

k1 N 6 t

t

k 1

k 3

D 0 t

k2

N 5T 1 t ,

N 6

i

t

N 6D 0 t

k 1 N 6T 1 t

k3 N 6 t

i

t

k 3 N 6

k3 N 6 t

D 0 t

N 6T 1 ' t

k1 N 6 t

T 1 t

N 6 eD 0 ' t

k2 N 6 T 1 t

k 3 N 6 eD 0 t

k3 N 7 t

i

k1 N 7 t

t

i

t ,

k 3 N 6D 0 t ,
k 1

k2

N 6T 1 t ,

k 3 N 6 eD 0 t ,

k 3

D 0 t

N 7

i

t

N 7D 0 t

k 1 N 7T 1 t

T 1 t ,

N 7 i ' t

k3 N 7 t

i

t

k 3 N 7

N 7D 0 ' t

k3 N 7 t

D 0 t

N 7T 1 ' t

k1 N 7 t

T 1 t

N 7 eD 0 ' t

H2 ' t

k 3 N 5D 0 t ,
k 3 N 5 eD 0 t ,

N 6D 0 ' t

NH3 ' t

t ,

T 1 t ,

N 6 i ' t

N 7 ' t

i

k 3

k2 N 7 T 1 t

k11 CN2 H 4 t

t ,

k 3 N 7D 0 t ,
k 1

k2

N 7T 1 t ,

k 3 N 7 eD 0 t ,

N 6 eD 0 t

k7 H 2 t

i

N 7 eD 0 t

k8 H 3 t

;
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k9 H 4 t

,
k10 CN2 H 3 t

solution

NDSolve equations,

HSO3 , S2 O4 , SO2 ,
0T 1

,

0 e

i

, T 1, D 0,

D 0, H 1, H 1

i

0

,

0

i

,

0D 0

,

, H 1 D 0 , H 1T 1 ,

H 1 eD 0 , H 2, H 2 i , H 2 D 0 , H 2 T 1 , H 2 eD 0 ,
H 3, H 3

i

, H 3D 0 , H 3 T 1, H 3 e D 0 , H 4,

H 4 i, H 4D 0, N 3, N 3

i

, N 3D 0, N 3T 1 ,

N 3 eD 0 , N 3 4, N 3 4 i , N 3 4D 0, N 3 4T 1,
N 3 4 eD 0 , N 4 , N 4 i , N 4 D 0 , N 4T 1 , N 4 eD 0 ,
N 5, N 5

i

, N 5D 0 , N 5 T 1, N 5 e D 0 , N 6,

N 6 i , N 6D 0, N 6T 1 , N 6 eD 0, N 7, N 7 i ,
N 7 D 0 , N 7 T 1 , N 7 e D 0 , NH3 , H2 , t, 0, tmax ,
AccuracyGoal 12, PrecisionGoal 12,
InterpolationPrecision

10, MaxSteps

5000 ;

B.2. Pre-steady State Kinetics
Having loaded all the previous functions into your current Mathematica session by
pressing Shift - Enter in each of the cells where they are found, you are equipped to run
basic kinetic simulations. Recall the order of the input variables for the simulation
function:

simulation
.

0_,

0_,

active_, DT0_, PN2_, PH2_, tmax_

Here's an example of a basic simulation of the classical model for 50 M Kp1, 100 M
Kp2, and 10 mM DT, under 1.0 atm of nitrogen, 0.0 atm hydrogen, and 0.0005 atm
acetylene:

constants 1
simulation 50 10 6 , 100 10 6 , 0.45, 10 10 3 , 1.0, 0.0,
10
Now any of the 128 chemical species solved by the simulation function can be graphed
for time scales up to tmax chosen above. For example, here is a plot of natural product
evolution:
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Plot
Evaluate
106

NH3 t , H2 t
axis units of

multiplying

by this factor makes the y

M, or nmol for a 1 mL assay vial

solution , t, 0.0, 5 , PlotRange
"time

FrameLabel

All, Frame

s", " Product

M"

.

True,

;
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M

125

Product

150

100

Figure B-1. Presteady state
kinetics.
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Determining the total output of species from both natural evolution and quenching is only
slightly more complicated. The following cell defines functions for product formation
from various quench sources:
H2 AcidQuench t_ :
H 2 t
H 3 t
2

H 4 t

H 2

t

i

H 3

t

i

H 4

H 2D 0 t
H 3D 0 t
t

i

H 2T 1 t

H 2 eD 0 t

H 3T 1 t

H 4D 0 t

H 3 eD 0 t

;

NH3 AcidQuench t_ :
2

N 5 t
N 6 t
N 7 t

N 5

i

N 6
N 7

i

t
i

N 5D 0 t
t

t

N 5T 1 t

N 6D 0 t
N 7D 0 t

N 5 eD 0 t

N 6T 1 t

N 7T 1 t

N 6 eD 0 t

N 7 eD 0 t

;

N2 H4 AcidQuench t_ :
N 3 4 t

N 3 4

i

t

N 3 4D 0 t

N 3 4T 1 t

N 3 4 eD 0 t
N 4 t

N 4

i

t

N 4D 0 t
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N 4T 1 t

N 4 eD 0 t

;

B.3. Steady State Kinetics
The examples given so far are for pre-steady state kinetics. The steady-state case is a
composite of several pre-steady state simulations. In the following example, the activity
of ammonia production is determined as a function of the [Kp2]:[Kp1] ratio at constant
[Kp1] = 1 M.
constants 1
THIS CELL RESETS THE DATA FOR THE FOLLOWING DATA LISTS
hydrogen
;
ethylene
;
ammonia
;
totalepairflux
;
;
atp2e
Total H2 t_ :

H2 t

simulation 1.4 40
0.0, 0.0, 10

H2 AcidQuench t ;

10 6 , 4 40

10 6 , 0.45, 10 10 3 ,

kp2 1;
mocontent 1.4;
denom 20;
numer 1;
For q 1, q 20, q

1,

simulation mocontent

numer q
denom

kp2

0.0, 0.0, 20 ;
hydrogen Append hydrogen, N Flatten

10 6 , kp2

10 6 , 0.45, 10 10 3 ,

numer q
, Total H2 ' 20 6 107 . solution
denom

denom 2;
numer 1;
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;

For q 3, q 8, q

1,

simulation mocontent

numer q
denom

kp2

0.0, 0.0, 20 ;
hydrogen Append hydrogen, N Flatten

10 6 , kp2

10 6 , 0.45, 10 10 3 ,

numer q
, Total H2 ' 20 6 107 . solution
denom

Flatten hydrogen ;
Export "kp2 spec actNEW.dat", hydrogen ;

nmol min

35

Activity

Show ListPlot hydrogen, PlotJoined True,
DisplayFunction Identity ,
True,
DisplayFunction $DisplayFunction, Frame
FrameLabel
" Kp2 : Kp1 ", "Activity
nmol min "

20

;

Figure B-2.
Steady-state
kinetics.
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Unless the data lists for these parameters are reset by pressing Shift - Enter in the reset
cell, values obtained under different protein ratios are simply appended onto alreadydetermined values.
The utility of this approach is that it allows greater flexibility in determining how many
data points are simulated for certain values of the independent variable to cut down
considerably on simulation time.
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;

B.4. Data Analysis

B.4.1. Importing Data
Simulations are most useful if compared to actual data. Mathematica easily imports and
exports text or data files for this purpose.
For example, data from an Excel file was saved as a text file in C:/Program
Files/Mathematica/4.0. The following cell imports the data in "Table" format so there are
recognizable x and y values.
data

Import "excel data.txt", "Table"

0, 0 , 0.043353 , 0.714217 , 0.104479 , 0.353978 ,
0.159111 , 5.24023 , 0.203327 , 6.19976 ,
0.308932 , 11.3866 , 0.5031 , 20.7862 ,
0.70761 , 32.8018 , 1.00438 , 54.2713 , 1.99958 , 111.415

For those who don't have this particular text file, the following cell loads in this same
data and performs a simulation under parameters that should approximate the data. The
data and simulation are then graphed together.
data
0, 0 , 0.04335303`, 0.7142165` , 0.1044789`, 0.3539775` ,
0.159111`, 5.240233` , 0.2033272`, 6.199758` ,
0.3089319`, 11.38656` , 0.5031004`, 20.78617` ,
0.7076096`, 32.80179` , 1.00438`, 54.27129` ,
1.999582`, 111.4148` ;
constants 1
simulation 34 10 6 , 133 10 6 , 0.45, 10 10 3 , 0.0, 0.0, 2
Show
Plot
Evaluate
H2 t , H2 AcidQuench t , H2 t

H2 AcidQuench t

solution, t, 0, 2 , DisplayFunction

Identity

ListPlot data, DisplayFunction Identity ,
DisplayFunction $DisplayFunction, Frame
True,
FrameLabel

"time

s", " Product
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M"

;

,

10 ^6 .

Figure B-3. Data
vs. simulation.
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At this point it may be useful to eyeball the effects of varying starting protein
concentrations.

B.4.2. Exporting Data
A data-simulation comparison is easily performed in spreadsheet format as well by
exporting simulated data. The following cell gives an example of this.
exportsim
Table
Flatten
i 10 6, H2 i , H2 AcidQuench i , H2 i
106 . solution , i, 0, 2, 0.1

H2 AcidQuench i

;

Export "sim.dat", exportsim ;
The file sim .dat is saved in the
C: Program Files Mathematica 4.0 folder by default .
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B.5. A Curve Fitting Program
(A simple and less rigorous alternative to the Nelder-Mead Simplex)
At the preliminary stages of modeling the simulated parameters to match the data, you
will find it most efficient to do data-simulation comparisons directly in Mathematica.
Still, this method is only marginally useful with only the eyeballing method of fitting data
mentioned above. The following cells show how a more rigorous curve fit can be
performed for the same data loaded in previously.
We will attempt to fit the data to total H2 evolution, from both natural and quench
sources. The curve-fitting program is set up to solve a single simulated function to the
data, so we define a single function in terms of two others that have been defined
previously:
Total H2 t_ :

H2 t

H2 AcidQuench t ;

We have found it useful to define two procedural functions to be used to fit the data. The
resetfit function below requires input of initial search parameters (x1 and x2, which can
be any two of the input parameters for the simulation function) for a good fit. The
curvefit function then takes the parameters from the resetfit function, and requires
almost the same input that the simulation function would require.
resetfit x1min_, x1max_, x2min_, x2max_ :
fitlist
;
trackerlist
0 ;
x1n x1min;
x1x x1max;
x2n x2min;
x2x x2max;
x1x x1n
dx1
;
resolutionx1
x2x x2n
dx2
;
resolutionx2

curvefit 0_, 0_,
simvariable_ :
For num 1, num
Do simulation

active_, DT0_, PN2_, PH2_, tmax_,

iterations, num ,
0, 0, active, DT0, PN2, PH2, tmax ;
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simtable
;
independentvar data All, 1 ;
For p 1, p Length independentvar ,
p , independentvarval independentvar p ;
simtable Append simtable,
simvariable independentvarval 106 . solution ;
Flatten simtable data All, 2
^ 2;
differencesquared
sumsquaresofdiff Apply Plus, differencesquared ;
fitlist Append fitlist, x1, x2, sumsquaresofdiff
,
x1, x1n, x1x, dx1 , x2, x2n, x2x, dx2 ;
mindiff Min fitlist All, 3
;
1
1 ;
location Position fitlist, mindiff
var1 fitlist location, 1 ;
var2 fitlist location, 2 ;
x1n var1 dx1;
x1x var1 dx1;
x2n var2 dx2;
x2x var2 dx2;
x1x x1n
dx1
;
resolutionx1
x2x x2n
dx2
;
resolutionx2
trackerlist Flatten Append trackerlist, mindiff ;
If And Abs trackerlist
2
trackerlist
1
precision, trackerlist
2
trackerlist
1
0 ,
Interrupt

;

Print N var1, var2, mindiff
Print num 1 ;

;

Print trackerlist ;

Usually from eyeballing the goodness of fit from seeing the effects of changing the
parameters of the simulation function, you should have some idea of the minimum and
maximum expected values for each fit parameter to give the resetfit function. In this
example, the given concentrations of Kp1 and Kp2 are 34 and 133 M, respectively. For
the sake of argument, let's say that eyeballing gives you an idea that the best fit will not be
greater than 20% different from these given concentrations. For 34 M, we then have a
range of 27.2-40.8 M, and for 133 M, we have a range of values of 106.4-159.6 M:
resetfit 27.2 10 6 , 40.8 10 6 , 106.4 10 6 , 159.6 10 6

With the initial parameters of the fit loaded in, all we need to do is call up the fitting
function. Remember the order of the input for this function:
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curvefit[ 0_, 0_, active_,DT0_,PN2_,PH2_,tmax_,simvariable_].
The first several parameters are the same as those for the simulation function, and the
last one is specific to the curvefit function.
You specify which of the curvefit function parameters are going to vary (from among
the species also assigned to the simulation function) by typing in "x1" for your first
choice, and "x2" for your second. All the others are kept constant according to the values
you input.
The simvariable parameter specifies which function is going to be fit to the data. In
our case, we defined the function Total H2 .
The curvefit function takes these input parameters, then calculates which sum of the
squares of the differences between each simulation and the data is the smallest, and
determines its location in the two-dimensional grid to magnify that region of space for
future iterations of the function.
When the calculation is complete, the curvefit function returns: (1) the coordinates of
the best fit simulation to the data, along with the sum of the squares of the differences
between this simulation and the data; (2) the number of completed iterations for the
present operation of the curvefit function; and (3) a list of least squares sums for
successive iterations since the last time the resetfit function was called, starting with a
default value of 0. In other words, calling up the curvefit function in succession,
without calling up the resetfit function, continues the search of the best-fit simulation
from where it left off the last time the curvefit function was called, rather than starting
from scratch.
Let's see how this works. . .
iterations 1;
Tells the curvefitfunction to perform
at least one fit
when iterations
1 over the
range of values for each parameter
x1 and x2
given in the resetfit function .
resolutionx1 2;
Tells the curvefit function to
divide up each range of x1 and x2 into equal
divisions in number equal to the corresponding
resolution. The 2 D grid of these values then
has intersections
of x1 and x2 values where the
simulation function is performed .
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resolutionx2 2;
Specifies the minimum allowable
precision 0.1;
difference between successive iterations ,
aborting further calculation if the desired precision
is achieved .
curvefit x1, x2, 0.45, 10 10 3 , 0.0, 0.0, 2.0, Total H2
0.0000272 , 0.0001064 , 65.3057
1
0, 65.3057

As long as the resetfit function is not accessed the basic parameters of the curvefit
function can be changed for a continuation of the search for the best fit at the point last
left off. This is reflected in the last reported list, which accrues values until the resetfit
function is run. If the difference between terms in this list ever drops beneath the
precision limit, the program aborts rather than waste time on further calculation. The
exception to this is if consecutive iterations give the same coordinates for the least
squares sum, and hence the same value. In such cases, resolving power is compromised,
and the program will continue to run until the number of iterations is finished or a nonzero precision limit is achieved. Unfortunately, it is possible this could happen for
several iterations in a row, in which case too much computer time is wasted. Once you
have a feel for this basic curve-fitting program, you may consider improving it, or simply
keeping the number of iterations to a minimum for problematic simulations.
For a final example, data points from a T&L simulation are analyzed with the fitting
procedure.
data
0.01679546`, 0 , 0.02862917`, 0 , 0.04243516`, 0 ,
0.05849639`, 0.00095085` , 0.06014975`, 0.00089142` ,
0.06180312`, 0.00083199` , 0.06345649`, 0.00077256` ,
0.06512079`, 0.00969862` , 0.06677415`, 0.00963919` ,
0.06842753`, 0.00957977` , 0.07008089`, 0.00952034` ,
0.07173426`, 0.00946091` , 0.07337669`, 0.000416` ,
0.07503005`, 0.00035657` , 0.07668342`, 0.00029714` ,
0.07833679`, 0.00023771` , 0.08000109`, 0.00916377` ,
0.1777466`, 0.16739627` , 0.2126313`, 0.30093057` ,
0.2725899`, 0.65821057` , 0.3327453`, 1.17722897` ,
0.393032`, 1.80407397` , 0.4533952`, 2.49381697` ,
0.5137912`, 3.21051697` , 0.5741435`, 3.89127397` ,
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0.634441`, 4.52710397` , 0.7096736`, 5.20732697` ,
0.7847202`, 5.73479597` , 0.8446023`, 6.02917797` ,
0.904375`, 6.23370397` , 1.00373`, 6.35593597` ,
1.063218`, 6.32683997` , 1.122641`, 6.24383097` ,
1.219884`, 5.98873097` , 1.279175`, 5.79789697` ,
1.338434`, 5.58010597` , 1.397693`, 5.36231497` ,
1.45693`, 5.12655297` , 1.516199`, 4.91774697` ,
1.624895`, 4.56339097` , 1.684209`, 4.39052697` ,
1.743544`, 4.23563397` , 1.802923`, 4.11668397` ,
1.862313`, 4.00671897` , 1.921736`, 3.92370997` ,
1.981191`, 3.86765697` , 2.099705`, 3.80798797` ,
2.21917`, 3.80729697` , 2.338929`, 3.86213197` ,
2.458817`, 3.94125997` , 2.578815`, 4.04121097` ,
2.698757`, 4.13074997` , 2.818626`, 4.20640797` ,
2.938404`, 4.26471297` , 2.955033`, 4.27155797` ,
3.18762`, 4.32574097` , 3.190939`, 4.32572197` ,
3.535914`, 4.29596197` , 3.880651`, 4.22108797` ,
4.225498`, 4.16703597` , 4.570528`, 4.14768697` ,
4.915632`, 4.14222097` , 5.144607`, 4.14089597` ,
5.489693`, 4.13195897` , 5.493011`, 4.13193997` ,
5.83806`, 4.11606197` , 6.18309`, 4.09671397` ,
6.528139`, 4.08083597` , 6.873188`, 4.06495897` ,
7.218237`, 4.04907997` , 7.563267`, 4.02973197` ,
7.908316`, 4.01385497` , 8.253346`, 3.99450597` ,
8.598395`, 3.97862797` , 8.943425`, 3.95927997` ,
9.288456`, 3.93993197` , 9.633487`, 3.92058397` ,
9.975198`, 3.90125497` ;
resetfit 33.3 10 6 , 40.7 10 6 , 112.5 10 6 , 137.5 10 6
iterations 2;
resolutionx1 3;
resolutionx2 3;
precision 0.1;
curvefit x1, x2, 0.45, 0.01, 1.0, 0.0, 10.0, N2 H4 AcidQuench
0.0000390556 , 0.000134722 , 1.02842
2
0, 1.59078 , 1.02842
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simulation var1, var2, 0.45, 10 10 3 , 1.0, 0.0, 10

Show Plot Evaluate

N2 H4 AcidQuench t

t, 0, 10 , DisplayFunction

10 ^6 . solution,

Identity

,

ListPlot data, DisplayFunction Identity ,
True,
DisplayFunction $DisplayFunction, Frame
FrameLabel

"time

s", " Product

M"

;

Product

M

5

Figure B-4. Simple
curve-fitting.
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This one is more detailed than Figure 4 of the primary publication (Figure 2-10) in
showing how the program written by T&L differs from our reproduction. Notice the
excellent comparison until the 4-second mark, where the T&L simulation starts to display
a bizarre negative drift. This example is just a reminder that this effort was not entirely
successful in duplicating the T&L model. Unless the original authors of the model were
to perform the same analysis we have done, the reasons for the differences may never be
known. We can only give conjecture. But based on the graph at hand, it would seem that
their program is not as rigorous as ours in maintaining realistically mathematical
simulations. The steady state conditions of hydrazine formation should plateau and
remain constant after a time, as ours does, not drift away as the T&L model predicts.
There are as many ways to fit your data as there are kinds of simulations you can perform
with this material. Hopefully, these examples have given you an idea of some of the
approaches we have taken in our analysis of the T&L model.
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Appendix C
The Nitrogenase Prep
• BUFFERS
o Glycerol buffer: 4 M glycerol = 300 mL glycerol per L of soln; 50 mM Tris,

anaerobic but NO dithionite, pH 7-8.
o Tris buffers: breaking 50 mM Tris, anaerobic but NO dithionite, pH 7-8.
o Q-sepharose column: 25 mM Tris, 2 mM DT, pH 7.4;
 Buffer A: no-salt, ~1 L;
 Buffer B: 2 M NaCl, ~0.5 L.

• DAY 1
o Thaw cells
 In a large Erlenmeyer flask, combine 1part frozen cells with 3 parts degassed

glycerol buffer.
 Prop a tray in the sink with a rubber stopper or something so the tray doesn’t

block the drain, and run a medium stream of hot water into it. Put flask in to
melt the cells, swirling occasionally, or even vigorous shaking if necessary.
 Once re-suspended, the cells should be stirred on ice for about 20 min.
o Spin down cells
 Pour cell soln into centrifuge bottles, and spin @ 8 500 RPM (about 12 000 x g)

for 15-20 min.
 Pour off supernatant, but be careful to save the soft pellet.
o Break cells
 With N2 blowing into bottles, scrape pellet off sides and transfer to a large

Erlenmeyer flask.
 Add a pinch of DNase and RNase to this large collection.
 Working very quickly for each bottle, add a little Tris buffer and a few marbles,

blowing in N2 cap off and shake vigorously to break cells and re-suspend
residual pellet.
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 Once all the bottles are done, work quickly to add the wash and marbles to the

flask containing most of the collected pellets, then quickly add more Tris buffer
so the total volume of solution is 4 parts (buffer is 3 parts, cells are 1 part). Be
sure to hold the lid of the flask down while shaking quickly and violently.
 Add a stir bar and spin on ice for about 45 min, during which time cell breakage

continues and DNase and RNase do their thing. The color of the cell solution
should darken as foam settles out.
o Heat step
 Prepare a hot water bath in the metal bucket about 4 inches deep. It should take

about 45 min to heat up to 70oC.
 Exchange the rubber stopper on the cell extract flask for the one with the

thermometer, and transfer the flask to the hot water bath, continuing to stir the
extract solution till it reaches 56 oC, not over!
 Transfer back to ice, stirring till it reaches 15 oC (this takes about 30 min).

During this time, pull a vacuum periodically to get rid of foam, being careful
not to suck foam into tubing.
o Ultracentrifugation
 Bring flask under negative pressure into the glove box and pour into centrifuge

tubes and balance.
 Have the centrifuge rotor(s) cold (e.g. in the cold room), then spin cell extract at

27 000 RPM 0oC (under vacuum) for 30 min, and collect supernatant in glove
box into a large Erlenmeyer flask.
o Column loading
 Prepare a “bolus” dithionite (DT) solution of small volume but high [DT] to get

the large Q-sepharose column anaerobic quickly, and rinse with regular tris
buffer (25 mM, pH 7.4).
 Load crude protein onto large Q-Sepharose column overnight. FIRST

EXPOSURE TO DT HERE.
• DAY 2
o Gradient
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 Start the gradient at no salt (0% buffer B) at a flow rate of 3 mL/min. Set the

gradient to 60% of a 2-M NaCl buffer B by the time the total volume reaches
900 mL, collecting proteins anaerobically as they come off the column.
 Shethna peak off at ~25% (22-28); Av1 at ~35% (30-40); Av2 at ~40%, Flp

~45% (combined Av2-Flp peak 40-50).
o Concentrating
 While the large column is running, get the smaller two anaerobic with a bolus.
 Dilute the Av1 and Av2/Flp fractions by doubling their volumes with anaerobic

buffer. Put the fractions onto separate small Q-Sepharose columns. Once the
fractions are on the columns, rinse with enough buffer so that all the protein is
stuck to the column, not just traveling down to a vacancy in the beads (the
bottom of the protein). This takes about 15 min of wash.
 Back the small columns off with 1 M NaCl buffer and collect concentrated

component solutions for Dr Watt to finish the purification process. (Each
component is concentrated further. Av1 is then crystallized, and Av2 and Flp
are separated on the large size-exclusion column.)
 Concentrators.

• On Day 1 break cell batch A. On Day 2 run batch A on the column and break batch B.
Day 3 run batch B on the column…
• A good result for an elution profile shows good separation between the MoFe protein
and the Fe protein:

Figure C-1. Nitrogenase prep elution profile.
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